data_2mgs_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mgs _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.82999999999999996 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.85999999999999999 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76000000000000001 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.68000000000000005 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.68000000000000005 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.5 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.46999999999999997 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46000000000000002 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.58999999999999997 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.59999999999999998 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.64000000000000001 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.62 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.79000000000000004 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.68999999999999995 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.70999999999999996 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.76000000000000001 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.66000000000000003 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.76000000000000001 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.23 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.63 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.72999999999999998 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 37.1 t30 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.95999999999999996 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.91000000000000003 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.4099999999999999 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.76000000000000001 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.89000000000000001 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.71999999999999997 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.27 111.206 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66000000000000003 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.87 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.72999999999999998 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.70999999999999996 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 111.048 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.45 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 1.1100000000000001 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.76000000000000001 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.92000000000000004 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.60999999999999999 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.66000000000000003 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.84999999999999998 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.3700000000000001 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.0800000000000001 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.72999999999999998 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.29 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.76000000000000001 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.54000000000000004 109.778 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.48999999999999999 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.53000000000000003 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67000000000000004 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.85999999999999999 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.3500000000000001 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.98999999999999999 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.3200000000000001 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.26 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 1.03 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.8899999999999999 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.3400000000000001 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.92000000000000004 111.118 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.0700000000000001 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.6100000000000001 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.74 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.3700000000000001 112.058 -179.357 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.81000000000000005 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.55 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.85999999999999999 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.67000000000000004 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.69999999999999996 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.51000000000000001 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.47999999999999998 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.46999999999999997 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.59999999999999998 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.59999999999999998 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.62 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.421 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.58999999999999997 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.76000000000000001 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64000000000000001 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.66000000000000003 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.69999999999999996 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.60999999999999999 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.70999999999999996 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 1.05 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.65000000000000002 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 1.03 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.88 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.403 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.22 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.75 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 1.03 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.67000000000000004 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.25 111.423 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.84999999999999998 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.70999999999999996 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.29 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.98999999999999999 111.129 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.80000000000000004 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.408 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.67000000000000004 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.80000000000000004 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.57999999999999996 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.87 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.81999999999999995 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.4299999999999999 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 1.03 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.1399999999999999 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.78000000000000003 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.54000000000000004 109.749 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.47999999999999998 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.53000000000000003 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.408 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.82999999999999996 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.3999999999999999 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.96999999999999997 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.27 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.23 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 1.04 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.8700000000000001 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.4099999999999999 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.98999999999999999 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.1200000000000001 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.5900000000000001 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.74 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.47 111.39 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.82999999999999996 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.85999999999999999 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76000000000000001 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.68000000000000005 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.68000000000000005 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.5 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.46999999999999997 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46000000000000002 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.58999999999999997 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.59999999999999998 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.626 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.64000000000000001 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.62 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.79000000000000004 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.68999999999999995 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.70999999999999996 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.76000000000000001 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.66000000000000003 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.76000000000000001 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.23 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.63 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.72999999999999998 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.95999999999999996 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.91000000000000003 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 53.2 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.4099999999999999 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.76000000000000001 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.89000000000000001 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.71999999999999997 111.311 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66000000000000003 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.87 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.70999999999999996 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.0700000000000001 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.45 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 1.1100000000000001 110.635 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79000000000000004 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.76000000000000001 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.92000000000000004 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.60999999999999999 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.66000000000000003 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.84999999999999998 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.3700000000000001 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.0800000000000001 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.72999999999999998 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.29 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.76000000000000001 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.54000000000000004 109.847 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.48999999999999999 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.53000000000000003 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.626 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67000000000000004 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.85999999999999999 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.3500000000000001 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.98999999999999999 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.3200000000000001 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.26 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 1.03 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.8899999999999999 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.3400000000000001 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.92000000000000004 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.0700000000000001 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.6100000000000001 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.74 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.3700000000000001 112.609 -178.703 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.81000000000000005 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.85999999999999999 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77000000000000002 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.67000000000000004 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.69999999999999996 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.51000000000000001 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.47999999999999998 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.631 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.46999999999999997 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.59999999999999998 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.59999999999999998 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.62 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.424 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.58999999999999997 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.76000000000000001 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64000000000000001 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.66000000000000003 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.69999999999999996 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.60999999999999999 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.70999999999999996 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 1.05 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.65000000000000002 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.69999999999999996 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 1.03 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.88 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.22 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.75 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 1.03 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.67000000000000004 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.25 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.84999999999999998 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.70999999999999996 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.98999999999999999 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.80000000000000004 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.67000000000000004 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.631 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.80000000000000004 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.57999999999999996 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.87 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.81999999999999995 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 1.03 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.68999999999999995 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.1399999999999999 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.78000000000000003 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.54000000000000004 109.734 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.47999999999999998 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.53000000000000003 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.82999999999999996 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.3999999999999999 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.96999999999999997 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.27 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.23 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 1.04 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.8700000000000001 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.4099999999999999 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.98999999999999999 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.1200000000000001 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.5900000000000001 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.74 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.47 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.82999999999999996 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.85999999999999999 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76000000000000001 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.68000000000000005 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.68000000000000005 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.5 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.46999999999999997 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46000000000000002 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.58999999999999997 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.59999999999999998 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.604 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.64000000000000001 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.428 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.62 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.79000000000000004 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.68999999999999995 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.70999999999999996 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.76000000000000001 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.66000000000000003 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.76000000000000001 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.23 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.63 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.72999999999999998 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.95999999999999996 110.275 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.91000000000000003 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.4099999999999999 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.76000000000000001 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.89000000000000001 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.71999999999999997 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.27 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66000000000000003 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.87 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.72999999999999998 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.70999999999999996 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.0700000000000001 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 1.1100000000000001 110.552 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79000000000000004 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 112.101 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.401 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.92000000000000004 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.60999999999999999 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.66000000000000003 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.84999999999999998 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.3700000000000001 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.0800000000000001 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.72999999999999998 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.29 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.76000000000000001 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.54000000000000004 109.822 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.48999999999999999 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.428 HD22 ' HB ' ' A' ' 19' ' ' THR . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.53000000000000003 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.604 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67000000000000004 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.85999999999999999 112.072 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.3500000000000001 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.98999999999999999 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.3200000000000001 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.619 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.26 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 1.03 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.3400000000000001 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.92000000000000004 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.0700000000000001 110.048 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.6100000000000001 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.74 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.3700000000000001 111.686 -179.507 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.81000000000000005 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.85999999999999999 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77000000000000002 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.67000000000000004 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.51000000000000001 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.47999999999999998 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.46999999999999997 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.59999999999999998 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.59999999999999998 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.62 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.58999999999999997 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.76000000000000001 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.553 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64000000000000001 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.66000000000000003 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.69999999999999996 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.60999999999999999 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.70999999999999996 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 1.05 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.65000000000000002 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 1.03 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.427 HD13 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.88 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.469 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.22 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.75 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 1.03 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.67000000000000004 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.398 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.84999999999999998 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.70999999999999996 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67000000000000004 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.29 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.98999999999999999 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.80000000000000004 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.67000000000000004 111.3 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.80000000000000004 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.57999999999999996 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.87 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.81999999999999995 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.4299999999999999 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.68999999999999995 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.1399999999999999 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.54000000000000004 109.767 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.47999999999999998 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.53000000000000003 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.648 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.3999999999999999 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.96999999999999997 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.27 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.23 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 1.04 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.8700000000000001 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.4099999999999999 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.41 ' O ' HG21 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.98999999999999999 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.481 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.1200000000000001 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.5900000000000001 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.74 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt . . . . . 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.47 111.151 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.82999999999999996 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.85999999999999999 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76000000000000001 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.68000000000000005 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.68000000000000005 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.5 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.46999999999999997 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG11 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46000000000000002 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.58999999999999997 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.616 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.64000000000000001 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.62 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.79000000000000004 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.68999999999999995 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.70999999999999996 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.76000000000000001 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.66000000000000003 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.76000000000000001 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.23 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.63 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.72999999999999998 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.95999999999999996 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.91000000000000003 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.4099999999999999 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.76000000000000001 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.89000000000000001 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.71999999999999997 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.27 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66000000000000003 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.87 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.72999999999999998 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.70999999999999996 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.45 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 1.1100000000000001 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79000000000000004 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 111.962 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.586 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.92000000000000004 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.60999999999999999 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.66000000000000003 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.84999999999999998 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.3700000000000001 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.0800000000000001 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.72999999999999998 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.29 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.76000000000000001 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.54000000000000004 109.766 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.48999999999999999 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.53000000000000003 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.616 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67000000000000004 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.85999999999999999 113.216 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.3500000000000001 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.98999999999999999 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.3200000000000001 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.26 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 1.03 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.8899999999999999 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.3400000000000001 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.92000000000000004 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.0700000000000001 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.6100000000000001 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.74 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.3700000000000001 112.057 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.81000000000000005 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.85999999999999999 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77000000000000002 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.67000000000000004 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.69999999999999996 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.51000000000000001 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.47999999999999998 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.403 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.46999999999999997 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.59999999999999998 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.62 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.58999999999999997 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.495 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.76000000000000001 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64000000000000001 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.66000000000000003 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.69999999999999996 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.60999999999999999 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.70999999999999996 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 1.05 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.65000000000000002 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.69999999999999996 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 29.7 t30 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 1.03 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.88 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.22 110.878 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.75 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 1.03 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.251 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.25 111.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.84999999999999998 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.70999999999999996 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67000000000000004 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.98999999999999999 110.351 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.80000000000000004 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.67000000000000004 112.285 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.403 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.80000000000000004 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.57999999999999996 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.87 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.81999999999999995 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.4299999999999999 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 1.03 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.68999999999999995 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.1399999999999999 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.78000000000000003 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.54000000000000004 109.758 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.47999999999999998 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.53000000000000003 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.639 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.82999999999999996 112.175 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.3999999999999999 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.96999999999999997 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.27 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.23 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 1.04 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.8700000000000001 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.4099999999999999 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.98999999999999999 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.462 HG12 ' O ' ' B' ' 63' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.1200000000000001 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.5900000000000001 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.74 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.47 112.083 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.82999999999999996 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.85999999999999999 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.68000000000000005 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.68000000000000005 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.5 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.46999999999999997 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.58999999999999997 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.59999999999999998 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.64000000000000001 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.62 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.79000000000000004 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.68999999999999995 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.70999999999999996 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.76000000000000001 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.66000000000000003 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.76000000000000001 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.23 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.63 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.72999999999999998 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.95999999999999996 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.91000000000000003 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.4099999999999999 110.581 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.89000000000000001 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.27 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66000000000000003 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.87 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.72999999999999998 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.70999999999999996 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.0700000000000001 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.45 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.1100000000000001 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.76000000000000001 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.92000000000000004 110.859 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.60999999999999999 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.66000000000000003 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.84999999999999998 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.3700000000000001 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.0800000000000001 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.72999999999999998 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.29 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.76000000000000001 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.54000000000000004 109.808 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.53000000000000003 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.526 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67000000000000004 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.85999999999999999 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.3500000000000001 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.98999999999999999 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.3200000000000001 113.339 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.26 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.575 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 1.03 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.8899999999999999 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.3400000000000001 113.076 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.92000000000000004 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.0700000000000001 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.6100000000000001 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.74 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.3700000000000001 111.355 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.81000000000000005 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.85999999999999999 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.67000000000000004 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.69999999999999996 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.51000000000000001 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.47999999999999998 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.423 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.46999999999999997 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.59999999999999998 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.59999999999999998 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.62 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.58999999999999997 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.76000000000000001 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64000000000000001 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.66000000000000003 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.69999999999999996 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.60999999999999999 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.70999999999999996 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 1.05 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.65000000000000002 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.69999999999999996 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 1.03 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.88 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.22 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.75 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 1.03 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.67000000000000004 111.762 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.25 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.84999999999999998 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.70999999999999996 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67000000000000004 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.29 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.98999999999999999 110.983 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.80000000000000004 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.67000000000000004 111.957 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.423 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.80000000000000004 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.57999999999999996 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.87 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.81999999999999995 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.4299999999999999 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 1.03 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.68999999999999995 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.1399999999999999 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.78000000000000003 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.54000000000000004 109.848 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.47999999999999998 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.53000000000000003 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 111.886 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.3999999999999999 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.96999999999999997 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.27 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.23 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.509 HD11 ' H ' ' B' ' 57' ' ' ASP . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 1.04 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.8700000000000001 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.4099999999999999 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.98999999999999999 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.1200000000000001 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.5900000000000001 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.74 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.47 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.82999999999999996 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.85999999999999999 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76000000000000001 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.68000000000000005 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.68000000000000005 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.5 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.46999999999999997 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46000000000000002 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.58999999999999997 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.59999999999999998 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.64000000000000001 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.62 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.79000000000000004 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.68999999999999995 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.70999999999999996 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.76000000000000001 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.66000000000000003 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.76000000000000001 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.23 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.63 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.72999999999999998 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.95999999999999996 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.91000000000000003 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.76000000000000001 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.89000000000000001 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.71999999999999997 111.618 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66000000000000003 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.87 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.72999999999999998 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.70999999999999996 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.0700000000000001 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.45 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 111.118 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79000000000000004 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.76000000000000001 112.119 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.92000000000000004 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.60999999999999999 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.66000000000000003 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.84999999999999998 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.0800000000000001 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.72999999999999998 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.29 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.76000000000000001 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.84 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.48999999999999999 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.53000000000000003 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.631 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67000000000000004 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.85999999999999999 112.471 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.98999999999999999 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.3200000000000001 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.26 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 1.03 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.8899999999999999 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.3400000000000001 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.92000000000000004 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.0700000000000001 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.6100000000000001 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.74 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.3700000000000001 111.19 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.81000000000000005 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.85999999999999999 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77000000000000002 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.67000000000000004 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.69999999999999996 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.51000000000000001 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.47999999999999998 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.51 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.46999999999999997 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.59999999999999998 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.585 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.62 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.58999999999999997 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.76000000000000001 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64000000000000001 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.66000000000000003 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.69999999999999996 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.60999999999999999 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.70999999999999996 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.65000000000000002 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 10.1 t30 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 1.03 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.88 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.22 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.75 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 1.03 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.67000000000000004 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.25 110.965 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.84999999999999998 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.70999999999999996 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67000000000000004 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.29 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.98999999999999999 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.478 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.80000000000000004 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.67000000000000004 112.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.51 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.80000000000000004 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.87 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.81999999999999995 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.4299999999999999 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 1.03 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.78000000000000003 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.54000000000000004 109.834 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.47999999999999998 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.53000000000000003 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.585 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.82999999999999996 112.782 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.3999999999999999 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.96999999999999997 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.27 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.23 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.504 ' O ' HG22 ' B' ' 67' ' ' ILE . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 1.04 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.8700000000000001 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.4099999999999999 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.98999999999999999 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.1200000000000001 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.5900000000000001 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.74 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.47 112.059 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.82999999999999996 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.85999999999999999 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.68000000000000005 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.68000000000000005 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.5 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.46999999999999997 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.502 ' SG ' HG11 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.58999999999999997 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.59999999999999998 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.64000000000000001 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.424 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.62 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.79000000000000004 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.68999999999999995 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.70999999999999996 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.76000000000000001 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.66000000000000003 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.76000000000000001 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.23 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.63 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.72999999999999998 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.95999999999999996 110.568 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.91000000000000003 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.4099999999999999 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.76000000000000001 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.89000000000000001 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.27 111.305 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66000000000000003 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.87 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.72999999999999998 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.70999999999999996 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.0700000000000001 110.653 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.45 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79000000000000004 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.76000000000000001 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.502 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.92000000000000004 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.60999999999999999 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.66000000000000003 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.84999999999999998 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.3700000000000001 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.0800000000000001 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.72999999999999998 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.29 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.76000000000000001 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.54000000000000004 109.786 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.48999999999999999 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.539 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.53000000000000003 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67000000000000004 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.85999999999999999 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.3500000000000001 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.98999999999999999 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.3200000000000001 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.26 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 1.03 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.8899999999999999 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.3400000000000001 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.92000000000000004 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.0700000000000001 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.6100000000000001 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.74 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.3700000000000001 111.213 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.81000000000000005 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.85999999999999999 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77000000000000002 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.67000000000000004 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.69999999999999996 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.51000000000000001 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.47999999999999998 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.46999999999999997 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.59999999999999998 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.58999999999999997 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.76000000000000001 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64000000000000001 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.66000000000000003 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.69999999999999996 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.60999999999999999 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.70999999999999996 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 1.05 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.65000000000000002 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.69999999999999996 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 1.03 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.88 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.22 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.75 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 1.03 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.67000000000000004 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.25 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.84999999999999998 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.70999999999999996 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67000000000000004 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.29 110.552 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.98999999999999999 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.80000000000000004 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.67000000000000004 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.80000000000000004 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.57999999999999996 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.87 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.81999999999999995 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.4299999999999999 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.68999999999999995 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.1399999999999999 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.78000000000000003 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.54000000000000004 109.742 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.47999999999999998 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.516 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.53000000000000003 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.573 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.41 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.82999999999999996 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.3999999999999999 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.62 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.96999999999999997 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.27 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.62 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.23 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 1.04 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.471 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.8700000000000001 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.4099999999999999 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.98999999999999999 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 63' ' ' LEU . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.1200000000000001 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.5900000000000001 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.74 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.47 111.364 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.82999999999999996 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.85999999999999999 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76000000000000001 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.68000000000000005 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.68000000000000005 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.5 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.46999999999999997 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46000000000000002 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.58999999999999997 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.59999999999999998 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.64000000000000001 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.62 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.79000000000000004 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.68999999999999995 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.70999999999999996 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.76000000000000001 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.66000000000000003 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.76000000000000001 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.23 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.63 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.72999999999999998 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.95999999999999996 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.91000000000000003 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.4099999999999999 110.447 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.76000000000000001 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.71999999999999997 111.944 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.27 111.425 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66000000000000003 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.87 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.72999999999999998 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.70999999999999996 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.0700000000000001 110.511 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.45 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 1.1100000000000001 110.767 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79000000000000004 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 44' ' ' VAL . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.76000000000000001 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 110.857 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.60999999999999999 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.66000000000000003 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.84999999999999998 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.3700000000000001 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.0800000000000001 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.72999999999999998 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.29 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.76000000000000001 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.54000000000000004 109.755 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.48999999999999999 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.429 HD22 ' HB ' ' A' ' 19' ' ' THR . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.53000000000000003 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67000000000000004 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.85999999999999999 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.3500000000000001 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.98999999999999999 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.3200000000000001 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.26 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 1.03 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.8899999999999999 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.3400000000000001 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.92000000000000004 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.62 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.0700000000000001 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.6100000000000001 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.74 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.3700000000000001 111.718 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.81000000000000005 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.85999999999999999 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77000000000000002 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.67000000000000004 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.69999999999999996 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.51000000000000001 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.47999999999999998 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.59999999999999998 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.59999999999999998 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.62 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.423 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.58999999999999997 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.76000000000000001 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64000000000000001 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.66000000000000003 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.69999999999999996 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.60999999999999999 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.70999999999999996 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 1.05 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.65000000000000002 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.69999999999999996 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 1.03 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.88 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.22 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.75 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 1.03 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.67000000000000004 111.262 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.25 110.982 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.84999999999999998 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.70999999999999996 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67000000000000004 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.29 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.98999999999999999 110.29 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.80000000000000004 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.67000000000000004 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.80000000000000004 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.57999999999999996 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.87 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.81999999999999995 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 1.03 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.68999999999999995 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.1399999999999999 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.78000000000000003 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.54000000000000004 109.762 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.47999999999999998 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.53000000000000003 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.82999999999999996 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.3999999999999999 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.629 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.96999999999999997 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.27 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.629 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.23 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 1.04 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.8700000000000001 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' B' ' 61' ' ' PRO . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.4099999999999999 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.98999999999999999 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.1200000000000001 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.5900000000000001 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.74 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.47 112.202 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.82999999999999996 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.85999999999999999 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76000000000000001 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.68000000000000005 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.68000000000000005 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.5 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 38' ' ' GLN . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.46999999999999997 111.463 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46000000000000002 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.58999999999999997 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.59999999999999998 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.64000000000000001 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.62 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.79000000000000004 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.68999999999999995 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.70999999999999996 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.576 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.76000000000000001 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.66000000000000003 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.76000000000000001 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.23 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.63 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.72999999999999998 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.95999999999999996 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.4099999999999999 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.76000000000000001 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.89000000000000001 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.71999999999999997 111.34 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.27 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66000000000000003 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.87 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 14' ' ' VAL . 19.9 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.72999999999999998 112.964 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.70999999999999996 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.0700000000000001 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.45 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 111.253 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79000000000000004 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.76000000000000001 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.92000000000000004 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.60999999999999999 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.66000000000000003 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.84999999999999998 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.3700000000000001 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.0800000000000001 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.72999999999999998 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.29 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.54000000000000004 109.841 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.48999999999999999 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.543 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.53000000000000003 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67000000000000004 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.85999999999999999 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.3500000000000001 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.98999999999999999 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.3200000000000001 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.26 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 1.03 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.8899999999999999 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.3400000000000001 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.92000000000000004 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 63' ' ' LEU . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.0700000000000001 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.6100000000000001 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.74 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.3700000000000001 111.769 -179.652 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.81000000000000005 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.85999999999999999 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77000000000000002 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.67000000000000004 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.69999999999999996 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.51000000000000001 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.47999999999999998 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.46999999999999997 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.59999999999999998 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.59999999999999998 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.62 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.422 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.58999999999999997 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.76000000000000001 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.66000000000000003 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.69999999999999996 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.60999999999999999 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.70999999999999996 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 1.05 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.65000000000000002 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.69999999999999996 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 1.03 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.88 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.22 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.75 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 1.03 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.67000000000000004 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.25 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.84999999999999998 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.70999999999999996 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67000000000000004 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.29 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.98999999999999999 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.421 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.80000000000000004 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.67000000000000004 112.243 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.447 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.80000000000000004 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.57999999999999996 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.87 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.81999999999999995 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.4299999999999999 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 1.03 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.68999999999999995 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.1399999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.78000000000000003 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.54000000000000004 109.713 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.47999999999999998 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.53000000000000003 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.82999999999999996 112.832 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.3999999999999999 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.96999999999999997 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.27 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.23 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 1.04 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.8700000000000001 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.4099999999999999 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.98999999999999999 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.1200000000000001 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.5900000000000001 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.74 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt . . . . . 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.47 111.606 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.82999999999999996 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.85999999999999999 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76000000000000001 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.68000000000000005 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.68000000000000005 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.5 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.46999999999999997 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46000000000000002 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.58999999999999997 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.59999999999999998 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.64000000000000001 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.62 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.79000000000000004 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.68999999999999995 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.70999999999999996 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.76000000000000001 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.66000000000000003 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.76000000000000001 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.23 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.63 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.72999999999999998 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.95999999999999996 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.4099999999999999 110.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.76000000000000001 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.89000000000000001 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.71999999999999997 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.27 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66000000000000003 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.87 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.72999999999999998 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.70999999999999996 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.45 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 1.1100000000000001 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.76000000000000001 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.92000000000000004 110.798 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.60999999999999999 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.66000000000000003 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.84999999999999998 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.3700000000000001 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.0800000000000001 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.29 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.76000000000000001 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.54000000000000004 109.917 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.477 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.53000000000000003 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67000000000000004 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.85999999999999999 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.3500000000000001 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.98999999999999999 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.3200000000000001 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.26 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 1.03 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.8899999999999999 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.3400000000000001 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.92000000000000004 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.0700000000000001 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.6100000000000001 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.74 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt . . . . . 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.3700000000000001 111.169 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.81000000000000005 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.85999999999999999 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77000000000000002 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.67000000000000004 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.69999999999999996 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.51000000000000001 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.47999999999999998 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.46999999999999997 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.59999999999999998 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.59999999999999998 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.62 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.58999999999999997 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.76000000000000001 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.66000000000000003 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.69999999999999996 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.60999999999999999 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.70999999999999996 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 1.05 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.69999999999999996 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 1.03 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.88 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.22 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.75 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 1.03 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.67000000000000004 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.25 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.84999999999999998 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.70999999999999996 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67000000000000004 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.29 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.98999999999999999 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.67000000000000004 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.80000000000000004 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.57999999999999996 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.87 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.81999999999999995 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.4299999999999999 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 1.03 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.1399999999999999 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.78000000000000003 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.54000000000000004 109.775 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.47999999999999998 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.516 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.53000000000000003 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.82999999999999996 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.96999999999999997 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.27 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.23 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 1.04 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.8700000000000001 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.4099999999999999 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.98999999999999999 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.5900000000000001 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.74 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.47 112.187 -179.371 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.82999999999999996 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.85999999999999999 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76000000000000001 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.68000000000000005 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.68000000000000005 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.5 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.46999999999999997 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46000000000000002 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.58999999999999997 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.59999999999999998 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.64000000000000001 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.62 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.79000000000000004 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.68999999999999995 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.70999999999999996 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.573 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.76000000000000001 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.66000000000000003 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.76000000000000001 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.23 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.63 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.72999999999999998 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.95999999999999996 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.91000000000000003 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.4099999999999999 110.215 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.76000000000000001 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.89000000000000001 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.71999999999999997 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.27 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66000000000000003 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.87 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.70999999999999996 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.0700000000000001 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.45 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 1.1100000000000001 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.76000000000000001 112.383 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.427 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.92000000000000004 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.60999999999999999 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.66000000000000003 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.84999999999999998 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.3700000000000001 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.0800000000000001 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.72999999999999998 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.29 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.76000000000000001 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.54000000000000004 109.809 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.48999999999999999 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.53000000000000003 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.511 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67000000000000004 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.85999999999999999 111.978 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.3500000000000001 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.98999999999999999 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.3200000000000001 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.26 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 1.03 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.8899999999999999 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.3400000000000001 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.92000000000000004 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.0700000000000001 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.6100000000000001 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.74 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.3700000000000001 111.715 -179.575 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.81000000000000005 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.85999999999999999 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77000000000000002 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.67000000000000004 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.69999999999999996 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.51000000000000001 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.47999999999999998 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.46999999999999997 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.59999999999999998 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.59999999999999998 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.62 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.422 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.58999999999999997 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.76000000000000001 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64000000000000001 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.66000000000000003 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.69999999999999996 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.60999999999999999 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.70999999999999996 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 1.05 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.65000000000000002 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 1.03 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.88 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.22 110.465 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.75 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.67000000000000004 111.031 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.25 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.84999999999999998 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.70999999999999996 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67000000000000004 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.29 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.98999999999999999 110.712 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.67000000000000004 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.80000000000000004 110.791 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.57999999999999996 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.87 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.81999999999999995 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.4299999999999999 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 1.03 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.68999999999999995 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.1399999999999999 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.78000000000000003 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.54000000000000004 109.821 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.47999999999999998 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.53000000000000003 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.441 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.82999999999999996 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.3999999999999999 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.96999999999999997 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.27 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.23 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 1.04 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.8700000000000001 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.4099999999999999 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.98999999999999999 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.1200000000000001 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.5900000000000001 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.74 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.47 111.614 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.82999999999999996 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.85999999999999999 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76000000000000001 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.68000000000000005 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.68000000000000005 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.5 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.46999999999999997 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.513 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46000000000000002 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.58999999999999997 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.59999999999999998 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.64000000000000001 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.62 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.79000000000000004 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.68999999999999995 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.70999999999999996 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.572 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.76000000000000001 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.66000000000000003 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.76000000000000001 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.23 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.63 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.72999999999999998 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.95999999999999996 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.91000000000000003 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.4099999999999999 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.76000000000000001 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.89000000000000001 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.71999999999999997 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.27 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66000000000000003 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.87 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.72999999999999998 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.70999999999999996 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.0700000000000001 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 1.1100000000000001 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79000000000000004 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.76000000000000001 112.278 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.92000000000000004 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.60999999999999999 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.66000000000000003 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.84999999999999998 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.3700000000000001 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.72999999999999998 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.29 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.76000000000000001 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.839 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.48999999999999999 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.53000000000000003 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.542 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67000000000000004 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.85999999999999999 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.3500000000000001 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.98999999999999999 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.3200000000000001 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.26 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 1.03 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.8899999999999999 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.3400000000000001 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.92000000000000004 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.0700000000000001 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.6100000000000001 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.74 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.3700000000000001 111.577 -179.599 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.81000000000000005 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.85999999999999999 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77000000000000002 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.67000000000000004 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.69999999999999996 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.47999999999999998 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.501 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.46999999999999997 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.59999999999999998 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.59999999999999998 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.586 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.62 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.41 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.58999999999999997 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.76000000000000001 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64000000000000001 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.66000000000000003 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.588 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.69999999999999996 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.60999999999999999 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.588 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.70999999999999996 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 1.05 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.65000000000000002 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.69999999999999996 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 1.03 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.22 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.75 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 1.03 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.67000000000000004 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.25 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.84999999999999998 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.70999999999999996 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.29 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.98999999999999999 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.466 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.67000000000000004 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.501 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.80000000000000004 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.57999999999999996 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.87 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.81999999999999995 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.4299999999999999 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 1.03 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.68999999999999995 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.1399999999999999 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.78000000000000003 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.54000000000000004 109.825 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.47999999999999998 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.53000000000000003 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.586 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.428 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.82999999999999996 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.3999999999999999 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.96999999999999997 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.27 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.23 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 1.04 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.8700000000000001 110.588 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.4099999999999999 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.98999999999999999 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.1200000000000001 110.111 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.5900000000000001 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.74 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.47 111.641 -179.62 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.82999999999999996 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.85999999999999999 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76000000000000001 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.68000000000000005 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.68000000000000005 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.5 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.46999999999999997 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46000000000000002 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.58999999999999997 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.64000000000000001 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.62 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.79000000000000004 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.68999999999999995 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.70999999999999996 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.575 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.76000000000000001 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.66000000000000003 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.76000000000000001 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.23 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.63 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.72999999999999998 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.95999999999999996 111.05 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.4099999999999999 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.76000000000000001 110.984 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.89000000000000001 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.71999999999999997 111.471 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.27 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66000000000000003 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.87 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.72999999999999998 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.70999999999999996 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0700000000000001 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.45 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 110.792 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.76000000000000001 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.462 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.92000000000000004 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.60999999999999999 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.66000000000000003 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.84999999999999998 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.3700000000000001 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.72999999999999998 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.29 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.76000000000000001 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.54000000000000004 109.827 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.48999999999999999 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.53000000000000003 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.563 ' N ' HD11 ' A' ' 63' ' ' LEU . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67000000000000004 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.85999999999999999 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.3500000000000001 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.628 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.98999999999999999 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.3200000000000001 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.628 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.26 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 1.03 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.8899999999999999 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.3400000000000001 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.92000000000000004 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.0700000000000001 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.6100000000000001 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.74 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.8 pt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.3700000000000001 111.623 -179.696 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.81000000000000005 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.85999999999999999 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77000000000000002 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.67000000000000004 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.69999999999999996 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.51000000000000001 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.47999999999999998 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.46999999999999997 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.59999999999999998 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.59999999999999998 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.76000000000000001 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64000000000000001 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.66000000000000003 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.69999999999999996 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.60999999999999999 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.70999999999999996 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 1.05 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.65000000000000002 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.69999999999999996 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 1.03 110.532 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.88 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.22 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.75 111.116 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 1.03 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.67000000000000004 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.25 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.84999999999999998 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.70999999999999996 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.29 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.98999999999999999 110.544 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.80000000000000004 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.67000000000000004 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.80000000000000004 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.57999999999999996 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.81999999999999995 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.4299999999999999 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 1.03 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.68999999999999995 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.1399999999999999 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.78000000000000003 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.54000000000000004 109.759 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.47999999999999998 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.53000000000000003 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.617 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.82999999999999996 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.3999999999999999 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.96999999999999997 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.27 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.23 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 1.04 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.8700000000000001 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.4099999999999999 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.98999999999999999 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.668 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.1200000000000001 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.5900000000000001 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.74 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.668 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.47 111.036 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.82999999999999996 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.85999999999999999 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76000000000000001 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.68000000000000005 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.68000000000000005 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.5 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.46999999999999997 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46000000000000002 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.58999999999999997 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.59999999999999998 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.64000000000000001 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.62 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.79000000000000004 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.68999999999999995 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.70999999999999996 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.76000000000000001 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.66000000000000003 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.76000000000000001 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.23 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.63 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.72999999999999998 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.95999999999999996 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.91000000000000003 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.4099999999999999 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.76000000000000001 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.89000000000000001 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.71999999999999997 111.683 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.27 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66000000000000003 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.87 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.72999999999999998 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.70999999999999996 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.0700000000000001 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.45 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 110.655 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79000000000000004 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.494 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.92000000000000004 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.60999999999999999 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.66000000000000003 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.84999999999999998 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.3700000000000001 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.0800000000000001 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.72999999999999998 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.29 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.76000000000000001 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.54000000000000004 109.851 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.48999999999999999 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.53000000000000003 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67000000000000004 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.85999999999999999 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.3500000000000001 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.98999999999999999 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.3200000000000001 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.26 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 1.03 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.8899999999999999 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.3400000000000001 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.92000000000000004 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.0700000000000001 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.6100000000000001 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.74 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.3700000000000001 111.868 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.81000000000000005 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.85999999999999999 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77000000000000002 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.67000000000000004 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.69999999999999996 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.51000000000000001 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.47999999999999998 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.59999999999999998 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.59999999999999998 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.62 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.423 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.58999999999999997 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.76000000000000001 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64000000000000001 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.66000000000000003 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.69999999999999996 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.60999999999999999 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.70999999999999996 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 1.05 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.65000000000000002 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.69999999999999996 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 1.03 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.88 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.22 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.75 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 1.03 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.67000000000000004 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.25 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.84999999999999998 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.70999999999999996 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67000000000000004 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.98999999999999999 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.80000000000000004 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.67000000000000004 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.80000000000000004 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.57999999999999996 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.87 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.81999999999999995 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.4299999999999999 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 1.03 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.68999999999999995 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.1399999999999999 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.54000000000000004 109.789 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.47999999999999998 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.53000000000000003 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . 0.41 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.82999999999999996 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.3999999999999999 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.96999999999999997 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.27 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.23 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.8700000000000001 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.4099999999999999 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.98999999999999999 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.1200000000000001 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.5900000000000001 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.74 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.47 111.839 -179.297 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.82999999999999996 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.85999999999999999 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76000000000000001 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.68000000000000005 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.68000000000000005 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.5 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.46999999999999997 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.619 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.58999999999999997 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.64000000000000001 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.62 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.79000000000000004 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.68999999999999995 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.70999999999999996 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.579 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.76000000000000001 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.66000000000000003 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.76000000000000001 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.23 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.63 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.72999999999999998 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.95999999999999996 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.91000000000000003 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.4099999999999999 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.76000000000000001 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.89000000000000001 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.71999999999999997 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.27 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66000000000000003 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.87 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.72999999999999998 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.70999999999999996 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.0700000000000001 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.45 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 1.1100000000000001 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79000000000000004 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.76000000000000001 112.378 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.619 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.92000000000000004 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.60999999999999999 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.66000000000000003 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.84999999999999998 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.3700000000000001 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.0800000000000001 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.72999999999999998 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.29 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.76000000000000001 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.54000000000000004 109.838 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.48999999999999999 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.53000000000000003 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.469 ' N ' HD12 ' A' ' 63' ' ' LEU . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67000000000000004 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.85999999999999999 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.3500000000000001 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.98999999999999999 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.3200000000000001 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.26 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 1.03 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.8899999999999999 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.3400000000000001 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.92000000000000004 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.0700000000000001 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.6100000000000001 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.74 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.3700000000000001 110.653 179.672 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.81000000000000005 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.548 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.85999999999999999 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77000000000000002 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.67000000000000004 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.69999999999999996 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.47999999999999998 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.46999999999999997 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.59999999999999998 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.62 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.415 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.58999999999999997 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.76000000000000001 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64000000000000001 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.66000000000000003 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.69999999999999996 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.60999999999999999 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.70999999999999996 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 1.05 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.65000000000000002 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.69999999999999996 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 8.8 t30 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 1.03 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.88 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.22 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 1.03 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.67000000000000004 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.25 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.84999999999999998 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.70999999999999996 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67000000000000004 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.29 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.98999999999999999 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.67000000000000004 111.98 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.80000000000000004 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.57999999999999996 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.87 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.81999999999999995 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 1.03 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.68999999999999995 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.1399999999999999 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.78000000000000003 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.54000000000000004 109.847 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.47999999999999998 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.503 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.53000000000000003 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.601 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.82999999999999996 112.743 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.3999999999999999 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.27 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.23 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 1.04 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.8700000000000001 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.4099999999999999 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.98999999999999999 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.1200000000000001 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.5900000000000001 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.74 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt . . . . . 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.47 111.947 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.82999999999999996 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.85999999999999999 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.68000000000000005 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.5 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.46999999999999997 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.674 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46000000000000002 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.58999999999999997 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.59999999999999998 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.636 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.64000000000000001 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.62 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.79000000000000004 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.553 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.68999999999999995 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.70999999999999996 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.76000000000000001 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.66000000000000003 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.76000000000000001 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.23 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.63 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.72999999999999998 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.95999999999999996 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.91000000000000003 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.4099999999999999 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.76000000000000001 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.89000000000000001 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.71999999999999997 111.158 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.27 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66000000000000003 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.87 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.72999999999999998 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.70999999999999996 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.0700000000000001 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 1.1100000000000001 110.936 179.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.76000000000000001 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.674 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.92000000000000004 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.60999999999999999 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.66000000000000003 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.84999999999999998 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.3700000000000001 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.0800000000000001 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.72999999999999998 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.29 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.76000000000000001 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.54000000000000004 109.833 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.48999999999999999 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.53000000000000003 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.636 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67000000000000004 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.85999999999999999 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.3500000000000001 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.98999999999999999 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.3200000000000001 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.26 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.567 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 1.03 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.8899999999999999 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.3400000000000001 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.92000000000000004 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.0700000000000001 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.6100000000000001 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.74 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 111.62 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.81000000000000005 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.85999999999999999 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.67000000000000004 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.69999999999999996 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.51000000000000001 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.47999999999999998 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.46999999999999997 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.59999999999999998 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.59999999999999998 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.62 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.58999999999999997 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.76000000000000001 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64000000000000001 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.66000000000000003 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.583 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.69999999999999996 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.60999999999999999 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.70999999999999996 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 1.05 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.65000000000000002 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 1.03 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.88 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.22 110.411 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.75 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 1.03 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.67000000000000004 111.148 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.25 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.84999999999999998 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.70999999999999996 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67000000000000004 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.29 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.98999999999999999 111.014 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.80000000000000004 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.67000000000000004 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.80000000000000004 110.699 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.57999999999999996 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.87 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.81999999999999995 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.68999999999999995 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.1399999999999999 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.78000000000000003 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.54000000000000004 109.811 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.47999999999999998 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.542 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.53000000000000003 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.576 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.82999999999999996 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.96999999999999997 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.27 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.627 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.23 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 1.04 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.8700000000000001 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.4099999999999999 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.98999999999999999 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.1200000000000001 110.226 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.5900000000000001 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.74 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.47 111.624 -179.839 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.82999999999999996 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.85999999999999999 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.68000000000000005 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.68000000000000005 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.5 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.46999999999999997 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.628 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46000000000000002 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.58999999999999997 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.59999999999999998 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.64000000000000001 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.62 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.79000000000000004 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.68999999999999995 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.70999999999999996 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.76000000000000001 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.66000000000000003 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.76000000000000001 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.23 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.63 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.72999999999999998 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.95999999999999996 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.91000000000000003 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.4099999999999999 110.196 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.76000000000000001 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.89000000000000001 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.71999999999999997 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.27 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66000000000000003 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.87 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.72999999999999998 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.70999999999999996 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.0700000000000001 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.45 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 1.1100000000000001 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.458 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.76000000000000001 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.628 HG11 ' SG ' ' A' ' 15' ' ' CYS . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.92000000000000004 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.60999999999999999 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.66000000000000003 110.466 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.84999999999999998 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.0800000000000001 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.72999999999999998 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.29 110.834 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.76000000000000001 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.54000000000000004 109.778 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.48999999999999999 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.511 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.53000000000000003 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67000000000000004 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.85999999999999999 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.3500000000000001 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.629 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.98999999999999999 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.3200000000000001 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.26 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 1.03 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.8899999999999999 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.3400000000000001 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.92000000000000004 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.0700000000000001 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.6100000000000001 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.74 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.3700000000000001 111.858 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.81000000000000005 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.85999999999999999 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77000000000000002 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.67000000000000004 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.69999999999999996 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.51000000000000001 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.47999999999999998 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.465 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.46999999999999997 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.59999999999999998 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.59999999999999998 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.62 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.58999999999999997 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . 0.498 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.76000000000000001 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64000000000000001 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.66000000000000003 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.69999999999999996 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.60999999999999999 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.70999999999999996 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 1.05 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.69999999999999996 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 1.03 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.88 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.459 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.22 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.75 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.67000000000000004 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.25 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.84999999999999998 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.70999999999999996 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.29 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.98999999999999999 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.80000000000000004 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.67000000000000004 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.465 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.80000000000000004 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.57999999999999996 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.87 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.81999999999999995 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.4299999999999999 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 1.03 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.68999999999999995 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.1399999999999999 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.54000000000000004 109.851 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.47999999999999998 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.53000000000000003 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.637 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.3999999999999999 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.96999999999999997 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.27 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.23 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 1.04 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.8700000000000001 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.4099999999999999 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.98999999999999999 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.471 HG22 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.1200000000000001 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.5900000000000001 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.74 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.47 111.994 -179.533 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.82999999999999996 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.85999999999999999 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76000000000000001 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.68000000000000005 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.68000000000000005 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.5 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.46999999999999997 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46000000000000002 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.58999999999999997 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.59999999999999998 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.64000000000000001 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.62 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.79000000000000004 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.68999999999999995 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.70999999999999996 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.76000000000000001 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.66000000000000003 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.76000000000000001 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.23 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.427 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.72999999999999998 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.95999999999999996 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.91000000000000003 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.4099999999999999 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.76000000000000001 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.89000000000000001 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.71999999999999997 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 35' ' ' ILE . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.27 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66000000000000003 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.87 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.72999999999999998 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.70999999999999996 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.0700000000000001 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.45 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 1.1100000000000001 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.517 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79000000000000004 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.76000000000000001 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.92000000000000004 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.60999999999999999 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.66000000000000003 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.84999999999999998 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.3700000000000001 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.0800000000000001 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.72999999999999998 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.29 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.76000000000000001 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.54000000000000004 109.795 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.48999999999999999 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.53000000000000003 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67000000000000004 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.85999999999999999 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.3500000000000001 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.98999999999999999 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.3200000000000001 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.26 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 1.03 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.8899999999999999 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.3400000000000001 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.92000000000000004 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.0700000000000001 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.6100000000000001 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.3700000000000001 111.907 -179.476 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.81000000000000005 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.85999999999999999 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77000000000000002 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.67000000000000004 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.69999999999999996 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.51000000000000001 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.47999999999999998 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.46999999999999997 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.59999999999999998 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.59999999999999998 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.62 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.417 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.58999999999999997 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.76000000000000001 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64000000000000001 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.66000000000000003 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.69999999999999996 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.60999999999999999 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.70999999999999996 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 1.05 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.65000000000000002 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.69999999999999996 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 t30 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 1.03 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.88 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.22 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.75 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 1.03 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.67000000000000004 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.25 111.051 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.84999999999999998 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.70999999999999996 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67000000000000004 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.29 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.98999999999999999 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.80000000000000004 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' B' ' 56' ' ' LEU . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.67000000000000004 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.80000000000000004 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.57999999999999996 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 47' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.87 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.81999999999999995 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.4299999999999999 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 1.03 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.68999999999999995 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.1399999999999999 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.78000000000000003 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.54000000000000004 109.812 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.47999999999999998 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.53000000000000003 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.82999999999999996 112.983 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.3999999999999999 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.96999999999999997 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.27 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.23 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 1.04 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.8700000000000001 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.4099999999999999 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.98999999999999999 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.1200000000000001 109.972 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.5900000000000001 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.74 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.47 111.452 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.82999999999999996 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.85999999999999999 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76000000000000001 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.68000000000000005 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.68000000000000005 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.5 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.46999999999999997 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46000000000000002 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.58999999999999997 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.64000000000000001 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 18' ' ' THR . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.62 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.79000000000000004 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.558 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.68999999999999995 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.70999999999999996 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.76000000000000001 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HB3' HG21 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.66000000000000003 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.76000000000000001 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.23 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.63 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.72999999999999998 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 10.3 t30 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.95999999999999996 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.91000000000000003 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.4099999999999999 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.76000000000000001 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.89000000000000001 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.71999999999999997 111.022 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.27 110.996 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66000000000000003 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.87 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.70999999999999996 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 110.49 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.45 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 1.1100000000000001 110.549 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79000000000000004 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.76000000000000001 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.92000000000000004 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.60999999999999999 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.66000000000000003 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.84999999999999998 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.3700000000000001 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.72999999999999998 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.29 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.76000000000000001 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.54000000000000004 109.818 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.48999999999999999 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.53000000000000003 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67000000000000004 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.85999999999999999 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.98999999999999999 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.3200000000000001 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.26 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 1.03 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.3400000000000001 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.92000000000000004 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.0700000000000001 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.6100000000000001 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.74 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.3700000000000001 112.275 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.81000000000000005 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.544 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.85999999999999999 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.544 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77000000000000002 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.67000000000000004 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.69999999999999996 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.47999999999999998 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.409 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.46999999999999997 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.59999999999999998 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.59999999999999998 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.62 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.412 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.58999999999999997 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.76000000000000001 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64000000000000001 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.66000000000000003 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.588 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.69999999999999996 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.60999999999999999 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.588 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.70999999999999996 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 1.05 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.65000000000000002 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.69999999999999996 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 1.03 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.88 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.22 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.75 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 1.03 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.67000000000000004 111.824 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.25 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.84999999999999998 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.70999999999999996 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67000000000000004 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.29 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.98999999999999999 111.464 179.75 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.67000000000000004 112.326 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.409 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.80000000000000004 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.57999999999999996 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.87 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.81999999999999995 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 1.03 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.68999999999999995 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.1399999999999999 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.78000000000000003 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.726 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.47999999999999998 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB3' HD22 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.53000000000000003 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.82999999999999996 112.831 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.3999999999999999 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.96999999999999997 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.27 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.627 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.23 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 1.04 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.8700000000000001 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.4099999999999999 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.98999999999999999 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . 0.424 HG12 ' HA ' ' B' ' 64' ' ' LYS . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.1200000000000001 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.5900000000000001 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.74 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 pt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.47 112.212 -179.289 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.82999999999999996 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.85999999999999999 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76000000000000001 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.68000000000000005 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.68000000000000005 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.5 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.46999999999999997 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46000000000000002 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.58999999999999997 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.64000000000000001 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.432 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.62 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.79000000000000004 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.68999999999999995 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.70999999999999996 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.76000000000000001 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.66000000000000003 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.76000000000000001 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.23 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.63 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.72999999999999998 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.95999999999999996 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 70' ' ' ILE . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.91000000000000003 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.4099999999999999 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.76000000000000001 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.89000000000000001 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.71999999999999997 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.27 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.87 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.72999999999999998 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.70999999999999996 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.0700000000000001 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.45 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 1.1100000000000001 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLU . . . . . 0.548 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79000000000000004 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.76000000000000001 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' VAL . . . . . 0.481 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.92000000000000004 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.60999999999999999 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.66000000000000003 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.84999999999999998 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.72999999999999998 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.29 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.76000000000000001 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.54000000000000004 109.814 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.48999999999999999 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.53000000000000003 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67000000000000004 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.85999999999999999 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.3500000000000001 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.98999999999999999 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.3200000000000001 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.26 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 1.03 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.8899999999999999 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.3400000000000001 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.92000000000000004 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.0700000000000001 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.6100000000000001 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.74 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.3700000000000001 112.19 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.81000000000000005 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.85999999999999999 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77000000000000002 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.67000000000000004 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.69999999999999996 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.51000000000000001 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.47999999999999998 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' CYS . . . . . 0.509 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.46999999999999997 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.59999999999999998 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.59999999999999998 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.62 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' THR . . . . . 0.415 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.58999999999999997 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.76000000000000001 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64000000000000001 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.66000000000000003 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.69999999999999996 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.60999999999999999 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.70999999999999996 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 1.05 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.65000000000000002 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.69999999999999996 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 1.03 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.88 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLN . . . . . 0.426 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.22 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.75 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 1.03 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.67000000000000004 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.25 111.052 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.84999999999999998 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.70999999999999996 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67000000000000004 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.29 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.98999999999999999 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.80000000000000004 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.67000000000000004 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 45' ' ' VAL . . . . . 0.509 HG11 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.80000000000000004 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.57999999999999996 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.87 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.81999999999999995 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.4299999999999999 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 1.03 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.68999999999999995 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.1399999999999999 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.78000000000000003 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.54000000000000004 109.869 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.47999999999999998 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 56' ' ' LEU . . . . . 0.543 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.53000000000000003 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 57' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.82999999999999996 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.3999999999999999 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.96999999999999997 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.27 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.23 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 63' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 1.04 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.8700000000000001 110.625 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.4099999999999999 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.98999999999999999 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.1200000000000001 110.158 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.5900000000000001 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.74 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 70' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.47 111.603 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.82999999999999996 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.85999999999999999 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76000000000000001 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.68000000000000005 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.68000000000000005 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.5 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.46999999999999997 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.479 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46000000000000002 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.58999999999999997 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.59999999999999998 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.64000000000000001 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.425 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.62 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.79000000000000004 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.68999999999999995 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.70999999999999996 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.76000000000000001 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.66000000000000003 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.76000000000000001 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.23 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.63 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.72999999999999998 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 37.1 t30 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.95999999999999996 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.91000000000000003 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.4099999999999999 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.76000000000000001 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.89000000000000001 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.71999999999999997 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.27 111.206 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66000000000000003 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.87 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.72999999999999998 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.70999999999999996 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 111.048 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.45 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 1.1100000000000001 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.479 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.76000000000000001 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.413 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.92000000000000004 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.60999999999999999 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.66000000000000003 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.84999999999999998 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.3700000000000001 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.0800000000000001 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.72999999999999998 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.478 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.29 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.76000000000000001 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.54000000000000004 109.778 178.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.48999999999999999 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.491 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.53000000000000003 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67000000000000004 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.85999999999999999 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.3500000000000001 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.98999999999999999 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.3200000000000001 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.26 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.491 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 1.03 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.464 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.8899999999999999 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.3400000000000001 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.92000000000000004 111.118 178.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.428 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.0700000000000001 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.464 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.6100000000000001 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.74 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.45 -5.68 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.3700000000000001 112.058 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -98.92 -38.43 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.679 -0.237 . . . . 1.8200000000000001 110.937 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.24 -31.05 25.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 2.21 110.724 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.08 -15.64 81.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.94 -0.647 . . . . 1.77 112.36 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.89 32.3 4.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.092 -0.575 . . . . 2.0899999999999999 112.433 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.75 -20.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 2.3999999999999999 110.648 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -77.85 -38.23 46.59 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.113 -0.494 . . . . 2.6099999999999999 110.743 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -80.09 106.39 12.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.266 -0.425 . . . . 2.7000000000000002 110.028 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.322 -0.847 . . . . 2.6200000000000001 111.085 -179.461 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.81000000000000005 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.55 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.85999999999999999 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.55 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.67000000000000004 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.69999999999999996 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.51000000000000001 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.47999999999999998 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.412 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.46999999999999997 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.59999999999999998 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.59999999999999998 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.609 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.62 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.421 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.58999999999999997 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.76000000000000001 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64000000000000001 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.66000000000000003 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.69999999999999996 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.60999999999999999 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.70999999999999996 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 1.05 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.65000000000000002 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 1.03 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.88 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.403 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.22 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.455 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.75 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 1.03 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.67000000000000004 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.25 111.423 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.84999999999999998 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.70999999999999996 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.29 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.98999999999999999 111.129 179.602 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.80000000000000004 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.408 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.67000000000000004 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.412 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.80000000000000004 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.57999999999999996 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.87 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.81999999999999995 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.4299999999999999 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 1.03 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.413 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.1399999999999999 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.78000000000000003 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.54000000000000004 109.749 178.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.47999999999999998 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.574 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.53000000000000003 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.609 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.408 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.82999999999999996 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.3999999999999999 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.96999999999999997 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.27 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.23 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.574 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 1.04 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.466 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.8700000000000001 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.4099999999999999 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.98999999999999999 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.427 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.1200000000000001 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.466 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.5900000000000001 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.74 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt -79.5 -3.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.47 111.39 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.2 mt -100.93 -32.13 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.98 110.213 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.2 -42.0 24.16 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.047 -0.524 . . . . 2.25 110.367 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.52 -15.33 78.37 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.834 -0.698 . . . . 1.76 112.772 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.28 -0.7 84.7 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.03 -0.605 . . . . 2.04 113.197 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -127.95 -0.4 5.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.009 0.433 . . . . 2.4199999999999999 110.654 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -80.12 -27.29 39.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 2.6000000000000001 111.109 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.56 123.83 23.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.966 0.412 . . . . 2.7799999999999998 110.837 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.29 -0.862 . . . . 2.5499999999999998 110.68 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.82999999999999996 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.85999999999999999 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76000000000000001 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.68000000000000005 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.68000000000000005 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.5 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.46999999999999997 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46000000000000002 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.58999999999999997 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.59999999999999998 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.626 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.64000000000000001 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.62 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.79000000000000004 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.68999999999999995 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.70999999999999996 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.76000000000000001 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.66000000000000003 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.76000000000000001 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.23 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.63 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.72999999999999998 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.95999999999999996 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.91000000000000003 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 53.2 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.4099999999999999 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.76000000000000001 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.89000000000000001 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.71999999999999997 111.311 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66000000000000003 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.87 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.70999999999999996 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.0700000000000001 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.45 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 1.1100000000000001 110.635 179.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79000000000000004 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.76000000000000001 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.92000000000000004 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.60999999999999999 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.66000000000000003 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.84999999999999998 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.3700000000000001 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.0800000000000001 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.72999999999999998 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.29 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.76000000000000001 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.54000000000000004 109.847 178.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.48999999999999999 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.534 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.53000000000000003 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.626 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67000000000000004 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.85999999999999999 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.3500000000000001 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.98999999999999999 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.3200000000000001 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.26 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.534 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 1.03 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.54 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.8899999999999999 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.3400000000000001 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.92000000000000004 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.488 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.0700000000000001 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.6100000000000001 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.74 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt -74.92 -2.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.3700000000000001 112.609 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.0 mt -96.23 -15.16 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 1.8200000000000001 110.43 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -93.2 -61.9 1.48 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.851 -0.613 . . . . 2.21 110.176 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.89 -17.15 75.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.924 -0.655 . . . . 1.77 112.768 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.6 -1.83 89.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.005 -0.617 . . . . 2.0899999999999999 112.858 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -119.96 -19.19 7.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 2.3999999999999999 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.03 -17.62 42.66 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.045 -0.525 . . . . 2.6099999999999999 111.186 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.87 120.92 16.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.848 0.356 . . . . 2.7000000000000002 110.947 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.278 -0.867 . . . . 2.6200000000000001 110.806 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.81000000000000005 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.85999999999999999 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77000000000000002 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.67000000000000004 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.69999999999999996 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.51000000000000001 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.47999999999999998 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.631 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.46999999999999997 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.59999999999999998 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.59999999999999998 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.62 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.424 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.58999999999999997 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.76000000000000001 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64000000000000001 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.66000000000000003 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.69999999999999996 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.60999999999999999 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.70999999999999996 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 1.05 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.65000000000000002 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.69999999999999996 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 1.03 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.465 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.88 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.422 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.22 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.75 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 1.03 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.67000000000000004 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.25 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.84999999999999998 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.70999999999999996 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.29 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.98999999999999999 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.80000000000000004 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.67000000000000004 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.631 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.80000000000000004 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.57999999999999996 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.87 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.81999999999999995 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.4299999999999999 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 1.03 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.68999999999999995 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.1399999999999999 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.78000000000000003 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.54000000000000004 109.734 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.47999999999999998 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.493 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.53000000000000003 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.82999999999999996 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.3999999999999999 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.538 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.96999999999999997 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.27 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.538 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.23 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.493 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 1.04 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.8700000000000001 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.4099999999999999 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.98999999999999999 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.1200000000000001 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.5900000000000001 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.74 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.414 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt -72.83 -20.66 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.47 111.136 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -88.42 -26.96 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 1.98 109.982 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.87 -40.89 24.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.845 -0.616 . . . . 2.25 110.258 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.7 -9.42 61.28 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.868 -0.682 . . . . 1.76 112.672 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.36 -33.49 25.52 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.107 -0.568 . . . . 2.04 112.885 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -93.99 9.48 37.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 2.4199999999999999 110.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -81.7 -18.46 44.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.13 -0.486 . . . . 2.6000000000000001 110.586 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 99.89 2.93 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.138 -0.483 . . . . 2.7799999999999998 110.273 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.345 -0.836 . . . . 2.5499999999999998 110.925 -179.457 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.82999999999999996 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.85999999999999999 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76000000000000001 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.68000000000000005 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.68000000000000005 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.5 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.46999999999999997 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.401 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46000000000000002 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.58999999999999997 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.59999999999999998 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.604 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.64000000000000001 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.428 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.62 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.79000000000000004 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.68999999999999995 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.70999999999999996 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.76000000000000001 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.66000000000000003 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.76000000000000001 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.402 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.23 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.63 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.72999999999999998 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.95999999999999996 110.275 179.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.91000000000000003 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.4099999999999999 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.76000000000000001 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.89000000000000001 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.71999999999999997 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.27 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66000000000000003 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.87 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.72999999999999998 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.70999999999999996 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.0700000000000001 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.45 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.456 HG21 ' HA ' ' B' ' 75' ' ' ASN . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 1.1100000000000001 110.552 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79000000000000004 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.76000000000000001 112.101 -179.033 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.401 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.92000000000000004 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.60999999999999999 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.581 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.66000000000000003 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.402 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.84999999999999998 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.3700000000000001 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.0800000000000001 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.72999999999999998 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.581 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.29 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.76000000000000001 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.54000000000000004 109.822 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.48999999999999999 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.428 HD22 ' HB ' ' A' ' 19' ' ' THR . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.53000000000000003 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.604 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67000000000000004 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.85999999999999999 112.072 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.3500000000000001 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.619 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.98999999999999999 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.3200000000000001 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.619 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.26 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 1.03 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.466 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.8899999999999999 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.3400000000000001 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.92000000000000004 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.0700000000000001 110.048 178.782 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.6100000000000001 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.74 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 36.0 pt -70.13 -24.4 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.3700000000000001 111.686 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.55 -18.41 38.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.391 . . . . 1.8200000000000001 110.658 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.59 -47.15 13.42 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.997 -0.547 . . . . 2.21 110.67 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 -17.85 72.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.083 -0.58 . . . . 1.77 112.665 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.29 21.45 34.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.901 -0.666 . . . . 2.0899999999999999 112.794 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.73 -20.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 2.3999999999999999 110.793 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -82.63 -25.11 33.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.356 -0.384 . . . . 2.6099999999999999 111.473 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.75 7.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.917 0.389 . . . . 2.7000000000000002 111.102 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.34 -0.838 . . . . 2.6200000000000001 110.777 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.81000000000000005 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.85999999999999999 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77000000000000002 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.67000000000000004 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.69999999999999996 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.51000000000000001 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.47999999999999998 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.46999999999999997 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.59999999999999998 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.59999999999999998 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.516 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.62 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.58999999999999997 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.76000000000000001 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.553 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64000000000000001 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.66000000000000003 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.69999999999999996 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.60999999999999999 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.70999999999999996 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 1.05 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.65000000000000002 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 1.03 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.427 HD13 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.88 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.469 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.22 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.75 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 1.03 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.67000000000000004 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.25 111.398 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.84999999999999998 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.70999999999999996 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67000000000000004 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.29 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.98999999999999999 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.80000000000000004 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.67000000000000004 111.3 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.469 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.80000000000000004 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.57999999999999996 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.87 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.81999999999999995 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.4299999999999999 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 1.03 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.68999999999999995 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.1399999999999999 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.78000000000000003 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.54000000000000004 109.767 178.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.47999999999999998 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.546 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.53000000000000003 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.516 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.648 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.3999999999999999 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.96999999999999997 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.27 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.23 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.546 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 1.04 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.8700000000000001 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.4099999999999999 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.41 ' O ' HG21 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.98999999999999999 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.481 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.1200000000000001 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.5900000000000001 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.74 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.481 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt -70.74 -28.09 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.47 111.151 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.97 -6.69 44.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 1.98 110.013 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -93.72 -45.51 7.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.697 -0.683 . . . . 2.25 110.314 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.78 -27.77 49.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.989 -0.624 . . . . 1.76 111.91 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.98 45.8 2.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 2.04 111.977 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . 0.456 ' HA ' HG21 ' A' ' 42' ' ' VAL . 64.3 t30 -164.51 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 2.4199999999999999 110.255 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.63 -38.16 55.13 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.021 -0.536 . . . . 2.6000000000000001 111.053 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -79.96 130.9 35.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 2.7799999999999998 110.858 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.335 -0.841 . . . . 2.5499999999999998 110.923 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.82999999999999996 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.85999999999999999 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76000000000000001 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.68000000000000005 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.68000000000000005 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.5 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.46999999999999997 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG11 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46000000000000002 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.58999999999999997 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.616 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.64000000000000001 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.442 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.62 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.79000000000000004 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.68999999999999995 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.70999999999999996 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.76000000000000001 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.453 ' HB3' HG21 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.66000000000000003 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.76000000000000001 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.23 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.63 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.72999999999999998 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.95999999999999996 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.91000000000000003 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.4099999999999999 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.405 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.76000000000000001 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.89000000000000001 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.71999999999999997 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.27 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66000000000000003 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.87 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.457 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.72999999999999998 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.70999999999999996 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.45 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 1.1100000000000001 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79000000000000004 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 111.962 -179.39 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.586 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.92000000000000004 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.60999999999999999 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.66000000000000003 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.84999999999999998 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.3700000000000001 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.0800000000000001 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.72999999999999998 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.29 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.76000000000000001 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.54000000000000004 109.766 178.031 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.48999999999999999 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.502 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.53000000000000003 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.616 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67000000000000004 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.85999999999999999 113.216 -179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.3500000000000001 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.98999999999999999 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.3200000000000001 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.26 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.502 ' CD1' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 1.03 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.8899999999999999 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.3400000000000001 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.92000000000000004 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.0700000000000001 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.6100000000000001 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.74 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.453 HG21 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt -84.79 -0.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.3700000000000001 112.057 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.05 -36.28 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 1.8200000000000001 110.715 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.04 -40.79 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 2.21 110.148 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.44 -22.09 76.3 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.001 -0.545 . . . . 1.77 112.59 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.22 -29.71 63.97 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.123 -0.56 . . . . 2.0899999999999999 112.071 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.2 -26.13 25.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.183 0.516 . . . . 2.3999999999999999 110.136 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -76.43 -31.62 57.98 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.724 -0.671 . . . . 2.6099999999999999 110.693 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.37 122.47 28.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.249 -0.432 . . . . 2.7000000000000002 110.614 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.358 -0.83 . . . . 2.6200000000000001 110.73 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.81000000000000005 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.85999999999999999 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77000000000000002 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.67000000000000004 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.69999999999999996 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.51000000000000001 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.47999999999999998 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.403 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.46999999999999997 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.59999999999999998 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.639 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.62 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.58999999999999997 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.495 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.76000000000000001 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64000000000000001 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.66000000000000003 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.69999999999999996 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.438 ' HB3' HG21 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.60999999999999999 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.70999999999999996 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 1.05 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.65000000000000002 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.69999999999999996 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.47 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 29.7 t30 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 1.03 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.88 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.22 110.878 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.75 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 1.03 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.67000000000000004 111.251 179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.25 111.456 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.84999999999999998 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.70999999999999996 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67000000000000004 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.98999999999999999 110.351 179.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.80000000000000004 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.67000000000000004 112.285 -179.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.403 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.80000000000000004 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.57999999999999996 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.47 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.87 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.81999999999999995 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.4299999999999999 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 1.03 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.68999999999999995 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.1399999999999999 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.78000000000000003 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.54000000000000004 109.758 179.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.47999999999999998 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.53000000000000003 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.639 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.82999999999999996 112.175 179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.3999999999999999 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.96999999999999997 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.27 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.23 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.558 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 1.04 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.8700000000000001 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.4099999999999999 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.98999999999999999 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.583 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.1200000000000001 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.5900000000000001 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.74 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.438 HG21 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt -85.61 -11.6 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.47 112.083 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.583 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 95.4 mt -84.96 -38.66 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 1.98 110.107 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.88 -25.89 34.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.875 -0.602 . . . . 2.25 110.336 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.8 -28.36 70.86 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.027 -0.533 . . . . 1.76 112.134 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.47 -17.08 76.69 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.038 -0.601 . . . . 2.04 111.868 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -93.58 -27.62 16.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 2.4199999999999999 109.973 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.12 -34.81 61.72 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.681 -0.69 . . . . 2.6000000000000001 111.011 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -73.87 117.48 15.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 2.7799999999999998 110.579 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.352 -0.832 . . . . 2.5499999999999998 110.797 -179.657 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.82999999999999996 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.85999999999999999 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.68000000000000005 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.68000000000000005 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.5 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.46999999999999997 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.58999999999999997 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.59999999999999998 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.526 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.64000000000000001 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.436 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.62 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.79000000000000004 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.68999999999999995 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.70999999999999996 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.76000000000000001 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.66000000000000003 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.76000000000000001 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.23 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.63 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.72999999999999998 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.406 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.95999999999999996 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.91000000000000003 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.4099999999999999 110.581 179.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.76000000000000001 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.89000000000000001 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.71999999999999997 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.27 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66000000000000003 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.87 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.72999999999999998 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.70999999999999996 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.0700000000000001 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.45 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.461 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 1.1100000000000001 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.76000000000000001 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.92000000000000004 110.859 179.179 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.60999999999999999 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.66000000000000003 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.84999999999999998 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.3700000000000001 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.0800000000000001 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.72999999999999998 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.29 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.76000000000000001 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.54000000000000004 109.808 177.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.575 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.53000000000000003 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.526 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67000000000000004 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.461 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.85999999999999999 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.3500000000000001 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.98999999999999999 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.3200000000000001 113.339 -178.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.26 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.575 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 1.03 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.8899999999999999 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.3400000000000001 113.076 179.125 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.92000000000000004 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.44 HG22 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.0700000000000001 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.6100000000000001 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.74 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt -74.22 -24.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.3700000000000001 111.355 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.07 -31.87 39.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 1.8200000000000001 110.579 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.45 -34.13 41.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 2.21 110.248 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.24 -27.01 64.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.091 -0.576 . . . . 1.77 112.135 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.69 17.32 56.77 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.129 -0.557 . . . . 2.0899999999999999 112.189 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -131.98 -29.8 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 2.3999999999999999 110.071 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -92.28 0.41 57.45 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.784 -0.643 . . . . 2.6099999999999999 110.355 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.2 111.09 4.91 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.938 -0.574 . . . . 2.7000000000000002 110.243 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.325 -0.845 . . . . 2.6200000000000001 111.001 -179.456 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.81000000000000005 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.85999999999999999 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.67000000000000004 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.69999999999999996 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.51000000000000001 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.47999999999999998 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.423 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.46999999999999997 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.59999999999999998 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.59999999999999998 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.62 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.58999999999999997 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.76000000000000001 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64000000000000001 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.66000000000000003 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.69999999999999996 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.60999999999999999 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.70999999999999996 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 1.05 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.65000000000000002 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.69999999999999996 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 1.03 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.88 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.22 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.75 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 1.03 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.67000000000000004 111.762 179.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.25 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.84999999999999998 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.70999999999999996 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67000000000000004 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.29 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.98999999999999999 110.983 179.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.80000000000000004 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.67000000000000004 111.957 -179.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.423 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.80000000000000004 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.57999999999999996 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.451 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.87 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.81999999999999995 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.4299999999999999 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 1.03 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.68999999999999995 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.451 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.1399999999999999 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.78000000000000003 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.54000000000000004 109.848 178.076 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.47999999999999998 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.481 ' HB3' HD13 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.53000000000000003 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 111.886 179.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.3999999999999999 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.96999999999999997 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.27 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.23 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.509 HD11 ' H ' ' B' ' 57' ' ' ASP . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 1.04 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.8700000000000001 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.4099999999999999 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.98999999999999999 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.1200000000000001 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.5900000000000001 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.74 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.419 HG22 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt -77.83 -19.77 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.47 112.116 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.446 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 81.7 mt -74.08 -34.93 64.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.852 0.358 . . . . 1.98 110.212 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.99 -36.72 48.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.885 -0.598 . . . . 2.25 110.398 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -22.63 78.95 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.167 -0.539 . . . . 1.76 112.167 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.41 17.4 58.52 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.125 -0.56 . . . . 2.04 112.293 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -131.31 -33.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 2.4199999999999999 110.522 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -78.55 -24.43 45.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.99 -0.55 . . . . 2.6000000000000001 110.798 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.82 123.34 20.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.383 -0.372 . . . . 2.7799999999999998 110.384 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.33 -0.843 . . . . 2.5499999999999998 110.955 -179.712 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.82999999999999996 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.85999999999999999 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76000000000000001 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.68000000000000005 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.68000000000000005 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.5 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.46999999999999997 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46000000000000002 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.58999999999999997 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.59999999999999998 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.631 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.64000000000000001 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.62 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.79000000000000004 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.68999999999999995 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.70999999999999996 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.76000000000000001 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.66000000000000003 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.76000000000000001 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.23 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.63 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.72999999999999998 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.95999999999999996 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.471 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.91000000000000003 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.4099999999999999 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.51 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.76000000000000001 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.89000000000000001 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.71999999999999997 111.618 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.27 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66000000000000003 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.87 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.72999999999999998 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.70999999999999996 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.0700000000000001 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.45 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 1.1100000000000001 111.118 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79000000000000004 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.76000000000000001 112.119 -179.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.92000000000000004 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.60999999999999999 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.66000000000000003 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.84999999999999998 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.3700000000000001 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.0800000000000001 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.72999999999999998 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.29 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.76000000000000001 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.84 178.058 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.48999999999999999 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.448 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.53000000000000003 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.631 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67000000000000004 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.85999999999999999 112.471 -179.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.98999999999999999 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.3200000000000001 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.26 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.448 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 1.03 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.8899999999999999 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.3400000000000001 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.92000000000000004 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.566 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.0700000000000001 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.6100000000000001 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.74 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.566 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt -79.48 -17.04 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.3700000000000001 111.19 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.33 -44.34 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 1.8200000000000001 110.048 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.53 -45.3 54.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.844 -0.617 . . . . 2.21 110.264 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.3 -27.51 67.89 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.984 -0.627 . . . . 1.77 112.38 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.69 -23.34 70.15 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.135 -0.555 . . . . 2.0899999999999999 112.57 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -85.2 -30.7 23.68 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.87 0.366 . . . . 2.3999999999999999 110.643 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -83.22 -16.1 47.8 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.138 -0.483 . . . . 2.6099999999999999 111.116 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.15 117.63 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 2.7000000000000002 110.874 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.35 -0.833 . . . . 2.6200000000000001 111.661 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.81000000000000005 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.85999999999999999 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77000000000000002 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.67000000000000004 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.69999999999999996 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.51000000000000001 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.47999999999999998 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.51 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.46999999999999997 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.59999999999999998 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.585 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.62 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.58999999999999997 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.76000000000000001 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64000000000000001 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.66000000000000003 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.581 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.69999999999999996 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.60999999999999999 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.70999999999999996 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 1.05 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.65000000000000002 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.51 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 10.1 t30 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 1.03 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.88 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.471 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.22 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.75 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 1.03 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.67000000000000004 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.25 110.965 179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.84999999999999998 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.70999999999999996 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67000000000000004 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.29 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.98999999999999999 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.478 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.80000000000000004 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.67000000000000004 112.316 -178.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.51 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.80000000000000004 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.57999999999999996 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.87 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.81999999999999995 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.4299999999999999 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 1.03 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.1399999999999999 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.78000000000000003 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.54000000000000004 109.834 178.075 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.47999999999999998 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.476 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.53000000000000003 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.585 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.82999999999999996 112.782 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.3999999999999999 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.96999999999999997 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.27 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.23 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.504 ' O ' HG22 ' B' ' 67' ' ' ILE . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 1.04 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.439 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.8700000000000001 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.4099999999999999 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.98999999999999999 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.504 HG22 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.1200000000000001 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.5900000000000001 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.74 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.434 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt -81.32 -13.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.47 112.059 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.403 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 62.9 mt -77.12 -36.45 55.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 1.98 110.811 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.67 -34.08 21.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 2.25 110.651 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.0 -24.67 73.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.056 -0.592 . . . . 1.76 112.603 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.15 15.02 63.02 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 2.04 112.57 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -130.47 -33.48 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 2.4199999999999999 110.559 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -79.76 -21.52 44.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.036 -0.529 . . . . 2.6000000000000001 111.137 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.96 116.82 8.23 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.468 -0.333 . . . . 2.7799999999999998 110.456 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.285 -0.864 . . . . 2.5499999999999998 110.921 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.82999999999999996 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.85999999999999999 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.68000000000000005 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.68000000000000005 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.5 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.46999999999999997 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.502 ' SG ' HG11 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.58999999999999997 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.59999999999999998 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.569 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.64000000000000001 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.424 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.62 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.79000000000000004 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.68999999999999995 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.70999999999999996 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.76000000000000001 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.66000000000000003 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.76000000000000001 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.23 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.63 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.72999999999999998 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.95999999999999996 110.568 -179.674 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.91000000000000003 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.433 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.4099999999999999 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.76000000000000001 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.89000000000000001 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG11 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.71999999999999997 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.27 111.305 -179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66000000000000003 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.87 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.72999999999999998 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.70999999999999996 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.0700000000000001 110.653 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.45 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.482 ' N ' ' HG2' ' A' ' 41' ' ' LYS . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 1.1100000000000001 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79000000000000004 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.76000000000000001 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.502 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.92000000000000004 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.60999999999999999 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.66000000000000003 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.84999999999999998 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.3700000000000001 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.0800000000000001 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.72999999999999998 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.29 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.76000000000000001 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.54000000000000004 109.786 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.48999999999999999 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.539 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.53000000000000003 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.569 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67000000000000004 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.512 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.85999999999999999 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.3500000000000001 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.98999999999999999 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.3200000000000001 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.26 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.539 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 1.03 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.8899999999999999 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.3400000000000001 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.92000000000000004 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.404 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.0700000000000001 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.6100000000000001 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.74 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt -73.81 -17.58 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.3700000000000001 111.213 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 mt -95.32 -26.74 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 1.8200000000000001 110.299 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.55 -41.85 21.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.096 -0.502 . . . . 2.21 110.123 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.84 -19.26 58.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.92 -0.657 . . . . 1.77 112.266 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.47 -39.6 41.77 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.052 -0.594 . . . . 2.0899999999999999 112.35 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -73.87 -20.14 60.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.989 0.423 . . . . 2.3999999999999999 110.891 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -76.12 -24.53 54.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.942 -0.572 . . . . 2.6099999999999999 110.372 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . 0.457 ' OE1' ' HA ' ' B' ' 41' ' ' LYS . 3.6 tm-20 -76.73 106.52 8.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.004 -0.544 . . . . 2.7000000000000002 109.837 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.332 -0.842 . . . . 2.6200000000000001 111.071 -179.259 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.81000000000000005 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.551 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.85999999999999999 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.551 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77000000000000002 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.67000000000000004 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.69999999999999996 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.51000000000000001 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.47999999999999998 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.46999999999999997 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.59999999999999998 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.573 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.58999999999999997 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.76000000000000001 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64000000000000001 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.66000000000000003 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.69999999999999996 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.60999999999999999 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.70999999999999996 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 1.05 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.65000000000000002 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.69999999999999996 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.413 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 1.03 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.88 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.433 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.22 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.75 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 1.03 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.67000000000000004 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.25 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.84999999999999998 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.70999999999999996 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67000000000000004 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.457 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.29 110.552 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.98999999999999999 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.80000000000000004 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.67000000000000004 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.433 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.80000000000000004 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.57999999999999996 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.413 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.87 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.81999999999999995 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.4299999999999999 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 1.03 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.68999999999999995 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.409 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.1399999999999999 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.78000000000000003 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.54000000000000004 109.742 178.122 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.47999999999999998 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.516 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.53000000000000003 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.573 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.41 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.82999999999999996 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.3999999999999999 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.62 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.96999999999999997 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.27 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.62 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.23 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.516 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 1.04 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.471 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.8700000000000001 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.4099999999999999 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.98999999999999999 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.476 HG22 ' O ' ' B' ' 63' ' ' LEU . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.1200000000000001 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.5900000000000001 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.74 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt -78.33 -18.88 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.47 111.364 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.78 -33.04 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 1.98 110.224 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -80.2 -41.42 25.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 2.25 110.251 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.33 -31.13 73.86 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.085 -0.578 . . . . 1.76 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.1 -17.44 76.75 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.027 -0.606 . . . . 2.04 112.404 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -90.99 -25.42 19.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.947 0.403 . . . . 2.4199999999999999 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -93.58 1.88 56.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.083 -0.508 . . . . 2.6000000000000001 111.053 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.14 108.58 3.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.883 0.373 . . . . 2.7799999999999998 110.471 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.549 -0.739 . . . . 2.5499999999999998 111.496 -178.847 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.82999999999999996 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.85999999999999999 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76000000000000001 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.68000000000000005 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.68000000000000005 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.5 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.46999999999999997 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46000000000000002 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.58999999999999997 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.59999999999999998 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.577 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.64000000000000001 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.62 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.79000000000000004 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.68999999999999995 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.70999999999999996 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.76000000000000001 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.66000000000000003 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.76000000000000001 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.23 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.63 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.72999999999999998 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.95999999999999996 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.91000000000000003 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.4099999999999999 110.447 179.504 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.76000000000000001 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.89000000000000001 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.71999999999999997 111.944 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.27 111.425 -179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66000000000000003 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.87 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.72999999999999998 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.70999999999999996 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.0700000000000001 110.511 179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.45 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 1.1100000000000001 110.767 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79000000000000004 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.413 ' H ' HG22 ' A' ' 44' ' ' VAL . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.76000000000000001 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.92000000000000004 110.857 178.364 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.60999999999999999 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.66000000000000003 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.84999999999999998 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.3700000000000001 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.0800000000000001 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.72999999999999998 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.29 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.76000000000000001 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.54000000000000004 109.755 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.48999999999999999 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.429 HD22 ' HB ' ' A' ' 19' ' ' THR . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.53000000000000003 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.577 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67000000000000004 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.85999999999999999 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.3500000000000001 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.98999999999999999 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.47 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.3200000000000001 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.26 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.427 HD23 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 1.03 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.8899999999999999 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.47 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.3400000000000001 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.92000000000000004 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.62 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.0700000000000001 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.6100000000000001 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.74 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.62 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt -75.46 -13.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.3700000000000001 111.718 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -5.26 54.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 1.8200000000000001 110.473 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -101.53 -59.95 1.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.848 -0.614 . . . . 2.21 110.212 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 -13.78 79.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.89 -0.671 . . . . 1.77 113.14 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.47 84.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.982 -0.627 . . . . 2.0899999999999999 113.038 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -114.34 -8.38 12.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.035 0.445 . . . . 2.3999999999999999 110.525 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -80.76 -32.06 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 2.6099999999999999 111.414 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.34 110.19 5.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 2.7000000000000002 110.928 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.44 -0.79 . . . . 2.6200000000000001 110.975 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.81000000000000005 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.85999999999999999 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77000000000000002 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.67000000000000004 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.69999999999999996 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.51000000000000001 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.47999999999999998 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.59999999999999998 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.59999999999999998 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.62 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.423 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.58999999999999997 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.76000000000000001 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64000000000000001 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.66000000000000003 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.69999999999999996 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.60999999999999999 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.70999999999999996 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' MET . . . . . 0.413 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 1.05 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.65000000000000002 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.69999999999999996 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 1.03 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.88 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.22 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.75 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 1.03 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.67000000000000004 111.262 179.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.25 110.982 179.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.84999999999999998 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.70999999999999996 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67000000000000004 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.29 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.98999999999999999 110.29 179.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.80000000000000004 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.67000000000000004 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.80000000000000004 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.57999999999999996 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.87 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . 0.413 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.81999999999999995 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.4299999999999999 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 1.03 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.68999999999999995 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.1399999999999999 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.78000000000000003 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.54000000000000004 109.762 178.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.47999999999999998 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.566 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.53000000000000003 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.82999999999999996 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.3999999999999999 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.629 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.96999999999999997 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . 0.443 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.27 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.629 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.23 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.566 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 1.04 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.507 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.8700000000000001 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . 0.443 ' HG3' ' O ' ' B' ' 61' ' ' PRO . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.4099999999999999 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.98999999999999999 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.414 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.1200000000000001 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.507 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.5900000000000001 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.74 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt -74.87 -7.81 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.47 112.202 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.2 -35.08 17.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.634 -0.257 . . . . 1.98 110.813 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.63 -40.89 18.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.404 -0.362 . . . . 2.25 110.253 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 -20.99 70.21 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.971 -0.633 . . . . 1.76 112.246 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.43 -27.97 58.53 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.112 -0.566 . . . . 2.04 112.465 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.17 -19.14 40.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.949 0.404 . . . . 2.4199999999999999 110.599 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -75.89 -21.55 57.03 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.953 -0.567 . . . . 2.6000000000000001 110.716 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -71.4 105.28 3.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.204 -0.453 . . . . 2.7799999999999998 110.034 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.317 -0.849 . . . . 2.5499999999999998 111.065 -179.361 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.82999999999999996 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.85999999999999999 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76000000000000001 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.68000000000000005 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.68000000000000005 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.5 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.4 ' HB ' ' NE2' ' A' ' 38' ' ' GLN . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.46999999999999997 111.463 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46000000000000002 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.58999999999999997 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.59999999999999998 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.64000000000000001 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.43 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.62 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.79000000000000004 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.68999999999999995 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.70999999999999996 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.576 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.76000000000000001 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.66000000000000003 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.576 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.76000000000000001 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' MET . . . . . 0.499 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.23 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.63 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.72999999999999998 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.95999999999999996 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.91000000000000003 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.446 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.4099999999999999 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.76000000000000001 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.89000000000000001 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.71999999999999997 111.34 179.602 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.27 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66000000000000003 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.87 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.4 ' NE2' ' HB ' ' A' ' 14' ' ' VAL . 19.9 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.72999999999999998 112.964 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.70999999999999996 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.0700000000000001 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.45 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 1.1100000000000001 111.253 179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79000000000000004 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.76000000000000001 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.446 ' CG2' ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.92000000000000004 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.60999999999999999 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.419 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.66000000000000003 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.84999999999999998 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.3700000000000001 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.0800000000000001 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.72999999999999998 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.29 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.76000000000000001 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.54000000000000004 109.841 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.48999999999999999 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.543 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.53000000000000003 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67000000000000004 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.85999999999999999 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.3500000000000001 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.98999999999999999 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.3200000000000001 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.26 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.543 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 1.03 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.496 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.8899999999999999 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.3400000000000001 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.92000000000000004 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.423 HG12 ' O ' ' A' ' 63' ' ' LEU . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.0700000000000001 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.496 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.6100000000000001 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.74 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt -79.36 -13.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.3700000000000001 111.769 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.13 -34.5 13.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.936 0.398 . . . . 1.8200000000000001 109.996 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.96 -35.39 37.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.734 -0.666 . . . . 2.21 110.758 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.67 -23.29 77.1 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.918 -0.583 . . . . 1.77 112.57 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.25 -26.03 69.34 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.099 -0.572 . . . . 2.0899999999999999 112.333 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.36 -26.89 56.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.885 0.374 . . . . 2.3999999999999999 110.767 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -92.81 -3.04 55.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.165 -0.47 . . . . 2.6099999999999999 110.814 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 119.86 17.15 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.169 -0.469 . . . . 2.7000000000000002 110.524 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.285 -0.864 . . . . 2.6200000000000001 110.722 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.81000000000000005 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.85999999999999999 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77000000000000002 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.67000000000000004 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.69999999999999996 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.51000000000000001 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.47999999999999998 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.421 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.46999999999999997 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.59999999999999998 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.59999999999999998 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.566 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.62 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.422 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.58999999999999997 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.76000000000000001 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.66000000000000003 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.582 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.69999999999999996 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.472 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.60999999999999999 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.70999999999999996 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 1.05 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.65000000000000002 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.69999999999999996 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 1.03 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.88 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.447 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.22 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.75 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 1.03 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.67000000000000004 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.25 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.84999999999999998 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.70999999999999996 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67000000000000004 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.29 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.98999999999999999 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.421 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.80000000000000004 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.67000000000000004 112.243 -178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.447 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.80000000000000004 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.57999999999999996 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.87 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.81999999999999995 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.4299999999999999 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 1.03 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.68999999999999995 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.1399999999999999 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.78000000000000003 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.54000000000000004 109.713 178.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.47999999999999998 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.475 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.53000000000000003 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.566 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.82999999999999996 112.832 179.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.3999999999999999 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.96999999999999997 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.27 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.23 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 1.04 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.467 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.8700000000000001 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.4099999999999999 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.98999999999999999 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.467 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.1200000000000001 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.452 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.5900000000000001 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.74 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.472 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt -72.9 -14.47 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.47 111.606 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -88.31 -15.13 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 1.98 110.309 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.5 -55.12 2.4 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.205 -0.452 . . . . 2.25 110.282 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.99 -27.39 68.79 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.057 -0.592 . . . . 1.76 112.559 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.92 -23.8 65.8 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.029 -0.605 . . . . 2.04 112.34 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.58 -3.7 56.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 2.4199999999999999 110.33 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -81.31 -14.46 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 2.6000000000000001 110.677 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.53 111.82 10.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.976 -0.556 . . . . 2.7799999999999998 110.07 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.235 -0.888 . . . . 2.5499999999999998 111.019 -179.571 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.82999999999999996 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.85999999999999999 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76000000000000001 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.68000000000000005 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.68000000000000005 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.5 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.46999999999999997 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46000000000000002 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.58999999999999997 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.59999999999999998 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.64000000000000001 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 18' ' ' THR . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.62 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.79000000000000004 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.556 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.68999999999999995 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.556 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.70999999999999996 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.76000000000000001 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.66000000000000003 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.76000000000000001 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.23 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.63 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.72999999999999998 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.95999999999999996 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.91000000000000003 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.4099999999999999 110.188 179.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.76000000000000001 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.89000000000000001 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.71999999999999997 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.27 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66000000000000003 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.87 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.72999999999999998 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.70999999999999996 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.45 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 1.1100000000000001 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.446 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.76000000000000001 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.92000000000000004 110.798 179.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.60999999999999999 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.66000000000000003 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.84999999999999998 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.3700000000000001 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.0800000000000001 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.72999999999999998 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.29 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.76000000000000001 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.54000000000000004 109.917 177.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.477 ' O ' ' HD3' ' A' ' 58' ' ' PRO . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.53000000000000003 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67000000000000004 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.477 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.85999999999999999 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.3500000000000001 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.98999999999999999 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.3200000000000001 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.26 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.461 HD22 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 1.03 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.45 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.8899999999999999 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.3400000000000001 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.92000000000000004 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.441 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.0700000000000001 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.6100000000000001 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.74 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt -76.32 -11.48 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.3700000000000001 111.169 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.2 mt -93.84 -31.44 14.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 1.8200000000000001 110.156 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -82.23 -41.05 20.76 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.195 -0.457 . . . . 2.21 110.191 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.57 -30.39 70.97 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.948 -0.644 . . . . 1.77 112.322 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.74 60.12 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.226 -0.511 . . . . 2.0899999999999999 112.204 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -82.87 -25.58 32.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.432 . . . . 2.3999999999999999 110.312 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.26 -27.18 59.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 2.6099999999999999 110.289 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.25 114.79 11.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.014 -0.539 . . . . 2.7000000000000002 109.957 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.7 m120 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.293 -0.86 . . . . 2.6200000000000001 110.929 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.81000000000000005 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.85999999999999999 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77000000000000002 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.67000000000000004 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.69999999999999996 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.51000000000000001 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.47999999999999998 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.46999999999999997 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.59999999999999998 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.59999999999999998 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.62 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.58999999999999997 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.76000000000000001 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.66000000000000003 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.69999999999999996 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.60999999999999999 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.70999999999999996 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 1.05 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.65000000000000002 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.69999999999999996 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 1.03 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.88 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.22 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.75 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 1.03 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.67000000000000004 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.25 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.84999999999999998 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.70999999999999996 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67000000000000004 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.29 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.98999999999999999 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.67000000000000004 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.80000000000000004 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.57999999999999996 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.87 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.81999999999999995 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.4299999999999999 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 1.03 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.68999999999999995 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.1399999999999999 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.78000000000000003 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.54000000000000004 109.775 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.47999999999999998 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.516 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.53000000000000003 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.82999999999999996 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.96999999999999997 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.27 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.23 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.516 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 1.04 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.494 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.8700000000000001 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.4099999999999999 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.98999999999999999 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.413 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.1200000000000001 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.494 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.5900000000000001 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.74 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt -85.33 2.21 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.47 112.187 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.65 -36.69 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.962 0.41 . . . . 1.98 110.46 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.47 -41.79 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.838 -0.619 . . . . 2.25 110.36 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.37 75.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.876 -0.602 . . . . 1.76 112.404 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -27.52 68.32 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 2.04 112.124 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -76.97 -24.87 52.29 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.018 0.437 . . . . 2.4199999999999999 110.274 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -81.8 -18.67 43.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.002 -0.544 . . . . 2.6000000000000001 110.748 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.47 116.6 10.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.988 -0.551 . . . . 2.7799999999999998 110.403 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.414 -0.803 . . . . 2.5499999999999998 111.668 -179.282 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.82999999999999996 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.85999999999999999 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76000000000000001 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.68000000000000005 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.68000000000000005 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.5 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.46999999999999997 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.427 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46000000000000002 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.58999999999999997 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.59999999999999998 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.511 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.64000000000000001 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.62 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.79000000000000004 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.68999999999999995 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.70999999999999996 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.573 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.76000000000000001 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.419 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.66000000000000003 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.76000000000000001 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.23 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.63 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.72999999999999998 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.95999999999999996 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.91000000000000003 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.4099999999999999 110.215 179.489 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.76000000000000001 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.89000000000000001 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.71999999999999997 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.27 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66000000000000003 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.87 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.70999999999999996 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.0700000000000001 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.45 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 1.1100000000000001 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.76000000000000001 112.383 -179.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.427 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.92000000000000004 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.60999999999999999 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.66000000000000003 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.84999999999999998 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.3700000000000001 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.0800000000000001 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.72999999999999998 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.29 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.76000000000000001 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.54000000000000004 109.809 178.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.48999999999999999 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.503 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.53000000000000003 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.511 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67000000000000004 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.85999999999999999 111.978 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.3500000000000001 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.98999999999999999 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.3200000000000001 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.26 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 1.03 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.8899999999999999 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.3400000000000001 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.92000000000000004 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.0700000000000001 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.6100000000000001 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.74 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt -80.27 -9.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.3700000000000001 111.715 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.98 -32.29 13.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.932 0.396 . . . . 1.8200000000000001 110.192 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.49 -41.31 21.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.621 -0.718 . . . . 2.21 110.16 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.67 -28.66 70.26 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.968 -0.56 . . . . 1.77 113.078 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.59 -33.32 58.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.024 -0.607 . . . . 2.0899999999999999 112.355 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.6 -7.87 59.09 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 2.3999999999999999 111.017 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -93.81 -14.06 26.6 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.388 -0.369 . . . . 2.6099999999999999 110.931 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.31 110.61 4.74 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.331 -0.395 . . . . 2.7000000000000002 110.341 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.422 -0.799 . . . . 2.6200000000000001 111.727 -178.994 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.81000000000000005 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.85999999999999999 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77000000000000002 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.67000000000000004 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.69999999999999996 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.51000000000000001 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.47999999999999998 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.46999999999999997 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.59999999999999998 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.59999999999999998 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.62 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.422 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.58999999999999997 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.76000000000000001 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64000000000000001 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.549 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.66000000000000003 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.58 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.69999999999999996 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.60999999999999999 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.70999999999999996 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 1.05 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.65000000000000002 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 1.03 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.88 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.22 110.465 179.418 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.75 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 1.03 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.67000000000000004 111.031 179.038 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.25 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.84999999999999998 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.70999999999999996 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67000000000000004 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.29 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.98999999999999999 110.712 179.108 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.441 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.67000000000000004 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.80000000000000004 110.791 178.594 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.57999999999999996 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.87 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.81999999999999995 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.4299999999999999 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 1.03 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.68999999999999995 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.1399999999999999 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.78000000000000003 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.54000000000000004 109.821 179.707 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.47999999999999998 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.5 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.53000000000000003 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.441 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.82999999999999996 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.3999999999999999 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.63 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.96999999999999997 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.27 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.63 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.23 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.5 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 1.04 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.8700000000000001 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.4099999999999999 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.98999999999999999 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.1200000000000001 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.5900000000000001 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.74 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.406 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt -76.82 -13.0 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.47 111.614 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.86 -28.06 16.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 1.98 110.627 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.81 -50.62 7.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 2.25 110.295 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.62 -25.13 70.78 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.928 -0.578 . . . . 1.76 112.29 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.07 -19.18 77.69 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.016 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -87.0 -29.41 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 2.4199999999999999 110.444 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -86.36 -2.04 58.07 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.914 -0.585 . . . . 2.6000000000000001 110.703 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.54 107.68 5.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.061 -0.518 . . . . 2.7799999999999998 110.101 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.286 -0.864 . . . . 2.5499999999999998 111.071 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.82999999999999996 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.85999999999999999 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76000000000000001 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.68000000000000005 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.68000000000000005 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.5 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.46999999999999997 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.513 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46000000000000002 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.58999999999999997 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.59999999999999998 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.542 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.64000000000000001 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.62 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.79000000000000004 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.68999999999999995 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.70999999999999996 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.572 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.76000000000000001 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.423 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.66000000000000003 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.76000000000000001 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.23 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.63 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.72999999999999998 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.95999999999999996 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.486 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.91000000000000003 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.489 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.4099999999999999 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.76000000000000001 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.89000000000000001 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.71999999999999997 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.27 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66000000000000003 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.87 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.72999999999999998 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.70999999999999996 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.0700000000000001 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.45 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.428 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 1.1100000000000001 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.513 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79000000000000004 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.76000000000000001 112.278 -178.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.449 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.92000000000000004 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.60999999999999999 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.428 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.66000000000000003 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.84999999999999998 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.3700000000000001 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.0800000000000001 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.72999999999999998 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.29 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.76000000000000001 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.839 178.085 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.48999999999999999 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.49 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.53000000000000003 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.542 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67000000000000004 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.428 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.85999999999999999 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.3500000000000001 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.98999999999999999 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.3200000000000001 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.26 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.513 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 1.03 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.8899999999999999 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.3400000000000001 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.92000000000000004 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.0700000000000001 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.6100000000000001 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.74 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt -76.28 -15.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.3700000000000001 111.577 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.99 -27.05 14.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.402 . . . . 1.8200000000000001 110.306 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.13 -37.05 29.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.157 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.13 -24.37 71.64 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.146 -0.549 . . . . 1.77 112.151 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.8 -32.29 57.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.097 -0.573 . . . . 2.0899999999999999 111.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -80.9 -5.01 56.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.12 0.486 . . . . 2.3999999999999999 110.705 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -90.97 -35.37 14.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.991 -0.55 . . . . 2.6099999999999999 110.745 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -75.7 117.18 17.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 2.7000000000000002 110.763 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.292 -0.861 . . . . 2.6200000000000001 111.02 -179.498 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.81000000000000005 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.543 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.85999999999999999 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.543 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77000000000000002 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.67000000000000004 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.69999999999999996 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.51000000000000001 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.47999999999999998 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.501 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.46999999999999997 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.59999999999999998 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.59999999999999998 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.586 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.62 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.41 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.58999999999999997 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.76000000000000001 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64000000000000001 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.66000000000000003 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.588 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.69999999999999996 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.418 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.60999999999999999 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.588 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.70999999999999996 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 1.05 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.65000000000000002 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.69999999999999996 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 1.03 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.489 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.88 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.486 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.22 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.75 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 1.03 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.67000000000000004 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.25 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.84999999999999998 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.70999999999999996 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.29 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.98999999999999999 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.466 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.461 HG21 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.67000000000000004 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.501 HG11 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.80000000000000004 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.57999999999999996 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.87 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.81999999999999995 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.4299999999999999 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 1.03 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.68999999999999995 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.1399999999999999 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.78000000000000003 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.54000000000000004 109.825 178.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.47999999999999998 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.485 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.53000000000000003 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.586 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.428 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.82999999999999996 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.3999999999999999 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.96999999999999997 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.27 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.23 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.485 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 1.04 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.8700000000000001 110.588 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.4099999999999999 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.98999999999999999 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.1200000000000001 110.111 178.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.5900000000000001 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.74 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -74.37 -19.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.47 111.641 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.18 -30.63 25.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 1.98 110.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.75 -45.07 30.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.868 -0.606 . . . . 2.25 110.476 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.65 -16.22 79.57 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.09 -0.576 . . . . 1.76 112.275 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.11 11.24 72.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.462 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -124.41 -32.0 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 2.4199999999999999 110.388 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.72 -10.95 54.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.97 -0.559 . . . . 2.6000000000000001 110.749 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.66 111.08 4.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.202 -0.454 . . . . 2.7799999999999998 110.087 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.361 -0.828 . . . . 2.5499999999999998 111.028 -179.386 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.82999999999999996 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.555 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.85999999999999999 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.555 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76000000000000001 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.68000000000000005 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.68000000000000005 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.5 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.46999999999999997 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.462 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46000000000000002 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.58999999999999997 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.59999999999999998 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.479 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.64000000000000001 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.62 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.79000000000000004 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.68999999999999995 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.70999999999999996 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.575 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.76000000000000001 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.66000000000000003 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.575 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.76000000000000001 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.23 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.63 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.72999999999999998 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.95999999999999996 111.05 -179.808 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.429 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.91000000000000003 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.43 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.4099999999999999 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.76000000000000001 110.984 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.89000000000000001 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.71999999999999997 111.471 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.27 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66000000000000003 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.87 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.72999999999999998 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.70999999999999996 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0700000000000001 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.45 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 1.1100000000000001 110.792 179.541 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.76000000000000001 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.462 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.92000000000000004 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.60999999999999999 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.66000000000000003 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.84999999999999998 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.3700000000000001 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.0800000000000001 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.72999999999999998 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.29 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.76000000000000001 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.54000000000000004 109.827 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.48999999999999999 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.529 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.53000000000000003 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' N ' HD11 ' A' ' 63' ' ' LEU . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67000000000000004 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.505 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.85999999999999999 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.3500000000000001 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.628 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.98999999999999999 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.3200000000000001 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.628 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.26 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.563 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 1.03 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.8899999999999999 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.3400000000000001 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.92000000000000004 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.0700000000000001 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.6100000000000001 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.74 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.8 pt -74.25 -23.16 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.3700000000000001 111.623 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.27 -23.18 30.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.47 -0.332 . . . . 1.8200000000000001 110.58 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.78 -38.12 62.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.1 -0.5 . . . . 2.21 110.634 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.49 78.07 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.392 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -86.26 -9.83 75.57 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.054 -0.593 . . . . 2.0899999999999999 112.581 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.68 -29.37 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 2.3999999999999999 110.451 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -83.24 -26.91 30.31 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.004 -0.544 . . . . 2.6099999999999999 110.966 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -71.54 114.75 9.95 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.901 0.381 . . . . 2.7000000000000002 110.688 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.403 -0.808 . . . . 2.6200000000000001 110.889 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.81000000000000005 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.85999999999999999 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77000000000000002 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.67000000000000004 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.69999999999999996 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.51000000000000001 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.47999999999999998 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.46999999999999997 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.59999999999999998 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.59999999999999998 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.617 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.42 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.58999999999999997 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.76000000000000001 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64000000000000001 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.66000000000000003 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.69999999999999996 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.60999999999999999 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.70999999999999996 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 1.05 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.65000000000000002 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.69999999999999996 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 1.03 110.532 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.43 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.88 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.429 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.22 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.75 111.116 -179.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 1.03 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.67000000000000004 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.25 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.84999999999999998 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.70999999999999996 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.29 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.98999999999999999 110.544 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.80000000000000004 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.437 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.67000000000000004 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.80000000000000004 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.57999999999999996 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.87 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.81999999999999995 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.4299999999999999 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 1.03 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.68999999999999995 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.1399999999999999 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.78000000000000003 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.54000000000000004 109.759 178.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.47999999999999998 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.457 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.53000000000000003 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.617 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.437 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.82999999999999996 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.3999999999999999 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.96999999999999997 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.27 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.23 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.457 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 1.04 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.8700000000000001 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.4099999999999999 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.98999999999999999 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.668 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.1200000000000001 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.5900000000000001 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.74 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.668 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt -70.56 -24.84 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.47 111.036 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.53 -0.56 40.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 1.98 110.514 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -99.6 -34.95 10.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.123 -0.49 . . . . 2.25 110.281 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.21 -19.73 71.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.76 112.676 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.7 -13.56 56.61 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.918 -0.658 . . . . 2.04 112.825 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -95.28 -30.71 13.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 2.4199999999999999 110.779 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -80.28 -18.02 50.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.277 -0.419 . . . . 2.6000000000000001 111.291 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.75 115.55 9.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.017 0.437 . . . . 2.7799999999999998 110.703 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.333 -0.842 . . . . 2.5499999999999998 110.76 -179.777 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.82999999999999996 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.85999999999999999 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76000000000000001 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.68000000000000005 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.68000000000000005 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.5 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.46999999999999997 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.494 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46000000000000002 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.58999999999999997 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.59999999999999998 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.64000000000000001 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.62 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.79000000000000004 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.68999999999999995 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.70999999999999996 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.76000000000000001 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.425 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.66000000000000003 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.76000000000000001 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.23 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.63 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.72999999999999998 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.95999999999999996 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.402 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.91000000000000003 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.4099999999999999 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.523 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.76000000000000001 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.89000000000000001 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.71999999999999997 111.683 -179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.27 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66000000000000003 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.87 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.72999999999999998 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.70999999999999996 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.0700000000000001 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.45 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 1.1100000000000001 110.655 179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79000000000000004 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.76000000000000001 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.494 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.92000000000000004 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.60999999999999999 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.66000000000000003 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.84999999999999998 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.3700000000000001 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.0800000000000001 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.72999999999999998 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.29 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.76000000000000001 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.54000000000000004 109.851 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.48999999999999999 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.501 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.53000000000000003 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67000000000000004 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.406 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.85999999999999999 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.3500000000000001 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.631 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.98999999999999999 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.3200000000000001 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.631 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.26 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.501 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 1.03 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.53 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.8899999999999999 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.3400000000000001 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.92000000000000004 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.0700000000000001 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.6100000000000001 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.74 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt -87.52 -3.05 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.3700000000000001 111.868 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -102.73 -37.8 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 1.8200000000000001 110.339 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -89.05 -35.96 16.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.136 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.15 -35.63 78.16 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.104 -0.569 . . . . 1.77 112.487 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -40.56 50.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.9 -0.667 . . . . 2.0899999999999999 111.837 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -68.59 -24.67 64.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.813 0.339 . . . . 2.3999999999999999 110.803 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -73.62 -41.31 62.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.973 -0.558 . . . . 2.6099999999999999 110.814 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -75.87 123.7 26.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.981 0.42 . . . . 2.7000000000000002 110.661 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 2.6200000000000001 110.923 -179.467 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.81000000000000005 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.85999999999999999 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77000000000000002 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.67000000000000004 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.69999999999999996 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.51000000000000001 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.47999999999999998 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.59999999999999998 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.59999999999999998 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.62 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.423 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.58999999999999997 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.76000000000000001 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.559 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64000000000000001 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.559 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.66000000000000003 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.69999999999999996 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.60999999999999999 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.70999999999999996 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 1.05 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.65000000000000002 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.69999999999999996 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.523 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 1.03 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.88 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.436 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.22 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.404 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.75 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 1.03 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.67000000000000004 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.25 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.84999999999999998 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.70999999999999996 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67000000000000004 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.29 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.98999999999999999 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.80000000000000004 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.41 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.67000000000000004 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.80000000000000004 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.57999999999999996 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.87 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.81999999999999995 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.4299999999999999 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 1.03 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.68999999999999995 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.421 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.1399999999999999 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.78000000000000003 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.54000000000000004 109.789 178.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.47999999999999998 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.462 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.53000000000000003 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . 0.41 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.82999999999999996 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.3999999999999999 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.96999999999999997 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.27 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.23 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.462 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 1.04 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.477 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.8700000000000001 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.4099999999999999 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.98999999999999999 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.408 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.1200000000000001 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.5900000000000001 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.74 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt -81.57 -6.27 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.47 111.839 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.17 -32.58 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 1.98 110.638 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.14 -40.02 11.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.007 -0.542 . . . . 2.25 110.122 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.76 -24.32 72.61 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.975 -0.557 . . . . 1.76 112.02 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.44 -14.5 80.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.071 -0.585 . . . . 2.04 112.054 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -81.89 -20.25 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.748 0.309 . . . . 2.4199999999999999 111.05 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -77.36 -20.42 54.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.073 -0.512 . . . . 2.6000000000000001 110.705 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.07 107.98 4.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.092 -0.504 . . . . 2.7799999999999998 110.235 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.314 -0.851 . . . . 2.5499999999999998 110.922 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.82999999999999996 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.85999999999999999 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76000000000000001 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.68000000000000005 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.68000000000000005 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.5 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.46999999999999997 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.619 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.58999999999999997 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.59999999999999998 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.442 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.64000000000000001 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.62 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.79000000000000004 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.557 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.68999999999999995 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.557 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.70999999999999996 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.579 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.76000000000000001 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.415 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.66000000000000003 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.76000000000000001 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.23 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.63 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.72999999999999998 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.95999999999999996 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.406 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.91000000000000003 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.4099999999999999 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.438 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.76000000000000001 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.89000000000000001 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.71999999999999997 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.27 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66000000000000003 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.87 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.72999999999999998 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.70999999999999996 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.0700000000000001 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.45 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.425 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 1.1100000000000001 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79000000000000004 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.76000000000000001 112.378 179.933 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.619 HG11 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.92000000000000004 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.60999999999999999 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.66000000000000003 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.84999999999999998 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.3700000000000001 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.0800000000000001 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.72999999999999998 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.29 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.76000000000000001 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.54000000000000004 109.838 178.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.48999999999999999 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.507 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.53000000000000003 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.469 ' N ' HD12 ' A' ' 63' ' ' LEU . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67000000000000004 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.85999999999999999 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.3500000000000001 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.98999999999999999 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.3200000000000001 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.26 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.507 ' CD1' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 1.03 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.8899999999999999 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.3400000000000001 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.92000000000000004 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.0700000000000001 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.6100000000000001 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.74 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt -80.22 -22.63 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.3700000000000001 110.653 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -102.78 22.64 13.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.92 -0.582 . . . . 1.8200000000000001 110.079 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -133.16 -66.79 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 2.21 110.198 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.77 90.46 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.583 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.28 -14.76 56.89 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.931 -0.652 . . . . 2.0899999999999999 112.417 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -79.13 -5.47 54.22 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 2.3999999999999999 110.994 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.95 -18.97 61.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.506 . . . . 2.6099999999999999 111.176 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.91 113.47 4.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.848 0.356 . . . . 2.7000000000000002 111.115 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.326 -0.845 . . . . 2.6200000000000001 110.758 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.81000000000000005 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.548 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.85999999999999999 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.548 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77000000000000002 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.67000000000000004 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.69999999999999996 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.51000000000000001 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.47999999999999998 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.46999999999999997 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.59999999999999998 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.59999999999999998 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.601 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.62 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.415 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.58999999999999997 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.76000000000000001 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64000000000000001 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.66000000000000003 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.584 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.69999999999999996 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.60999999999999999 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.70999999999999996 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 1.05 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.65000000000000002 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.69999999999999996 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.438 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 8.8 t30 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 1.03 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.88 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.406 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.22 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.75 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 1.03 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.67000000000000004 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.25 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.84999999999999998 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.70999999999999996 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67000000000000004 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.29 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.98999999999999999 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.67000000000000004 111.98 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.80000000000000004 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.57999999999999996 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.432 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.87 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.81999999999999995 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.4299999999999999 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 1.03 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.68999999999999995 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.432 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.1399999999999999 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.78000000000000003 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.54000000000000004 109.847 178.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.47999999999999998 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.503 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.53000000000000003 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.601 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.82999999999999996 112.743 -179.499 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.3999999999999999 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.96999999999999997 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.27 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.23 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.503 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 1.04 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.8700000000000001 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.4099999999999999 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.98999999999999999 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.1200000000000001 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.5900000000000001 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.74 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.431 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt -78.4 -10.9 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.47 111.947 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.13 -11.43 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 1.98 110.716 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.58 -38.0 7.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 2.25 110.298 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.66 58.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.017 -0.611 . . . . 1.76 112.218 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.59 -26.49 60.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.143 -0.551 . . . . 2.04 112.49 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -85.3 -27.17 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 2.4199999999999999 110.572 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -77.54 -30.12 52.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.947 -0.57 . . . . 2.6000000000000001 110.391 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 113.62 7.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.977 -0.556 . . . . 2.7799999999999998 110.174 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.417 -0.801 . . . . 2.5499999999999998 111.564 -179.016 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.82999999999999996 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.85999999999999999 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.68000000000000005 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.68000000000000005 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.5 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.46999999999999997 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.674 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46000000000000002 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.58999999999999997 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.59999999999999998 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.636 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.64000000000000001 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.62 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.487 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.79000000000000004 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.553 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.68999999999999995 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.553 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.70999999999999996 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.569 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.76000000000000001 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.424 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.66000000000000003 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.569 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.76000000000000001 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.23 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.63 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.72999999999999998 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.455 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.95999999999999996 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.91000000000000003 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.424 ' HB2' ' CG2' ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.4099999999999999 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.76000000000000001 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.89000000000000001 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.71999999999999997 111.158 179.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.27 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66000000000000003 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.87 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.72999999999999998 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.70999999999999996 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.0700000000000001 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.45 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.485 HG21 ' O ' ' B' ' 74' ' ' GLY . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 1.1100000000000001 110.936 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.76000000000000001 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.674 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.92000000000000004 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.60999999999999999 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.455 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.66000000000000003 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.84999999999999998 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.3700000000000001 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.0800000000000001 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.72999999999999998 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.29 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.76000000000000001 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.54000000000000004 109.833 179.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.48999999999999999 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.567 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.53000000000000003 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.636 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67000000000000004 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.85999999999999999 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.3500000000000001 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.638 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.98999999999999999 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.3200000000000001 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.638 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.26 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.567 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 1.03 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.495 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.8899999999999999 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.448 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.3400000000000001 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.92000000000000004 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.412 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.0700000000000001 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.6100000000000001 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.74 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.412 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt -71.02 -19.25 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 111.62 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.7 mt -83.11 -13.5 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.945 0.402 . . . . 1.8200000000000001 110.153 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -98.87 -43.77 6.61 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.864 -0.607 . . . . 2.21 110.176 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.5 61.62 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 1.77 112.307 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.13 -23.14 75.07 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.202 -0.523 . . . . 2.0899999999999999 112.177 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -81.45 -23.47 37.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.012 0.434 . . . . 2.3999999999999999 110.39 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.48 -24.56 45.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 2.6099999999999999 110.597 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.28 106.12 7.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.16 -0.473 . . . . 2.7000000000000002 110.033 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.283 -0.865 . . . . 2.6200000000000001 111.105 -179.295 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.81000000000000005 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.85999999999999999 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.67000000000000004 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.69999999999999996 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.51000000000000001 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.47999999999999998 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.46999999999999997 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.59999999999999998 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.59999999999999998 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.576 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.62 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.426 ' HB ' HD22 ' B' ' 56' ' ' LEU . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.58999999999999997 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.76000000000000001 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64000000000000001 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.66000000000000003 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.583 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.69999999999999996 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.60999999999999999 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.70999999999999996 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 1.05 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.65000000000000002 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 1.03 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.88 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 29.0 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.22 110.411 179.527 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.75 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 1.03 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.67000000000000004 111.148 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.25 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.84999999999999998 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.70999999999999996 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67000000000000004 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.29 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.98999999999999999 111.014 179.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.80000000000000004 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.67000000000000004 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.80000000000000004 110.699 178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.57999999999999996 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.87 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.81999999999999995 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.4299999999999999 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 1.03 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.68999999999999995 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.1399999999999999 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.78000000000000003 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.54000000000000004 109.811 178.153 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.47999999999999998 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.542 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.53000000000000003 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.576 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.82999999999999996 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.96999999999999997 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.27 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.627 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.23 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.542 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 1.04 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.8700000000000001 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.4099999999999999 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.98999999999999999 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.1200000000000001 110.226 178.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.5900000000000001 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.74 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.69 -23.37 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.47 111.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.8 -33.93 30.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 1.98 110.333 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.02 -32.38 26.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 2.25 110.212 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.23 -28.52 66.02 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.901 -0.591 . . . . 1.76 112.268 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . 0.485 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -74.39 -24.82 72.09 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.544 . . . . 2.04 111.983 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -88.02 -14.31 39.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 2.4199999999999999 110.405 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -92.94 -12.26 31.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.819 -0.628 . . . . 2.6000000000000001 111.054 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.09 113.98 7.8 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.819 0.342 . . . . 2.7799999999999998 110.399 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.33 -0.843 . . . . 2.5499999999999998 111.034 -179.503 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.82999999999999996 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.553 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.85999999999999999 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.553 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.68000000000000005 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.68000000000000005 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.5 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.46999999999999997 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.628 ' SG ' HG11 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46000000000000002 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.58999999999999997 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.59999999999999998 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.64000000000000001 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.429 ' HB ' HD22 ' A' ' 56' ' ' LEU . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.62 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.79000000000000004 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.555 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.68999999999999995 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.555 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.70999999999999996 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.574 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.76000000000000001 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.66000000000000003 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.76000000000000001 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.23 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.63 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.72999999999999998 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.95999999999999996 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.91000000000000003 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.4099999999999999 110.196 179.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.76000000000000001 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.89000000000000001 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.71999999999999997 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.27 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66000000000000003 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.87 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.72999999999999998 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.70999999999999996 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.0700000000000001 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.45 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 1.1100000000000001 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.458 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.76000000000000001 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.628 HG11 ' SG ' ' A' ' 15' ' ' CYS . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.92000000000000004 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.60999999999999999 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.401 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.66000000000000003 110.466 176.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.84999999999999998 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.3700000000000001 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.0800000000000001 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.72999999999999998 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.401 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.29 110.834 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.76000000000000001 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.54000000000000004 109.778 178.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.48999999999999999 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.511 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.53000000000000003 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67000000000000004 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.458 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.85999999999999999 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.3500000000000001 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.629 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.98999999999999999 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.3200000000000001 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.629 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.26 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 1.03 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.8899999999999999 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.3400000000000001 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.92000000000000004 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.445 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.0700000000000001 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.48 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.6100000000000001 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.74 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -82.66 -7.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.3700000000000001 111.858 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.6 -38.92 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 1.8200000000000001 110.429 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.91 -41.21 21.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 2.21 110.209 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.82 73.93 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.844 -0.617 . . . . 1.77 112.784 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.4 -26.33 70.46 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.09 -0.576 . . . . 2.0899999999999999 112.223 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.53 -27.95 25.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.039 0.447 . . . . 2.3999999999999999 110.4 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -82.49 -18.21 42.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.932 -0.577 . . . . 2.6099999999999999 110.792 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.36 122.21 18.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 2.7000000000000002 110.547 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 2.6200000000000001 111.066 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.81000000000000005 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.85999999999999999 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77000000000000002 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.67000000000000004 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.69999999999999996 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.51000000000000001 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.47999999999999998 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.465 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.46999999999999997 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.59999999999999998 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.59999999999999998 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.637 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.62 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.418 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.58999999999999997 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . 0.498 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.76000000000000001 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64000000000000001 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.66000000000000003 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.69999999999999996 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.416 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.60999999999999999 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.70999999999999996 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 1.05 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.65000000000000002 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.69999999999999996 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 1.03 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.88 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.459 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.22 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.75 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 1.03 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.67000000000000004 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.25 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.84999999999999998 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.70999999999999996 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.29 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.98999999999999999 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . 0.412 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.80000000000000004 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.67000000000000004 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.465 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.80000000000000004 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.57999999999999996 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.87 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.81999999999999995 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.4299999999999999 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 1.03 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.68999999999999995 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.1399999999999999 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.78000000000000003 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.54000000000000004 109.851 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.47999999999999998 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.544 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.53000000000000003 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.637 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.3999999999999999 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.96999999999999997 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.27 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.23 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.544 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 1.04 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.8700000000000001 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.4099999999999999 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.98999999999999999 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.471 HG22 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.1200000000000001 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . 0.492 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.5900000000000001 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.74 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.27 8.9 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.47 111.994 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 45.3 mt -108.26 -52.34 2.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.776 0.322 . . . . 1.98 110.632 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.26 -23.01 26.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 2.25 110.948 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.3 73.36 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.947 -0.644 . . . . 1.76 112.573 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.76 -28.08 43.98 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.938 -0.648 . . . . 2.04 112.391 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -63.72 -19.46 64.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 2.4199999999999999 111.208 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -78.17 -32.22 50.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.099 -0.501 . . . . 2.6000000000000001 110.666 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.14 118.19 11.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.266 -0.425 . . . . 2.7799999999999998 111.387 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 2.5499999999999998 110.852 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.82999999999999996 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.85999999999999999 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76000000000000001 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.68000000000000005 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.68000000000000005 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.5 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.46999999999999997 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.517 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46000000000000002 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.58999999999999997 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.59999999999999998 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.64000000000000001 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.427 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.62 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.79000000000000004 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.551 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.68999999999999995 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.551 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.70999999999999996 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.76000000000000001 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.422 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.66000000000000003 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.76000000000000001 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.23 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.63 111.427 -179.082 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.72999999999999998 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.95999999999999996 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.91000000000000003 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.4099999999999999 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.42 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.76000000000000001 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.89000000000000001 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.71999999999999997 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.406 HG23 HD13 ' A' ' 35' ' ' ILE . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.27 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66000000000000003 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.87 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.72999999999999998 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.70999999999999996 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.0700000000000001 110.87 -179.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.45 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 1.1100000000000001 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.517 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79000000000000004 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.76000000000000001 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.92000000000000004 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.60999999999999999 111.104 179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.66000000000000003 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.84999999999999998 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.3700000000000001 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.0800000000000001 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.72999999999999998 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.411 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.29 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.76000000000000001 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.54000000000000004 109.795 178.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.48999999999999999 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.53000000000000003 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67000000000000004 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.85999999999999999 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.3500000000000001 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.98999999999999999 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.3200000000000001 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.26 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.511 HD11 ' N ' ' A' ' 57' ' ' ASP . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 1.03 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.489 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.8899999999999999 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.3400000000000001 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.92000000000000004 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.489 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.0700000000000001 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.6100000000000001 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.74 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.87 -16.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.3700000000000001 111.907 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.38 -8.57 44.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.516 -0.311 . . . . 1.8200000000000001 111.17 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.79 -35.82 11.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.481 -0.327 . . . . 2.21 110.81 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.8 74.1 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.978 -0.629 . . . . 1.77 112.608 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.05 27.14 11.87 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.098 -0.572 . . . . 2.0899999999999999 112.467 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.5 -40.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 2.3999999999999999 110.533 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -69.32 -38.16 78.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.902 -0.59 . . . . 2.6099999999999999 111.136 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.19 115.53 13.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.352 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.318 -0.849 . . . . 2.6200000000000001 110.877 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.81000000000000005 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.549 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.85999999999999999 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.549 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77000000000000002 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.67000000000000004 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.69999999999999996 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.51000000000000001 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.47999999999999998 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.46999999999999997 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.59999999999999998 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.59999999999999998 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.62 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.417 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.58999999999999997 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.76000000000000001 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.552 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64000000000000001 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.552 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.66000000000000003 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.585 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.69999999999999996 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.454 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.60999999999999999 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.585 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.70999999999999996 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 1.05 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.65000000000000002 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.69999999999999996 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.42 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 t30 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 1.03 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.88 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.22 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.75 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 1.03 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.67000000000000004 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.25 111.051 179.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.84999999999999998 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.70999999999999996 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67000000000000004 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.29 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.98999999999999999 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.80000000000000004 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . 0.431 HG21 ' HB2' ' B' ' 56' ' ' LEU . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.67000000000000004 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.80000000000000004 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.57999999999999996 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 47' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.87 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.81999999999999995 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.4299999999999999 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 1.03 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.68999999999999995 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . 0.462 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.1399999999999999 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.78000000000000003 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.54000000000000004 109.812 178.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.47999999999999998 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.488 ' HB3' ' CD2' ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.53000000000000003 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.82999999999999996 112.983 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.3999999999999999 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.96999999999999997 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.27 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.23 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.488 ' CD2' ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 1.04 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.8700000000000001 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.4099999999999999 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . 0.454 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.98999999999999999 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.1200000000000001 109.972 178.357 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.5900000000000001 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.74 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -77.5 -13.39 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.47 111.452 -179.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.7 mt -99.24 -25.41 14.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.369 . . . . 1.98 110.568 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -91.73 -50.09 5.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 2.25 110.253 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.37 -25.27 73.3 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.973 -0.632 . . . . 1.76 112.174 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.56 -19.32 76.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.084 -0.579 . . . . 2.04 112.001 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -83.56 -19.93 34.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.03 0.443 . . . . 2.4199999999999999 110.267 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -74.83 -25.44 59.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.832 -0.622 . . . . 2.6000000000000001 110.694 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.54 117.42 9.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.447 -0.342 . . . . 2.7799999999999998 110.364 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.328 -0.844 . . . . 2.5499999999999998 110.996 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.82999999999999996 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.556 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.85999999999999999 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.556 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76000000000000001 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.68000000000000005 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.68000000000000005 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.5 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.46999999999999997 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46000000000000002 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.58999999999999997 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.64000000000000001 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.433 ' HG1' ' C ' ' A' ' 18' ' ' THR . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.62 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.79000000000000004 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.558 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.68999999999999995 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.558 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.70999999999999996 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.57 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.76000000000000001 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.444 ' HB3' HG21 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.66000000000000003 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.57 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.76000000000000001 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.23 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.63 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.72999999999999998 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.485 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 10.3 t30 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.95999999999999996 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.91000000000000003 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.4099999999999999 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.76000000000000001 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.89000000000000001 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.71999999999999997 111.022 179.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.27 110.996 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66000000000000003 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.87 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.70999999999999996 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 110.49 179.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.45 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 1.1100000000000001 110.549 179.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79000000000000004 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.76000000000000001 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.44 HG23 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.92000000000000004 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.60999999999999999 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.66000000000000003 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.84999999999999998 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.3700000000000001 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.0800000000000001 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.72999999999999998 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.505 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.29 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.76000000000000001 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.54000000000000004 109.818 178.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.48999999999999999 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.509 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.53000000000000003 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67000000000000004 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.85999999999999999 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.633 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.98999999999999999 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.3200000000000001 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.633 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.26 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.509 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 1.03 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . 0.47 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.8899999999999999 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.3400000000000001 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.92000000000000004 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.406 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.0700000000000001 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . 0.47 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.6100000000000001 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.74 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.444 HG21 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt -82.55 -1.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.3700000000000001 112.275 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . 0.405 ' HG ' ' O ' ' A' ' 67' ' ' ILE . 95.6 mt -97.23 -36.86 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 1.8200000000000001 110.728 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.98 -42.98 22.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 2.21 110.295 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.63 -23.47 70.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.965 -0.636 . . . . 1.77 112.022 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . 0.479 ' O ' HG21 ' B' ' 42' ' ' VAL . . . -75.65 -30.56 57.87 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.154 -0.546 . . . . 2.0899999999999999 112.287 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.93 -20.85 28.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 2.3999999999999999 110.597 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -81.84 -15.8 52.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.984 -0.553 . . . . 2.6099999999999999 110.771 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.21 105.77 3.07 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.079 -0.509 . . . . 2.7000000000000002 110.34 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.433 -0.794 . . . . 2.6200000000000001 111.065 -179.319 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.81000000000000005 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.544 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.85999999999999999 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.544 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77000000000000002 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.67000000000000004 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.69999999999999996 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.51000000000000001 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.47999999999999998 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.409 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.46999999999999997 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.59999999999999998 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.59999999999999998 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.62 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.412 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.58999999999999997 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.76000000000000001 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64000000000000001 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.66000000000000003 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.588 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.69999999999999996 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.60999999999999999 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.588 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.70999999999999996 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 1.05 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.65000000000000002 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.69999999999999996 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 1.03 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.88 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.457 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.22 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.75 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 1.03 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.67000000000000004 111.824 179.762 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.25 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.84999999999999998 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.70999999999999996 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67000000000000004 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.29 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 74' ' ' GLY . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.98999999999999999 111.464 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.67000000000000004 112.326 -178.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.409 HG11 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.80000000000000004 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.57999999999999996 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.87 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.81999999999999995 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.4299999999999999 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 1.03 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.68999999999999995 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.1399999999999999 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.78000000000000003 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.54000000000000004 109.726 178.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.47999999999999998 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.558 ' HB3' HD22 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.53000000000000003 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.82999999999999996 112.831 -179.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.3999999999999999 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.627 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.96999999999999997 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.27 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.627 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.23 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.558 HD22 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 1.04 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . 0.424 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.8700000000000001 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.4099999999999999 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.98999999999999999 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . 0.461 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.1200000000000001 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.5900000000000001 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.74 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 26.4 pt -86.9 -1.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.47 112.212 -179.289 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . 0.461 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 60.3 mt -98.05 -54.46 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 1.98 110.809 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -76.5 -29.01 56.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.08 -0.509 . . . . 2.25 110.313 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.85 -25.8 70.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.024 -0.608 . . . . 1.76 112.123 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.75 -32.0 54.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.098 -0.572 . . . . 2.04 112.375 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -81.15 -27.56 35.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 2.4199999999999999 110.542 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -76.25 -31.45 58.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.864 -0.607 . . . . 2.6000000000000001 110.611 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -78.01 126.93 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 2.7799999999999998 110.518 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 2.5499999999999998 110.922 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.82999999999999996 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ARG . . . . . 0.554 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.85999999999999999 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLU . . . . . 0.554 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76000000000000001 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.68000000000000005 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.68000000000000005 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.5 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.46999999999999997 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' CYS . . . . . 0.548 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46000000000000002 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.58999999999999997 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.59999999999999998 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.64000000000000001 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.432 ' HB ' HD22 ' A' ' 56' ' ' LEU . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.62 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.79000000000000004 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.55 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.68999999999999995 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' VAL . . . . . 0.55 ' HB ' ' CA ' ' A' ' 21' ' ' GLY . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.70999999999999996 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' HIS . . . . . 0.571 ' ND1' ' HB2' ' A' ' 25' ' ' LYS . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.76000000000000001 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.513 ' HB3' HG21 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.66000000000000003 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.76000000000000001 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.23 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.63 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.72999999999999998 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.95999999999999996 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' LEU . . . . . 0.412 ' HB2' HD11 ' A' ' 70' ' ' ILE . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.91000000000000003 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.4099999999999999 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.76000000000000001 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.89000000000000001 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.71999999999999997 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.27 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.87 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.72999999999999998 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.70999999999999996 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.0700000000000001 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.45 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 1.1100000000000001 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLU . . . . . 0.548 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79000000000000004 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.408 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.76000000000000001 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' VAL . . . . . 0.481 HG11 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.92000000000000004 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.60999999999999999 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.66000000000000003 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.84999999999999998 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.3700000000000001 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.0800000000000001 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.72999999999999998 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.29 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.76000000000000001 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . . . . . . . . . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.54000000000000004 109.814 178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.48999999999999999 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LEU . . . . . 0.524 ' HB3' ' CD2' ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.53000000000000003 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67000000000000004 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PRO . . . . . 0.408 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.85999999999999999 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.3500000000000001 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.637 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.98999999999999999 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.3200000000000001 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.26 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.524 ' CD2' ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 1.03 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.8899999999999999 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.3400000000000001 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.92000000000000004 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.0700000000000001 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.6100000000000001 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.74 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ILE . . . . . 0.513 HG21 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt -91.41 16.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.3700000000000001 112.19 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.84 -46.99 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 1.8200000000000001 110.444 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -87.55 -31.47 19.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.24 -0.436 . . . . 2.21 110.354 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.79 77.6 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.901 -0.59 . . . . 1.77 112.182 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -27.96 70.6 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.162 -0.542 . . . . 2.0899999999999999 112.265 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.34 -28.14 47.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.111 0.482 . . . . 2.3999999999999999 110.22 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -78.54 -32.47 47.95 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.673 -0.694 . . . . 2.6099999999999999 110.802 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.89 134.7 44.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.304 -0.407 . . . . 2.7000000000000002 110.87 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.377 -0.821 . . . . 2.6200000000000001 110.82 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.81000000000000005 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' ARG . . . . . 0.547 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.85999999999999999 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' GLU . . . . . 0.547 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77000000000000002 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.67000000000000004 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.69999999999999996 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.51000000000000001 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.47999999999999998 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' CYS . . . . . 0.509 ' SG ' HG11 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.46999999999999997 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.59999999999999998 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.59999999999999998 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' THR . . . . . 0.535 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.62 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' THR . . . . . 0.415 ' HB ' HD22 ' B' ' 56' ' ' LEU . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.58999999999999997 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.76000000000000001 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.554 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64000000000000001 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' VAL . . . . . 0.554 ' HB ' ' CA ' ' B' ' 21' ' ' GLY . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.66000000000000003 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' HIS . . . . . 0.586 ' ND1' ' HB2' ' B' ' 25' ' ' LYS . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.69999999999999996 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' PRO . . . . . 0.506 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.60999999999999999 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.70999999999999996 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 1.05 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.65000000000000002 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.69999999999999996 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' ASN . . . . . 0.517 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 1.03 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' LEU . . . . . 0.511 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.88 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLN . . . . . 0.426 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.22 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.75 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 1.03 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.67000000000000004 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.25 111.052 -179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.84999999999999998 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.70999999999999996 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67000000000000004 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.29 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.98999999999999999 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.80000000000000004 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.67000000000000004 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' VAL . . . . . 0.509 HG11 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.80000000000000004 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.57999999999999996 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.87 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.81999999999999995 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.4299999999999999 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 1.03 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.68999999999999995 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.1399999999999999 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.78000000000000003 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 54' ' ' ILE . . . . . . . . . . . . . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.54000000000000004 109.869 178.139 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.47999999999999998 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 56' ' ' LEU . . . . . 0.543 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.53000000000000003 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 57' ' ' ASP . . . . . 0.535 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.82999999999999996 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.3999999999999999 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.96999999999999997 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.27 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.23 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 63' ' ' LEU . . . . . 0.543 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 1.04 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.8700000000000001 110.625 179.435 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.4099999999999999 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.98999999999999999 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.1200000000000001 110.158 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.5900000000000001 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.74 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 70' ' ' ILE . . . . . 0.506 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt -74.96 -12.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.47 111.603 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.3 -31.24 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 1.98 110.532 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.06 -41.3 17.33 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.065 -0.516 . . . . 2.25 110.318 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.35 -28.53 61.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.054 -0.593 . . . . 1.76 112.03 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.86 42.4 2.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 2.04 111.982 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -152.39 -28.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.953 0.406 . . . . 2.4199999999999999 110.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -84.34 -26.51 28.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.873 -0.603 . . . . 2.6000000000000001 111.067 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -62.82 135.54 57.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 2.7799999999999998 111.32 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.262 -0.875 . . . . 2.5499999999999998 110.939 -179.88 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.81 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.84 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.65 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.66 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.49 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.45 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.57 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.57 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.61 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.76 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.69 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.69 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.73 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.64 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.74 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.08 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.58 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.69 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 2.6 t-20 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.78 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.74 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.16 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.62 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.73 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.66 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.625 HG23 ' HA ' ' A' ' 40' ' ' SER . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.14 111.206 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.81 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.73 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.71 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.625 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.07 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.29 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.83 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.66 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.69 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.58 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.65 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.79 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.23 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.05 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.7 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.19 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.69 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.53 109.778 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.49 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.51 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.86 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.35 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.95 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.24 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.19 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 0.89 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.71 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 24' ' ' PRO . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.91 111.118 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.05 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.52 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.58 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.37 112.058 -179.357 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.8 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.85 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.65 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.68 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.5 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.47 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.47 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.58 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.58 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.6 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.58 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.73 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.64 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.68 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.59 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.69 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 0.95 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.58 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.7 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 0.83 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.75 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.08 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.61 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.86 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.61 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.1 111.423 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.79 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.71 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.585 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.16 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.404 HG22 ' H ' ' B' ' 42' ' ' VAL . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.78 111.129 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.8 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.6 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.62 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.55 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.63 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.75 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 0.99 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.05 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.71 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.52 109.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.48 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.649 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.49 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.435 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.83 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.4 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.91 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.19 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.15 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 0.9 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.71 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.36 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.97 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.08 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.52 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.61 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.43 111.39 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.81 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.84 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.65 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.66 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.49 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.45 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.57 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.57 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.62 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.61 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.76 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.69 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.69 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.73 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.64 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.74 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.08 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.58 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.69 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.78 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 47.3 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.16 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.62 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.73 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.66 111.311 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.81 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.07 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.29 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 0.83 110.635 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.66 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.69 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.58 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.65 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.79 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.23 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.05 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.7 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.19 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.69 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 19' ' ' THR . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.53 109.847 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.49 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.51 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.86 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.35 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.95 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.24 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.19 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.89 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.71 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.29 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.91 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.05 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.52 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.58 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.37 112.609 -178.703 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.8 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.85 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.65 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.68 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.5 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.47 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.47 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.58 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.58 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.6 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.58 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.73 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.64 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.68 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.59 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.69 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 0.95 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.58 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.7 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 0.83 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.75 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.08 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.61 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.86 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.61 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.1 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.79 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.71 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.16 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.78 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.8 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.6 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.642 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.62 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.55 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.63 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.75 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 0.99 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.67 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.05 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.71 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.52 109.734 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.48 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.49 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.653 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.83 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.4 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.91 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.19 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.15 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 0.9 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.71 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.36 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.97 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.08 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.52 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.61 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.509 HG22 ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.43 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.81 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.84 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.65 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.66 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.49 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.45 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.57 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.57 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.61 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.76 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.69 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.69 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.73 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 70' ' ' ILE . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.64 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.74 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.08 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.58 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.69 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.275 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.74 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.16 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.62 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.73 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.66 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.14 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.81 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.73 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.71 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.07 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.29 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 0.83 110.552 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.66 112.101 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.69 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.58 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.65 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.79 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.05 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.7 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.19 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.69 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.53 109.822 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.49 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.687 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.51 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 44' ' ' VAL . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.86 112.072 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.35 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.95 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.24 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.19 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 0.89 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.71 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.29 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.91 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 64' ' ' LYS . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.05 110.048 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.58 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 24' ' ' PRO . 36.0 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.37 111.686 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.8 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.85 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.65 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.68 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.5 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.47 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.47 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.58 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.58 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.6 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.58 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.73 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.64 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.68 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.59 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.69 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 0.95 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.58 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.7 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 0.83 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.75 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.08 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.61 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.86 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.61 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' B' ' 40' ' ' SER . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.1 111.398 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.79 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.71 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.508 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.16 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.78 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.8 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.6 111.3 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.62 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.55 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.63 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.75 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.27 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.99 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.67 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.05 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.71 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.52 109.767 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.48 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.886 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.49 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' B' ' 44' ' ' VAL . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.83 111.648 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.4 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.91 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.19 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.15 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 0.9 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.71 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.36 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.439 ' O ' HG23 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.97 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.08 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.52 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.61 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt . . . . . 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.43 111.151 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.81 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.84 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.571 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.65 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.66 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.49 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.45 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.57 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.57 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.62 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.61 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.76 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.587 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.69 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.69 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.73 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB3' HG23 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.64 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.74 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.08 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.58 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.69 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.78 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.74 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.16 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.62 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.73 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.66 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.14 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.81 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.73 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.71 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.07 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.29 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 0.83 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 58' ' ' PRO . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.66 111.962 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.69 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.58 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.65 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.79 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.23 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.05 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.7 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.19 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.69 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.53 109.766 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.49 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.51 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.86 113.216 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.35 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.95 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.24 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.19 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 0.89 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.71 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.29 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.91 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.05 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.52 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.58 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.8 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.85 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.65 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.68 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.5 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.47 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.404 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.47 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.58 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.58 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.6 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.607 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.58 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.523 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.73 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.573 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.64 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.68 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.45 ' HB3' HG23 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.59 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.69 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 0.95 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.58 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.7 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 4.2 t-20 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 0.83 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.75 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' B' ' 45' ' ' VAL . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.08 110.878 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.61 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.86 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.61 111.251 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.42 HG23 ' HA ' ' B' ' 40' ' ' SER . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.1 111.456 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.79 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.71 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.42 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.16 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' B' ' 34' ' ' ALA . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.78 110.351 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.8 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.6 112.285 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.404 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.62 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.55 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.63 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.75 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.27 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 0.99 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.67 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.05 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.71 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.607 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.52 109.758 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.48 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.74 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.49 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.655 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.413 ' HG3' HG22 ' B' ' 44' ' ' VAL . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.83 112.175 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.4 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.91 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.19 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.15 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 0.9 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.36 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.97 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.461 HG12 ' O ' ' B' ' 63' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.08 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.52 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.61 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.43 112.083 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.81 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.84 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.65 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.66 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.49 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.45 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.57 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.57 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.62 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.61 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.76 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.69 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.69 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.73 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.64 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.74 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.08 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.58 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.69 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.78 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.74 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HB2' HG22 ' A' ' 45' ' ' VAL . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.16 110.581 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.62 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.73 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.66 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.81 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.73 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.71 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.07 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.29 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.83 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.433 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.66 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.69 110.859 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.58 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.65 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.79 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.23 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.05 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.7 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.19 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.69 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.53 109.808 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.49 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.906 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.51 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.529 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.86 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.35 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.95 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.24 113.339 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.19 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.906 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 0.89 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.71 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.29 113.076 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.91 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.05 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.52 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.58 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.37 111.355 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.8 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.85 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.65 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.68 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.5 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.47 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.47 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.58 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.58 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.6 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.604 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.58 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.73 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.64 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.68 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.451 ' HB3' HG23 ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.59 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.69 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 0.95 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.58 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.7 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 0.83 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.75 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.08 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.61 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.86 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.61 111.762 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.1 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.79 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.71 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.16 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 34' ' ' ALA . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.78 110.983 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.6 111.957 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.62 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.55 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.63 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.75 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.27 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.67 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.05 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.71 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.604 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.52 109.848 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.48 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.49 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.83 111.886 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.4 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.91 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.19 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.15 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 0.9 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.71 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.36 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.97 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.08 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.52 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.61 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.43 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.81 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.84 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.65 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.66 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.49 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.45 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.57 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.57 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.62 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.61 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.76 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.69 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.69 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.73 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.64 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.74 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.08 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.58 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.69 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.78 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.74 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.16 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.62 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.73 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.66 111.618 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.14 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.81 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.73 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.71 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.07 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 0.83 111.118 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 58' ' ' PRO . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.66 112.119 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.69 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.58 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.65 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.79 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.23 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.05 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.7 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.19 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.69 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.53 109.84 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.49 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.51 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 44' ' ' VAL . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.86 112.471 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.35 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.95 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.24 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.19 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.89 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.71 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.29 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.91 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.575 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.05 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.52 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.58 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.37 111.19 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.8 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.85 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.65 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.68 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.5 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.47 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.47 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.58 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.58 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.6 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.58 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.73 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.64 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.68 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.59 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.69 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 0.95 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.58 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 25.7 t-20 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 0.83 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.75 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.08 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.61 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 0.86 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.61 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' B' ' 40' ' ' SER . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.1 110.965 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.79 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.71 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 35' ' ' ILE . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.16 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.78 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.8 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.6 112.316 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.62 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.55 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.63 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.75 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.27 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 0.99 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.05 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.71 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.52 109.834 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.48 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.724 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.49 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' B' ' 44' ' ' VAL . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.83 112.782 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.4 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.91 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.19 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.15 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.724 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 0.9 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.71 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.36 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.97 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.08 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.52 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.61 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.43 112.059 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.81 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.84 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.65 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.66 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.49 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.45 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.57 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.57 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.62 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.61 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.76 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.69 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.69 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.73 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.64 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.74 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.08 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.58 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.69 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 47' ' ' SER . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.78 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.74 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB2' HG22 ' A' ' 45' ' ' VAL . 50.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.16 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.62 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.73 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.66 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' HA ' ' A' ' 40' ' ' SER . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.14 111.305 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.81 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.73 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.71 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.07 110.653 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 0.83 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.66 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.69 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.58 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.65 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.79 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.23 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.05 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.7 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.19 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.69 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.53 109.786 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.49 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.51 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.86 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.35 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.95 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.24 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.19 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 0.89 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.71 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.29 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.91 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.05 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.52 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.58 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.37 111.213 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.8 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.85 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.65 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.68 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.5 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.47 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.47 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.58 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.58 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.6 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.58 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.73 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.731 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.64 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.731 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.68 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.59 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.69 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 0.95 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.58 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.7 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.431 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.83 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.75 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.455 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.08 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.61 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.86 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.61 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.1 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.79 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.71 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.16 110.552 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.78 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.8 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.6 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.62 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.55 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.63 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.75 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.27 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 0.99 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.67 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.05 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.71 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.52 109.742 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.48 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.871 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.49 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.582 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.83 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.4 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.91 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.19 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.15 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 0.9 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.71 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.36 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.97 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' B' ' 64' ' ' LYS . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.08 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.52 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.61 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.43 111.364 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.81 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.84 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.65 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.66 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.49 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.45 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.57 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.57 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.62 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' A' ' 54' ' ' ILE . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.61 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.76 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.69 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.69 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.73 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.64 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.74 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.08 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.58 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.69 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.78 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.16 110.447 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.73 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.66 111.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.693 HG23 ' HA ' ' A' ' 40' ' ' SER . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.14 111.425 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.81 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.73 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.71 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.693 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.07 110.511 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 34' ' ' ALA . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 0.83 110.767 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.66 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.69 110.857 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.58 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.65 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.79 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.23 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.05 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.7 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.19 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.69 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.53 109.755 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.49 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.51 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.86 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.35 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.95 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.24 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.19 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 0.89 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.71 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.29 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.05 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.52 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.58 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.37 111.718 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.8 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.85 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.65 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.68 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.5 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.47 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.47 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.58 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.58 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.6 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.58 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.73 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.64 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.68 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.59 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.69 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 26' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 0.95 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.58 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.7 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 0.83 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.75 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.08 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.61 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.86 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.61 111.262 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' B' ' 40' ' ' SER . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.1 110.982 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.79 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.545 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.16 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 34' ' ' ALA . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.78 110.29 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.8 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.6 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.62 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.55 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.63 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 48' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.75 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.27 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.99 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.67 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.05 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.71 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.52 109.762 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.48 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.587 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.49 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.83 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.4 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.91 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 61' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.19 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.15 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 0.9 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.71 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' ' 62' ' ' PHE . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.36 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.97 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.08 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.52 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.61 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.43 112.202 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.81 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.84 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.65 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.66 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.49 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.45 111.463 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.57 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.57 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.62 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 54' ' ' ILE . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.61 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.76 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.69 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.69 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.73 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.64 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.74 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.08 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.58 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.69 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.78 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.74 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.16 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.62 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.73 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.66 111.34 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.14 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.81 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.73 112.964 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.71 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.07 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 34' ' ' ALA . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 0.83 111.253 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.66 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.69 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.58 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.65 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.79 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.23 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.05 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.7 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.19 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.69 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.53 109.841 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.49 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.51 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.86 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.35 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.95 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.24 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.642 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.19 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.89 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.71 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.29 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.91 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 64' ' ' LYS . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.52 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.58 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.37 111.769 -179.652 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.8 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.85 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.65 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.68 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.5 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.47 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.431 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.47 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.58 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.58 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.6 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.58 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.73 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.64 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.68 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.59 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.69 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 0.95 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.58 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.7 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 0.83 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.75 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.08 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.61 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.86 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.61 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.1 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.79 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.71 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.78 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.431 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.8 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.6 112.243 -178.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.62 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.63 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.75 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.27 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 0.99 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.67 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.05 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.71 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.52 109.713 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.48 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.49 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HG3' HG22 ' B' ' 44' ' ' VAL . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.83 112.832 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.4 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.91 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.19 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.15 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 0.9 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.71 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.36 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.97 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.08 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.52 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.61 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt . . . . . 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.43 111.606 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.81 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.84 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.65 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.66 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.49 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.45 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.57 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.57 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.61 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.76 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.69 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.69 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.73 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.64 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.74 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.08 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.58 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.69 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.78 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.74 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' HG22 ' A' ' 45' ' ' VAL . 48.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.16 110.188 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.62 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.73 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.66 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.14 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.81 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.73 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.71 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.07 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.29 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.83 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.66 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.69 110.798 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.58 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.65 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.79 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.23 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.7 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.19 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.69 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.53 109.917 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.767 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.51 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.86 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.35 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.95 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.24 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.19 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 0.89 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.71 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.29 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.91 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.05 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.52 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.58 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt . . . . . 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.37 111.169 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.8 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.85 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.65 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.68 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.5 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.47 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.47 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.58 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.58 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.6 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.58 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.73 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.64 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.68 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.59 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.69 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 0.95 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.58 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.7 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 0.83 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.75 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.08 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.61 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.86 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.61 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.1 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.79 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.71 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.16 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.78 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.8 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.6 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.62 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.55 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.63 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.75 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.27 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.99 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.05 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.71 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.52 109.775 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.48 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.83 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.4 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.91 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.19 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.15 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 0.9 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.71 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.36 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.97 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.08 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.52 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.61 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.43 112.187 -179.371 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.81 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.84 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.65 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.66 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.49 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.45 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.57 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.57 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 54' ' ' ILE . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.61 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.76 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.69 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.69 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.73 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.64 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.74 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.08 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.58 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.69 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.78 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.74 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.551 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.16 110.215 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.62 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.73 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.66 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.14 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.81 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.71 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.07 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.29 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 0.83 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 58' ' ' PRO . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.66 112.383 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.69 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.58 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.65 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.79 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.23 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.7 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.19 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.69 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.53 109.809 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.49 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.51 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.594 ' HG3' HG22 ' A' ' 44' ' ' VAL . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.86 111.978 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.35 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.95 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.24 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.19 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 0.89 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.71 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.29 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.91 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.05 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.52 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.58 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.37 111.715 -179.575 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.8 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.85 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.65 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.68 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.5 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.47 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.47 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.58 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.58 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.6 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.58 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.73 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.64 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.68 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.59 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.69 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 0.95 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.58 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 0.83 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' B' ' 45' ' ' VAL . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.08 110.465 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.61 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.86 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.61 111.031 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.79 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.71 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.16 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' B' ' 34' ' ' ALA . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.78 110.712 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.8 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.6 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.62 110.791 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.55 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.63 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.75 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.27 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.99 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.67 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.05 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.71 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.52 109.821 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.48 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.49 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.481 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.83 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.4 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.91 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.19 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.15 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 0.9 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.71 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.36 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.97 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.08 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.52 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.61 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.43 111.614 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.81 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.84 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.65 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.66 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.49 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.45 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.57 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.57 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.62 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.61 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.76 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.69 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.69 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.73 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.64 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.74 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.08 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.58 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.69 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.78 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.74 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' HB2' HG22 ' A' ' 45' ' ' VAL . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.16 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.62 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.73 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.66 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.14 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.81 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.73 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.71 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.07 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.29 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.83 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.66 112.278 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.69 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.58 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.65 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.79 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.23 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.05 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.7 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.19 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.69 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.53 109.839 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.49 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.51 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.86 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.35 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.95 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.24 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.19 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.89 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.71 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.29 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.91 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.05 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.52 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.58 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.37 111.577 -179.599 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.8 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.85 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.65 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.68 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.47 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.47 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.58 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.58 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.6 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.599 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.58 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.73 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.64 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.68 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.59 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.595 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.69 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 0.95 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.58 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 0.83 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.75 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.61 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.61 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.1 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.79 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.71 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.16 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.78 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.477 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.8 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.6 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.62 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.55 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.63 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.75 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.99 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.67 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.05 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.71 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.599 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.52 109.825 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.48 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.793 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.49 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.83 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.4 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.91 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.19 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.15 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 0.9 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' B' ' 67' ' ' ILE . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.71 110.588 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.36 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.97 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' B' ' 64' ' ' LYS . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.08 110.111 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.52 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.61 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.43 111.641 -179.62 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.81 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.84 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.65 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.66 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.49 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.45 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.57 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.57 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.62 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.61 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.76 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.69 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.69 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.721 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.73 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.64 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.74 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.08 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.58 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.69 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.78 111.05 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.74 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.16 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.62 110.984 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.73 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.66 111.471 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.14 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.81 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.73 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.71 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.07 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.29 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.83 110.792 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.66 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.69 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.58 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.65 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.79 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.23 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.05 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.7 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.19 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.69 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.53 109.827 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.49 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.51 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.86 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.35 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.95 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.19 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 0.89 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.71 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.29 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.91 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.05 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.52 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.58 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 24' ' ' PRO . 38.8 pt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.37 111.623 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.8 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.85 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.65 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.68 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.5 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.47 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.47 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.58 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.58 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.6 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.58 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.73 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.64 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.68 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.59 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.69 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 0.95 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.58 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.7 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 0.83 110.532 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.75 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.08 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.61 111.116 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.86 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.61 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.1 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.79 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.71 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.16 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.78 110.544 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.8 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.6 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.62 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.55 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.63 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.75 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.27 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 0.99 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.67 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.05 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.71 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.52 109.759 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.48 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.736 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.49 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.625 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.83 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.4 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.91 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.19 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.15 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 0.9 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.71 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.36 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.97 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.681 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.08 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.52 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.61 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.43 111.036 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.81 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.84 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.65 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.66 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.49 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.45 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.57 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.57 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.62 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.61 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.76 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.69 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.69 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.714 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.73 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.64 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.74 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.08 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.58 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.69 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.78 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.74 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.16 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.62 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.73 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.66 111.683 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.14 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.81 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.73 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.71 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.07 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.29 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 34' ' ' ALA . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 0.83 110.655 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.66 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.69 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.58 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.65 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.79 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.05 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.7 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.19 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.69 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.53 109.851 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.49 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.86 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.35 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.95 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.24 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.19 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 0.89 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.71 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.91 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.05 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.52 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.58 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.37 111.868 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.8 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.85 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.65 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.68 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.5 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.47 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.47 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.58 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.58 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.6 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.58 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.73 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.64 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.68 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.59 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.69 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 0.95 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.58 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.7 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 0.83 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.75 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.08 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.61 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.61 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.1 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.79 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.71 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.16 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.78 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.8 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.6 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.62 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.55 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.63 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.75 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.27 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.99 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.67 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.05 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.71 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.52 109.789 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.48 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.49 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.83 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.4 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.91 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.19 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.15 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 0.9 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.71 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.36 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.97 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.08 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.52 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.61 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.43 111.839 -179.297 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.81 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.84 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.65 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.66 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.49 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.45 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.57 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.57 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.62 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 54' ' ' ILE . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.61 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.76 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.69 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.728 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.69 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.728 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.73 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.64 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.74 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.08 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.58 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.69 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.78 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.74 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.16 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.62 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.73 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.66 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.14 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.81 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.73 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.71 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.07 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.29 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 0.83 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.66 112.378 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.624 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.69 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.58 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.65 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.79 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.23 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.7 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.19 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.69 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.53 109.838 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.49 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.51 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.86 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.35 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.95 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.24 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.19 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 0.89 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.71 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.29 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.91 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.05 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.52 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.58 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.37 110.653 179.672 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.8 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.85 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.65 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.68 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.5 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.47 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.47 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.58 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.58 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.6 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.606 HG21 HD12 ' B' ' 54' ' ' ILE . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.58 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.73 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.736 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.64 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.736 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.68 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.59 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.69 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 0.95 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.58 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.7 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 18.2 t-20 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 0.83 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.75 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.08 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.61 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.86 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.61 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.1 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.79 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.71 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.16 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.78 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.8 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.6 111.98 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.62 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.55 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.63 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.75 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.27 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.99 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.67 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.05 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.71 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.606 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.52 109.847 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.48 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.49 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.83 112.743 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.4 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.91 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.19 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.15 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.9 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.71 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.36 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.97 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.08 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.52 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.61 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt . . . . . 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.43 111.947 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.81 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.84 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.65 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.66 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.49 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.45 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.678 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.57 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.57 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.62 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.61 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.76 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.69 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.69 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.73 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.64 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.74 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.08 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.58 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.69 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.78 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.74 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.16 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.62 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.73 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.66 111.158 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.14 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.81 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.73 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.71 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.07 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.29 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 34' ' ' ALA . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 0.83 110.936 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.66 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.678 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.69 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.58 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.65 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.79 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.7 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.19 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.69 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.53 109.833 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.49 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.51 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.649 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.86 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.35 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.95 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.19 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 0.89 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.71 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.29 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.91 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.05 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.52 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.58 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.37 111.62 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.8 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.85 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.65 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.68 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.5 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.47 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.47 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.58 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.6 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.58 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.73 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.64 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.68 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.59 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.69 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 0.95 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.58 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.7 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 0.83 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.75 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.48 ' HB2' HG22 ' B' ' 45' ' ' VAL . 27.8 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.08 110.411 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.61 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.86 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.61 111.148 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.1 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.79 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.71 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.16 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 34' ' ' ALA . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.78 111.014 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.8 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.6 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.62 110.699 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.55 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.63 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.75 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.27 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 0.99 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.67 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.05 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.71 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.52 109.811 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.48 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.49 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.83 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.4 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.643 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.91 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.19 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.643 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.15 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 0.9 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.36 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.97 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.08 110.226 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.61 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.43 111.624 -179.839 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.81 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.84 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.65 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.66 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.49 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.45 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.57 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.57 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.62 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.61 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.76 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.69 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.69 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.73 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.64 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.74 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.08 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.58 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.69 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.78 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.74 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.655 ' HB2' HG23 ' A' ' 45' ' ' VAL . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.16 110.196 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.62 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.73 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.66 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.14 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.81 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.73 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.71 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.07 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.29 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 0.83 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.66 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 31' ' ' GLN . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.69 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.58 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.65 110.466 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.79 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.7 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.19 110.834 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.69 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.53 109.778 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.49 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.869 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.51 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.86 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.35 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.95 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.24 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.19 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.89 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.71 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.29 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.91 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.05 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.52 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.58 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.37 111.858 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.8 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.85 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.65 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.68 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.5 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.47 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.47 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.58 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.58 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.6 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.58 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' GLN . . . . . 0.526 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.73 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.64 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.68 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.59 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.594 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.69 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 0.95 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.58 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.7 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 0.83 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.75 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.603 ' HB2' HG22 ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.08 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.61 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.86 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.61 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.1 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.79 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.71 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.16 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.78 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 43' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.8 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.6 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.62 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.55 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.63 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.75 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.27 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 0.99 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.67 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.05 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.71 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.52 109.851 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.48 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.647 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.49 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.646 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.83 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.4 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.91 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.19 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.15 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 0.9 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.71 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.36 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.97 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.474 HG23 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.08 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.52 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.61 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.43 111.994 -179.533 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.81 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.84 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.65 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.66 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.49 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.45 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.57 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.57 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.62 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.61 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.76 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.69 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.69 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.73 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.64 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.74 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.08 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 46' ' ' ALA . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.427 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.69 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.78 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.74 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.16 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.62 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.73 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.66 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 40' ' ' SER . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.14 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.81 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.73 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.71 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.598 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.07 110.87 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.29 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 0.83 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.66 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.69 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 27' ' ' ILE . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.58 111.104 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.65 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.79 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.05 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.7 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.19 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.69 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.53 109.795 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.49 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.51 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.564 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.86 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.35 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.95 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.24 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.19 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 0.89 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.71 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.29 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.91 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.05 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.52 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.58 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.37 111.907 -179.476 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.8 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.85 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.65 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.68 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.5 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.47 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.47 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.58 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.58 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.6 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.608 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.58 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.73 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.64 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.68 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.59 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.69 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 0.95 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.58 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.7 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 t-20 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 0.83 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.75 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.61 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.86 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.61 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' B' ' 40' ' ' SER . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.1 111.051 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.79 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.71 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.16 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.78 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.8 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.6 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.62 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.55 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 47' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.63 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.75 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.27 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 0.99 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.67 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.05 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.71 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.608 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.52 109.812 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.48 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.49 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.587 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.447 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.83 112.983 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.4 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.91 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.19 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.15 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.71 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.36 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.97 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 70' ' ' ILE . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.08 109.972 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.52 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.61 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 67' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.43 111.452 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.81 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.84 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.65 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.66 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.49 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.45 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.57 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.57 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.61 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.76 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.69 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.69 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.73 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' HG23 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.64 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.74 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.08 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.58 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.69 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 24.9 t-20 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.78 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.74 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.16 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.62 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.73 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.66 111.022 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' SER . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.14 110.996 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.81 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.71 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.482 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.07 110.49 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.29 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 34' ' ' ALA . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 0.83 110.549 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.66 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.69 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.58 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.65 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.79 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.23 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.7 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.19 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.69 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.53 109.818 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.49 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.832 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.51 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.86 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.35 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.95 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.24 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.19 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 0.89 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.71 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.29 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.91 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.52 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.58 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.37 112.275 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.8 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.85 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.65 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.68 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.5 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.47 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.47 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.58 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.58 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.6 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.596 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.58 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.73 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.64 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.68 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.59 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.69 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 0.95 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.58 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.7 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 0.83 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.75 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.61 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.86 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.61 111.824 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.1 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.79 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.71 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.16 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' B' ' 34' ' ' ALA . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.78 111.464 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.8 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.6 112.326 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.62 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.55 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.63 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.75 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.27 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.99 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.67 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.05 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.71 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.596 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.52 109.726 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.48 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.49 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' B' ' 44' ' ' VAL . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.83 112.831 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.4 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.91 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.19 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.15 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 0.9 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.71 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.36 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.97 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.08 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.52 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.61 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.4 pt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.43 112.212 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.81 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.84 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.65 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.66 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.49 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.45 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.57 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.57 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.62 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.61 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.76 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.69 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.69 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.73 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HB3' HG23 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.64 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.74 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.08 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.58 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.69 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.78 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.74 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.16 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.62 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.73 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.66 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.14 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.81 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.73 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.71 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.07 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 0.83 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 56' ' ' LEU . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.66 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.69 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.58 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.65 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.79 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.7 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.19 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.69 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.53 109.814 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.49 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LEU . . . . . 0.868 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.51 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.86 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.35 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.95 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.24 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.19 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 0.89 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.71 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.29 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.91 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.05 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.52 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.58 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.37 112.19 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.8 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.85 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.65 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.68 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.5 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.47 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.47 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.58 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.58 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.6 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.58 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.73 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.64 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.68 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' PRO . . . . . 0.541 ' HB3' HG23 ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.59 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.69 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 0.95 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.58 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.7 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 0.83 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.75 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.08 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.61 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.61 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 35' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.1 111.052 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.79 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.71 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.16 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.78 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.8 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.6 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 45' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.62 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.55 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.63 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.75 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 0.99 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.67 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.05 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.71 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.52 109.869 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.48 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 56' ' ' LEU . . . . . 0.716 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.49 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 57' ' ' ASP . . . . . 0.538 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.83 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.4 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.91 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.19 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.15 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 63' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 0.9 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' B' ' 67' ' ' ILE . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.71 110.625 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.36 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.97 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.08 110.158 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.52 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.61 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 70' ' ' ILE . . . . . 0.541 HG23 ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.43 111.603 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.81 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.84 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.65 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.66 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.49 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.45 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.57 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.57 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.61 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.76 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.69 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.69 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.73 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.64 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.74 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.08 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.58 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.69 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 2.6 t-20 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.78 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.74 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.16 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.62 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.73 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.66 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.625 HG23 ' HA ' ' A' ' 40' ' ' SER . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.14 111.206 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.81 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.73 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.71 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.625 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.07 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.29 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.83 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.66 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.69 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.58 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.65 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.79 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.23 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.05 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.7 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.19 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.69 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.53 109.778 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.49 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.51 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.86 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.35 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.95 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.24 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.19 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 0.89 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.71 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 24' ' ' PRO . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.91 111.118 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.05 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.52 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.58 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.45 -5.68 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.37 112.058 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -98.92 -38.43 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.679 -0.237 . . . . 1.67 110.937 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.24 -31.05 25.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 2.21 110.724 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.08 -15.64 81.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.94 -0.647 . . . . 1.77 112.36 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.89 32.3 4.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.092 -0.575 . . . . 2.09 112.433 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.75 -20.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 2.29 110.648 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -77.85 -38.23 46.59 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.113 -0.494 . . . . 2.44 110.743 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -80.09 106.39 12.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.266 -0.425 . . . . 2.7 110.028 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.322 -0.847 . . . . 2.56 111.085 -179.461 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.8 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.85 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.65 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.68 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.5 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.47 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.47 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.58 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.58 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.6 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.58 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.73 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.64 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.68 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.59 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.69 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 0.95 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.58 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.7 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 0.83 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.75 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.08 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.61 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.86 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.61 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.1 111.423 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.79 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.71 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.585 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.16 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.404 HG22 ' H ' ' B' ' 42' ' ' VAL . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.78 111.129 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.8 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.6 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.62 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.55 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.63 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.75 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 0.99 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.05 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.71 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.52 109.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.48 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.649 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.49 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.435 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.83 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.4 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.91 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.19 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.15 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 0.9 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.71 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.36 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.97 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.08 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.52 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.61 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt -79.5 -3.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.43 111.39 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.2 mt -100.93 -32.13 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.79 110.213 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.2 -42.0 24.16 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.047 -0.524 . . . . 2.25 110.367 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.52 -15.33 78.37 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.834 -0.698 . . . . 1.76 112.772 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.28 -0.7 84.7 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.03 -0.605 . . . . 2.04 113.197 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -127.95 -0.4 5.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.009 0.433 . . . . 2.32 110.654 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -80.12 -27.29 39.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 2.46 111.109 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.56 123.83 23.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.966 0.412 . . . . 2.78 110.837 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.29 -0.862 . . . . 2.48 110.68 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.81 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.84 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.65 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.66 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.49 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.45 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.57 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.57 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.62 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.61 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.76 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.69 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.69 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.73 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.64 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.74 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.08 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.58 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.69 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 25.4 t-20 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.78 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 47.3 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.16 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.62 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.73 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.66 111.311 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.14 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.81 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.71 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.07 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.29 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 0.83 110.635 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.66 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.69 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.58 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.65 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.79 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.23 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.05 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.7 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.19 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.69 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 19' ' ' THR . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.53 109.847 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.49 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.51 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.86 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.35 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.95 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.24 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.19 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.89 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.71 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.29 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.91 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.05 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.52 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.58 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt -74.92 -2.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.37 112.609 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.0 mt -96.23 -15.16 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 1.67 110.43 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -93.2 -61.9 1.48 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.851 -0.613 . . . . 2.21 110.176 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.89 -17.15 75.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.924 -0.655 . . . . 1.77 112.768 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.6 -1.83 89.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.005 -0.617 . . . . 2.09 112.858 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -119.96 -19.19 7.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 2.29 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.03 -17.62 42.66 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.045 -0.525 . . . . 2.44 111.186 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.87 120.92 16.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.848 0.356 . . . . 2.7 110.947 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.278 -0.867 . . . . 2.56 110.806 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.8 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.85 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.65 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.68 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.5 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.47 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.47 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.58 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.58 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.6 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.58 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.73 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.64 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.68 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.59 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.69 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 0.95 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.58 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.7 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 0.83 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.75 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.08 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.61 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.86 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.61 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.1 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.79 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.71 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.16 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.78 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.8 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.6 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.642 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.62 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.55 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.63 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.75 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 0.99 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.67 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.05 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.71 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.52 109.734 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.48 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.49 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.653 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.83 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.4 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.91 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.19 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.15 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 0.9 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.71 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.36 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.97 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.08 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.52 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.61 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.509 HG22 ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt -72.83 -20.66 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.43 111.136 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -88.42 -26.96 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 1.79 109.982 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.87 -40.89 24.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.845 -0.616 . . . . 2.25 110.258 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.7 -9.42 61.28 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.868 -0.682 . . . . 1.76 112.672 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.36 -33.49 25.52 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.107 -0.568 . . . . 2.04 112.885 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -93.99 9.48 37.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 2.32 110.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -81.7 -18.46 44.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.13 -0.486 . . . . 2.46 110.586 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 99.89 2.93 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.138 -0.483 . . . . 2.78 110.273 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.345 -0.836 . . . . 2.48 110.925 -179.457 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.81 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.84 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.65 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.66 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.49 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.45 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.57 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.57 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.61 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.76 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.69 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.69 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.73 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 70' ' ' ILE . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.64 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.74 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.08 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.58 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.69 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.78 110.275 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.74 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.16 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.62 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.73 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.66 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.14 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.81 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.73 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.71 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.07 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.29 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' B' ' 75' ' ' ASN . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 0.83 110.552 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.66 112.101 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.69 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.58 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.65 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.79 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.05 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.7 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.19 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.69 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.53 109.822 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.49 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.687 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.51 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 44' ' ' VAL . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.86 112.072 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.35 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.95 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.24 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.19 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 0.89 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.71 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.29 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.91 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 64' ' ' LYS . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.05 110.048 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.58 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 24' ' ' PRO . 36.0 pt -70.13 -24.4 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.37 111.686 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.55 -18.41 38.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.391 . . . . 1.67 110.658 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.59 -47.15 13.42 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.997 -0.547 . . . . 2.21 110.67 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 -17.85 72.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.083 -0.58 . . . . 1.77 112.665 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.29 21.45 34.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.901 -0.666 . . . . 2.09 112.794 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.73 -20.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 2.29 110.793 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -82.63 -25.11 33.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.356 -0.384 . . . . 2.44 111.473 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.75 7.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.917 0.389 . . . . 2.7 111.102 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.34 -0.838 . . . . 2.56 110.777 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.8 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.85 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.65 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.68 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.5 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.47 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.47 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.58 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.58 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.6 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.58 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.73 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.64 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.68 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.59 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.69 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 0.95 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.58 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.7 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 22.1 t-20 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 0.83 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.75 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.08 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.61 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.86 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.61 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' B' ' 40' ' ' SER . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.1 111.398 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.79 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.71 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.508 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.16 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.78 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.8 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.6 111.3 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.62 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.55 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.63 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.75 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.27 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.99 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.67 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.05 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.71 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.52 109.767 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.48 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.886 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.49 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' B' ' 44' ' ' VAL . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.83 111.648 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.4 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.91 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.19 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.15 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 0.9 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.71 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.36 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.439 ' O ' HG23 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.97 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.08 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.52 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.61 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt -70.74 -28.09 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.43 111.151 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.97 -6.69 44.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.013 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -93.72 -45.51 7.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.697 -0.683 . . . . 2.25 110.314 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.78 -27.77 49.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.989 -0.624 . . . . 1.76 111.91 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.98 45.8 2.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 2.04 111.977 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 75' ' ' ASN . . . . . 0.609 ' HA ' HG21 ' A' ' 42' ' ' VAL . 64.3 t30 -164.51 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 2.32 110.255 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.63 -38.16 55.13 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.021 -0.536 . . . . 2.46 111.053 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -79.96 130.9 35.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 2.78 110.858 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 81.3 m-20 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.335 -0.841 . . . . 2.48 110.923 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.81 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.84 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.571 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.65 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.66 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.49 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.45 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.57 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.57 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.62 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.61 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.76 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.587 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.69 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.69 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.73 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB3' HG23 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.64 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.74 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.08 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.58 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.69 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.78 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.74 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.16 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.62 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.73 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.66 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.14 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.81 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.73 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.71 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.07 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.29 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 0.83 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 58' ' ' PRO . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.66 111.962 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.69 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.58 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.65 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.79 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.23 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.05 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.7 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.19 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.69 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.53 109.766 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.49 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.51 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.86 113.216 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.35 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.95 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.24 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.19 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 0.89 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.71 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.29 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.91 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.05 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.52 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.58 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt -84.79 -0.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.37 112.057 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.05 -36.28 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 1.67 110.715 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.04 -40.79 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 2.21 110.148 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.44 -22.09 76.3 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.001 -0.545 . . . . 1.77 112.59 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.22 -29.71 63.97 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.123 -0.56 . . . . 2.09 112.071 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.2 -26.13 25.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.183 0.516 . . . . 2.29 110.136 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -76.43 -31.62 57.98 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.724 -0.671 . . . . 2.44 110.693 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.37 122.47 28.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.249 -0.432 . . . . 2.7 110.614 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 90.3 m-20 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.358 -0.83 . . . . 2.56 110.73 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.8 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.85 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.65 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.68 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.5 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.47 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.404 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.47 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.58 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.58 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.6 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.607 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.58 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.523 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.73 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.573 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.64 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.68 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.45 ' HB3' HG23 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.59 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.69 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 0.95 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.58 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.7 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 4.2 t-20 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 0.83 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.75 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' B' ' 45' ' ' VAL . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.08 110.878 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.61 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.86 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.61 111.251 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.42 HG23 ' HA ' ' B' ' 40' ' ' SER . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.1 111.456 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.79 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.71 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.42 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.16 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' B' ' 34' ' ' ALA . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.78 110.351 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.8 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.6 112.285 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.404 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.62 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.55 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.63 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.75 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.27 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 0.99 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.67 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.05 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.71 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.607 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.52 109.758 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.48 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.74 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.49 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.655 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.413 ' HG3' HG22 ' B' ' 44' ' ' VAL . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.83 112.175 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.4 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.91 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.19 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.15 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 0.9 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.36 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.97 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.08 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.52 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.61 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt -85.61 -11.6 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.43 112.083 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 95.4 mt -84.96 -38.66 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 1.79 110.107 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.88 -25.89 34.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.875 -0.602 . . . . 2.25 110.336 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.8 -28.36 70.86 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.027 -0.533 . . . . 1.76 112.134 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.47 -17.08 76.69 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.038 -0.601 . . . . 2.04 111.868 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -93.58 -27.62 16.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 2.32 109.973 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.12 -34.81 61.72 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.681 -0.69 . . . . 2.46 111.011 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -73.87 117.48 15.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 2.78 110.579 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.352 -0.832 . . . . 2.48 110.797 -179.657 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.81 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.84 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.65 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.66 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.49 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.45 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.57 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.57 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.62 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.61 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.76 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.69 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.69 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.73 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.64 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.74 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.08 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.58 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.69 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.78 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.74 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HB2' HG22 ' A' ' 45' ' ' VAL . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.16 110.581 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.62 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.73 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.66 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.14 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.81 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.73 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.71 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.07 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.29 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' HA2' ' B' ' 74' ' ' GLY . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.83 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.433 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.66 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.69 110.859 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.58 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.65 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.79 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.23 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.05 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.7 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.19 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.69 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.53 109.808 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.49 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.906 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.51 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.86 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.35 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.95 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.24 113.339 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.19 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.906 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 0.89 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.71 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.29 113.076 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.91 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.05 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.52 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.58 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt -74.22 -24.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.37 111.355 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.07 -31.87 39.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 1.67 110.579 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.45 -34.13 41.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 2.21 110.248 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.24 -27.01 64.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.091 -0.576 . . . . 1.77 112.135 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.69 17.32 56.77 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.129 -0.557 . . . . 2.09 112.189 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -131.98 -29.8 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 2.29 110.071 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -92.28 0.41 57.45 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.784 -0.643 . . . . 2.44 110.355 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.2 111.09 4.91 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.938 -0.574 . . . . 2.7 110.243 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.325 -0.845 . . . . 2.56 111.001 -179.456 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.8 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.85 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.65 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.68 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.5 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.47 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.47 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.58 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.58 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.6 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.604 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.58 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.73 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.64 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.68 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.451 ' HB3' HG23 ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.59 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.69 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 0.95 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.58 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.7 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 0.83 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.75 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.08 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.61 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.86 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.61 111.762 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.1 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.79 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.71 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.16 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 34' ' ' ALA . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.78 110.983 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.8 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.6 111.957 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.62 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.55 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.63 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.75 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.27 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.99 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.67 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.05 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.71 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.604 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.52 109.848 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.48 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.49 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.83 111.886 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.4 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.91 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.19 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.15 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 0.9 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.71 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.36 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.97 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.08 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.52 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.61 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt -77.83 -19.77 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.43 112.116 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 81.7 mt -74.08 -34.93 64.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.852 0.358 . . . . 1.79 110.212 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.99 -36.72 48.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.885 -0.598 . . . . 2.25 110.398 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -22.63 78.95 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.167 -0.539 . . . . 1.76 112.167 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -93.41 17.4 58.52 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.125 -0.56 . . . . 2.04 112.293 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -131.31 -33.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 2.32 110.522 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -78.55 -24.43 45.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.99 -0.55 . . . . 2.46 110.798 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.82 123.34 20.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.383 -0.372 . . . . 2.78 110.384 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.33 -0.843 . . . . 2.48 110.955 -179.712 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.81 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.84 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.65 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.66 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.49 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.45 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.57 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.57 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.62 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.61 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.76 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.69 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.69 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.73 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.64 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.74 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.08 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.58 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.69 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.78 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.74 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.16 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.62 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.73 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.66 111.618 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.14 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.81 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.73 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.71 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.07 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 0.83 111.118 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 58' ' ' PRO . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.66 112.119 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.69 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.58 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.65 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.79 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.23 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.05 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.7 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.19 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.69 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.53 109.84 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.49 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.51 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 44' ' ' VAL . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.86 112.471 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.35 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.95 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.24 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.19 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.89 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.71 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.29 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.91 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.575 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.05 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.52 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.58 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt -79.48 -17.04 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.37 111.19 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.33 -44.34 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 1.67 110.048 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.53 -45.3 54.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.844 -0.617 . . . . 2.21 110.264 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.3 -27.51 67.89 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.984 -0.627 . . . . 1.77 112.38 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.69 -23.34 70.15 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.135 -0.555 . . . . 2.09 112.57 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -85.2 -30.7 23.68 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.87 0.366 . . . . 2.29 110.643 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -83.22 -16.1 47.8 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.138 -0.483 . . . . 2.44 111.116 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.15 117.63 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 2.7 110.874 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 92.0 m-20 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.35 -0.833 . . . . 2.56 111.661 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.8 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.85 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.65 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.68 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.5 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.47 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.47 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.58 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.58 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.6 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.58 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.73 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.64 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.68 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.59 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.69 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 0.95 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.58 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.7 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 25.7 t-20 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 0.83 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.75 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.08 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.61 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 0.86 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.61 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' B' ' 40' ' ' SER . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.1 110.965 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.79 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.71 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 35' ' ' ILE . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.16 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.78 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.8 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.6 112.316 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.62 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.55 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.63 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.75 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.27 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 0.99 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.05 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.71 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.52 109.834 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.48 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.724 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.49 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' B' ' 44' ' ' VAL . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.83 112.782 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.4 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.91 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.19 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.15 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.724 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 0.9 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.71 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.36 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.97 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.08 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.52 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.61 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt -81.32 -13.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.43 112.059 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 62.9 mt -77.12 -36.45 55.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 1.79 110.811 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.67 -34.08 21.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 2.25 110.651 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.0 -24.67 73.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.056 -0.592 . . . . 1.76 112.603 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.15 15.02 63.02 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 2.04 112.57 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -130.47 -33.48 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 2.32 110.559 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -79.76 -21.52 44.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.036 -0.529 . . . . 2.46 111.137 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.96 116.82 8.23 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.468 -0.333 . . . . 2.78 110.456 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.285 -0.864 . . . . 2.48 110.921 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.81 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.84 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.65 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.66 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.49 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.45 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.57 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.57 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.62 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.61 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.76 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.69 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.69 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.73 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.64 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.74 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.08 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.58 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.69 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 47' ' ' SER . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.78 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.74 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB2' HG22 ' A' ' 45' ' ' VAL . 50.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.16 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.62 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.73 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.66 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' HA ' ' A' ' 40' ' ' SER . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.14 111.305 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.81 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.73 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.71 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.07 110.653 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 0.83 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.66 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.69 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.58 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.65 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.79 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.23 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.05 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.7 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.19 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.69 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.53 109.786 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.49 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.51 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.86 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.35 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.95 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.24 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.19 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 0.89 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.71 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.29 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.91 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.05 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.52 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.58 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt -73.81 -17.58 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.37 111.213 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 mt -95.32 -26.74 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 1.67 110.299 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.55 -41.85 21.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.096 -0.502 . . . . 2.21 110.123 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.84 -19.26 58.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.92 -0.657 . . . . 1.77 112.266 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.47 -39.6 41.77 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.052 -0.594 . . . . 2.09 112.35 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -73.87 -20.14 60.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.989 0.423 . . . . 2.29 110.891 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -76.12 -24.53 54.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.942 -0.572 . . . . 2.44 110.372 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' B' ' 41' ' ' LYS . 3.6 tm-20 -76.73 106.52 8.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.004 -0.544 . . . . 2.7 109.837 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.8 m-20 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.332 -0.842 . . . . 2.56 111.071 -179.259 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.8 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.85 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.65 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.68 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.5 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.47 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.47 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.58 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.58 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.6 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.58 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.73 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.731 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.64 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.731 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.68 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.59 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.69 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 0.95 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.58 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.7 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.431 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.83 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.75 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.455 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.08 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.61 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.86 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.61 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.1 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.79 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.71 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.466 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.16 110.552 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.78 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.8 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.6 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.62 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.55 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.63 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.75 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.27 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 0.99 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.67 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.05 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.71 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.52 109.742 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.48 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.871 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.49 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.582 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.83 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.4 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.91 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.19 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.15 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 0.9 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.71 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.36 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.97 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' B' ' 64' ' ' LYS . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.08 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.52 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.61 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt -78.33 -18.88 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.43 111.364 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.78 -33.04 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 1.79 110.224 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -80.2 -41.42 25.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 2.25 110.251 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.33 -31.13 73.86 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.085 -0.578 . . . . 1.76 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.1 -17.44 76.75 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.027 -0.606 . . . . 2.04 112.404 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -90.99 -25.42 19.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.947 0.403 . . . . 2.32 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -93.58 1.88 56.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.083 -0.508 . . . . 2.46 111.053 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.14 108.58 3.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.883 0.373 . . . . 2.78 110.471 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.549 -0.739 . . . . 2.48 111.496 -178.847 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.81 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.84 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.65 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.66 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.49 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.45 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.57 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.57 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.62 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' A' ' 54' ' ' ILE . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.61 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.76 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.69 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.69 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.73 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.64 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.74 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.08 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.58 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.69 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.78 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.74 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.16 110.447 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.73 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.66 111.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.693 HG23 ' HA ' ' A' ' 40' ' ' SER . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.14 111.425 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.81 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.73 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.71 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.693 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.07 110.511 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 34' ' ' ALA . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 0.83 110.767 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.66 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.69 110.857 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.58 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.65 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.79 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.23 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.05 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.7 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.19 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.69 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.53 109.755 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.49 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.51 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.86 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.35 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.95 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.24 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.19 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 0.89 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.71 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.29 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.05 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.52 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.58 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt -75.46 -13.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.37 111.718 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -5.26 54.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 1.67 110.473 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -101.53 -59.95 1.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.848 -0.614 . . . . 2.21 110.212 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 -13.78 79.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.89 -0.671 . . . . 1.77 113.14 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.47 84.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.982 -0.627 . . . . 2.09 113.038 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -114.34 -8.38 12.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.035 0.445 . . . . 2.29 110.525 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -80.76 -32.06 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 2.44 111.414 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.34 110.19 5.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 2.7 110.928 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 93.7 m-20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.44 -0.79 . . . . 2.56 110.975 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.8 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.85 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.65 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.68 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.5 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.47 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.47 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.58 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.58 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.6 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.58 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.73 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.64 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.68 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.59 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.69 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 26' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 0.95 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.58 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.7 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 0.83 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.75 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.08 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.61 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.86 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.61 111.262 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' B' ' 40' ' ' SER . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.1 110.982 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.79 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.71 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.545 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.16 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 34' ' ' ALA . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.78 110.29 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.8 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.6 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.62 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.55 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.63 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 48' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.75 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.27 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.99 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.67 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.05 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.71 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.52 109.762 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.48 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.587 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.49 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.83 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.4 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.91 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 61' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.19 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.15 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 0.9 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.71 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' ' 62' ' ' PHE . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.36 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.97 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.08 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.52 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.61 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt -74.87 -7.81 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.43 112.202 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.2 -35.08 17.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.634 -0.257 . . . . 1.79 110.813 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.63 -40.89 18.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.404 -0.362 . . . . 2.25 110.253 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 -20.99 70.21 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.971 -0.633 . . . . 1.76 112.246 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.43 -27.97 58.53 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.112 -0.566 . . . . 2.04 112.465 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.17 -19.14 40.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.949 0.404 . . . . 2.32 110.599 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -75.89 -21.55 57.03 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.953 -0.567 . . . . 2.46 110.716 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -71.4 105.28 3.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.204 -0.453 . . . . 2.78 110.034 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.317 -0.849 . . . . 2.48 111.065 -179.361 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.81 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.84 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.65 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.66 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.49 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.45 111.463 177.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.57 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.57 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.62 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 54' ' ' ILE . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.61 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.76 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.69 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.69 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.73 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.64 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.74 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.08 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.58 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.69 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.78 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.74 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.16 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.62 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.73 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.66 111.34 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.14 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.81 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.73 112.964 -179.544 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.71 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.07 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 34' ' ' ALA . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 0.83 111.253 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.66 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.69 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.58 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.65 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.79 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.23 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.05 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.7 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.19 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.69 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.53 109.841 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.49 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.51 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.86 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.35 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.95 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.24 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.642 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.19 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.89 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.71 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.29 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.91 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 64' ' ' LYS . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.52 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.58 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt -79.36 -13.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.37 111.769 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.13 -34.5 13.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.936 0.398 . . . . 1.67 109.996 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.96 -35.39 37.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.734 -0.666 . . . . 2.21 110.758 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.67 -23.29 77.1 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.918 -0.583 . . . . 1.77 112.57 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.25 -26.03 69.34 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.099 -0.572 . . . . 2.09 112.333 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.36 -26.89 56.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.885 0.374 . . . . 2.29 110.767 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -92.81 -3.04 55.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.165 -0.47 . . . . 2.44 110.814 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 119.86 17.15 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.169 -0.469 . . . . 2.7 110.524 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.285 -0.864 . . . . 2.56 110.722 -179.813 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.8 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.85 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.65 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.68 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.5 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.47 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.431 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.47 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.58 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.58 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.6 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.58 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.73 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.64 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.68 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.59 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.69 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 0.95 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.58 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.7 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 0.83 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.75 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.08 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.61 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.86 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.61 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.1 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.79 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.71 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.78 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.431 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.8 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.6 112.243 -178.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.62 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.55 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.63 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.75 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.27 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 0.99 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.67 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.05 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.71 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.52 109.713 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.48 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.49 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HG3' HG22 ' B' ' 44' ' ' VAL . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.83 112.832 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.4 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.91 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.19 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.15 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 0.9 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.71 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.36 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.97 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.08 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.52 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.61 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt -72.9 -14.47 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.43 111.606 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -88.31 -15.13 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 1.79 110.309 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.5 -55.12 2.4 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.205 -0.452 . . . . 2.25 110.282 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.99 -27.39 68.79 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.057 -0.592 . . . . 1.76 112.559 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.92 -23.8 65.8 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.029 -0.605 . . . . 2.04 112.34 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.58 -3.7 56.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 2.32 110.33 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -81.31 -14.46 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 2.46 110.677 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.53 111.82 10.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.976 -0.556 . . . . 2.78 110.07 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.235 -0.888 . . . . 2.48 111.019 -179.571 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.81 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.84 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.65 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.66 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.49 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.45 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.57 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.57 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.61 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.76 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.69 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.69 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.73 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.64 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.74 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.08 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.58 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.69 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.78 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.74 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' HG22 ' A' ' 45' ' ' VAL . 48.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.16 110.188 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.62 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.73 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.66 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.14 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.81 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.73 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.71 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.07 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.29 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.83 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.66 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.69 110.798 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.58 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.65 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.79 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.23 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.7 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.19 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.69 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.53 109.917 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.49 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.767 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.51 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.86 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.35 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.95 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.24 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.19 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 0.89 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.71 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.29 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.91 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.05 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.52 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.58 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt -76.32 -11.48 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.37 111.169 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.2 mt -93.84 -31.44 14.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 1.67 110.156 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -82.23 -41.05 20.76 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.195 -0.457 . . . . 2.21 110.191 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.57 -30.39 70.97 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.948 -0.644 . . . . 1.77 112.322 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.74 60.12 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.226 -0.511 . . . . 2.09 112.204 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -82.87 -25.58 32.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.432 . . . . 2.29 110.312 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.26 -27.18 59.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 2.44 110.289 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.25 114.79 11.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.014 -0.539 . . . . 2.7 109.957 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.5 m-20 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.293 -0.86 . . . . 2.56 110.929 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.8 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.85 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.65 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.68 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.5 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.47 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.47 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.58 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.58 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.6 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.58 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.73 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.64 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.68 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.59 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.69 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 0.95 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.58 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.7 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 0.83 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.75 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.08 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.61 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.86 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.61 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.1 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.79 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.71 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.16 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.78 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.8 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.6 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.62 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.55 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.63 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.75 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.27 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.99 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.67 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.05 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.71 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.52 109.775 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.48 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.49 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.83 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.4 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.91 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.19 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.15 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 0.9 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.71 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.36 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.97 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.08 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.52 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.61 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt -85.33 2.21 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.43 112.187 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.65 -36.69 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.962 0.41 . . . . 1.79 110.46 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.47 -41.79 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.838 -0.619 . . . . 2.25 110.36 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.37 75.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.876 -0.602 . . . . 1.76 112.404 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -27.52 68.32 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 2.04 112.124 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -76.97 -24.87 52.29 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.018 0.437 . . . . 2.32 110.274 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -81.8 -18.67 43.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.002 -0.544 . . . . 2.46 110.748 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.47 116.6 10.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.988 -0.551 . . . . 2.78 110.403 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 89.2 m-20 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.414 -0.803 . . . . 2.48 111.668 -179.282 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.81 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.84 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.65 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.66 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.49 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.45 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.57 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.57 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 54' ' ' ILE . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.61 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.76 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.69 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.69 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.73 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.64 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.74 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.08 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.58 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.69 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.78 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.74 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.551 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.16 110.215 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.62 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.73 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.66 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.14 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.81 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.71 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.07 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.29 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 0.83 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 58' ' ' PRO . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.66 112.383 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.69 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.58 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.65 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.79 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.23 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.7 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.19 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.69 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.53 109.809 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.49 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.51 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.594 ' HG3' HG22 ' A' ' 44' ' ' VAL . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.86 111.978 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.35 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.95 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.24 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.19 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 0.89 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.71 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.29 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.91 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.05 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.52 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.58 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt -80.27 -9.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.37 111.715 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.98 -32.29 13.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.932 0.396 . . . . 1.67 110.192 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.49 -41.31 21.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.621 -0.718 . . . . 2.21 110.16 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.67 -28.66 70.26 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.968 -0.56 . . . . 1.77 113.078 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.59 -33.32 58.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.024 -0.607 . . . . 2.09 112.355 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.6 -7.87 59.09 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 2.29 111.017 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -93.81 -14.06 26.6 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.388 -0.369 . . . . 2.44 110.931 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.31 110.61 4.74 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.331 -0.395 . . . . 2.7 110.341 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 83.3 m-20 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.422 -0.799 . . . . 2.56 111.727 -178.994 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.8 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.85 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.65 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.68 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.5 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.47 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.47 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.58 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.58 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.6 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.58 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.73 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.64 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.68 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.59 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.69 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 0.95 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.58 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.7 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 0.83 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' B' ' 45' ' ' VAL . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.08 110.465 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.61 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.86 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.61 111.031 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.79 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.71 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.16 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' B' ' 34' ' ' ALA . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.78 110.712 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.8 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.6 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.62 110.791 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.55 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.63 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.75 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.27 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.99 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.67 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.05 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.71 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.52 109.821 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.48 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.49 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.481 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.83 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.4 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.91 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.19 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.15 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 0.9 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.71 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.36 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.97 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.08 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.52 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.61 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt -76.82 -13.0 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.43 111.614 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.86 -28.06 16.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.627 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.81 -50.62 7.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 2.25 110.295 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.62 -25.13 70.78 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.928 -0.578 . . . . 1.76 112.29 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.07 -19.18 77.69 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.016 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -87.0 -29.41 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 2.32 110.444 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -86.36 -2.04 58.07 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.703 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.54 107.68 5.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.061 -0.518 . . . . 2.78 110.101 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 89.8 m-20 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.286 -0.864 . . . . 2.48 111.071 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.81 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.84 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.65 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.66 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.49 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.45 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.57 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.57 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.62 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.61 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.76 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.69 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.69 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.73 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.64 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.74 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.08 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.58 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.69 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.78 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.74 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' HB2' HG22 ' A' ' 45' ' ' VAL . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.16 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.62 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.73 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.66 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.14 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.81 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.73 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.71 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.07 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.29 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.83 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.66 112.278 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.69 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.58 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.65 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.79 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.23 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.05 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.7 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.19 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.69 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.53 109.839 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.49 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.51 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.86 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.35 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.95 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.24 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.19 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.89 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.71 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.29 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.91 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.05 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.52 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.58 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt -76.28 -15.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.37 111.577 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.99 -27.05 14.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.402 . . . . 1.67 110.306 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.13 -37.05 29.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.157 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.13 -24.37 71.64 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.146 -0.549 . . . . 1.77 112.151 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.8 -32.29 57.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.097 -0.573 . . . . 2.09 111.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -80.9 -5.01 56.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.12 0.486 . . . . 2.29 110.705 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -90.97 -35.37 14.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.991 -0.55 . . . . 2.44 110.745 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -75.7 117.18 17.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 2.7 110.763 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.292 -0.861 . . . . 2.56 111.02 -179.498 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.8 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.85 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.65 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.68 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.47 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.47 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.58 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.58 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.6 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.599 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.58 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.73 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.64 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.68 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.59 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.595 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.69 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 0.95 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.58 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.7 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 0.83 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.75 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.08 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.61 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.86 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.61 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.1 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.79 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.71 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.16 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.78 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.477 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.8 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.6 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.62 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.55 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.63 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.75 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.99 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.67 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.05 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.71 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.599 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.52 109.825 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.48 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.793 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.49 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.83 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.4 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.91 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.19 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.15 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 0.9 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' B' ' 67' ' ' ILE . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.71 110.588 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.36 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.97 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' B' ' 64' ' ' LYS . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.08 110.111 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.52 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.61 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -74.37 -19.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.43 111.641 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.18 -30.63 25.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 1.79 110.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.75 -45.07 30.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.868 -0.606 . . . . 2.25 110.476 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.65 -16.22 79.57 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.09 -0.576 . . . . 1.76 112.275 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.11 11.24 72.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.462 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -124.41 -32.0 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 2.32 110.388 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.72 -10.95 54.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.749 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.66 111.08 4.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.202 -0.454 . . . . 2.78 110.087 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.361 -0.828 . . . . 2.48 111.028 -179.386 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.81 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.84 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.65 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.66 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.49 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.45 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.57 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.57 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.62 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.61 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.76 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.69 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.69 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.721 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.73 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.64 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.74 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.08 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.58 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.69 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.78 111.05 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.74 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.16 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.62 110.984 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.73 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.66 111.471 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.14 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.81 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.73 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.71 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.07 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.29 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.83 110.792 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.66 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.69 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.58 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.65 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.79 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.23 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.05 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.7 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.19 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.69 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.53 109.827 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.49 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.51 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.86 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.35 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.95 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.19 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 0.89 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.71 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.29 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.91 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.05 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.52 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.58 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 24' ' ' PRO . 38.8 pt -74.25 -23.16 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.37 111.623 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.27 -23.18 30.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.47 -0.332 . . . . 1.67 110.58 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.78 -38.12 62.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.1 -0.5 . . . . 2.21 110.634 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.49 78.07 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.392 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.447 ' CA ' HG21 ' B' ' 42' ' ' VAL . . . -86.26 -9.83 75.57 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.054 -0.593 . . . . 2.09 112.581 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.68 -29.37 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 2.29 110.451 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -83.24 -26.91 30.31 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.004 -0.544 . . . . 2.44 110.966 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -71.54 114.75 9.95 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.901 0.381 . . . . 2.7 110.688 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 89.9 m-20 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.403 -0.808 . . . . 2.56 110.889 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.8 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.85 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.65 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.68 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.5 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.47 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.47 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.58 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.58 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.6 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.58 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.73 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.64 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.68 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.59 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.69 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 0.95 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.58 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.7 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 0.83 110.532 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.75 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.08 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.61 111.116 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.86 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.61 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.1 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.79 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.71 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.16 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.447 HG21 ' CA ' ' A' ' 74' ' ' GLY . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.78 110.544 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.8 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.6 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.62 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.55 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.63 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.75 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.27 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 0.99 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.67 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.05 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.71 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.52 109.759 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.48 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.736 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.49 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.625 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.83 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.4 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.91 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.19 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.15 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 0.9 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.71 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.36 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.97 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.681 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.08 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.52 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.61 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt -70.56 -24.84 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.43 111.036 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.53 -0.56 40.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.514 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -99.6 -34.95 10.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.123 -0.49 . . . . 2.25 110.281 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.21 -19.73 71.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.76 112.676 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.7 -13.56 56.61 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.918 -0.658 . . . . 2.04 112.825 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -95.28 -30.71 13.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 2.32 110.779 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -80.28 -18.02 50.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.277 -0.419 . . . . 2.46 111.291 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.75 115.55 9.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.017 0.437 . . . . 2.78 110.703 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 86.2 m-20 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.333 -0.842 . . . . 2.48 110.76 -179.777 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.81 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.84 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.65 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.66 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.49 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.45 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.57 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.57 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.62 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.61 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.76 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.69 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.69 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.714 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.73 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.64 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.74 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.08 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.58 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.69 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.78 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.74 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.16 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.62 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.73 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.66 111.683 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.14 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.81 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.73 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.71 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.07 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.29 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 34' ' ' ALA . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 0.83 110.655 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.66 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.69 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.58 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.65 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.79 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.05 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.7 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.19 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.69 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.53 109.851 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.49 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.51 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.86 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.35 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.95 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.24 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.19 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 0.89 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.71 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.91 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.05 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.52 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.58 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt -87.52 -3.05 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.37 111.868 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -102.73 -37.8 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 1.67 110.339 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -89.05 -35.96 16.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.136 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.15 -35.63 78.16 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.104 -0.569 . . . . 1.77 112.487 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -40.56 50.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.9 -0.667 . . . . 2.09 111.837 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -68.59 -24.67 64.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.813 0.339 . . . . 2.29 110.803 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -73.62 -41.31 62.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.973 -0.558 . . . . 2.44 110.814 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -75.87 123.7 26.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.981 0.42 . . . . 2.7 110.661 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.2 m-20 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 2.56 110.923 -179.467 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.8 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.85 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.65 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.68 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.5 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.47 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.47 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.58 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.58 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.6 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.58 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.73 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.64 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.68 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.59 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.69 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 0.95 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.58 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.7 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 0.83 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.75 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.08 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.61 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.86 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.61 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.1 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.79 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.71 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.16 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.78 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.8 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.6 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.62 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.55 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.63 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.75 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.27 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.99 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.67 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.05 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.71 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.52 109.789 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.48 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.49 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.83 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.4 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.91 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.19 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.15 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 0.9 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.71 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.36 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.97 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.08 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.52 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.61 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt -81.57 -6.27 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.43 111.839 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.17 -32.58 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 1.79 110.638 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.14 -40.02 11.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.007 -0.542 . . . . 2.25 110.122 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.76 -24.32 72.61 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.975 -0.557 . . . . 1.76 112.02 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.44 -14.5 80.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.071 -0.585 . . . . 2.04 112.054 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -81.89 -20.25 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.748 0.309 . . . . 2.32 111.05 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -77.36 -20.42 54.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.073 -0.512 . . . . 2.46 110.705 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.07 107.98 4.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.092 -0.504 . . . . 2.78 110.235 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.314 -0.851 . . . . 2.48 110.922 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.81 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.84 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.65 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.66 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.49 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.45 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.57 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.57 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.62 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 54' ' ' ILE . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.61 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.76 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.69 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.728 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.69 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.728 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.73 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.64 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.74 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.08 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.58 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.69 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.78 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.74 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.16 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.62 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.73 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.66 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.14 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.81 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.73 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.71 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.07 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.29 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 0.83 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.66 112.378 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.624 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.69 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.58 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.65 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.79 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.23 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.7 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.19 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.69 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.53 109.838 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.49 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.51 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.86 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.35 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.95 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.24 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.19 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 0.89 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.71 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.29 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.91 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.05 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.52 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.58 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt -80.22 -22.63 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.37 110.653 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -102.78 22.64 13.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.92 -0.582 . . . . 1.67 110.079 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -133.16 -66.79 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 2.21 110.198 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.77 90.46 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.583 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.28 -14.76 56.89 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.931 -0.652 . . . . 2.09 112.417 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -79.13 -5.47 54.22 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 2.29 110.994 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.95 -18.97 61.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.506 . . . . 2.44 111.176 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.91 113.47 4.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.848 0.356 . . . . 2.7 111.115 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 72.3 m-20 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.326 -0.845 . . . . 2.56 110.758 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.8 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.85 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.65 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.68 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.5 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.47 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.47 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.58 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.58 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.6 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.606 HG21 HD12 ' B' ' 54' ' ' ILE . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.58 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.73 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.736 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.64 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.736 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.68 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.59 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.69 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 0.95 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.58 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.7 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 18.2 t-20 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 0.83 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.75 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.08 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.61 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.86 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.61 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.1 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.79 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.71 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.16 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.78 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.8 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.6 111.98 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.62 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.55 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.63 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.75 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.27 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.99 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.67 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.05 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.71 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.606 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.52 109.847 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.48 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.49 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.83 112.743 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.4 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.91 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.19 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.15 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.9 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.71 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.36 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.97 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.08 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.52 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.61 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt -78.4 -10.9 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.43 111.947 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.13 -11.43 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 1.79 110.716 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.58 -38.0 7.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 2.25 110.298 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.66 58.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.017 -0.611 . . . . 1.76 112.218 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.59 -26.49 60.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.143 -0.551 . . . . 2.04 112.49 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -85.3 -27.17 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 2.32 110.572 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -77.54 -30.12 52.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.947 -0.57 . . . . 2.46 110.391 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 113.62 7.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.977 -0.556 . . . . 2.78 110.174 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 86.4 m-20 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.417 -0.801 . . . . 2.48 111.564 -179.016 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.81 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.84 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.65 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.66 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.49 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.45 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.678 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.57 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.57 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.62 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.61 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.76 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.69 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.69 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.73 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.64 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.74 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.08 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.58 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.69 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.78 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.74 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.16 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.62 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.73 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.66 111.158 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.14 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.81 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.73 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.71 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.07 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.29 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG21 ' O ' ' B' ' 74' ' ' GLY . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 0.83 110.936 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.66 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.69 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.58 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.65 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.79 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.7 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.19 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.69 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.53 109.833 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.49 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.51 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.649 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.86 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.35 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.95 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.19 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 0.89 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.71 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.29 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.91 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.05 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.52 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.58 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt -71.02 -19.25 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.37 111.62 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.7 mt -83.11 -13.5 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.945 0.402 . . . . 1.67 110.153 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -98.87 -43.77 6.61 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.864 -0.607 . . . . 2.21 110.176 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.5 61.62 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 1.77 112.307 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.13 -23.14 75.07 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.202 -0.523 . . . . 2.09 112.177 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -81.45 -23.47 37.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.012 0.434 . . . . 2.29 110.39 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.48 -24.56 45.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 2.44 110.597 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.28 106.12 7.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.16 -0.473 . . . . 2.7 110.033 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 82.1 m-20 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.283 -0.865 . . . . 2.56 111.105 -179.295 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.8 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.85 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.65 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.68 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.5 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.47 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.47 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.58 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.58 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.6 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.58 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.73 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.64 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.68 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.59 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.69 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 0.95 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.58 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.7 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 0.83 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.75 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.48 ' HB2' HG22 ' B' ' 45' ' ' VAL . 27.8 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.08 110.411 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.61 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.86 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.61 111.148 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.1 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.79 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.71 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.16 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 34' ' ' ALA . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.78 111.014 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.8 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.6 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.62 110.699 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.55 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.63 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.75 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.27 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 0.99 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.67 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.05 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.71 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.52 109.811 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.48 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.49 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.83 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.4 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.643 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.91 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.19 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.643 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.15 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 0.9 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.36 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.97 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.08 110.226 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.61 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.69 -23.37 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.43 111.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.8 -33.93 30.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 1.79 110.333 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.02 -32.38 26.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 2.25 110.212 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.23 -28.52 66.02 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.901 -0.591 . . . . 1.76 112.268 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -74.39 -24.82 72.09 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.544 . . . . 2.04 111.983 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -88.02 -14.31 39.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 2.32 110.405 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -92.94 -12.26 31.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.054 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.09 113.98 7.8 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.819 0.342 . . . . 2.78 110.399 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.33 -0.843 . . . . 2.48 111.034 -179.503 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.81 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.84 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.65 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.66 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.49 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.45 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.57 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.57 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.62 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.61 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.76 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.69 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.69 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.73 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.64 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.74 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.08 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.58 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.69 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.78 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.74 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.655 ' HB2' HG23 ' A' ' 45' ' ' VAL . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.16 110.196 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.62 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.73 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.66 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.14 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.81 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.73 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.71 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.07 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.29 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 0.83 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.66 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 31' ' ' GLN . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.69 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.58 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.65 110.466 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.79 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.7 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.19 110.834 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.69 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.53 109.778 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.49 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.869 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.51 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.86 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.35 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.95 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.24 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.19 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.89 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.71 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.29 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.91 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.05 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.52 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.58 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -82.66 -7.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.37 111.858 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.6 -38.92 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 1.67 110.429 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.91 -41.21 21.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 2.21 110.209 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.82 73.93 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.844 -0.617 . . . . 1.77 112.784 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.4 -26.33 70.46 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.09 -0.576 . . . . 2.09 112.223 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.53 -27.95 25.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.039 0.447 . . . . 2.29 110.4 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -82.49 -18.21 42.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.932 -0.577 . . . . 2.44 110.792 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.36 122.21 18.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 2.7 110.547 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 2.56 111.066 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.8 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.85 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.65 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.68 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.5 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.47 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.47 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.58 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.58 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.6 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.58 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' GLN . . . . . 0.526 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.73 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.64 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.68 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.59 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.594 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.69 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 0.95 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.58 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.7 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 0.83 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.75 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.603 ' HB2' HG22 ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.08 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.61 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.86 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.61 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.1 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.79 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.71 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.16 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.78 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.8 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.6 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.62 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.55 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.63 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.75 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.27 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 0.99 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.67 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.05 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.71 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.52 109.851 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.48 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.647 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.49 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.646 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.83 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.4 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.91 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.19 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.15 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 0.9 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.71 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.36 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.97 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.474 HG23 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.08 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.52 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.61 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.27 8.9 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.43 111.994 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 45.3 mt -108.26 -52.34 2.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.776 0.322 . . . . 1.79 110.632 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.26 -23.01 26.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 2.25 110.948 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.3 73.36 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.947 -0.644 . . . . 1.76 112.573 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.76 -28.08 43.98 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.938 -0.648 . . . . 2.04 112.391 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -63.72 -19.46 64.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 2.32 111.208 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -78.17 -32.22 50.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.099 -0.501 . . . . 2.46 110.666 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.14 118.19 11.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.266 -0.425 . . . . 2.78 111.387 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 74.4 m-20 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 2.48 110.852 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.81 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.84 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.65 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.66 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.49 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.45 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.57 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.57 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.62 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.61 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.76 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.69 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.69 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.73 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.64 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.74 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.08 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 46' ' ' ALA . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.58 111.427 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.69 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.78 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.74 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.16 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.62 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.73 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.66 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 40' ' ' SER . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.14 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.81 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.73 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.71 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.598 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.07 110.87 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.29 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 0.83 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.66 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.69 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 27' ' ' ILE . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.58 111.104 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.65 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.79 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.05 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.7 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.19 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.69 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.53 109.795 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.49 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.51 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.564 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.86 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.35 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.95 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.24 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.19 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 0.89 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.71 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.29 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.91 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.05 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.52 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.58 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.87 -16.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.37 111.907 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.38 -8.57 44.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.516 -0.311 . . . . 1.67 111.17 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.79 -35.82 11.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.481 -0.327 . . . . 2.21 110.81 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.8 74.1 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.978 -0.629 . . . . 1.77 112.608 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.05 27.14 11.87 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.098 -0.572 . . . . 2.09 112.467 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -144.5 -40.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 2.29 110.533 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -69.32 -38.16 78.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.902 -0.59 . . . . 2.44 111.136 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.19 115.53 13.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.467 -0.333 . . . . 2.7 110.352 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.0 m-20 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.318 -0.849 . . . . 2.56 110.877 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.8 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.85 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.65 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.68 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.5 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.47 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.47 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.58 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.58 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.6 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.608 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.58 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.73 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.64 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.68 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.59 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.69 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 0.95 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.58 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.7 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 2.8 t-20 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 0.83 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.75 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.08 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.61 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.86 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.61 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' B' ' 40' ' ' SER . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.1 111.051 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.79 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.71 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.16 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.78 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.8 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.6 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.62 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.55 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 47' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.63 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.75 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.27 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 0.99 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.67 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.05 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.71 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.608 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.52 109.812 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.48 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.49 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.587 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.447 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.83 112.983 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.4 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.91 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.19 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.15 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 0.9 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.71 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.36 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.97 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 70' ' ' ILE . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.08 109.972 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.52 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.61 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 67' ' ' ILE . 0.0 OUTLIER -77.5 -13.39 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.43 111.452 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.7 mt -99.24 -25.41 14.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.369 . . . . 1.79 110.568 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -91.73 -50.09 5.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 2.25 110.253 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.37 -25.27 73.3 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.973 -0.632 . . . . 1.76 112.174 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.56 -19.32 76.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.084 -0.579 . . . . 2.04 112.001 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -83.56 -19.93 34.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.03 0.443 . . . . 2.32 110.267 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -74.83 -25.44 59.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.832 -0.622 . . . . 2.46 110.694 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.54 117.42 9.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.447 -0.342 . . . . 2.78 110.364 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.328 -0.844 . . . . 2.48 110.996 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.81 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.84 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.65 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.66 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.49 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.45 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.57 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.57 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.61 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.76 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.69 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.69 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.73 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' HG23 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.64 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.74 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.08 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.58 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.69 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 24.9 t-20 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.78 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.74 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.16 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.62 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.73 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.66 111.022 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' SER . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.14 110.996 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.81 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 5.0 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.73 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.71 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.482 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.07 110.49 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.29 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 34' ' ' ALA . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 0.83 110.549 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.66 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.69 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.58 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.65 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.79 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.23 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.7 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.19 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.69 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.53 109.818 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.49 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.832 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.51 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.86 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.35 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.95 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.24 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.19 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 0.89 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.71 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.29 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.91 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.52 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.58 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt -82.55 -1.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.37 112.275 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD13 HD13 ' B' ' 71' ' ' LEU . 95.6 mt -97.23 -36.86 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 1.67 110.728 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.98 -42.98 22.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 2.21 110.295 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.63 -23.47 70.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.965 -0.636 . . . . 1.77 112.022 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' HG21 ' B' ' 42' ' ' VAL . . . -75.65 -30.56 57.87 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.154 -0.546 . . . . 2.09 112.287 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.93 -20.85 28.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 2.29 110.597 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -81.84 -15.8 52.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.984 -0.553 . . . . 2.44 110.771 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.21 105.77 3.07 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.079 -0.509 . . . . 2.7 110.34 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.433 -0.794 . . . . 2.56 111.065 -179.319 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.8 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.85 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.65 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.68 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.5 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.47 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.47 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.58 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.58 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.6 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.596 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.58 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.73 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.64 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.68 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.59 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.69 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 0.95 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.58 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.7 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 0.83 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.75 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.08 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.61 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.86 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.61 111.824 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.1 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.79 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.71 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.16 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' B' ' 34' ' ' ALA . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.78 111.464 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.8 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.6 112.326 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.62 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.55 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.63 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.75 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.27 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.99 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.67 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.05 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.71 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.596 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.52 109.726 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.48 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.49 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' B' ' 44' ' ' VAL . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.83 112.831 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.4 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.91 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.19 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.15 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 0.9 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.71 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.36 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.97 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.08 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.52 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.61 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.4 pt -86.9 -1.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.43 112.212 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 71' ' ' LEU . . . . . 0.614 HD13 HD13 ' A' ' 71' ' ' LEU . 60.3 mt -98.05 -54.46 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 1.79 110.809 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -76.5 -29.01 56.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.08 -0.509 . . . . 2.25 110.313 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.85 -25.8 70.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.024 -0.608 . . . . 1.76 112.123 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.75 -32.0 54.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.098 -0.572 . . . . 2.04 112.375 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -81.15 -27.56 35.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 2.32 110.542 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -76.25 -31.45 58.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.864 -0.607 . . . . 2.46 110.611 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -78.01 126.93 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 2.78 110.518 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 85.7 m-20 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 2.48 110.922 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.81 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.84 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.65 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.66 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.49 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.45 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.57 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.57 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.62 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.61 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.76 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.69 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.69 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.73 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HB3' HG23 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.64 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.74 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.08 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.58 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.69 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.78 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.74 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.16 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.62 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.73 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.66 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.14 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.81 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.73 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.71 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.07 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 0.83 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 56' ' ' LEU . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.66 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.69 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.58 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.65 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.79 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.7 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.19 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.69 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.53 109.814 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.49 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LEU . . . . . 0.868 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.51 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.86 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.35 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.95 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.24 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.19 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 0.89 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.71 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.29 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.91 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.05 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.52 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.58 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt -91.41 16.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.37 112.19 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.84 -46.99 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 1.67 110.444 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -87.55 -31.47 19.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.24 -0.436 . . . . 2.21 110.354 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.79 77.6 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.901 -0.59 . . . . 1.77 112.182 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -27.96 70.6 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.162 -0.542 . . . . 2.09 112.265 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.34 -28.14 47.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.111 0.482 . . . . 2.29 110.22 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -78.54 -32.47 47.95 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.673 -0.694 . . . . 2.44 110.802 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.89 134.7 44.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.304 -0.407 . . . . 2.7 110.87 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.377 -0.821 . . . . 2.56 110.82 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.8 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.85 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.65 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.68 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.5 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.47 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.47 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.58 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.58 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.6 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.58 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.73 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.64 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.68 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' PRO . . . . . 0.541 ' HB3' HG23 ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.59 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.69 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 0.95 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.58 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.7 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 0.83 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.75 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.08 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.61 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.86 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.61 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 35' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.1 111.052 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.79 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.71 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.16 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.78 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.8 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.6 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 45' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.62 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.55 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.63 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.75 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 0.99 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.67 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.05 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.71 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.52 109.869 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.48 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 56' ' ' LEU . . . . . 0.716 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.49 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 57' ' ' ASP . . . . . 0.538 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.83 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.4 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.91 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.19 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.15 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 63' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 0.9 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' B' ' 67' ' ' ILE . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.71 110.625 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.36 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.97 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.08 110.158 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.52 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.61 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 70' ' ' ILE . . . . . 0.541 HG23 ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt -74.96 -12.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.43 111.603 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.3 -31.24 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 1.79 110.532 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.06 -41.3 17.33 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.065 -0.516 . . . . 2.25 110.318 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.35 -28.53 61.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.054 -0.593 . . . . 1.76 112.03 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.86 42.4 2.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 2.04 111.982 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -152.39 -28.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.953 0.406 . . . . 2.32 110.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -84.34 -26.51 28.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.873 -0.603 . . . . 2.46 111.067 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -62.82 135.54 57.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 2.78 111.32 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 91.3 m-20 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.262 -0.875 . . . . 2.48 110.939 -179.88 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.81000000000000005 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.83999999999999997 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76000000000000001 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.65000000000000002 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.66000000000000003 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.48999999999999999 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.45000000000000001 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46000000000000002 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.56999999999999995 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.56999999999999995 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.60999999999999999 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.76000000000000001 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.68999999999999995 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.68999999999999995 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.72999999999999998 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.64000000000000001 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.73999999999999999 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.0800000000000001 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.57999999999999996 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.68999999999999995 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 37.1 t30 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.78000000000000003 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.73999999999999999 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.1599999999999999 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.62 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.72999999999999998 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.66000000000000003 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.625 HG23 ' HA ' ' A' ' 40' ' ' SER . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.1399999999999999 111.206 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66000000000000003 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.81000000000000005 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.72999999999999998 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.70999999999999996 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.625 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.29 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.82999999999999996 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.66000000000000003 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.68999999999999995 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.57999999999999996 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.65000000000000002 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.79000000000000004 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.23 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.05 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.69999999999999996 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.1899999999999999 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.68999999999999995 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.53000000000000003 109.778 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.48999999999999999 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.51000000000000001 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67000000000000004 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.85999999999999999 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.3500000000000001 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.94999999999999996 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.24 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.1899999999999999 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 0.89000000000000001 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.71 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 24' ' ' PRO . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 111.118 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.05 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.52 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.5800000000000001 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt . . . . . 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.3700000000000001 112.058 -179.357 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.80000000000000004 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.84999999999999998 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.65000000000000002 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.68000000000000005 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.5 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.46999999999999997 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.46999999999999997 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.57999999999999996 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.57999999999999996 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.59999999999999998 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.57999999999999996 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.72999999999999998 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64000000000000001 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.64000000000000001 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.68000000000000005 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.58999999999999997 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.68999999999999995 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 0.94999999999999996 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.57999999999999996 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 0.82999999999999996 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.75 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.0800000000000001 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.60999999999999999 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.85999999999999999 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.60999999999999999 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.423 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.79000000000000004 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.70999999999999996 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.585 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.1599999999999999 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.404 HG22 ' H ' ' B' ' 42' ' ' VAL . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.78000000000000003 111.129 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.80000000000000004 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.59999999999999998 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.62 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.55000000000000004 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.63 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.75 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 0.98999999999999999 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.05 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.70999999999999996 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.52000000000000002 109.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.47999999999999998 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.649 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.48999999999999999 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.435 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.82999999999999996 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.3999999999999999 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.91000000000000003 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.1899999999999999 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.1499999999999999 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 0.90000000000000002 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.71 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.3600000000000001 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.96999999999999997 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.0800000000000001 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.52 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt . . . . . 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.4299999999999999 111.39 -179.968 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.81000000000000005 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.83999999999999997 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76000000000000001 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.65000000000000002 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.66000000000000003 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.48999999999999999 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.45000000000000001 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46000000000000002 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.56999999999999995 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.56999999999999995 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.62 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.60999999999999999 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.76000000000000001 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.68999999999999995 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.68999999999999995 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.72999999999999998 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.64000000000000001 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.73999999999999999 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.0800000000000001 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.57999999999999996 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.68999999999999995 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.78000000000000003 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.73999999999999999 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 53.2 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.1599999999999999 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.62 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.72999999999999998 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.66000000000000003 111.311 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66000000000000003 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.81000000000000005 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.70999999999999996 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.0700000000000001 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.29 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 0.82999999999999996 110.635 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79000000000000004 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.66000000000000003 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.68999999999999995 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.57999999999999996 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.65000000000000002 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.79000000000000004 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.23 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.05 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.69999999999999996 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.1899999999999999 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.68999999999999995 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 19' ' ' THR . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.53000000000000003 109.847 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.48999999999999999 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.51000000000000001 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67000000000000004 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.85999999999999999 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.3500000000000001 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.94999999999999996 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.24 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.1899999999999999 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.89000000000000001 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.71 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.29 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.91000000000000003 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.05 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.52 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.5800000000000001 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt . . . . . 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.3700000000000001 112.609 -178.703 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.80000000000000004 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.84999999999999998 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77000000000000002 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.65000000000000002 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.68000000000000005 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.5 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.46999999999999997 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.46999999999999997 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.57999999999999996 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.57999999999999996 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.59999999999999998 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.57999999999999996 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.72999999999999998 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64000000000000001 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.64000000000000001 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.68000000000000005 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.58999999999999997 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.68999999999999995 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 0.94999999999999996 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.57999999999999996 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.69999999999999996 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 0.82999999999999996 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.75 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.60999999999999999 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.85999999999999999 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.60999999999999999 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.79000000000000004 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.70999999999999996 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.1599999999999999 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.78000000000000003 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.80000000000000004 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.59999999999999998 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.642 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.62 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.55000000000000004 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.63 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.75 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 0.98999999999999999 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.67000000000000004 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.05 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.70999999999999996 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.52000000000000002 109.734 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.47999999999999998 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.48999999999999999 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.653 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.82999999999999996 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.3999999999999999 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.91000000000000003 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.1899999999999999 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.1499999999999999 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 0.90000000000000002 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.71 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.3600000000000001 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.96999999999999997 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.0800000000000001 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.52 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.6100000000000001 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.509 HG22 ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt . . . . . 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.4299999999999999 111.136 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.81000000000000005 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.83999999999999997 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76000000000000001 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.65000000000000002 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.66000000000000003 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.48999999999999999 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.45000000000000001 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46000000000000002 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.56999999999999995 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.60999999999999999 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.76000000000000001 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.68999999999999995 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.68999999999999995 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.72999999999999998 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 70' ' ' ILE . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.64000000000000001 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.73999999999999999 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.0800000000000001 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.57999999999999996 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.68999999999999995 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.78000000000000003 110.275 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.73999999999999999 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.1599999999999999 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.62 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.72999999999999998 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.66000000000000003 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.1399999999999999 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66000000000000003 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.81000000000000005 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.72999999999999998 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.70999999999999996 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.0700000000000001 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.29 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 0.82999999999999996 110.552 179.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79000000000000004 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.66000000000000003 112.101 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.68999999999999995 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.57999999999999996 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.65000000000000002 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.79000000000000004 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.05 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.69999999999999996 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.1899999999999999 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.68999999999999995 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.53000000000000003 109.822 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.48999999999999999 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.687 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.51000000000000001 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67000000000000004 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 44' ' ' VAL . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.85999999999999999 112.072 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.3500000000000001 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.94999999999999996 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.24 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 0.89000000000000001 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.71 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.29 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.91000000000000003 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 64' ' ' LYS . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.05 110.048 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.5800000000000001 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 24' ' ' PRO . 36.0 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.3700000000000001 111.686 -179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.80000000000000004 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.84999999999999998 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77000000000000002 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.65000000000000002 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.68000000000000005 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.5 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.46999999999999997 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.46999999999999997 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.57999999999999996 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.57999999999999996 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.59999999999999998 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.57999999999999996 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.72999999999999998 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64000000000000001 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.64000000000000001 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.68000000000000005 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.58999999999999997 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.68999999999999995 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 0.94999999999999996 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.57999999999999996 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 0.82999999999999996 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.75 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.60999999999999999 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.85999999999999999 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.60999999999999999 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' B' ' 40' ' ' SER . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.1000000000000001 111.398 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.79000000000000004 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.70999999999999996 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67000000000000004 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.508 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.1599999999999999 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.78000000000000003 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.80000000000000004 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.59999999999999998 111.3 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.62 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.55000000000000004 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.63 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.75 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.27 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.98999999999999999 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.67000000000000004 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.05 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.70999999999999996 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.52000000000000002 109.767 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.47999999999999998 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.886 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.48999999999999999 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' B' ' 44' ' ' VAL . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.648 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.3999999999999999 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.91000000000000003 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.1899999999999999 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 0.90000000000000002 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.71 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.3600000000000001 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.439 ' O ' HG23 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.96999999999999997 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.0800000000000001 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.52 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.6100000000000001 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt . . . . . 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.4299999999999999 111.151 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.81000000000000005 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.83999999999999997 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.571 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76000000000000001 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.65000000000000002 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.66000000000000003 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.48999999999999999 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.45000000000000001 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46000000000000002 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.56999999999999995 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.62 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.60999999999999999 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.76000000000000001 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.587 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.68999999999999995 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.68999999999999995 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.72999999999999998 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB3' HG23 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.64000000000000001 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.73999999999999999 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.0800000000000001 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.57999999999999996 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.68999999999999995 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.73999999999999999 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.1599999999999999 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.62 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.72999999999999998 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.66000000000000003 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66000000000000003 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.81000000000000005 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.72999999999999998 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.70999999999999996 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.29 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 0.82999999999999996 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79000000000000004 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 58' ' ' PRO . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.66000000000000003 111.962 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.68999999999999995 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.57999999999999996 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.65000000000000002 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.79000000000000004 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.23 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.05 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.69999999999999996 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.1899999999999999 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.68999999999999995 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.53000000000000003 109.766 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.48999999999999999 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.51000000000000001 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67000000000000004 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.85999999999999999 113.216 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.3500000000000001 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.94999999999999996 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.24 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.1899999999999999 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 0.89000000000000001 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.71 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.29 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.91000000000000003 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.05 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.52 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.5800000000000001 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt . . . . . 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.3700000000000001 112.057 -179.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.80000000000000004 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.84999999999999998 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77000000000000002 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.65000000000000002 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.68000000000000005 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.5 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.46999999999999997 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.404 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.46999999999999997 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.57999999999999996 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.57999999999999996 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.59999999999999998 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.607 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.57999999999999996 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.523 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.72999999999999998 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.573 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64000000000000001 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.64000000000000001 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.68000000000000005 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.45 ' HB3' HG23 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.58999999999999997 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.68999999999999995 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 0.94999999999999996 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.57999999999999996 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.69999999999999996 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 29.7 t30 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 0.82999999999999996 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.75 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' B' ' 45' ' ' VAL . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.0800000000000001 110.878 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.60999999999999999 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.60999999999999999 111.251 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.42 HG23 ' HA ' ' B' ' 40' ' ' SER . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.1000000000000001 111.456 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.79000000000000004 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.70999999999999996 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67000000000000004 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.42 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.1599999999999999 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' B' ' 34' ' ' ALA . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.78000000000000003 110.351 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.80000000000000004 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.59999999999999998 112.285 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.404 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.62 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.55000000000000004 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.63 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.75 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.27 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 0.98999999999999999 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.05 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.70999999999999996 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.607 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.52000000000000002 109.758 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.47999999999999998 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.74 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.48999999999999999 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.655 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.413 ' HG3' HG22 ' B' ' 44' ' ' VAL . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.82999999999999996 112.175 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.3999999999999999 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.91000000000000003 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.1899999999999999 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.1499999999999999 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 0.90000000000000002 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.3600000000000001 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.461 HG12 ' O ' ' B' ' 63' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.0800000000000001 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.52 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.6100000000000001 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.4299999999999999 112.083 -179.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.81000000000000005 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.83999999999999997 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.65000000000000002 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.66000000000000003 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.48999999999999999 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.45000000000000001 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.56999999999999995 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.56999999999999995 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.62 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.60999999999999999 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.76000000000000001 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.68999999999999995 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.68999999999999995 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.72999999999999998 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.64000000000000001 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.73999999999999999 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.0800000000000001 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.57999999999999996 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.68999999999999995 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.78000000000000003 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.73999999999999999 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HB2' HG22 ' A' ' 45' ' ' VAL . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.1599999999999999 110.581 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.62 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.72999999999999998 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.66000000000000003 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.1399999999999999 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66000000000000003 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.81000000000000005 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.72999999999999998 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.70999999999999996 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.0700000000000001 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.29 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.82999999999999996 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.433 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.66000000000000003 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.68999999999999995 110.859 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.57999999999999996 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.65000000000000002 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.79000000000000004 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.23 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.05 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.69999999999999996 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.1899999999999999 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.68999999999999995 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.53000000000000003 109.808 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.906 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.51000000000000001 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.529 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67000000000000004 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.85999999999999999 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.3500000000000001 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.94999999999999996 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.24 113.339 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.1899999999999999 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.906 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 0.89000000000000001 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.71 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.29 113.076 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.91000000000000003 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.05 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.52 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.5800000000000001 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt . . . . . 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.3700000000000001 111.355 -179.951 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.80000000000000004 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.84999999999999998 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.65000000000000002 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.68000000000000005 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.5 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.46999999999999997 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.46999999999999997 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.57999999999999996 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.57999999999999996 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.59999999999999998 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.604 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.57999999999999996 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.72999999999999998 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64000000000000001 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.64000000000000001 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.68000000000000005 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.451 ' HB3' HG23 ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.58999999999999997 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.68999999999999995 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 0.94999999999999996 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.57999999999999996 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.69999999999999996 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 0.82999999999999996 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.75 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.0800000000000001 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.60999999999999999 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.85999999999999999 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.60999999999999999 111.762 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.1000000000000001 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.79000000000000004 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.70999999999999996 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67000000000000004 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.1599999999999999 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 34' ' ' ALA . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.78000000000000003 110.983 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.80000000000000004 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.59999999999999998 111.957 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.62 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.55000000000000004 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.63 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.75 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.27 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.98999999999999999 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.67000000000000004 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.05 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.70999999999999996 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.604 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.52000000000000002 109.848 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.47999999999999998 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.48999999999999999 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 111.886 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.3999999999999999 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.91000000000000003 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.1899999999999999 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.1499999999999999 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 0.90000000000000002 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.71 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.3600000000000001 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.0800000000000001 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.52 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.6100000000000001 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt . . . . . 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.4299999999999999 112.116 -179.299 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.81000000000000005 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.83999999999999997 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76000000000000001 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.65000000000000002 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.66000000000000003 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.48999999999999999 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.45000000000000001 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46000000000000002 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.56999999999999995 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.62 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.60999999999999999 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.76000000000000001 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.68999999999999995 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.68999999999999995 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.72999999999999998 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.64000000000000001 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.73999999999999999 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.0800000000000001 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.57999999999999996 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.68999999999999995 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.78000000000000003 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.73999999999999999 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.1599999999999999 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.62 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.72999999999999998 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.66000000000000003 111.618 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.1399999999999999 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66000000000000003 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.81000000000000005 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.72999999999999998 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.70999999999999996 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.0700000000000001 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 0.82999999999999996 111.118 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79000000000000004 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 58' ' ' PRO . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.66000000000000003 112.119 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.68999999999999995 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.57999999999999996 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.65000000000000002 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.79000000000000004 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.23 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.05 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.69999999999999996 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.1899999999999999 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.68999999999999995 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.53000000000000003 109.84 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.48999999999999999 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.51000000000000001 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67000000000000004 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 44' ' ' VAL . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.85999999999999999 112.471 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.94999999999999996 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.24 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.71 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.29 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.91000000000000003 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.575 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.05 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.52 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.5800000000000001 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt . . . . . 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.3700000000000001 111.19 179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.80000000000000004 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.84999999999999998 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77000000000000002 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.65000000000000002 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.68000000000000005 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.5 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.46999999999999997 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.46999999999999997 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.57999999999999996 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.57999999999999996 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.59999999999999998 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.57999999999999996 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.72999999999999998 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64000000000000001 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.64000000000000001 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.68000000000000005 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.58999999999999997 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.68999999999999995 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 0.94999999999999996 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.57999999999999996 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 10.1 t30 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 0.82999999999999996 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.75 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.0800000000000001 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.60999999999999999 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 0.85999999999999999 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.60999999999999999 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' B' ' 40' ' ' SER . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.1000000000000001 110.965 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.79000000000000004 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.70999999999999996 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67000000000000004 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 35' ' ' ILE . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.78000000000000003 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.80000000000000004 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.59999999999999998 112.316 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.62 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.55000000000000004 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.63 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.75 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.27 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 0.98999999999999999 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.05 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.70999999999999996 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.52000000000000002 109.834 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.47999999999999998 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.724 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.48999999999999999 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' B' ' 44' ' ' VAL . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.82999999999999996 112.782 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.3999999999999999 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.91000000000000003 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.1899999999999999 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.1499999999999999 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.724 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 0.90000000000000002 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.71 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.3600000000000001 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.96999999999999997 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.0800000000000001 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.52 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.6100000000000001 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt . . . . . 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.4299999999999999 112.059 -179.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.81000000000000005 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.83999999999999997 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.65000000000000002 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.66000000000000003 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.45000000000000001 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.56999999999999995 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.56999999999999995 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.62 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.60999999999999999 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.76000000000000001 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.68999999999999995 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.68999999999999995 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.72999999999999998 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.64000000000000001 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.73999999999999999 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.0800000000000001 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.57999999999999996 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.68999999999999995 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 47' ' ' SER . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.78000000000000003 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.73999999999999999 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB2' HG22 ' A' ' 45' ' ' VAL . 52.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.1599999999999999 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.62 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.72999999999999998 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.66000000000000003 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' HA ' ' A' ' 40' ' ' SER . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 111.305 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66000000000000003 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.81000000000000005 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.72999999999999998 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.70999999999999996 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.0700000000000001 110.653 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 0.82999999999999996 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79000000000000004 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.66000000000000003 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.68999999999999995 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.57999999999999996 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.65000000000000002 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.23 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.05 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.69999999999999996 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.1899999999999999 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.68999999999999995 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.53000000000000003 109.786 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.48999999999999999 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.51000000000000001 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67000000000000004 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.85999999999999999 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.3500000000000001 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.94999999999999996 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.24 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.1899999999999999 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 0.89000000000000001 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.71 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.29 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.91000000000000003 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.05 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.52 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.5800000000000001 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt . . . . . 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.3700000000000001 111.213 -179.813 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.80000000000000004 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.84999999999999998 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77000000000000002 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.65000000000000002 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.68000000000000005 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.5 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.46999999999999997 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.46999999999999997 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.57999999999999996 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.57999999999999996 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.59999999999999998 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.57999999999999996 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.72999999999999998 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64000000000000001 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.731 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.64000000000000001 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.731 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.68000000000000005 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.58999999999999997 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.68999999999999995 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 0.94999999999999996 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.57999999999999996 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.69999999999999996 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.431 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.82999999999999996 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.75 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.455 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.0800000000000001 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.60999999999999999 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.85999999999999999 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.60999999999999999 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.1000000000000001 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.79000000000000004 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.70999999999999996 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67000000000000004 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.1599999999999999 110.552 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.78000000000000003 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.80000000000000004 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.59999999999999998 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.62 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.55000000000000004 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.63 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.75 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.27 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 0.98999999999999999 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.67000000000000004 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.05 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.70999999999999996 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.52000000000000002 109.742 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.47999999999999998 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.871 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.48999999999999999 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.582 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.82999999999999996 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.3999999999999999 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.91000000000000003 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.1899999999999999 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.1499999999999999 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 0.90000000000000002 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.71 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.3600000000000001 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.96999999999999997 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' B' ' 64' ' ' LYS . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.0800000000000001 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.52 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.6100000000000001 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt . . . . . 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.4299999999999999 111.364 -179.898 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.81000000000000005 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.83999999999999997 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76000000000000001 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.65000000000000002 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.66000000000000003 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.48999999999999999 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.45000000000000001 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46000000000000002 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.56999999999999995 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.62 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' A' ' 54' ' ' ILE . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.60999999999999999 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.76000000000000001 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.68999999999999995 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.68999999999999995 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.72999999999999998 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.64000000000000001 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.73999999999999999 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.0800000000000001 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.57999999999999996 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.68999999999999995 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.78000000000000003 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.73999999999999999 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.1599999999999999 110.447 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.72999999999999998 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.66000000000000003 111.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.693 HG23 ' HA ' ' A' ' 40' ' ' SER . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 111.425 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66000000000000003 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.81000000000000005 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.72999999999999998 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.70999999999999996 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.693 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.0700000000000001 110.511 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 34' ' ' ALA . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 0.82999999999999996 110.767 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79000000000000004 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.66000000000000003 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.68999999999999995 110.857 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.57999999999999996 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.65000000000000002 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.79000000000000004 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.23 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.05 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.69999999999999996 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.1899999999999999 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.68999999999999995 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.53000000000000003 109.755 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.48999999999999999 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.51000000000000001 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67000000000000004 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.85999999999999999 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.3500000000000001 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.94999999999999996 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.24 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 0.89000000000000001 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.71 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.29 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91000000000000003 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.05 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.52 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.5800000000000001 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt . . . . . 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.3700000000000001 111.718 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.80000000000000004 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.84999999999999998 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77000000000000002 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.65000000000000002 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.68000000000000005 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.5 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.46999999999999997 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.57999999999999996 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.57999999999999996 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.59999999999999998 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.57999999999999996 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.72999999999999998 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64000000000000001 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.64000000000000001 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.68000000000000005 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.58999999999999997 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.68999999999999995 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 0.94999999999999996 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.57999999999999996 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.69999999999999996 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 0.82999999999999996 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.75 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.0800000000000001 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.60999999999999999 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.85999999999999999 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 111.262 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' B' ' 40' ' ' SER . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.1000000000000001 110.982 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.79000000000000004 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.70999999999999996 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67000000000000004 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.545 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.1599999999999999 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 34' ' ' ALA . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.78000000000000003 110.29 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.80000000000000004 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.59999999999999998 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.62 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.55000000000000004 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.63 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.75 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.27 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.98999999999999999 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.67000000000000004 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.05 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.70999999999999996 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.52000000000000002 109.762 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.47999999999999998 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.587 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.48999999999999999 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.82999999999999996 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.3999999999999999 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.91000000000000003 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.1899999999999999 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.1499999999999999 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 0.90000000000000002 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.71 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' ' 62' ' ' PHE . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.3600000000000001 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.96999999999999997 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.0800000000000001 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.52 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.6100000000000001 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt . . . . . 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.4299999999999999 112.202 -179.196 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.81000000000000005 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.83999999999999997 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76000000000000001 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.65000000000000002 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.66000000000000003 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.48999999999999999 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' NE2' ' A' ' 38' ' ' GLN . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.45000000000000001 111.463 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46000000000000002 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.56999999999999995 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.56999999999999995 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.62 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 54' ' ' ILE . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.60999999999999999 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.76000000000000001 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.68999999999999995 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.68999999999999995 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.72999999999999998 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.64000000000000001 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.73999999999999999 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.0800000000000001 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.57999999999999996 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.68999999999999995 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.78000000000000003 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.73999999999999999 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.1599999999999999 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.62 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.72999999999999998 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.66000000000000003 111.34 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.1399999999999999 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66000000000000003 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.81000000000000005 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 14' ' ' VAL . 19.9 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.72999999999999998 112.964 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.70999999999999996 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.0700000000000001 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 34' ' ' ALA . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 0.82999999999999996 111.253 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79000000000000004 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.66000000000000003 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.68999999999999995 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.57999999999999996 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.65000000000000002 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.79000000000000004 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.23 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.05 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.69999999999999996 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.1899999999999999 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.68999999999999995 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.53000000000000003 109.841 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.48999999999999999 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.51000000000000001 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67000000000000004 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.85999999999999999 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.3500000000000001 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.94999999999999996 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.24 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.642 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.1899999999999999 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.89000000000000001 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.71 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.29 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 64' ' ' LYS . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.52 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.5800000000000001 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt . . . . . 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.3700000000000001 111.769 -179.652 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.80000000000000004 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.84999999999999998 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77000000000000002 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.65000000000000002 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.68000000000000005 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.5 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.46999999999999997 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.431 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.46999999999999997 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.57999999999999996 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.57999999999999996 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.59999999999999998 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.57999999999999996 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.72999999999999998 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.64000000000000001 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.68000000000000005 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.58999999999999997 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.68999999999999995 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 0.94999999999999996 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.57999999999999996 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.69999999999999996 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 0.82999999999999996 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.75 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.0800000000000001 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.60999999999999999 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.85999999999999999 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.60999999999999999 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.1000000000000001 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.79000000000000004 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.70999999999999996 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67000000000000004 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.78000000000000003 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.431 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.80000000000000004 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.59999999999999998 112.243 -178.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.62 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.55000000000000004 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.63 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.75 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.27 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 0.98999999999999999 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.67000000000000004 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.05 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.70999999999999996 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.52000000000000002 109.713 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.47999999999999998 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.48999999999999999 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HG3' HG22 ' B' ' 44' ' ' VAL . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.82999999999999996 112.832 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.3999999999999999 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.91000000000000003 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.1899999999999999 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.1499999999999999 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 0.90000000000000002 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.71 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.3600000000000001 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.96999999999999997 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.0800000000000001 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.52 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.6100000000000001 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt . . . . . 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.4299999999999999 111.606 -179.806 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.81000000000000005 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.83999999999999997 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76000000000000001 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.65000000000000002 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.66000000000000003 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.48999999999999999 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.45000000000000001 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46000000000000002 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.56999999999999995 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.56999999999999995 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.60999999999999999 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.76000000000000001 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.68999999999999995 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.68999999999999995 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.72999999999999998 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.64000000000000001 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.73999999999999999 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.0800000000000001 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.57999999999999996 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.68999999999999995 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.78000000000000003 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.73999999999999999 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.1599999999999999 110.188 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.62 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.72999999999999998 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.66000000000000003 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.1399999999999999 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66000000000000003 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.81000000000000005 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.72999999999999998 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.70999999999999996 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.29 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.82999999999999996 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.66000000000000003 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.68999999999999995 110.798 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.57999999999999996 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.65000000000000002 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.79000000000000004 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.23 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.69999999999999996 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.1899999999999999 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.68999999999999995 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.53000000000000003 109.917 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.767 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67000000000000004 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.85999999999999999 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.3500000000000001 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.94999999999999996 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.24 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.1899999999999999 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.71 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.29 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.91000000000000003 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.05 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.52 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.5800000000000001 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt . . . . . 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.3700000000000001 111.169 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.80000000000000004 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.84999999999999998 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77000000000000002 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.65000000000000002 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.68000000000000005 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.5 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.46999999999999997 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.46999999999999997 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.57999999999999996 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.57999999999999996 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.59999999999999998 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.57999999999999996 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.72999999999999998 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.64000000000000001 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.68000000000000005 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.58999999999999997 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.68999999999999995 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 0.94999999999999996 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.57999999999999996 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.69999999999999996 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 0.82999999999999996 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.75 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.0800000000000001 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.85999999999999999 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.60999999999999999 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.1000000000000001 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.79000000000000004 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.70999999999999996 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67000000000000004 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.1599999999999999 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.78000000000000003 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.59999999999999998 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.62 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.55000000000000004 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.63 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.75 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.27 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.98999999999999999 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.05 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.70999999999999996 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.52000000000000002 109.775 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.47999999999999998 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.48999999999999999 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.82999999999999996 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.91000000000000003 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.1899999999999999 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.1499999999999999 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 0.90000000000000002 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.71 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.3600000000000001 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.0800000000000001 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.52 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.6100000000000001 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt . . . . . 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.4299999999999999 112.187 -179.371 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.81000000000000005 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.83999999999999997 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76000000000000001 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.65000000000000002 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.66000000000000003 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.48999999999999999 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.45000000000000001 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46000000000000002 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.56999999999999995 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.56999999999999995 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 54' ' ' ILE . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.60999999999999999 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.76000000000000001 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.68999999999999995 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.68999999999999995 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.72999999999999998 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.64000000000000001 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.73999999999999999 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.0800000000000001 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.57999999999999996 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.68999999999999995 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.78000000000000003 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.73999999999999999 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.551 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.1599999999999999 110.215 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.62 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.1399999999999999 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66000000000000003 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.81000000000000005 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.70999999999999996 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.0700000000000001 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.29 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 0.82999999999999996 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 58' ' ' PRO . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.66000000000000003 112.383 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.68999999999999995 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.57999999999999996 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.65000000000000002 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.79000000000000004 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.23 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.69999999999999996 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.1899999999999999 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.68999999999999995 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.53000000000000003 109.809 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.48999999999999999 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.51000000000000001 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67000000000000004 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.594 ' HG3' HG22 ' A' ' 44' ' ' VAL . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.85999999999999999 111.978 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.3500000000000001 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.94999999999999996 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.24 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.1899999999999999 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 0.89000000000000001 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.71 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.29 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.91000000000000003 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.05 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.52 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.5800000000000001 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt . . . . . 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.3700000000000001 111.715 -179.575 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.80000000000000004 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.84999999999999998 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77000000000000002 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.65000000000000002 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.68000000000000005 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.5 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.46999999999999997 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.46999999999999997 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.57999999999999996 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.57999999999999996 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.59999999999999998 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.57999999999999996 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.72999999999999998 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64000000000000001 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.64000000000000001 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.68000000000000005 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.58999999999999997 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.68999999999999995 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 0.94999999999999996 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.57999999999999996 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 0.82999999999999996 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' B' ' 45' ' ' VAL . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.0800000000000001 110.465 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.60999999999999999 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.85999999999999999 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.60999999999999999 111.031 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1000000000000001 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.79000000000000004 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.70999999999999996 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67000000000000004 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.1599999999999999 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' B' ' 34' ' ' ALA . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.78000000000000003 110.712 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.59999999999999998 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.62 110.791 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.55000000000000004 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.63 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.75 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.27 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.98999999999999999 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.67000000000000004 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.05 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.70999999999999996 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.52000000000000002 109.821 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.47999999999999998 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.48999999999999999 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.481 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.82999999999999996 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.3999999999999999 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.91000000000000003 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.1899999999999999 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.1499999999999999 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 0.90000000000000002 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.71 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.3600000000000001 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.96999999999999997 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.0800000000000001 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.52 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.6100000000000001 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt . . . . . 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.4299999999999999 111.614 -179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.81000000000000005 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.83999999999999997 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76000000000000001 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.65000000000000002 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.66000000000000003 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.48999999999999999 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.45000000000000001 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46000000000000002 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.56999999999999995 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.56999999999999995 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.62 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.60999999999999999 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.76000000000000001 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.68999999999999995 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.68999999999999995 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.72999999999999998 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.64000000000000001 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.73999999999999999 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.0800000000000001 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.57999999999999996 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.68999999999999995 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.78000000000000003 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.73999999999999999 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.514 ' HB2' HG22 ' A' ' 45' ' ' VAL . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.1599999999999999 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.62 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.72999999999999998 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.66000000000000003 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.1399999999999999 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66000000000000003 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.81000000000000005 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.72999999999999998 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.70999999999999996 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.0700000000000001 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.29 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79000000000000004 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.66000000000000003 112.278 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.68999999999999995 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.57999999999999996 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.65000000000000002 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.79000000000000004 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.23 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.05 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.69999999999999996 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.1899999999999999 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.68999999999999995 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.53000000000000003 109.839 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.48999999999999999 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.51000000000000001 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67000000000000004 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.85999999999999999 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.3500000000000001 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.94999999999999996 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.24 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.1899999999999999 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.89000000000000001 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.71 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.29 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.91000000000000003 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.05 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.52 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.5800000000000001 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt . . . . . 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.3700000000000001 111.577 -179.599 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.80000000000000004 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.84999999999999998 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77000000000000002 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.65000000000000002 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.68000000000000005 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.46999999999999997 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.46999999999999997 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.57999999999999996 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.57999999999999996 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.59999999999999998 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.599 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.57999999999999996 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.72999999999999998 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64000000000000001 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.64000000000000001 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.68000000000000005 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.58999999999999997 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.595 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.68999999999999995 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 0.94999999999999996 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.57999999999999996 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.69999999999999996 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 0.82999999999999996 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.75 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.60999999999999999 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.85999999999999999 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.60999999999999999 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.1000000000000001 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.79000000000000004 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.70999999999999996 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.1599999999999999 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.477 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.59999999999999998 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.62 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.55000000000000004 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.63 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.75 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.98999999999999999 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.67000000000000004 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.05 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.70999999999999996 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.599 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.52000000000000002 109.825 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.47999999999999998 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.793 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.48999999999999999 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.82999999999999996 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.3999999999999999 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.91000000000000003 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.1899999999999999 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.1499999999999999 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 0.90000000000000002 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' B' ' 67' ' ' ILE . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.71 110.588 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.3600000000000001 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.96999999999999997 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' B' ' 64' ' ' LYS . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.0800000000000001 110.111 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.52 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.6100000000000001 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt . . . . . 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.4299999999999999 111.641 -179.62 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.81000000000000005 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.83999999999999997 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76000000000000001 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.65000000000000002 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.66000000000000003 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.48999999999999999 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.45000000000000001 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46000000000000002 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.56999999999999995 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.56999999999999995 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.62 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.60999999999999999 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.76000000000000001 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.68999999999999995 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.68999999999999995 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.721 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.72999999999999998 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.64000000000000001 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.73999999999999999 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.0800000000000001 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.57999999999999996 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.68999999999999995 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.78000000000000003 111.05 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.1599999999999999 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.62 110.984 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.72999999999999998 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.66000000000000003 111.471 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.1399999999999999 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66000000000000003 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.81000000000000005 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.72999999999999998 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.70999999999999996 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0700000000000001 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.29 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.82999999999999996 110.792 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.66000000000000003 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.68999999999999995 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.57999999999999996 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.65000000000000002 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.79000000000000004 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.23 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.05 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.1899999999999999 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.68999999999999995 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.53000000000000003 109.827 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.48999999999999999 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.51000000000000001 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.482 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67000000000000004 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.85999999999999999 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.3500000000000001 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.94999999999999996 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.1899999999999999 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 0.89000000000000001 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.71 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.29 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.91000000000000003 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.05 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.52 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.5800000000000001 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 24' ' ' PRO . 38.8 pt . . . . . 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.3700000000000001 111.623 -179.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.84999999999999998 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77000000000000002 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.65000000000000002 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.68000000000000005 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.5 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.46999999999999997 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.46999999999999997 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.57999999999999996 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.57999999999999996 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.59999999999999998 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.57999999999999996 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.72999999999999998 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64000000000000001 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.64000000000000001 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.68000000000000005 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.58999999999999997 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.68999999999999995 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 0.94999999999999996 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.57999999999999996 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.69999999999999996 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 0.82999999999999996 110.532 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.75 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.0800000000000001 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.60999999999999999 111.116 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.60999999999999999 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.1000000000000001 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.79000000000000004 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.70999999999999996 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.1599999999999999 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.78000000000000003 110.544 179.338 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.80000000000000004 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.59999999999999998 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.62 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.55000000000000004 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.63 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.75 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.27 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 0.98999999999999999 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.67000000000000004 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.05 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.70999999999999996 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.52000000000000002 109.759 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.47999999999999998 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.736 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.48999999999999999 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.625 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.82999999999999996 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.3999999999999999 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.91000000000000003 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.1899999999999999 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.1499999999999999 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 0.90000000000000002 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.71 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.3600000000000001 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.96999999999999997 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.681 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.0800000000000001 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.52 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.6100000000000001 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt . . . . . 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.4299999999999999 111.036 -179.759 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.81000000000000005 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.83999999999999997 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76000000000000001 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.65000000000000002 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.66000000000000003 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.48999999999999999 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.45000000000000001 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46000000000000002 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.56999999999999995 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.56999999999999995 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.62 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.60999999999999999 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.76000000000000001 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.68999999999999995 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.68999999999999995 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.714 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.72999999999999998 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.64000000000000001 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.73999999999999999 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.0800000000000001 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.57999999999999996 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.68999999999999995 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.73999999999999999 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.1599999999999999 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.62 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.72999999999999998 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.66000000000000003 111.683 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.1399999999999999 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66000000000000003 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.81000000000000005 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.72999999999999998 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.70999999999999996 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.0700000000000001 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.29 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 34' ' ' ALA . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 0.82999999999999996 110.655 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79000000000000004 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.518 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.66000000000000003 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.68999999999999995 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.65000000000000002 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.79000000000000004 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.05 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.69999999999999996 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.1899999999999999 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.68999999999999995 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.53000000000000003 109.851 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.48999999999999999 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.51000000000000001 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67000000000000004 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.85999999999999999 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.3500000000000001 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.94999999999999996 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.24 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.1899999999999999 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 0.89000000000000001 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.71 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.91000000000000003 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.05 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.52 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.5800000000000001 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt . . . . . 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.3700000000000001 111.868 -179.573 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.80000000000000004 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.84999999999999998 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77000000000000002 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.65000000000000002 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.68000000000000005 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.5 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.46999999999999997 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.57999999999999996 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.57999999999999996 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.59999999999999998 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.57999999999999996 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.72999999999999998 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64000000000000001 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.64000000000000001 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.68000000000000005 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.58999999999999997 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.68999999999999995 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 0.94999999999999996 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.57999999999999996 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.69999999999999996 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 0.82999999999999996 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.75 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.0800000000000001 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.60999999999999999 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.60999999999999999 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.1000000000000001 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.79000000000000004 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.70999999999999996 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67000000000000004 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.1599999999999999 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.80000000000000004 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.59999999999999998 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.62 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.55000000000000004 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.63 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.75 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.27 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.98999999999999999 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.67000000000000004 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.05 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.70999999999999996 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.52000000000000002 109.789 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.47999999999999998 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.48999999999999999 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.82999999999999996 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.3999999999999999 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.91000000000000003 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.1899999999999999 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.1499999999999999 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 0.90000000000000002 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.71 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.3600000000000001 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.96999999999999997 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.0800000000000001 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.52 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.6100000000000001 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt . . . . . 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.4299999999999999 111.839 -179.297 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.81000000000000005 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.83999999999999997 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76000000000000001 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.66000000000000003 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.48999999999999999 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.45000000000000001 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.56999999999999995 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.62 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 54' ' ' ILE . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.60999999999999999 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.76000000000000001 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.68999999999999995 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.728 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.68999999999999995 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.728 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.72999999999999998 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.64000000000000001 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.73999999999999999 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.0800000000000001 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.57999999999999996 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.68999999999999995 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.78000000000000003 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.73999999999999999 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.1599999999999999 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.62 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.72999999999999998 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.66000000000000003 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.1399999999999999 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66000000000000003 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.81000000000000005 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.72999999999999998 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.70999999999999996 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.0700000000000001 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.29 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 0.82999999999999996 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79000000000000004 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.66000000000000003 112.378 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.624 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.68999999999999995 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.57999999999999996 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.65000000000000002 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.79000000000000004 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.23 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.69999999999999996 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.1899999999999999 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.68999999999999995 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.53000000000000003 109.838 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.48999999999999999 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.51000000000000001 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67000000000000004 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.85999999999999999 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.3500000000000001 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.94999999999999996 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.24 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.1899999999999999 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 0.89000000000000001 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.71 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.29 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.91000000000000003 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.05 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.52 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.5800000000000001 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.3700000000000001 110.653 179.672 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.80000000000000004 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.84999999999999998 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77000000000000002 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.65000000000000002 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.68000000000000005 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.5 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.46999999999999997 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.46999999999999997 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.57999999999999996 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.57999999999999996 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.59999999999999998 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.606 HG21 HD12 ' B' ' 54' ' ' ILE . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.57999999999999996 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.72999999999999998 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64000000000000001 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.736 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.64000000000000001 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.736 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.68000000000000005 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.58999999999999997 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.68999999999999995 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 0.94999999999999996 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.57999999999999996 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.69999999999999996 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 8.8 t30 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 0.82999999999999996 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.75 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.0800000000000001 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.60999999999999999 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.85999999999999999 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.60999999999999999 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.1000000000000001 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.79000000000000004 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.70999999999999996 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67000000000000004 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.1599999999999999 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.78000000000000003 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.59999999999999998 111.98 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.62 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.55000000000000004 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.63 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.75 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.27 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.98999999999999999 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.67000000000000004 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.05 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.70999999999999996 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.606 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.52000000000000002 109.847 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.47999999999999998 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.48999999999999999 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.82999999999999996 112.743 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.3999999999999999 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.91000000000000003 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.1899999999999999 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.1499999999999999 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.90000000000000002 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.71 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.3600000000000001 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.96999999999999997 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.0800000000000001 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.52 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.6100000000000001 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt . . . . . 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.4299999999999999 111.947 -179.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.81000000000000005 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.83999999999999997 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.65000000000000002 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.66000000000000003 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.48999999999999999 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.45000000000000001 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.678 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46000000000000002 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.56999999999999995 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.56999999999999995 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.62 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.60999999999999999 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.76000000000000001 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.68999999999999995 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.68999999999999995 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.72999999999999998 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.64000000000000001 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.73999999999999999 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.0800000000000001 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.57999999999999996 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.68999999999999995 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.78000000000000003 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.73999999999999999 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.1599999999999999 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.62 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.72999999999999998 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.66000000000000003 111.158 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.1399999999999999 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66000000000000003 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.81000000000000005 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.72999999999999998 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.70999999999999996 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.0700000000000001 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.29 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.411 HG12 ' HA ' ' A' ' 34' ' ' ALA . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 0.82999999999999996 110.936 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.66000000000000003 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.678 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.68999999999999995 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.57999999999999996 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.65000000000000002 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.79000000000000004 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.69999999999999996 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.1899999999999999 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.68999999999999995 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.53000000000000003 109.833 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.48999999999999999 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.51000000000000001 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.649 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67000000000000004 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.85999999999999999 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.3500000000000001 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.94999999999999996 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.1899999999999999 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.71 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.29 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.05 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.52 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.5800000000000001 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt . . . . . 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 111.62 -179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.80000000000000004 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.84999999999999998 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.65000000000000002 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.68000000000000005 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.5 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.46999999999999997 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.46999999999999997 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.57999999999999996 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.57999999999999996 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.59999999999999998 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.57999999999999996 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.72999999999999998 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64000000000000001 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.64000000000000001 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.68000000000000005 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.58999999999999997 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.68999999999999995 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 0.94999999999999996 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.57999999999999996 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 0.82999999999999996 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.75 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.48 ' HB2' HG22 ' B' ' 45' ' ' VAL . 29.0 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 110.411 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.60999999999999999 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.85999999999999999 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.60999999999999999 111.148 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.1000000000000001 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.79000000000000004 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.70999999999999996 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67000000000000004 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.1599999999999999 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 34' ' ' ALA . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.014 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.80000000000000004 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.59999999999999998 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.62 110.699 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.55000000000000004 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.63 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.75 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.27 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 0.98999999999999999 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.67000000000000004 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.05 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.70999999999999996 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.52000000000000002 109.811 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.47999999999999998 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.48999999999999999 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.82999999999999996 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.643 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.91000000000000003 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.1899999999999999 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.643 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.1499999999999999 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.3600000000000001 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.0800000000000001 110.226 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.6100000000000001 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt . . . . . 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.4299999999999999 111.624 -179.839 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.81000000000000005 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.83999999999999997 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.65000000000000002 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.66000000000000003 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.48999999999999999 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.45000000000000001 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.635 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46000000000000002 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.56999999999999995 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.56999999999999995 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.62 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.60999999999999999 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.76000000000000001 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.583 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.68999999999999995 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.68999999999999995 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.72999999999999998 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.64000000000000001 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.73999999999999999 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.0800000000000001 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.57999999999999996 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.68999999999999995 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.78000000000000003 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.73999999999999999 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.655 ' HB2' HG23 ' A' ' 45' ' ' VAL . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.1599999999999999 110.196 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.62 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.72999999999999998 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.66000000000000003 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.1399999999999999 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66000000000000003 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.81000000000000005 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.72999999999999998 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.70999999999999996 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.0700000000000001 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.29 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 0.82999999999999996 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.66000000000000003 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 31' ' ' GLN . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.68999999999999995 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.57999999999999996 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.65000000000000002 110.466 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.79000000000000004 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.69999999999999996 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.1899999999999999 110.834 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.68999999999999995 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.53000000000000003 109.778 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.48999999999999999 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.869 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67000000000000004 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.85999999999999999 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.3500000000000001 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.94999999999999996 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.24 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.1899999999999999 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.89000000000000001 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.71 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.29 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.05 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.52 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.5800000000000001 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt . . . . . 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.3700000000000001 111.858 -179.598 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.80000000000000004 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.84999999999999998 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77000000000000002 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.65000000000000002 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.68000000000000005 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.5 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.46999999999999997 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.46999999999999997 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.57999999999999996 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.57999999999999996 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.59999999999999998 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.57999999999999996 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . 0.526 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.72999999999999998 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64000000000000001 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.64000000000000001 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.68000000000000005 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.58999999999999997 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.594 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.68999999999999995 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 0.94999999999999996 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.57999999999999996 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.69999999999999996 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.75 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.603 ' HB2' HG22 ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.0800000000000001 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.60999999999999999 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.85999999999999999 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.60999999999999999 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.1000000000000001 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.79000000000000004 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.70999999999999996 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.1599999999999999 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.78000000000000003 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.80000000000000004 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.59999999999999998 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.62 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.55000000000000004 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.63 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.75 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.27 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 0.98999999999999999 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.67000000000000004 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.05 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.70999999999999996 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.52000000000000002 109.851 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.47999999999999998 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.647 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.48999999999999999 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.646 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.3999999999999999 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.91000000000000003 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.1899999999999999 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.1499999999999999 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.71 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.3600000000000001 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.96999999999999997 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.474 HG23 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.0800000000000001 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.52 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.6100000000000001 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt . . . . . 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.4299999999999999 111.994 -179.533 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.81000000000000005 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.83999999999999997 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76000000000000001 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.65000000000000002 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.66000000000000003 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.48999999999999999 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.45000000000000001 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46000000000000002 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.56999999999999995 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.62 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.60999999999999999 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.76000000000000001 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.68999999999999995 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.68999999999999995 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.72999999999999998 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.64000000000000001 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.73999999999999999 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.0800000000000001 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 46' ' ' ALA . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.57999999999999996 111.427 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.68999999999999995 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.78000000000000003 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.73999999999999999 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.1599999999999999 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.62 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.72999999999999998 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.66000000000000003 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 40' ' ' SER . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.1399999999999999 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66000000000000003 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.81000000000000005 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.72999999999999998 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.70999999999999996 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.598 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.0700000000000001 110.87 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.29 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 0.82999999999999996 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79000000000000004 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.66000000000000003 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.68999999999999995 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 27' ' ' ILE . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.57999999999999996 111.104 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.65000000000000002 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.79000000000000004 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.05 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.69999999999999996 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.1899999999999999 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.68999999999999995 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.53000000000000003 109.795 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.48999999999999999 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.51000000000000001 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.564 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67000000000000004 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.85999999999999999 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.3500000000000001 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.94999999999999996 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.24 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.1899999999999999 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 0.89000000000000001 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.71 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.29 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.91000000000000003 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.05 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.52 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.5800000000000001 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt . . . . . 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.3700000000000001 111.907 -179.476 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.80000000000000004 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.84999999999999998 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77000000000000002 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.65000000000000002 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.68000000000000005 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.5 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.46999999999999997 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.46999999999999997 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.57999999999999996 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.59999999999999998 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.608 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.57999999999999996 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.72999999999999998 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64000000000000001 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.64000000000000001 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.68000000000000005 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.58999999999999997 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.68999999999999995 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 0.94999999999999996 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.57999999999999996 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.69999999999999996 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 t30 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 0.82999999999999996 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.75 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.0800000000000001 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.60999999999999999 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.85999999999999999 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.60999999999999999 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' B' ' 40' ' ' SER . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.1000000000000001 111.051 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.79000000000000004 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.70999999999999996 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67000000000000004 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.1599999999999999 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.80000000000000004 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.59999999999999998 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.62 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.55000000000000004 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.63 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.75 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.27 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 0.98999999999999999 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.67000000000000004 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.05 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.70999999999999996 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.608 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.52000000000000002 109.812 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.47999999999999998 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.48999999999999999 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.587 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.447 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.82999999999999996 112.983 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.3999999999999999 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.91000000000000003 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.1899999999999999 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.1499999999999999 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.71 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.3600000000000001 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.96999999999999997 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 70' ' ' ILE . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.0800000000000001 109.972 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.52 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.6100000000000001 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 67' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.4299999999999999 111.452 -179.853 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.81000000000000005 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.83999999999999997 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76000000000000001 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.65000000000000002 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.66000000000000003 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.48999999999999999 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.45000000000000001 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46000000000000002 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.56999999999999995 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.60999999999999999 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.76000000000000001 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.68999999999999995 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.68999999999999995 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.72999999999999998 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' HG23 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.64000000000000001 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.73999999999999999 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.0800000000000001 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.57999999999999996 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.68999999999999995 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 10.3 t30 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.78000000000000003 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.73999999999999999 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.1599999999999999 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.62 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.72999999999999998 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.66000000000000003 111.022 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' SER . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.1399999999999999 110.996 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66000000000000003 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.81000000000000005 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.70999999999999996 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.482 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 110.49 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.29 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 34' ' ' ALA . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 0.82999999999999996 110.549 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79000000000000004 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.66000000000000003 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.68999999999999995 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.57999999999999996 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.65000000000000002 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.79000000000000004 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.23 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.69999999999999996 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.1899999999999999 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.68999999999999995 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.53000000000000003 109.818 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.48999999999999999 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.832 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.51000000000000001 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67000000000000004 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.85999999999999999 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.94999999999999996 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.24 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.1899999999999999 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.832 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 0.89000000000000001 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.71 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.29 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.91000000000000003 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.52 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.5800000000000001 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt . . . . . 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.3700000000000001 112.275 -179.447 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.80000000000000004 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.84999999999999998 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77000000000000002 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.65000000000000002 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.68000000000000005 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.5 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.46999999999999997 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.46999999999999997 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.57999999999999996 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.57999999999999996 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.59999999999999998 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.596 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.57999999999999996 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.72999999999999998 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64000000000000001 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.64000000000000001 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.68000000000000005 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.58999999999999997 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.68999999999999995 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 0.94999999999999996 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.57999999999999996 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.69999999999999996 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 0.82999999999999996 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.75 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.0800000000000001 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.60999999999999999 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.85999999999999999 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.60999999999999999 111.824 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.1000000000000001 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.79000000000000004 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.70999999999999996 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67000000000000004 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.1599999999999999 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' B' ' 34' ' ' ALA . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.78000000000000003 111.464 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.59999999999999998 112.326 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.62 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.55000000000000004 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.63 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.75 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.27 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.98999999999999999 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.67000000000000004 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.05 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.70999999999999996 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.596 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.52000000000000002 109.726 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.47999999999999998 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.48999999999999999 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' B' ' 44' ' ' VAL . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.82999999999999996 112.831 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.3999999999999999 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.91000000000000003 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.1899999999999999 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.1499999999999999 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 0.90000000000000002 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.71 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.3600000000000001 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.96999999999999997 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.0800000000000001 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.52 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.6100000000000001 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.4 pt . . . . . 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.4299999999999999 112.212 -179.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.81000000000000005 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.83999999999999997 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76000000000000001 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.65000000000000002 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.66000000000000003 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.48999999999999999 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.45000000000000001 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' CYS . . . . . 0.554 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46000000000000002 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.56999999999999995 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.56999999999999995 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.62 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.60999999999999999 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.76000000000000001 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.68999999999999995 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.68999999999999995 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.72999999999999998 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HB3' HG23 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.64000000000000001 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.73999999999999999 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.0800000000000001 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.57999999999999996 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.68999999999999995 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.78000000000000003 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.73999999999999999 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.1599999999999999 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.62 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.72999999999999998 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.66000000000000003 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.1399999999999999 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.81000000000000005 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.72999999999999998 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.70999999999999996 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.0700000000000001 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79000000000000004 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 56' ' ' LEU . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.66000000000000003 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' VAL . . . . . 0.479 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.68999999999999995 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.57999999999999996 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.65000000000000002 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.79000000000000004 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.69999999999999996 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.1899999999999999 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.68999999999999995 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.53000000000000003 109.814 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.48999999999999999 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LEU . . . . . 0.868 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.51000000000000001 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67000000000000004 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.85999999999999999 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.3500000000000001 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.94999999999999996 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.24 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.1899999999999999 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 0.89000000000000001 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.71 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.29 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.91000000000000003 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.05 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.52 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.5800000000000001 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt . . . . . 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.3700000000000001 112.19 -179.715 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.80000000000000004 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.84999999999999998 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77000000000000002 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.65000000000000002 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.68000000000000005 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.5 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.46999999999999997 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.46999999999999997 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.57999999999999996 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.57999999999999996 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.59999999999999998 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.57999999999999996 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.72999999999999998 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64000000000000001 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.64000000000000001 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.68000000000000005 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' PRO . . . . . 0.541 ' HB3' HG23 ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.58999999999999997 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.68999999999999995 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 0.94999999999999996 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.57999999999999996 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.69999999999999996 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 0.82999999999999996 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.75 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.0800000000000001 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.60999999999999999 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.85999999999999999 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.1000000000000001 111.052 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.79000000000000004 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.70999999999999996 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67000000000000004 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.1599999999999999 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.78000000000000003 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.80000000000000004 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.59999999999999998 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 45' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.62 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.55000000000000004 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.63 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.75 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 0.98999999999999999 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.05 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.70999999999999996 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.52000000000000002 109.869 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.47999999999999998 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 56' ' ' LEU . . . . . 0.716 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.48999999999999999 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 57' ' ' ASP . . . . . 0.538 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.82999999999999996 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.3999999999999999 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.91000000000000003 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.1899999999999999 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.1499999999999999 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 63' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 0.90000000000000002 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' B' ' 67' ' ' ILE . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.71 110.625 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.3600000000000001 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.96999999999999997 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.0800000000000001 110.158 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.52 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.6100000000000001 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 70' ' ' ILE . . . . . 0.541 HG23 ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt . . . . . 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.4299999999999999 111.603 -179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.725 1.25 . . . . 0.81000000000000005 110.031 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.403 -1.726 . . . . 0.83999999999999997 111.369 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.4 mt-10 -152.53 114.97 4.49 Favored 'General case' 0 N--CA 1.468 0.426 0 C-N-CA 124.066 0.946 . . . . 0.76000000000000001 110.474 -173.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.02 140.13 52.85 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 113.813 -1.54 . . . . 0.65000000000000002 110.26 178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.43 30.26 Favored 'General case' 0 N--CA 1.475 0.787 0 CA-C-N 114.102 -1.408 . . . . 0.66000000000000003 108.367 -176.148 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.88 151.06 9.1 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 116.01 -0.541 . . . . 0.48999999999999999 109.912 172.93 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.08 -31.0 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.304 0 CA-C-O 121.599 0.714 . . . . 0.45000000000000001 111.523 177.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.489 ' HB2' ' CD ' ' A' ' 43' ' ' GLU . 62.7 m -119.06 104.33 10.37 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.737 1.215 . . . . 0.46000000000000002 111.335 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.45 -33.32 28.55 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 114.578 -1.192 . . . . 0.56999999999999995 113.671 175.135 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.76 3.52 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.876 1.271 . . . . 0.56999999999999995 110.025 -179.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.73 -171.65 2.52 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 113.776 -1.556 . . . . 0.62 111.33 178.704 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.85 152.34 24.85 Favored 'General case' 0 N--CA 1.472 0.662 0 C-N-CA 125.795 1.638 . . . . 0.60999999999999999 110.168 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.27 72.24 1.42 Allowed 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 123.654 1.692 . . . . 0.76000000000000001 112.017 177.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.99 -177.33 51.46 Favored Glycine 0 CA--C 1.542 1.738 0 CA-C-N 113.214 -1.812 . . . . 0.68999999999999995 110.963 174.256 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.793 1 C-N-CA 136.218 5.807 . . . . 0.68999999999999995 106.354 8.114 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.49 143.34 31.95 Favored Pre-proline 0 CA--C 1.544 0.732 0 O-C-N 121.921 -0.487 . . . . 0.72999999999999998 110.117 175.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HD3' HG12 ' A' ' 66' ' ' VAL . 85.8 Cg_exo -51.2 -21.96 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.602 0 C-N-CA 124.737 3.625 . . . . 0.64000000000000001 112.885 174.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -30.8 23.96 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 124.604 1.162 . . . . 0.73999999999999999 112.683 179.645 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 22.0 mmt -88.02 -22.09 24.43 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.534 0.207 . . . . 1.0800000000000001 111.558 179.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 19.9 mm -81.1 150.62 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 CA-C-O 120.86 0.362 . . . . 0.57999999999999996 111.39 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.7 m -142.54 -31.97 0.51 Allowed 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.249 -0.432 . . . . 0.68999999999999995 110.991 179.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.476 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 37.1 t30 -130.02 124.86 33.92 Favored 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 120.713 0.292 . . . . 0.78000000000000003 110.827 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 14.8 tp -116.1 119.63 36.45 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 116.433 -0.349 . . . . 0.73999999999999999 111.289 -179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 44.5 mt-30 -112.06 119.94 40.14 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.321 -0.4 . . . . 1.1599999999999999 110.583 179.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 31.0 t -113.29 126.29 70.69 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.189 0 CA-C-N 116.265 -0.425 . . . . 0.62 111.171 -179.408 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -116.66 137.54 52.11 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.064 -0.517 . . . . 0.72999999999999998 110.918 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.63 -158.65 0.4 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-O 120.918 0.39 . . . . 0.66000000000000003 111.62 179.711 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.625 HG23 ' HA ' ' A' ' 40' ' ' SER . 75.1 mt -72.3 127.27 34.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.188 0 CA-C-N 116.046 -0.525 . . . . 1.1399999999999999 111.206 179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.77 -174.72 14.08 Favored Glycine 0 C--N 1.332 0.34 0 C-N-CA 121.024 -0.608 . . . . 0.66000000000000003 112.727 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -76.32 -10.49 19.11 Favored 'Trans proline' 0 C--N 1.349 0.555 0 C-N-CA 123.495 2.796 . . . . 0.81000000000000005 112.659 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.67 -21.23 12.79 Favored 'General case' 0 N--CA 1.47 0.551 0 N-CA-C 113.08 0.77 . . . . 0.72999999999999998 113.08 -179.559 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.6 t -146.4 123.18 11.25 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.091 -0.504 . . . . 0.70999999999999996 110.846 -177.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.625 ' HA ' HG23 ' A' ' 35' ' ' ILE . 20.9 t -90.21 -3.45 57.83 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.917 0.389 . . . . 1.0700000000000001 111.048 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.5 tttt -109.29 137.39 47.24 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.172 -0.467 . . . . 1.29 110.925 -179.55 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 16.6 m -74.63 132.86 32.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 CA-C-N 116.282 -0.417 . . . . 0.82999999999999996 110.61 179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.489 ' CD ' ' HB2' ' A' ' 15' ' ' CYS . 24.5 mt-10 -129.12 130.17 46.12 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 110.24 -179.237 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.8 m -100.6 106.41 19.29 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.702 0.763 . . . . 0.66000000000000003 112.312 -178.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.416 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.86 150.49 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 CA-C-O 122.483 1.135 . . . . 0.68999999999999995 110.812 178.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.33 46.43 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 115.183 -0.917 . . . . 0.57999999999999996 111.085 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.474 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.66 134.06 53.81 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.08 -0.964 . . . . 0.65000000000000002 110.457 176.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -79.18 172.67 13.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.257 -0.883 . . . . 0.79000000000000004 110.958 179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.2 tptp -76.12 -20.42 57.65 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 116.013 -0.54 . . . . 1.23 110.633 179.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 67.5 m-20 -74.72 -33.42 62.37 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.944 -0.571 . . . . 1.05 111.045 179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.12 44.92 0.47 Allowed Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.919 -0.658 . . . . 0.69999999999999996 112.542 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 47' ' ' SER . 57.1 mtpt -127.33 158.48 37.12 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.618 0.247 . . . . 1.1899999999999999 110.871 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.21 129.54 41.79 Favored 'General case' 0 N--CA 1.472 0.634 0 CA-C-O 121.275 0.56 . . . . 0.68999999999999995 110.002 179.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.83 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.738 -1.119 . . . . 0.53000000000000003 109.778 178.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.44 138.04 52.86 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.378 -1.283 . . . . 0.48999999999999999 109.306 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.96 152.89 30.22 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-N 114.082 -1.417 . . . . 0.51000000000000001 108.608 -178.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -103.79 114.03 64.97 Favored Pre-proline 0 N--CA 1.467 0.398 0 O-C-N 120.938 -1.101 . . . . 0.67000000000000004 110.66 178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_exo -55.15 -16.75 13.32 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 123.245 2.63 . . . . 0.85999999999999999 112.617 -179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.69 -16.5 62.96 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 114.908 -1.042 . . . . 1.3500000000000001 113.645 178.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.49 135.09 20.27 Favored Pre-proline 0 CA--C 1.543 0.674 0 O-C-N 122.314 -0.241 . . . . 0.94999999999999996 110.662 -179.002 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.26 -41.95 14.78 Favored 'Trans proline' 0 N--CA 1.478 0.614 0 C-N-CA 123.549 2.833 . . . . 1.24 113.39 -178.842 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.72 -27.24 67.75 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-O 121.33 0.586 . . . . 1.1899999999999999 111.808 176.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -66.24 -42.43 88.64 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.404 -0.816 . . . . 0.89000000000000001 110.342 178.48 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.482 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 32.9 ttpt -67.04 -24.91 66.04 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 115.68 -0.691 . . . . 1.71 111.095 179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -74.63 -55.45 5.89 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.009 0.744 . . . . 1.29 113.009 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.438 HG12 ' HD3' ' A' ' 24' ' ' PRO . 19.6 m -62.48 -29.71 47.44 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 116.158 -0.474 . . . . 0.91000000000000003 111.118 178.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.45 HG12 ' HA ' ' A' ' 64' ' ' LYS . 31.9 pt -85.1 -20.62 8.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 120.864 -0.334 . . . . 1.05 110.202 178.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.482 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 58.3 tt0 -75.91 -44.34 40.79 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.902 -0.319 . . . . 1.52 110.552 176.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.2 mttt -60.31 -31.83 70.65 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.772 0.656 . . . . 1.5800000000000001 112.772 -179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 15.1 pt -85.45 -5.68 9.93 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.289 0 N-CA-C 112.058 0.392 . . . . 1.3700000000000001 112.058 -179.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.6 mt -98.92 -38.43 9.01 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.679 -0.237 . . . . 1.6699999999999999 110.937 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -84.24 -31.05 25.21 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.345 -0.389 . . . . 2.21 110.724 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.08 -15.64 81.0 Favored Glycine 0 C--N 1.332 0.347 0 C-N-CA 120.94 -0.647 . . . . 1.77 112.36 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -89.89 32.3 4.91 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.092 -0.575 . . . . 2.0899999999999999 112.433 179.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -141.75 -20.59 0.74 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.986 0.422 . . . . 2.29 110.648 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -77.85 -38.23 46.59 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 116.113 -0.494 . . . . 2.4399999999999999 110.743 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -80.09 106.39 12.07 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.266 -0.425 . . . . 2.7000000000000002 110.028 179.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.9 m120 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.322 -0.847 . . . . 2.5600000000000001 111.085 -179.461 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.034 0 CA-C-O 122.826 1.298 . . . . 0.80000000000000004 110.148 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.364 -1.743 . . . . 0.84999999999999998 111.319 -179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.52 114.99 4.5 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.911 0.884 . . . . 0.77000000000000002 110.513 -173.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.05 140.29 52.72 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.76 -1.564 . . . . 0.65000000000000002 110.084 179.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.32 30.42 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.942 -1.481 . . . . 0.68000000000000005 108.461 -176.205 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.76 150.92 9.03 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 116.07 -0.514 . . . . 0.5 109.875 172.929 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.94 -31.08 46.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.616 0.722 . . . . 0.46999999999999997 111.502 177.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.419 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.0 104.17 10.25 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.74 1.216 . . . . 0.46999999999999997 111.307 179.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.33 29.01 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.697 -1.138 . . . . 0.57999999999999996 113.785 175.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.77 -178.82 3.53 Favored 'General case' 0 C--N 1.315 -0.908 0 C-N-CA 124.862 1.265 . . . . 0.57999999999999996 110.057 -178.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.615 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.66 -171.67 2.52 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 113.874 -1.512 . . . . 0.59999999999999998 111.426 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.76 152.3 24.95 Favored 'General case' 0 N--CA 1.472 0.634 0 C-N-CA 125.803 1.641 . . . . 0.57999999999999996 110.184 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.12 72.26 1.41 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 123.611 1.672 . . . . 0.72999999999999998 112.116 177.116 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.05 -177.18 51.4 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.268 -1.787 . . . . 0.64000000000000001 110.919 174.445 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.196 5.799 . . . . 0.64000000000000001 106.395 7.965 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.63 143.33 32.1 Favored Pre-proline 0 CA--C 1.542 0.66 0 O-C-N 121.986 -0.446 . . . . 0.68000000000000005 110.041 174.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.1 Cg_exo -51.18 -22.01 10.38 Favored 'Trans proline' 0 N--CA 1.478 0.561 0 C-N-CA 124.856 3.704 . . . . 0.58999999999999997 112.795 174.102 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.95 16.02 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 124.663 1.185 . . . . 0.68999999999999995 112.62 179.64 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.5 mmt -87.99 -19.48 27.14 Favored 'General case' 0 N--CA 1.475 0.82 0 N-CA-C 113.542 0.942 . . . . 0.94999999999999996 113.542 175.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 26.9 mm -91.84 139.64 17.49 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 O-C-N 122.1 -0.375 . . . . 0.57999999999999996 111.58 -178.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 75.6 m -140.42 2.54 1.86 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.461 -0.336 . . . . 0.69999999999999996 111.374 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -149.38 136.93 20.18 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.407 -0.36 . . . . 0.82999999999999996 110.71 179.692 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.4 tp -128.05 125.62 39.67 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.475 -0.329 . . . . 0.75 111.306 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.42 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 48.0 mt-30 -121.13 120.81 36.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.051 0.453 . . . . 1.0800000000000001 110.798 179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.476 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 25.5 t -103.38 122.46 55.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-N 115.96 -0.564 . . . . 0.60999999999999999 111.001 -179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 17.3 m-85 -112.8 128.94 56.57 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.361 -0.381 . . . . 0.85999999999999999 110.878 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.71 -158.91 0.57 Allowed 'General case' 0 CA--C 1.53 0.181 0 CA-C-O 121.067 0.461 . . . . 0.60999999999999999 111.773 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.585 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -78.15 128.25 38.32 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 CA-C-N 115.863 -0.608 . . . . 1.1000000000000001 111.423 -179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -133.16 -167.41 11.68 Favored Glycine 0 CA--C 1.52 0.406 0 CA-C-N 115.998 -0.546 . . . . 0.63 112.426 179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.13 -9.21 17.81 Favored 'Trans proline' 0 C--N 1.348 0.536 0 C-N-CA 123.32 2.68 . . . . 0.79000000000000004 112.797 179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.73 -20.79 12.95 Favored 'General case' 0 N--CA 1.47 0.564 0 N-CA-C 113.098 0.777 . . . . 0.70999999999999996 113.098 -179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.4 t -148.59 124.48 10.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.357 -0.383 . . . . 0.67000000000000004 111.069 -177.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.585 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -95.34 21.22 8.28 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.089 0.471 . . . . 1.01 110.688 179.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -134.48 152.33 51.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.87 -0.605 . . . . 1.1599999999999999 110.62 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.404 HG22 ' H ' ' B' ' 42' ' ' VAL . 4.3 m -84.45 127.0 40.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.182 0.515 . . . . 0.78000000000000003 111.129 179.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -125.74 137.77 53.83 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.957 -0.565 . . . . 0.80000000000000004 110.494 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.435 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -107.78 111.35 35.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-O 121.445 0.641 . . . . 0.59999999999999998 111.886 -179.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.42 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -100.95 150.51 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.916 0 CA-C-O 122.477 1.132 . . . . 0.62 110.73 179.404 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.37 46.49 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 115.195 -0.911 . . . . 0.55000000000000004 111.257 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.406 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.1 m -123.77 133.01 53.91 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 115.078 -0.965 . . . . 0.63 110.473 176.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -77.26 169.35 18.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.141 -0.936 . . . . 0.75 110.764 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -77.73 -13.77 59.8 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.069 -0.514 . . . . 1.27 110.699 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.33 -16.66 51.7 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.958 -0.564 . . . . 0.98999999999999999 111.137 179.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.47 43.17 1.89 Allowed Glycine 0 C--N 1.332 0.307 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.584 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.406 ' O ' ' HA ' ' B' ' 47' ' ' SER . 60.6 mtpt -128.71 161.06 30.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.681 0.276 . . . . 1.05 110.855 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.4 129.54 31.37 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.437 0.637 . . . . 0.70999999999999996 109.966 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.83 179.62 3.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.96 0 CA-C-N 114.695 -1.138 . . . . 0.52000000000000002 109.749 178.117 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.4 138.01 52.88 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 114.425 -1.261 . . . . 0.47999999999999998 109.3 177.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.649 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.8 mt -113.98 151.52 32.23 Favored 'General case' 0 C--N 1.312 -1.036 0 CA-C-N 114.007 -1.451 . . . . 0.48999999999999999 108.743 -178.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.615 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -98.89 112.16 62.23 Favored Pre-proline 0 N--CA 1.468 0.459 0 O-C-N 121.554 -0.716 . . . . 0.63 110.354 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.435 ' HG3' HG22 ' B' ' 44' ' ' VAL . 16.5 Cg_exo -64.6 -7.29 14.12 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.908 2.405 . . . . 0.82999999999999996 113.146 -179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -78.63 -11.59 59.98 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.268 -0.424 . . . . 1.3999999999999999 111.076 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.21 135.1 20.86 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 120.047 -0.661 . . . . 0.91000000000000003 110.793 -179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.75 14.87 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 123.569 2.846 . . . . 1.1899999999999999 113.317 -178.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.8 -28.0 68.45 Favored 'General case' 0 N--CA 1.479 1.009 0 CA-C-O 121.288 0.566 . . . . 1.1499999999999999 111.665 177.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.649 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -71.16 -35.34 71.61 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.387 -0.824 . . . . 0.90000000000000002 110.49 179.124 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.485 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.5 ttpt -69.03 -24.35 64.18 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 115.884 -0.598 . . . . 1.71 110.996 179.585 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.46 -55.53 6.24 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 113.042 0.756 . . . . 1.3600000000000001 113.042 179.449 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 17.6 m -62.35 -29.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-N 116.198 -0.456 . . . . 0.96999999999999997 111.216 178.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.444 HG12 ' HA ' ' B' ' 64' ' ' LYS . 32.1 pt -85.12 -20.68 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 CA-C-O 120.79 0.328 . . . . 1.0800000000000001 110.221 178.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.485 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.92 -39.84 55.44 Favored 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 120.916 -0.314 . . . . 1.52 110.522 176.395 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -65.32 -27.15 68.4 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 115.589 -0.732 . . . . 1.6100000000000001 112.532 179.181 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 22.9 pt -79.5 -3.18 5.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.565 0 O-C-N 121.721 -0.612 . . . . 1.4299999999999999 111.39 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 41.2 mt -100.93 -32.13 10.8 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.045 -0.525 . . . . 1.79 110.213 179.091 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -80.2 -42.0 24.16 Favored 'General case' 0 N--CA 1.457 -0.102 0 CA-C-N 116.047 -0.524 . . . . 2.25 110.367 179.747 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.52 -15.33 78.37 Favored Glycine 0 C--N 1.332 0.352 0 C-N-CA 120.834 -0.698 . . . . 1.76 112.772 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -87.28 -0.7 84.7 Favored Glycine 0 CA--C 1.52 0.386 0 C-N-CA 121.03 -0.605 . . . . 2.04 113.197 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 54.3 t30 -127.95 -0.4 5.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.009 0.433 . . . . 2.3199999999999998 110.654 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -80.12 -27.29 39.15 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.03 -0.532 . . . . 2.46 111.109 -179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -72.56 123.83 23.99 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-O 120.966 0.412 . . . . 2.7799999999999998 110.837 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.29 -0.862 . . . . 2.48 110.68 -179.935 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 122.705 1.241 . . . . 0.81000000000000005 110.104 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.577 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.8 ptt-85 -131.62 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 113.415 -1.72 . . . . 0.83999999999999997 111.468 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.577 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 123.943 0.897 . . . . 0.76000000000000001 110.446 -173.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.15 52.82 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 113.713 -1.585 . . . . 0.65000000000000002 110.262 178.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.41 30.24 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.12 -1.4 . . . . 0.66000000000000003 108.458 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.86 151.04 9.08 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.09 -0.504 . . . . 0.48999999999999999 109.888 172.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.1 46.98 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.357 0 CA-C-O 121.613 0.72 . . . . 0.45000000000000001 111.476 177.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.04 104.34 10.39 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.742 1.217 . . . . 0.46000000000000002 111.271 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.34 -33.45 28.88 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.603 -1.181 . . . . 0.56999999999999995 113.7 175.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.67 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.864 1.265 . . . . 0.56999999999999995 110.068 -179.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.638 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.76 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-N 113.788 -1.551 . . . . 0.62 111.432 178.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.617 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.4 24.97 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.823 1.649 . . . . 0.60999999999999999 110.217 179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.08 1.41 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 123.5 1.619 . . . . 0.76000000000000001 111.992 177.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.89 -177.36 51.52 Favored Glycine 0 CA--C 1.542 1.781 0 CA-C-N 113.343 -1.753 . . . . 0.68999999999999995 111.007 174.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.723 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.91 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.665 1 C-N-CA 136.222 5.809 . . . . 0.68999999999999995 106.374 8.192 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.723 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.42 143.34 31.89 Favored Pre-proline 0 CA--C 1.544 0.73 0 O-C-N 121.907 -0.496 . . . . 0.72999999999999998 110.133 174.924 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 84.1 Cg_exo -51.15 -21.94 10.16 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.777 3.651 . . . . 0.64000000000000001 112.915 174.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.85 16.41 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.615 1.166 . . . . 0.73999999999999999 112.617 179.669 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -87.97 -19.73 26.83 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.582 0.956 . . . . 1.0800000000000001 113.582 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 10.9 mm -98.58 146.77 7.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.454 0 O-C-N 121.879 -0.513 . . . . 0.57999999999999996 111.665 -178.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -142.86 0.59 1.24 Allowed 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 116.487 -0.324 . . . . 0.68999999999999995 111.506 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -142.16 129.68 21.37 Favored 'General case' 0 N--CA 1.463 0.203 0 CA-C-O 120.77 0.319 . . . . 0.78000000000000003 110.711 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 29.4 tp -122.41 129.66 52.3 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.337 -0.392 . . . . 0.73999999999999999 110.839 179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.477 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 53.2 mt-30 -127.58 128.94 46.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.309 -0.405 . . . . 1.1599999999999999 111.032 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.433 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 26.2 t -112.76 113.08 43.09 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.116 0 CA-C-N 115.882 -0.599 . . . . 0.62 110.879 -179.941 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 71.4 m-85 -111.1 132.97 53.83 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.946 -0.57 . . . . 0.72999999999999998 111.252 -179.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.461 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.08 -161.46 0.79 Allowed 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.378 -0.374 . . . . 0.66000000000000003 111.311 179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -71.62 128.87 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.205 0 CA-C-N 116.127 -0.488 . . . . 1.1399999999999999 110.869 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -166.02 12.06 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.869 -0.682 . . . . 0.66000000000000003 112.989 -179.779 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -78.27 -10.27 16.3 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.352 2.701 . . . . 0.81000000000000005 112.775 179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -108.56 -20.43 13.1 Favored 'General case' 0 CA--C 1.54 0.559 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.1 t -136.69 142.81 43.15 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.991 -0.549 . . . . 0.70999999999999996 111.187 -177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.99 8.06 39.01 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.114 -0.493 . . . . 1.0700000000000001 110.595 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 84.4 tttt -136.13 159.22 42.39 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.833 -0.621 . . . . 1.29 110.534 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.8 m -82.98 134.43 26.91 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 116.34 -0.391 . . . . 0.82999999999999996 110.635 179.378 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.7 mt-10 -132.61 130.2 39.92 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.364 -0.38 . . . . 0.79000000000000004 110.231 -179.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.3 m -100.68 106.06 18.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.694 0.759 . . . . 0.66000000000000003 112.26 -178.94 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -93.56 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 CA-C-O 122.585 1.183 . . . . 0.68999999999999995 110.75 178.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.39 46.51 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 115.103 -0.953 . . . . 0.57999999999999996 111.168 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.6 m -123.68 133.16 53.94 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 115.093 -0.958 . . . . 0.65000000000000002 110.413 176.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.9 mp -87.67 175.34 7.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.738 -0.665 . . . . 0.79000000000000004 111.562 -179.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.9 tptp -80.74 -16.97 52.49 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 115.61 -0.723 . . . . 1.23 110.886 179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.7 m-20 -81.76 -5.95 58.62 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 115.927 -0.578 . . . . 1.05 111.335 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.3 28.45 14.87 Favored Glycine 0 C--N 1.33 0.235 0 C-N-CA 120.971 -0.633 . . . . 0.69999999999999996 112.565 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -116.32 165.01 13.68 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.712 0.291 . . . . 1.1899999999999999 110.872 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -144.51 132.79 21.8 Favored 'General case' 0 N--CA 1.473 0.698 0 CA-C-O 121.424 0.63 . . . . 0.68999999999999995 109.88 179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.617 HD12 HG21 ' A' ' 19' ' ' THR . 49.3 pt -127.77 179.56 3.63 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.084 0 CA-C-N 114.642 -1.163 . . . . 0.53000000000000003 109.847 178.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.88 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 114.387 -1.279 . . . . 0.48999999999999999 109.271 177.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.623 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.8 mt -114.0 152.78 30.43 Favored 'General case' 0 C--N 1.314 -0.956 0 CA-C-N 114.043 -1.435 . . . . 0.51000000000000001 108.714 -178.57 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.638 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.9 t0 -104.83 115.73 62.05 Favored Pre-proline 0 N--CA 1.468 0.452 0 O-C-N 121.047 -1.033 . . . . 0.67000000000000004 110.687 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.76 -16.83 12.09 Favored 'Trans proline' 0 C--N 1.359 1.109 0 C-N-CA 123.111 2.541 . . . . 0.85999999999999999 112.611 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.36 -16.53 62.45 Favored 'General case' 0 CA--C 1.545 0.763 0 CA-C-N 115.021 -0.99 . . . . 1.3500000000000001 113.66 178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.47 135.15 20.27 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 122.271 -0.268 . . . . 0.94999999999999996 110.682 -179.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.28 -41.9 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 123.507 2.805 . . . . 1.24 113.388 -178.792 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.78 -25.85 66.83 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-O 121.389 0.614 . . . . 1.1899999999999999 111.89 176.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.623 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -65.53 -40.9 93.46 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.56 -0.745 . . . . 0.89000000000000001 110.335 177.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.559 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 35.2 ttpt -76.13 -17.59 59.51 Favored 'General case' 0 CA--C 1.533 0.301 0 CA-C-N 115.641 -0.709 . . . . 1.71 111.076 179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.54 -54.73 5.83 Favored 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 112.987 0.736 . . . . 1.29 112.987 179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.4 m -62.14 -29.14 45.88 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.854 -1.067 . . . . 0.91000000000000003 111.185 178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.487 HG12 ' O ' ' A' ' 63' ' ' LEU . 45.4 pt -87.02 -22.5 6.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.25 0 CA-C-O 120.653 0.264 . . . . 1.05 110.312 178.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.559 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 60.9 tt0 -74.07 -44.49 53.92 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 116.456 -0.338 . . . . 1.52 110.514 177.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.77 -34.47 71.47 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 113.592 0.96 . . . . 1.5800000000000001 113.592 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 25.9 pt -74.92 -2.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 N-CA-C 112.609 0.596 . . . . 1.3700000000000001 112.609 -178.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 54.0 mt -96.23 -15.16 22.17 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.963 0.411 . . . . 1.6699999999999999 110.43 179.178 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 33.4 t70 -93.2 -61.9 1.48 Allowed 'General case' 0 C--N 1.333 -0.152 0 CA-C-N 115.851 -0.613 . . . . 2.21 110.176 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.89 -17.15 75.56 Favored Glycine 0 CA--C 1.519 0.326 0 C-N-CA 120.924 -0.655 . . . . 1.77 112.768 -179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -84.6 -1.83 89.02 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.005 -0.617 . . . . 2.0899999999999999 112.858 -179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -119.96 -19.19 7.96 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.974 0.416 . . . . 2.29 110.399 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.9 tptp -83.03 -17.62 42.66 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.045 -0.525 . . . . 2.4399999999999999 111.186 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -69.87 120.92 16.33 Favored 'General case' 0 C--O 1.232 0.168 0 CA-C-O 120.848 0.356 . . . . 2.7000000000000002 110.947 179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.278 -0.867 . . . . 2.5600000000000001 110.806 -179.952 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.707 1.242 . . . . 0.80000000000000004 110.154 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.65 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.821 0 CA-C-N 113.382 -1.736 . . . . 0.84999999999999998 111.377 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.66 114.9 4.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.992 0.917 . . . . 0.77000000000000002 110.52 -173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -125.99 140.24 52.78 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 113.757 -1.565 . . . . 0.65000000000000002 110.234 178.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.47 30.25 Favored 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 114.022 -1.444 . . . . 0.68000000000000005 108.388 -176.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.97 151.05 9.31 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.061 -0.518 . . . . 0.5 109.873 172.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.86 -31.15 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.339 0 CA-C-O 121.792 0.806 . . . . 0.46999999999999997 111.573 177.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.642 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.08 104.19 10.24 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 114.453 -1.248 . . . . 0.46999999999999997 111.35 179.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.18 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.709 -1.132 . . . . 0.57999999999999996 113.725 175.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.871 0 C-N-CA 124.921 1.288 . . . . 0.57999999999999996 110.137 -179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.653 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.71 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 113.895 -1.502 . . . . 0.59999999999999998 111.364 178.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.81 152.33 24.91 Favored 'General case' 0 N--CA 1.471 0.598 0 C-N-CA 125.844 1.658 . . . . 0.57999999999999996 110.13 179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-O 123.698 1.713 . . . . 0.72999999999999998 112.122 177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.1 -177.19 51.38 Favored Glycine 0 CA--C 1.544 1.86 0 CA-C-N 113.219 -1.809 . . . . 0.64000000000000001 110.928 174.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.02 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.841 1 C-N-CA 136.152 5.781 . . . . 0.64000000000000001 106.279 8.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.51 32.33 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 121.988 -0.445 . . . . 0.68000000000000005 109.97 174.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.26 -22.07 10.81 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.837 3.692 . . . . 0.58999999999999997 112.855 174.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.61 -28.72 15.06 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 124.635 1.174 . . . . 0.68999999999999995 112.691 179.602 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.6 mmt -88.22 -18.5 28.52 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 113.513 0.931 . . . . 0.94999999999999996 113.513 175.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 25.5 mm -88.89 139.63 17.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.489 -0.323 . . . . 0.57999999999999996 111.303 -179.412 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.0 m -139.22 -10.48 1.27 Allowed 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.487 -0.324 . . . . 0.69999999999999996 111.133 179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.433 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 36.9 t30 -143.21 136.78 28.45 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 116.382 -0.372 . . . . 0.82999999999999996 110.774 -179.788 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.477 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 43.0 tp -122.89 135.73 54.61 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 116.268 -0.424 . . . . 0.75 110.85 179.812 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.438 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.1 mt-30 -130.61 112.13 12.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.206 -0.452 . . . . 1.0800000000000001 110.187 179.43 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.6 t -109.53 121.83 63.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-O 120.988 0.423 . . . . 0.60999999999999999 111.481 -179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -115.7 128.25 55.75 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.748 -0.66 . . . . 0.85999999999999999 110.249 179.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -83.61 -155.93 0.19 Allowed 'General case' 0 CA--C 1.53 0.201 0 CA-C-O 121.125 0.488 . . . . 0.60999999999999999 111.746 -179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 82.5 mt -71.38 121.75 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 CA-C-N 115.905 -0.589 . . . . 1.1000000000000001 111.087 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.8 -170.46 13.35 Favored Glycine 0 N--CA 1.45 -0.39 0 C-N-CA 120.949 -0.643 . . . . 0.63 112.817 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.44 -7.97 17.08 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.275 2.65 . . . . 0.79000000000000004 112.883 -179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.25 -20.93 12.13 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.052 0.76 . . . . 0.70999999999999996 113.052 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -142.07 133.77 26.97 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.251 -0.431 . . . . 0.67000000000000004 111.096 -177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 12.7 t -99.66 -3.88 32.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.183 -0.462 . . . . 1.01 110.526 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -112.06 146.38 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.997 -0.547 . . . . 1.1599999999999999 110.657 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 10.0 m -81.58 129.61 37.21 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 CA-C-O 120.976 0.417 . . . . 0.78000000000000003 110.723 179.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -129.57 130.01 45.17 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.334 -0.394 . . . . 0.80000000000000004 110.347 -179.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.4 m -100.43 106.08 18.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.616 0.722 . . . . 0.59999999999999998 112.246 -178.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.642 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.55 150.46 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-O 122.475 1.131 . . . . 0.62 110.84 178.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 115.222 -0.899 . . . . 0.55000000000000004 111.184 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.4 m -123.77 133.4 53.84 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 115.04 -0.982 . . . . 0.63 110.475 176.83 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -79.57 172.55 13.64 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 114.858 -1.064 . . . . 0.75 110.925 179.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.22 -14.87 59.27 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.127 -0.488 . . . . 1.27 110.659 179.555 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -76.82 -18.25 58.51 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 115.896 -0.593 . . . . 0.98999999999999999 111.277 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.02 29.61 5.13 Favored Glycine 0 C--N 1.332 0.329 0 C-N-CA 120.844 -0.693 . . . . 0.67000000000000004 112.57 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.5 mtpt -116.05 163.74 15.48 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.163 0.506 . . . . 1.05 111.412 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -136.45 129.55 31.29 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 115.443 -0.798 . . . . 0.70999999999999996 109.987 179.431 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.94 179.58 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.007 0 CA-C-N 114.714 -1.13 . . . . 0.52000000000000002 109.734 178.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.36 138.18 52.96 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.409 -1.269 . . . . 0.47999999999999998 109.247 177.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -114.09 153.32 29.67 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.007 -1.451 . . . . 0.48999999999999999 108.69 -178.505 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.653 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.3 t0 -107.16 115.17 60.38 Favored Pre-proline 0 C--N 1.326 -0.449 0 O-C-N 121.621 -0.675 . . . . 0.63 110.668 178.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.86 -16.09 30.07 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 123.12 2.546 . . . . 0.82999999999999996 112.092 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 8.3 tt0 -65.68 -16.47 63.78 Favored 'General case' 0 CA--C 1.545 0.778 0 CA-C-N 114.876 -1.057 . . . . 1.3999999999999999 113.534 178.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.549 ' HB1' ' CZ ' ' B' ' 62' ' ' PHE . . . -100.61 135.07 20.22 Favored Pre-proline 0 CA--C 1.54 0.595 0 O-C-N 122.192 -0.318 . . . . 0.91000000000000003 110.683 -179.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.3 -41.82 15.01 Favored 'Trans proline' 0 CA--C 1.536 0.576 0 C-N-CA 123.588 2.859 . . . . 1.1899999999999999 113.322 -178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.549 ' CZ ' ' HB1' ' B' ' 60' ' ' ALA . 21.9 p90 -60.71 -25.36 66.36 Favored 'General case' 0 N--CA 1.48 1.039 0 CA-C-O 121.394 0.616 . . . . 1.1499999999999999 111.779 176.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -76.22 -35.41 59.06 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-N 115.189 -0.914 . . . . 0.90000000000000002 110.369 178.201 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 36.6 ttpt -71.83 -16.68 62.17 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-O 121.441 0.639 . . . . 1.71 110.875 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -81.47 -54.85 5.09 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 115.446 -0.797 . . . . 1.3600000000000001 113.057 179.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.9 m -61.86 -27.91 43.22 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.113 -0.949 . . . . 0.96999999999999997 111.655 178.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 48.4 pt -76.06 -28.78 19.03 Favored 'Isoleucine or valine' 0 C--N 1.346 0.446 0 C-N-CA 120.694 -0.402 . . . . 1.0800000000000001 109.937 178.541 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 55.2 tt0 -74.55 -41.3 60.81 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.577 -0.449 . . . . 1.52 110.35 175.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 88.0 mttt -62.59 -33.49 75.08 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.852 0.686 . . . . 1.6100000000000001 112.852 -179.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.509 HG22 ' HB3' ' B' ' 24' ' ' PRO . 31.8 pt -72.83 -20.66 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.646 0 C-N-CA 120.76 -0.376 . . . . 1.4299999999999999 111.136 179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 74.0 mt -88.42 -26.96 21.86 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 1.79 109.982 179.148 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -80.87 -40.89 24.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.845 -0.616 . . . . 2.25 110.258 179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -92.7 -9.42 61.28 Favored Glycine 0 CA--C 1.519 0.285 0 C-N-CA 120.868 -0.682 . . . . 1.76 112.672 179.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.36 -33.49 25.52 Favored Glycine 0 C--N 1.332 0.357 0 C-N-CA 121.107 -0.568 . . . . 2.04 112.885 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -93.99 9.48 37.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.981 0.42 . . . . 2.3199999999999998 110.79 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -81.7 -18.46 44.34 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.13 -0.486 . . . . 2.46 110.586 179.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -73.16 99.89 2.93 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 116.138 -0.483 . . . . 2.7799999999999998 110.273 179.582 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.104 0 CA-C-O 118.345 -0.836 . . . . 2.48 110.925 -179.457 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 122.665 1.221 . . . . 0.81000000000000005 110.005 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.68 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 113.452 -1.704 . . . . 0.83999999999999997 111.384 -179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.55 115.08 4.51 Favored 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 123.944 0.897 . . . . 0.76000000000000001 110.335 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.12 52.83 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 113.757 -1.565 . . . . 0.65000000000000002 110.296 178.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 114.057 -1.429 . . . . 0.66000000000000003 108.41 -176.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.78 151.04 8.91 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 115.947 -0.57 . . . . 0.48999999999999999 109.856 172.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.91 -31.13 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-O 121.71 0.767 . . . . 0.45000000000000001 111.568 177.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.407 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -119.08 104.29 10.33 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.756 1.222 . . . . 0.46000000000000002 111.276 179.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.44 -33.27 28.59 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 114.59 -1.186 . . . . 0.56999999999999995 113.737 175.093 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.79 -178.69 3.5 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.766 1.226 . . . . 0.56999999999999995 110.009 -179.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.61 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.364 178.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.85 152.42 24.93 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.722 1.609 . . . . 0.60999999999999999 110.14 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 123.622 1.677 . . . . 0.76000000000000001 112.133 177.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.97 -177.31 51.46 Favored Glycine 0 CA--C 1.543 1.812 0 CA-C-N 113.238 -1.801 . . . . 0.68999999999999995 110.927 174.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.95 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.199 5.799 . . . . 0.68999999999999995 106.379 8.167 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.27 31.9 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.835 -0.541 . . . . 0.72999999999999998 110.102 174.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HB3' HG22 ' A' ' 70' ' ' ILE . 86.8 Cg_exo -51.16 -21.99 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.799 3.666 . . . . 0.64000000000000001 112.827 174.139 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.81 15.61 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.619 1.168 . . . . 0.73999999999999999 112.656 179.615 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.414 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 36.8 mmt -88.13 -19.07 27.5 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.434 0.902 . . . . 1.0800000000000001 113.434 175.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.2 mm -82.16 138.45 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-O 120.79 0.328 . . . . 0.57999999999999996 111.351 -179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 52.5 m -132.36 -46.78 0.9 Allowed 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 116.233 -0.439 . . . . 0.68999999999999995 110.632 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.4 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 6.6 t30 -118.4 140.24 50.15 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.267 -0.424 . . . . 0.78000000000000003 110.275 179.729 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 3.8 tp -131.85 146.95 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.574 -0.285 . . . . 0.73999999999999999 110.731 -179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -137.29 125.56 23.21 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.017 0.437 . . . . 1.1599999999999999 110.824 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 43.1 t -108.95 125.83 65.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 115.858 -0.61 . . . . 0.62 110.783 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 98.6 m-85 -116.82 122.07 43.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.854 -0.612 . . . . 0.72999999999999998 110.515 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.47 -155.02 0.14 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.819 0.342 . . . . 0.66000000000000003 111.371 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 80.5 mt -69.93 120.12 17.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.207 -0.452 . . . . 1.1399999999999999 111.116 179.869 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.47 -174.66 14.28 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.946 -0.645 . . . . 0.66000000000000003 112.803 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.31 -9.75 17.6 Favored 'Trans proline' 0 C--N 1.348 0.514 0 C-N-CA 123.343 2.695 . . . . 0.81000000000000005 113.07 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.06 -20.78 12.59 Favored 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 113.02 0.748 . . . . 0.72999999999999998 113.02 -179.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -147.76 127.27 13.22 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.28 -0.418 . . . . 0.70999999999999996 111.229 -177.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 23.4 t -86.03 -28.99 23.8 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.013 0.435 . . . . 1.0700000000000001 110.446 179.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 81.9 tttt -86.15 142.16 28.84 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.728 -0.669 . . . . 1.29 110.515 179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG21 ' HA ' ' B' ' 75' ' ' ASN . 33.8 m -78.86 135.16 26.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.156 0.503 . . . . 0.82999999999999996 110.552 179.359 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 26.1 mt-10 -127.33 136.19 51.57 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.111 -0.495 . . . . 0.79000000000000004 110.685 -179.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -104.91 116.67 49.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.546 0.689 . . . . 0.66000000000000003 112.101 -179.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.407 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -104.51 150.46 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 CA-C-O 122.658 1.218 . . . . 0.68999999999999995 110.681 179.088 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.29 46.44 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.106 -0.952 . . . . 0.57999999999999996 111.181 179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.58 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.6 m -123.7 133.37 53.89 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.064 -0.971 . . . . 0.65000000000000002 110.416 176.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' HA ' ' O ' ' A' ' 26' ' ' MET . 8.9 mp -81.99 173.44 12.2 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.036 -0.984 . . . . 0.79000000000000004 110.765 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -76.81 -14.03 59.95 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.107 -0.497 . . . . 1.23 110.736 179.782 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -83.88 -4.31 58.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.974 -0.557 . . . . 1.05 111.184 179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.03 48.26 4.17 Favored Glycine 0 C--N 1.332 0.337 0 C-N-CA 120.983 -0.627 . . . . 0.69999999999999996 112.584 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.58 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.1 mtpt -130.44 160.58 33.62 Favored 'General case' 0 C--O 1.218 -0.562 0 CA-C-O 120.626 0.25 . . . . 1.1899999999999999 110.939 -179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.97 129.58 36.42 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 121.377 0.608 . . . . 0.68999999999999995 109.872 179.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.8 179.57 3.62 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.106 0 CA-C-N 114.722 -1.127 . . . . 0.53000000000000003 109.822 178.061 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.39 138.04 52.9 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 114.401 -1.272 . . . . 0.48999999999999999 109.221 177.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.687 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.98 154.03 28.32 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 113.973 -1.467 . . . . 0.51000000000000001 108.704 -178.705 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.61 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -105.13 109.67 63.51 Favored Pre-proline 0 C--N 1.327 -0.402 0 O-C-N 121.632 -0.667 . . . . 0.67000000000000004 110.555 178.189 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.43 ' HG3' HG22 ' A' ' 44' ' ' VAL . 27.3 Cg_exo -60.18 -14.67 30.13 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 123.227 2.618 . . . . 0.85999999999999999 112.072 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -67.58 -16.48 64.2 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 114.628 -1.169 . . . . 1.3500000000000001 113.582 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.542 0.667 0 O-C-N 122.287 -0.258 . . . . 0.94999999999999996 110.654 -178.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.32 -41.91 14.68 Favored 'Trans proline' 0 N--CA 1.479 0.63 0 C-N-CA 123.539 2.826 . . . . 1.24 113.267 -178.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.634 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -23.91 65.34 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-O 121.381 0.61 . . . . 1.1899999999999999 111.849 177.033 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.07 -37.32 46.89 Favored 'General case' 0 N--CA 1.439 -1.008 0 CA-C-N 114.766 -1.106 . . . . 0.89000000000000001 109.879 177.375 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.474 ' O ' ' HG2' ' A' ' 64' ' ' LYS . 29.3 ttpt -68.23 -13.04 61.95 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 115.723 -0.671 . . . . 1.71 111.399 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -83.45 -56.14 3.91 Favored 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 113.013 0.745 . . . . 1.29 113.013 179.322 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.1 m -62.13 -27.23 42.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.272 -0.876 . . . . 0.91000000000000003 111.525 178.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.405 HG12 ' HA ' ' A' ' 64' ' ' LYS . 49.2 pt -77.39 -23.73 14.56 Favored 'Isoleucine or valine' 0 C--N 1.343 0.294 0 N-CA-C 110.048 -0.352 . . . . 1.05 110.048 178.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 64.6 tt0 -71.79 -43.5 65.57 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.524 176.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -63.07 -34.59 77.9 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 112.916 0.71 . . . . 1.5800000000000001 112.916 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.46 HG22 ' HB3' ' A' ' 24' ' ' PRO . 36.0 pt -70.13 -24.4 26.13 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 117.834 0.288 . . . . 1.3700000000000001 111.686 -179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 86.9 mt -83.55 -18.41 38.46 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.92 0.391 . . . . 1.6699999999999999 110.658 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -81.59 -47.15 13.42 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 115.997 -0.547 . . . . 2.21 110.67 179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.46 -17.85 72.56 Favored Glycine 0 CA--C 1.519 0.312 0 C-N-CA 121.083 -0.58 . . . . 1.77 112.665 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.29 21.45 34.79 Favored Glycine 0 C--N 1.331 0.258 0 C-N-CA 120.901 -0.666 . . . . 2.0899999999999999 112.794 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 60.6 t30 -148.73 -20.26 0.31 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.757 0.313 . . . . 2.29 110.793 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -82.63 -25.11 33.45 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.356 -0.384 . . . . 2.4399999999999999 111.473 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -67.72 115.75 7.64 Favored 'General case' 0 N--CA 1.464 0.262 0 CA-C-O 120.917 0.389 . . . . 2.7000000000000002 111.102 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.3 m120 . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.34 -0.838 . . . . 2.5600000000000001 110.777 -179.902 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.032 0 CA-C-O 122.728 1.251 . . . . 0.80000000000000004 110.101 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.91 0.78 Allowed 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 113.481 -1.691 . . . . 0.84999999999999998 111.239 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.37 115.01 4.55 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 123.972 0.909 . . . . 0.77000000000000002 110.52 -173.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.18 52.76 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.9 -1.5 . . . . 0.65000000000000002 110.198 178.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.1 146.43 30.19 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.94 -1.482 . . . . 0.68000000000000005 108.43 -176.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.6 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-N 116.141 -0.481 . . . . 0.5 109.902 172.914 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.08 46.99 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.253 0 CA-C-O 121.71 0.767 . . . . 0.46999999999999997 111.471 177.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.03 104.19 10.26 Favored 'General case' 0 N--CA 1.47 0.551 0 CA-C-N 114.538 -1.21 . . . . 0.46999999999999997 111.352 178.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.12 -33.49 29.65 Favored 'General case' 0 N--CA 1.477 0.911 0 CA-C-N 114.707 -1.133 . . . . 0.57999999999999996 113.793 175.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.78 3.52 Favored 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 124.847 1.259 . . . . 0.57999999999999996 110.061 -178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.519 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.62 -171.58 2.5 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 113.755 -1.566 . . . . 0.59999999999999998 111.438 178.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.87 152.32 24.78 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 125.842 1.657 . . . . 0.57999999999999996 110.164 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.23 72.2 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.68 1.705 . . . . 0.72999999999999998 112.091 177.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -83.99 -177.26 51.45 Favored Glycine 0 CA--C 1.543 1.832 0 CA-C-N 113.248 -1.796 . . . . 0.64000000000000001 110.976 174.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.96 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.687 1 C-N-CA 136.212 5.805 . . . . 0.64000000000000001 106.369 8.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.54 143.39 32.11 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.907 -0.495 . . . . 0.68000000000000005 110.08 174.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.7 Cg_exo -51.28 -21.82 10.43 Favored 'Trans proline' 0 N--CA 1.479 0.642 0 C-N-CA 124.709 3.606 . . . . 0.58999999999999997 112.827 174.155 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.84 16.86 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 124.577 1.151 . . . . 0.68999999999999995 112.517 179.684 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.2 mmt -88.02 -19.39 27.22 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.501 0.926 . . . . 0.94999999999999996 113.501 175.872 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.0 mm -87.21 141.31 14.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 O-C-N 122.183 -0.323 . . . . 0.57999999999999996 111.518 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.0 m -144.06 2.92 1.19 Allowed 'General case' 0 CA--C 1.533 0.322 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 111.263 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 8.5 t30 -155.73 136.78 13.71 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.451 -0.341 . . . . 0.82999999999999996 110.391 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.435 HD12 ' O ' ' B' ' 45' ' ' VAL . 20.0 tp -128.01 121.13 29.03 Favored 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.868 0.366 . . . . 0.75 111.247 -179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.482 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 36.5 mt-30 -110.35 122.87 48.71 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.246 -0.434 . . . . 1.0800000000000001 110.578 179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 14.1 t -108.41 130.07 61.7 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 115.908 -0.587 . . . . 0.60999999999999999 110.849 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -127.19 122.93 35.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.095 -0.502 . . . . 0.85999999999999999 109.95 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -86.12 -157.56 0.35 Allowed 'General case' 0 C--O 1.234 0.251 0 CA-C-O 121.029 0.442 . . . . 0.60999999999999999 111.87 -179.796 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.508 HG23 ' HA ' ' B' ' 40' ' ' SER . 93.7 mt -71.42 121.57 21.74 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 CA-C-N 115.93 -0.577 . . . . 1.1000000000000001 111.398 -179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.97 -170.07 12.82 Favored Glycine 0 CA--C 1.52 0.405 0 CA-C-N 115.736 -0.665 . . . . 0.63 112.298 179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -77.27 -7.12 16.94 Favored 'Trans proline' 0 C--N 1.347 0.483 0 C-N-CA 123.183 2.589 . . . . 0.79000000000000004 112.949 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.98 11.66 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.117 0.784 . . . . 0.70999999999999996 113.117 -179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -150.35 124.76 9.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.263 -0.426 . . . . 0.67000000000000004 111.078 -177.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.508 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -102.39 33.91 2.96 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.181 0.515 . . . . 1.01 110.543 179.843 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.7 tttt -134.93 150.73 50.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.766 -0.652 . . . . 1.1599999999999999 110.084 -179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 6.7 m -91.76 116.02 32.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.256 0.551 . . . . 0.78000000000000003 111.332 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -122.21 139.39 53.82 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.842 -0.617 . . . . 0.80000000000000004 110.481 179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.479 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.33 106.74 21.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.352 0.596 . . . . 0.59999999999999998 111.3 -179.994 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.482 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 1.0 OUTLIER -96.59 150.56 4.36 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.979 0 CA-C-O 122.589 1.185 . . . . 0.62 110.693 179.843 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.36 153.4 46.38 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 115.162 -0.926 . . . . 0.55000000000000004 111.186 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 51.1 m -123.79 134.3 53.66 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 115.053 -0.976 . . . . 0.63 110.45 176.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -74.12 170.19 16.0 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 114.462 -1.245 . . . . 0.75 110.931 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.3 tptp -78.3 -16.9 57.28 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 116.005 -0.543 . . . . 1.27 110.588 179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -74.03 -18.94 60.77 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.055 -0.521 . . . . 0.98999999999999999 111.195 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.67 36.85 2.71 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.878 -0.677 . . . . 0.67000000000000004 112.571 179.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -126.06 152.42 45.85 Favored 'General case' 0 C--O 1.223 -0.292 0 CA-C-O 120.837 0.351 . . . . 1.05 111.321 -179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -125.26 129.66 50.48 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.431 0.634 . . . . 0.70999999999999996 109.95 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.91 179.68 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.761 -1.109 . . . . 0.52000000000000002 109.767 178.167 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.49 138.02 52.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 114.472 -1.24 . . . . 0.47999999999999998 109.25 177.526 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.886 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.97 154.43 27.62 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 114.018 -1.446 . . . . 0.48999999999999999 108.773 -178.625 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.519 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.4 t0 -100.81 110.27 60.29 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 122.091 -0.381 . . . . 0.63 110.294 177.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.479 ' HG3' HG22 ' B' ' 44' ' ' VAL . 21.5 Cg_exo -63.05 -14.36 41.12 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 122.98 2.453 . . . . 0.82999999999999996 111.648 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.61 -16.6 64.25 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 114.546 -1.206 . . . . 1.3999999999999999 113.559 178.617 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.647 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.47 135.13 20.27 Favored Pre-proline 0 CA--C 1.54 0.581 0 O-C-N 122.289 -0.257 . . . . 0.91000000000000003 110.706 -178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.32 -41.79 15.01 Favored 'Trans proline' 0 N--CA 1.477 0.546 0 C-N-CA 123.63 2.887 . . . . 1.1899999999999999 113.43 -178.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.647 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.88 -26.14 67.2 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-O 121.373 0.606 . . . . 1.1499999999999999 111.851 176.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.886 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -78.53 -31.32 47.49 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.321 -0.854 . . . . 0.90000000000000002 110.574 178.595 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -74.01 -15.75 61.08 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-O 121.551 0.691 . . . . 1.71 110.664 179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.71 -56.35 4.35 Favored 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 115.161 -0.927 . . . . 1.3600000000000001 113.053 179.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.439 ' O ' HG23 ' B' ' 70' ' ' ILE . 30.2 m -63.0 -28.9 45.96 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 115.125 -0.943 . . . . 0.96999999999999997 111.717 179.021 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.492 ' O ' HG12 ' B' ' 70' ' ' ILE . 49.9 pt -74.16 -22.97 18.33 Favored 'Isoleucine or valine' 0 C--N 1.344 0.33 0 C-N-CA 120.633 -0.427 . . . . 1.0800000000000001 109.936 178.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -70.38 -43.24 70.51 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 120.529 -0.469 . . . . 1.52 110.521 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 80.5 mttt -70.4 -25.5 63.26 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 113.664 0.987 . . . . 1.6100000000000001 113.664 -178.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.492 HG12 ' O ' ' B' ' 67' ' ' ILE . 25.9 pt -70.74 -28.09 32.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 CA-C-N 118.619 0.645 . . . . 1.4299999999999999 111.151 -179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 34.7 mt -93.97 -6.69 44.86 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.188 -0.46 . . . . 1.79 110.013 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -93.72 -45.51 7.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.697 -0.683 . . . . 2.25 110.314 179.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -80.78 -27.77 49.26 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.989 -0.624 . . . . 1.76 111.91 179.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -94.98 45.8 2.09 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 121.066 -0.588 . . . . 2.04 111.977 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . 0.609 ' HA ' HG21 ' A' ' 42' ' ' VAL . 64.3 t30 -164.51 -25.02 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.855 0.359 . . . . 2.3199999999999998 110.255 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -76.63 -38.16 55.13 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.021 -0.536 . . . . 2.46 111.053 179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.3 mm-40 -79.96 130.9 35.65 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.206 -0.452 . . . . 2.7799999999999998 110.858 -179.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 14.6 m120 . . . . . 0 C--O 1.25 1.091 0 CA-C-O 118.335 -0.841 . . . . 2.48 110.923 -179.679 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.02 0 CA-C-O 122.688 1.232 . . . . 0.81000000000000005 110.134 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.571 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.64 0.78 Allowed 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 113.382 -1.735 . . . . 0.83999999999999997 111.4 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.571 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.65 115.13 4.49 Favored 'General case' 0 N--CA 1.468 0.437 0 C-N-CA 123.985 0.914 . . . . 0.76000000000000001 110.372 -173.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.504 ' HB3' ' HB3' ' A' ' 38' ' ' GLN . 1.2 mt -126.16 140.16 52.78 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-N 113.745 -1.57 . . . . 0.65000000000000002 110.246 178.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.12 146.37 30.29 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.01 -1.45 . . . . 0.66000000000000003 108.425 -176.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.04 9.01 Favored 'General case' 0 N--CA 1.475 0.801 0 CA-C-N 115.979 -0.555 . . . . 0.48999999999999999 109.911 172.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.96 -31.15 47.01 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.363 0 CA-C-O 121.597 0.713 . . . . 0.45000000000000001 111.492 177.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.586 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.0 m -118.95 104.33 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.723 1.209 . . . . 0.46000000000000002 111.28 179.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.4 28.66 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.713 -1.13 . . . . 0.56999999999999995 113.691 175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.88 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 110.055 -179.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.622 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.71 -171.61 2.51 Favored 'General case' 0 N--CA 1.472 0.658 0 CA-C-N 113.848 -1.524 . . . . 0.62 111.435 178.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.82 152.33 24.89 Favored 'General case' 0 N--CA 1.471 0.606 0 C-N-CA 125.797 1.639 . . . . 0.60999999999999999 110.156 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 123.583 1.659 . . . . 0.76000000000000001 112.128 177.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.587 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.28 51.48 Favored Glycine 0 CA--C 1.544 1.845 0 CA-C-N 113.232 -1.803 . . . . 0.68999999999999995 110.891 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.724 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 1 C-N-CA 136.265 5.826 . . . . 0.68999999999999995 106.415 8.137 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.724 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.4 32.17 Favored Pre-proline 0 CA--C 1.545 0.756 0 O-C-N 121.858 -0.527 . . . . 0.72999999999999998 110.077 174.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.549 ' HB3' HG23 ' A' ' 70' ' ' ILE . 84.7 Cg_exo -51.05 -22.15 10.12 Favored 'Trans proline' 0 N--CA 1.478 0.569 0 C-N-CA 124.841 3.694 . . . . 0.64000000000000001 112.841 174.074 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.571 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -28.84 16.61 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 124.666 1.186 . . . . 0.73999999999999999 112.491 179.853 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.94 -19.23 27.55 Favored 'General case' 0 N--CA 1.475 0.804 0 N-CA-C 113.569 0.951 . . . . 1.0800000000000001 113.569 175.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 27.4 mm -93.63 140.86 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.41 0 O-C-N 121.96 -0.463 . . . . 0.57999999999999996 111.574 -178.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.1 m -139.44 2.22 2.03 Favored 'General case' 0 CA--C 1.535 0.397 0 CA-C-N 116.59 -0.277 . . . . 0.68999999999999995 111.331 179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 9.5 t30 -155.37 131.19 9.95 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 110.52 -179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 35.7 tp -125.87 121.47 33.32 Favored 'General case' 0 N--CA 1.461 0.106 0 CA-C-O 120.978 0.418 . . . . 0.73999999999999999 111.398 -179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -109.2 123.35 49.08 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.06 -0.518 . . . . 1.1599999999999999 110.563 179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.419 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 18.5 t -100.31 117.6 45.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.236 -0.438 . . . . 0.62 110.897 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -105.96 124.25 49.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.157 -0.474 . . . . 0.72999999999999998 110.69 179.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.03 -159.03 0.56 Allowed 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.93 0.395 . . . . 0.66000000000000003 111.492 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 71.1 mt -77.74 126.25 37.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-N 115.988 -0.551 . . . . 1.1399999999999999 111.184 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.87 -169.62 12.62 Favored Glycine 0 CA--C 1.519 0.313 0 C-N-CA 120.885 -0.674 . . . . 0.66000000000000003 112.897 -179.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.05 -10.91 17.97 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.418 2.745 . . . . 0.81000000000000005 112.692 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.504 ' HB3' ' HB3' ' A' ' 11' ' ' LEU . 10.4 pt20 -107.79 -21.19 12.95 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 112.96 0.726 . . . . 0.72999999999999998 112.96 -179.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -140.18 129.26 23.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.191 -0.459 . . . . 0.70999999999999996 111.118 -177.816 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 19.5 t -90.66 -17.5 26.72 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.128 -0.487 . . . . 1.0700000000000001 110.607 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 86.1 tttt -104.67 146.15 29.33 Favored 'General case' 0 C--N 1.333 -0.138 0 CA-C-N 115.972 -0.558 . . . . 1.29 110.711 179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -80.49 132.34 31.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.095 0.474 . . . . 0.82999999999999996 110.722 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -125.52 143.42 51.01 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.991 -0.549 . . . . 0.79000000000000004 110.701 -179.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' A' ' 58' ' ' PRO . 5.4 m -111.15 111.71 37.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.633 0.73 . . . . 0.66000000000000003 111.962 -179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.586 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -100.15 158.61 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.94 0 CA-C-O 122.518 1.152 . . . . 0.68999999999999995 110.865 178.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -150.04 155.41 39.85 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.709 -0.678 . . . . 0.57999999999999996 112.235 -178.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 23.6 m -119.49 142.37 48.34 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.732 -0.667 . . . . 0.65000000000000002 110.535 179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.7 mp -91.83 167.58 12.05 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.983 -0.553 . . . . 0.79000000000000004 110.911 179.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -72.19 -22.33 61.29 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 116.075 -0.511 . . . . 1.23 110.512 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -73.88 -23.28 59.56 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.952 -0.567 . . . . 1.05 110.947 179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.54 38.13 2.13 Favored Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.997 -0.621 . . . . 0.69999999999999996 112.57 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -122.11 161.38 23.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.795 0.331 . . . . 1.1899999999999999 110.98 -179.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.29 129.51 37.67 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.467 0.651 . . . . 0.68999999999999995 109.868 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.53 3.65 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.004 0 CA-C-N 114.657 -1.156 . . . . 0.53000000000000003 109.766 178.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.3 138.05 52.97 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 114.382 -1.281 . . . . 0.48999999999999999 109.275 177.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.752 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 151.41 32.4 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.06 -1.427 . . . . 0.51000000000000001 108.669 -178.598 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.622 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t70 -98.22 115.13 65.82 Favored Pre-proline 0 C--N 1.328 -0.331 0 O-C-N 121.692 -0.63 . . . . 0.67000000000000004 110.195 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -65.76 -6.36 13.85 Favored 'Trans proline' 0 C--N 1.352 0.736 0 C-N-CA 122.934 2.422 . . . . 0.85999999999999999 113.216 -179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -79.24 -12.43 59.96 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.204 -0.453 . . . . 1.3500000000000001 111.022 -179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.19 135.14 21.43 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 120.051 -0.66 . . . . 0.94999999999999996 110.722 -179.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.75 14.91 Favored 'Trans proline' 0 N--CA 1.478 0.606 0 C-N-CA 123.432 2.755 . . . . 1.24 113.438 -178.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.12 66.97 Favored 'General case' 0 N--CA 1.48 1.034 0 CA-C-O 121.33 0.586 . . . . 1.1899999999999999 111.762 176.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.752 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -74.4 -33.09 62.92 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.522 -0.763 . . . . 0.89000000000000001 110.642 178.631 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 35.5 ttpt -72.27 -19.64 61.66 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-O 121.167 0.508 . . . . 1.71 110.543 179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.45 -58.27 3.34 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 113.084 0.772 . . . . 1.29 113.084 178.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.4 m -57.5 -29.67 34.38 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.367 0 O-C-N 124.065 0.853 . . . . 0.91000000000000003 111.59 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.1 pt -80.12 -29.33 12.51 Favored 'Isoleucine or valine' 0 C--N 1.343 0.292 0 C-N-CA 120.803 -0.359 . . . . 1.05 110.081 178.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -65.73 -43.27 89.55 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 120.809 -0.357 . . . . 1.52 110.454 176.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 80.8 mttt -60.91 -34.43 74.67 Favored 'General case' 0 N--CA 1.468 0.437 0 N-CA-C 113.105 0.78 . . . . 1.5800000000000001 113.105 -179.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.549 HG23 ' HB3' ' A' ' 24' ' ' PRO . 13.8 pt -84.79 -0.59 6.01 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 N-CA-C 112.057 0.391 . . . . 1.3700000000000001 112.057 -179.6 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 76.8 mt -106.05 -36.28 6.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.995 0.426 . . . . 1.6699999999999999 110.715 179.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.4 t70 -82.04 -40.79 21.55 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.787 -0.642 . . . . 2.21 110.148 179.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.44 -22.09 76.3 Favored Glycine 0 C--N 1.332 0.345 0 CA-C-N 116.001 -0.545 . . . . 1.77 112.59 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.22 -29.71 63.97 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 121.123 -0.56 . . . . 2.0899999999999999 112.071 179.381 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -86.2 -26.13 25.26 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-O 121.183 0.516 . . . . 2.29 110.136 179.295 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -76.43 -31.62 57.98 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 115.724 -0.671 . . . . 2.4399999999999999 110.693 179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.0 mm-40 -84.37 122.47 28.98 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.249 -0.432 . . . . 2.7000000000000002 110.614 179.56 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 12.2 m120 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.358 -0.83 . . . . 2.5600000000000001 110.73 -179.95 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.99 0 CA-C-O 122.807 1.289 . . . . 0.80000000000000004 110.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.567 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.39 -1.732 . . . . 0.84999999999999998 111.329 -179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.567 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.99 4.49 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.977 0.911 . . . . 0.77000000000000002 110.479 -173.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.19 52.79 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-N 113.843 -1.526 . . . . 0.65000000000000002 110.187 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.35 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.022 -1.444 . . . . 0.68000000000000005 108.376 -176.117 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.12 8.87 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 116.039 -0.528 . . . . 0.5 109.873 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.13 -30.98 46.94 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.785 0.802 . . . . 0.46999999999999997 111.516 177.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.404 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.06 104.15 10.21 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.774 1.23 . . . . 0.46999999999999997 111.333 178.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.16 -33.45 29.53 Favored 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 114.7 -1.136 . . . . 0.57999999999999996 113.818 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.75 3.52 Favored 'General case' 0 C--N 1.316 -0.866 0 C-N-CA 124.9 1.28 . . . . 0.57999999999999996 110.144 -179.04 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.655 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.7 -171.58 2.5 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-N 113.857 -1.52 . . . . 0.59999999999999998 111.305 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.607 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.82 152.35 24.92 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 125.834 1.654 . . . . 0.57999999999999996 110.215 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.523 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.28 72.23 1.42 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.666 1.698 . . . . 0.72999999999999998 112.089 177.195 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.573 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.24 51.36 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 113.279 -1.782 . . . . 0.64000000000000001 110.916 174.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.0 p 138.0 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.717 1 C-N-CA 136.154 5.782 . . . . 0.64000000000000001 106.331 8.194 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.45 32.24 Favored Pre-proline 0 CA--C 1.543 0.711 0 O-C-N 121.88 -0.513 . . . . 0.68000000000000005 110.108 174.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.45 ' HB3' HG23 ' B' ' 70' ' ' ILE . 86.0 Cg_exo -51.38 -21.83 10.84 Favored 'Trans proline' 0 N--CA 1.476 0.499 0 C-N-CA 124.733 3.622 . . . . 0.58999999999999997 112.874 174.186 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -29.5 19.64 Favored 'General case' 0 N--CA 1.471 0.619 0 C-N-CA 124.461 1.104 . . . . 0.68999999999999995 112.633 179.633 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.0 mmt -103.09 29.52 5.44 Favored 'General case' 0 CA--C 1.536 0.414 0 CA-C-O 120.73 0.3 . . . . 0.94999999999999996 111.229 179.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 38.3 mm -128.54 145.7 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 CA-C-N 116.582 -0.281 . . . . 0.57999999999999996 110.609 -179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.4 m -143.28 5.63 1.47 Allowed 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 111.847 0.314 . . . . 0.69999999999999996 111.847 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.485 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 29.7 t30 -162.84 139.7 7.62 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 120.66 0.266 . . . . 0.82999999999999996 110.783 179.941 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 13.7 tp -139.99 109.4 6.2 Favored 'General case' 0 N--CA 1.461 0.109 0 CA-C-N 116.3 -0.409 . . . . 0.75 111.18 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.402 ' HB2' HG22 ' B' ' 45' ' ' VAL . 51.8 mt-30 -103.37 118.35 36.55 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.803 0.335 . . . . 1.0800000000000001 110.878 -179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.0 t -106.04 97.51 5.71 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-N 116.142 -0.481 . . . . 0.60999999999999999 111.332 -179.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 14.4 m-85 -95.49 142.09 28.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.008 -0.542 . . . . 0.85999999999999999 111.071 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.403 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.38 -156.14 0.49 Allowed 'General case' 0 CA--C 1.531 0.232 0 CA-C-O 120.847 0.356 . . . . 0.60999999999999999 111.251 179.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.42 HG23 ' HA ' ' B' ' 40' ' ' SER . 98.1 mt -73.18 126.29 33.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.252 0 CA-C-N 116.171 -0.468 . . . . 1.1000000000000001 111.456 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.79 -164.89 11.83 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 121.209 -0.519 . . . . 0.63 112.512 179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -76.2 -8.61 18.77 Favored 'Trans proline' 0 C--N 1.351 0.661 0 C-N-CA 123.047 2.498 . . . . 0.79000000000000004 112.158 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.31 -21.87 12.0 Favored 'General case' 0 N--CA 1.47 0.554 0 N-CA-C 113.068 0.766 . . . . 0.70999999999999996 113.068 -179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.8 t -135.12 138.31 43.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.045 -0.525 . . . . 0.67000000000000004 111.333 -177.648 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.42 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.1 t -102.56 18.37 21.4 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 115.974 -0.557 . . . . 1.01 110.478 178.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -146.26 157.31 43.8 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.431 -0.35 . . . . 1.1599999999999999 111.043 -179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.403 HG12 ' HA ' ' B' ' 34' ' ' ALA . 34.7 m -81.33 135.88 24.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.381 -0.372 . . . . 0.78000000000000003 110.351 179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -133.82 130.17 37.56 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.373 -0.376 . . . . 0.80000000000000004 110.233 -178.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.413 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.1 m -100.62 106.02 18.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.656 0.741 . . . . 0.59999999999999998 112.285 -179.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.404 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.6 OUTLIER -93.51 150.52 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.937 0 CA-C-O 122.549 1.166 . . . . 0.62 110.797 178.38 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.3 153.41 46.45 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.197 -0.91 . . . . 0.55000000000000004 111.185 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.485 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 23.2 m -123.75 133.34 53.86 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.087 -0.96 . . . . 0.63 110.454 176.901 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 5.6 mp -82.43 176.28 9.55 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 114.698 -1.137 . . . . 0.75 111.477 -179.458 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -78.57 -21.7 48.26 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 115.93 -0.577 . . . . 1.27 110.677 179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 42.8 m-80 -69.83 -28.7 65.91 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-N 116.01 -0.541 . . . . 0.98999999999999999 111.46 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.37 12.1 9.18 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.292 -179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.8 mtpt -102.47 155.57 18.18 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-O 121.037 0.446 . . . . 1.05 111.402 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -123.08 130.89 53.37 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.875 -0.602 . . . . 0.70999999999999996 110.825 179.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.607 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -124.74 179.61 2.9 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 CA-C-N 115.524 -0.762 . . . . 0.52000000000000002 109.758 179.621 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.32 138.02 52.95 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 114.48 -1.237 . . . . 0.47999999999999998 109.412 177.46 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.74 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.94 153.08 29.89 Favored 'General case' 0 C--N 1.312 -1.027 0 CA-C-N 114.062 -1.426 . . . . 0.48999999999999999 108.701 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.655 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -107.68 117.71 54.91 Favored Pre-proline 0 C--N 1.326 -0.425 0 O-C-N 121.345 -0.847 . . . . 0.63 110.528 178.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.413 ' HG3' HG22 ' B' ' 44' ' ' VAL . 39.3 Cg_exo -58.8 -15.59 27.3 Favored 'Trans proline' 0 C--N 1.358 1.064 0 C-N-CA 122.986 2.457 . . . . 0.82999999999999996 112.175 179.918 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.94 -16.46 63.89 Favored 'General case' 0 CA--C 1.545 0.784 0 CA-C-N 114.71 -1.132 . . . . 1.3999999999999999 113.54 178.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.55 135.06 20.25 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.287 -0.258 . . . . 0.91000000000000003 110.729 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.42 -41.78 14.72 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.615 2.877 . . . . 1.1899999999999999 113.342 -178.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.77 -27.43 67.97 Favored 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 121.397 0.617 . . . . 1.1499999999999999 111.824 176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.74 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -69.45 -42.42 74.95 Favored 'General case' 0 N--CA 1.444 -0.727 0 CA-C-N 115.178 -0.919 . . . . 0.90000000000000002 110.318 178.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 38.1 ttpt -62.78 -26.99 68.99 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 115.946 -0.57 . . . . 1.71 111.142 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.47 -55.7 5.42 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 113.057 0.762 . . . . 1.3600000000000001 113.057 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.6 m -62.24 -29.67 47.14 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.549 0 CA-C-N 116.175 -0.466 . . . . 0.96999999999999997 111.266 178.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.588 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 27.6 pt -85.1 -20.87 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.768 -0.373 . . . . 1.0800000000000001 110.235 178.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -75.58 -44.28 44.02 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.761 -0.376 . . . . 1.52 110.577 176.449 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.6 mttt -59.35 -30.92 68.74 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.153 0.797 . . . . 1.6100000000000001 113.153 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.45 HG23 ' HB3' ' B' ' 24' ' ' PRO . 7.6 pt -85.61 -11.6 11.33 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 N-CA-C 112.083 0.401 . . . . 1.4299999999999999 112.083 -179.37 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.588 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 95.4 mt -84.96 -38.66 19.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.897 0.38 . . . . 1.79 110.107 178.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -81.88 -25.89 34.64 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.875 -0.602 . . . . 2.25 110.336 179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -70.8 -28.36 70.86 Favored Glycine 0 C--N 1.335 0.483 0 CA-C-N 116.027 -0.533 . . . . 1.76 112.134 179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.47 -17.08 76.69 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.038 -0.601 . . . . 2.04 111.868 179.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -93.58 -27.62 16.51 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.982 0.42 . . . . 2.3199999999999998 109.973 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.12 -34.81 61.72 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 115.681 -0.69 . . . . 2.46 111.011 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 10.8 mm-40 -73.87 117.48 15.7 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.896 0.379 . . . . 2.7799999999999998 110.579 179.52 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 15.5 m120 . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.352 -0.832 . . . . 2.48 110.797 -179.657 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.051 0 CA-C-O 122.753 1.263 . . . . 0.81000000000000005 110.166 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.72 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 113.362 -1.745 . . . . 0.83999999999999997 111.343 -179.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.52 115.08 4.52 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.447 -173.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 113.846 -1.524 . . . . 0.65000000000000002 110.179 178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.22 146.34 30.42 Favored 'General case' 0 N--CA 1.475 0.806 0 CA-C-N 114.043 -1.435 . . . . 0.66000000000000003 108.306 -176.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.82 151.0 9.05 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.015 -0.539 . . . . 0.48999999999999999 109.947 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.93 -31.12 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-O 121.694 0.759 . . . . 0.45000000000000001 111.595 177.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.4 m -118.97 104.34 10.41 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.356 178.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.28 -33.44 29.11 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-N 114.611 -1.177 . . . . 0.56999999999999995 113.774 175.063 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.72 3.51 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 124.827 1.251 . . . . 0.56999999999999995 110.044 -179.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.529 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.81 -171.6 2.51 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.756 -1.565 . . . . 0.62 111.298 178.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.1 m -157.89 152.35 24.77 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 125.779 1.632 . . . . 0.60999999999999999 110.147 179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.2 1.41 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 123.564 1.65 . . . . 0.76000000000000001 112.091 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.96 -177.34 51.48 Favored Glycine 0 CA--C 1.543 1.783 0 CA-C-N 113.278 -1.783 . . . . 0.68999999999999995 110.956 174.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.91 -172.43 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.743 1 C-N-CA 136.149 5.78 . . . . 0.68999999999999995 106.425 8.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.33 32.04 Favored Pre-proline 0 CA--C 1.545 0.751 0 O-C-N 121.949 -0.47 . . . . 0.72999999999999998 110.043 174.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.27 -22.02 10.76 Favored 'Trans proline' 0 N--CA 1.479 0.654 0 C-N-CA 124.765 3.643 . . . . 0.64000000000000001 112.744 174.122 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.6 -28.88 15.5 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.548 1.139 . . . . 0.73999999999999999 112.692 179.624 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.99 -19.56 27.03 Favored 'General case' 0 N--CA 1.474 0.751 0 N-CA-C 113.507 0.929 . . . . 1.0800000000000001 113.507 175.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 34.1 mm -83.02 134.42 26.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 O-C-N 121.979 -0.45 . . . . 0.57999999999999996 111.597 -178.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.0 m -139.67 14.66 2.52 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.326 -0.397 . . . . 0.68999999999999995 111.192 -179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.421 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 8.9 t30 -168.19 132.93 1.73 Allowed 'General case' 0 N--CA 1.465 0.308 0 CA-C-N 116.224 -0.444 . . . . 0.78000000000000003 110.247 -179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 41.6 tp -126.88 137.81 53.22 Favored 'General case' 0 C--O 1.226 -0.16 0 CA-C-O 120.795 0.331 . . . . 0.73999999999999999 111.218 -179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.447 ' HB2' HG22 ' A' ' 45' ' ' VAL . 53.6 mt-30 -129.0 118.83 23.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.27 -0.423 . . . . 1.1599999999999999 110.581 179.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.7 t -101.98 113.1 37.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.239 0 CA-C-O 121.009 0.433 . . . . 0.62 111.146 -179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -110.15 120.49 42.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.726 -0.67 . . . . 0.72999999999999998 110.538 179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.43 -158.83 0.56 Allowed 'General case' 0 C--O 1.234 0.245 0 CA-C-O 120.816 0.341 . . . . 0.66000000000000003 111.524 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.5 mt -68.19 119.22 13.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-N 116.16 -0.473 . . . . 1.1399999999999999 111.024 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -123.1 -174.77 14.36 Favored Glycine 0 N--CA 1.45 -0.4 0 C-N-CA 121.031 -0.604 . . . . 0.66000000000000003 112.598 -179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.92 -9.01 18.08 Favored 'Trans proline' 0 C--N 1.346 0.424 0 C-N-CA 123.392 2.728 . . . . 0.81000000000000005 112.849 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.37 -20.93 12.44 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.094 0.775 . . . . 0.72999999999999998 113.094 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 5.1 t -150.24 122.93 8.6 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.122 -0.49 . . . . 0.70999999999999996 111.148 -177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 10.1 t -98.61 39.0 1.29 Allowed 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.174 0.511 . . . . 1.0700000000000001 110.422 179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.2 tttt -139.05 141.07 38.25 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.678 -0.692 . . . . 1.29 110.459 -179.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG11 ' HA2' ' B' ' 74' ' ' GLY . 6.8 m -83.81 117.29 29.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.099 0.476 . . . . 0.82999999999999996 110.662 179.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.3 mt-10 -126.62 138.43 53.44 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.059 -0.519 . . . . 0.79000000000000004 110.529 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.433 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -107.94 111.88 37.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-O 121.555 0.693 . . . . 0.66000000000000003 111.626 -179.773 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.447 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -101.31 150.5 5.87 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.527 1.156 . . . . 0.68999999999999995 110.859 179.179 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.39 46.61 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.18 -0.918 . . . . 0.57999999999999996 111.213 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.79 133.13 53.88 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 115.083 -0.962 . . . . 0.65000000000000002 110.41 176.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.6 mp -77.85 173.98 11.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 114.939 -1.028 . . . . 0.79000000000000004 110.895 179.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -78.74 -14.24 59.38 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.199 -0.455 . . . . 1.23 110.71 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 76.2 m-20 -83.07 0.14 46.33 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.992 -0.549 . . . . 1.05 111.108 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.31 42.1 7.62 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 121.051 -0.595 . . . . 0.69999999999999996 112.453 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.485 ' O ' ' HA ' ' A' ' 47' ' ' SER . 61.5 mtpt -123.88 150.0 45.16 Favored 'General case' 0 C--O 1.219 -0.538 0 CA-C-O 120.692 0.282 . . . . 1.1899999999999999 110.933 -179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.35 129.56 44.95 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 121.366 0.603 . . . . 0.68999999999999995 109.902 179.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.8 179.49 3.68 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 114.754 -1.112 . . . . 0.53000000000000003 109.808 177.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.23 138.0 53.01 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 114.371 -1.286 . . . . 0.48999999999999999 109.284 177.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.906 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -113.91 153.4 29.31 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.04 -1.437 . . . . 0.51000000000000001 108.742 -178.703 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.529 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 0.9 OUTLIER -100.52 111.3 62.52 Favored Pre-proline 0 C--N 1.324 -0.513 0 O-C-N 121.944 -0.472 . . . . 0.67000000000000004 110.123 177.49 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.474 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 23.7 Cg_exo -61.96 -16.42 49.58 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 123.045 2.496 . . . . 0.85999999999999999 111.638 179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.73 -16.57 63.13 Favored 'General case' 0 CA--C 1.546 0.792 0 CA-C-N 114.621 -1.172 . . . . 1.3500000000000001 113.656 178.415 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.1 20.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 122.299 -0.251 . . . . 0.94999999999999996 110.65 -178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.402 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.34 -41.86 14.75 Favored 'Trans proline' 0 CA--C 1.536 0.575 0 C-N-CA 123.563 2.842 . . . . 1.24 113.339 -178.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.54 66.52 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 121.261 0.553 . . . . 1.1899999999999999 111.811 176.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.906 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -82.52 -32.2 28.8 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-N 115.064 -0.971 . . . . 0.89000000000000001 110.394 178.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.6 ttpt -73.54 -12.99 60.95 Favored 'General case' 0 N--CA 1.469 0.523 0 CA-C-O 121.705 0.764 . . . . 1.71 110.673 179.383 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.402 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -84.3 -56.13 3.8 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 115.173 -0.921 . . . . 1.29 113.076 179.125 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 m -61.62 -25.9 38.13 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 CA-C-N 115.172 -0.922 . . . . 0.91000000000000003 111.689 178.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' O ' ' A' ' 63' ' ' LEU . 43.5 pt -72.0 -31.05 38.95 Favored 'Isoleucine or valine' 0 C--N 1.346 0.445 0 C-N-CA 120.607 -0.437 . . . . 1.05 110.087 178.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.16 -43.77 70.19 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.092 -0.643 . . . . 1.52 110.504 176.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 82.5 mttt -59.44 -38.39 80.58 Favored 'General case' 0 CA--C 1.533 0.293 0 N-CA-C 112.821 0.674 . . . . 1.5800000000000001 112.821 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 19.0 pt -74.22 -24.76 19.27 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.415 0 C-N-CA 120.882 -0.327 . . . . 1.3700000000000001 111.355 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 28.0 mt -80.07 -31.87 39.37 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.377 -0.374 . . . . 1.6699999999999999 110.579 179.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 14.4 t70 -79.45 -34.13 41.85 Favored 'General case' 0 C--O 1.232 0.136 0 CA-C-N 116.117 -0.492 . . . . 2.21 110.248 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.24 -27.01 64.74 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.091 -0.576 . . . . 1.77 112.135 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.69 17.32 56.77 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.129 -0.557 . . . . 2.0899999999999999 112.189 179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -131.98 -29.8 1.63 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.037 0.446 . . . . 2.29 110.071 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.2 tptp -92.28 0.41 57.45 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 115.784 -0.643 . . . . 2.4399999999999999 110.355 179.701 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -69.2 111.09 4.91 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 115.938 -0.574 . . . . 2.7000000000000002 110.243 179.577 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--O 1.25 1.128 0 CA-C-O 118.325 -0.845 . . . . 2.5600000000000001 111.001 -179.456 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.035 0 CA-C-O 122.87 1.319 . . . . 0.80000000000000004 110.132 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.88 0.78 Allowed 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.395 -1.73 . . . . 0.84999999999999998 111.362 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.03 4.52 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.491 -173.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.13 52.81 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-N 113.93 -1.487 . . . . 0.65000000000000002 110.193 179.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.49 30.2 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 113.955 -1.475 . . . . 0.68000000000000005 108.419 -176.16 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.83 151.04 9.02 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 116.069 -0.514 . . . . 0.5 109.9 172.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.03 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.727 0.775 . . . . 0.46999999999999997 111.563 177.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.425 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.03 104.16 10.22 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 124.836 1.254 . . . . 0.46999999999999997 111.349 178.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.2 -33.43 29.39 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-N 114.751 -1.113 . . . . 0.57999999999999996 113.791 175.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.72 3.51 Favored 'General case' 0 C--N 1.316 -0.889 0 C-N-CA 124.945 1.298 . . . . 0.57999999999999996 110.121 -178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.553 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.83 -171.63 2.52 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 113.856 -1.52 . . . . 0.59999999999999998 111.245 178.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.604 HG21 HD12 ' B' ' 54' ' ' ILE . 86.5 m -157.81 152.27 24.83 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 125.864 1.666 . . . . 0.57999999999999996 110.16 -179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.2 72.29 1.42 Allowed 'General case' 0 C--N 1.324 -0.505 0 CA-C-O 123.713 1.72 . . . . 0.72999999999999998 112.173 177.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.14 51.35 Favored Glycine 0 CA--C 1.543 1.823 0 CA-C-N 113.181 -1.827 . . . . 0.64000000000000001 110.832 174.544 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.16 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.741 1 C-N-CA 136.106 5.762 . . . . 0.64000000000000001 106.304 7.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.35 32.18 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.023 -0.423 . . . . 0.68000000000000005 110.001 174.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.451 ' HB3' HG23 ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.17 -21.9 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.553 0 C-N-CA 124.776 3.65 . . . . 0.58999999999999997 112.88 174.081 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.8 -28.82 16.81 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.694 1.198 . . . . 0.68999999999999995 112.574 179.716 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -88.04 -18.58 28.63 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 113.472 0.915 . . . . 0.94999999999999996 113.472 175.847 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 11.4 mm -99.14 151.11 4.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 O-C-N 122.137 -0.352 . . . . 0.57999999999999996 111.528 -178.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 65.4 m -145.66 -10.57 0.53 Allowed 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.602 -0.272 . . . . 0.69999999999999996 111.27 179.768 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 44.7 t30 -138.77 135.28 34.51 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.731 0.3 . . . . 0.82999999999999996 110.953 -179.777 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 40.2 tp -126.45 114.9 18.78 Favored 'General case' 0 C--N 1.334 -0.104 0 CA-C-N 116.27 -0.423 . . . . 0.75 110.861 179.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -105.7 117.1 33.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.248 -0.433 . . . . 1.0800000000000001 110.909 179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.7 t -107.44 123.91 63.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.902 -0.59 . . . . 0.60999999999999999 110.784 -179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -115.11 137.22 52.26 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.255 -0.429 . . . . 0.85999999999999999 110.571 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.493 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -90.67 -148.93 0.21 Allowed 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.828 0.347 . . . . 0.60999999999999999 111.762 179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 41.4 mt -70.95 129.9 34.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 115.935 -0.575 . . . . 1.1000000000000001 111.597 -179.48 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.85 179.65 17.42 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.097 -0.573 . . . . 0.63 112.714 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -75.46 -12.76 20.62 Favored 'Trans proline' 0 C--N 1.35 0.622 0 C-N-CA 123.398 2.732 . . . . 0.79000000000000004 112.627 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -106.53 -20.84 13.24 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 113.094 0.776 . . . . 0.70999999999999996 113.094 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -152.83 115.46 4.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.185 -0.461 . . . . 0.67000000000000004 110.956 -177.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -76.64 -26.45 54.91 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.304 -0.407 . . . . 1.01 110.725 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 59.0 tttt -85.21 146.63 26.99 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.052 -0.522 . . . . 1.1599999999999999 110.351 179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.493 HG12 ' HA ' ' B' ' 34' ' ' ALA . 29.3 m -80.78 132.06 32.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 121.204 0.526 . . . . 0.78000000000000003 110.983 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -124.96 138.4 54.23 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.074 -0.512 . . . . 0.80000000000000004 110.888 -179.808 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.471 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -108.04 111.02 34.09 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.178 0 CA-C-O 121.265 0.555 . . . . 0.59999999999999998 111.957 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.425 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -100.47 150.45 5.57 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.888 0 CA-C-O 122.455 1.121 . . . . 0.62 110.77 179.003 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.46 46.58 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-N 115.237 -0.892 . . . . 0.55000000000000004 111.159 179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.81 133.2 53.85 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.061 -0.972 . . . . 0.63 110.507 176.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -76.09 172.36 12.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.054 -0.975 . . . . 0.75 110.937 179.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -78.31 -9.37 59.22 Favored 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 116.202 -0.454 . . . . 1.27 110.848 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 73.0 m-20 -87.67 -7.74 57.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.086 -0.506 . . . . 0.98999999999999999 110.992 179.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 93.12 37.0 5.79 Favored Glycine 0 C--N 1.333 0.383 0 C-N-CA 120.861 -0.685 . . . . 0.67000000000000004 112.073 -179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' B' ' 47' ' ' SER . 55.2 mtpt -119.72 156.8 29.84 Favored 'General case' 0 C--O 1.222 -0.36 0 N-CA-C 110.495 -0.187 . . . . 1.05 110.495 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -132.63 129.46 38.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 121.419 0.628 . . . . 0.70999999999999996 109.995 179.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.604 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.8 179.6 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.991 0 CA-C-N 114.741 -1.118 . . . . 0.52000000000000002 109.848 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.2 m -127.26 137.98 52.98 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 114.471 -1.241 . . . . 0.47999999999999998 109.406 177.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.777 ' HB3' HD11 ' B' ' 63' ' ' LEU . 40.0 mt -114.01 153.3 29.61 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 114.053 -1.431 . . . . 0.48999999999999999 108.675 -178.547 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.553 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -100.74 111.28 62.78 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.736 -0.602 . . . . 0.63 110.29 177.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.471 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -61.14 -15.82 42.15 Favored 'Trans proline' 0 C--N 1.358 1.057 0 C-N-CA 122.957 2.438 . . . . 0.82999999999999996 111.886 179.756 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.95 -16.44 63.88 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.52 -1.218 . . . . 1.3999999999999999 113.48 178.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.48 135.11 20.27 Favored Pre-proline 0 CA--C 1.541 0.598 0 O-C-N 122.223 -0.298 . . . . 0.91000000000000003 110.764 -179.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.78 14.75 Favored 'Trans proline' 0 CA--C 1.535 0.535 0 C-N-CA 123.646 2.897 . . . . 1.1899999999999999 113.327 -178.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -27.46 68.07 Favored 'General case' 0 N--CA 1.48 1.062 0 CA-C-O 121.319 0.58 . . . . 1.1499999999999999 111.756 176.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.777 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -72.88 -31.52 64.76 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 115.718 -0.674 . . . . 0.90000000000000002 110.776 179.199 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.501 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 36.0 ttpt -74.28 -20.22 60.21 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-N 116.055 -0.521 . . . . 1.71 110.549 179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.12 -55.54 5.63 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.401 -0.818 . . . . 1.3600000000000001 113.071 179.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.5 m -62.37 -29.64 47.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 116.148 -0.478 . . . . 0.96999999999999997 111.301 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.457 HG12 ' HA ' ' B' ' 64' ' ' LYS . 36.4 pt -85.08 -20.54 8.26 Favored 'Isoleucine or valine' 0 C--N 1.346 0.438 0 C-N-CA 120.794 -0.362 . . . . 1.0800000000000001 110.279 178.561 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.501 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.91 -42.57 48.54 Favored 'General case' 0 N--CA 1.475 0.799 0 C-N-CA 120.818 -0.353 . . . . 1.52 110.415 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -56.02 -34.01 65.44 Favored 'General case' 0 N--CA 1.471 0.601 0 N-CA-C 113.089 0.774 . . . . 1.6100000000000001 113.089 -179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.451 HG23 ' HB3' ' B' ' 24' ' ' PRO . 11.4 pt -77.83 -19.77 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.36 0 N-CA-C 112.116 0.413 . . . . 1.4299999999999999 112.116 -179.299 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.449 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 81.7 mt -74.08 -34.93 64.16 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.852 0.358 . . . . 1.79 110.212 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -77.99 -36.72 48.55 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 115.885 -0.598 . . . . 2.25 110.398 179.351 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.89 -22.63 78.95 Favored Glycine 0 C--N 1.332 0.354 0 C-N-CA 121.167 -0.539 . . . . 1.76 112.167 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' HA2' HG11 ' A' ' 42' ' ' VAL . . . -93.41 17.4 58.52 Favored Glycine 0 C--N 1.332 0.331 0 C-N-CA 121.125 -0.56 . . . . 2.04 112.293 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.9 t30 -131.31 -33.11 1.51 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.993 0.425 . . . . 2.3199999999999998 110.522 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -78.55 -24.43 45.62 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.99 -0.55 . . . . 2.46 110.798 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.82 123.34 20.29 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.383 -0.372 . . . . 2.7799999999999998 110.384 179.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.251 1.161 0 CA-C-O 118.33 -0.843 . . . . 2.48 110.955 -179.712 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.998 0 CA-C-O 122.71 1.243 . . . . 0.81000000000000005 110.029 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.75 -64.87 0.77 Allowed 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.339 -1.755 . . . . 0.83999999999999997 111.366 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.09 4.54 Favored 'General case' 0 N--CA 1.467 0.424 0 C-N-CA 123.987 0.915 . . . . 0.76000000000000001 110.441 -173.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.16 140.19 52.76 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 113.852 -1.522 . . . . 0.65000000000000002 110.193 178.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.35 30.37 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.067 -1.424 . . . . 0.66000000000000003 108.393 -176.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.81 151.04 8.97 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 116.07 -0.513 . . . . 0.48999999999999999 109.877 172.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.01 -31.06 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-O 121.6 0.714 . . . . 0.45000000000000001 111.475 177.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.6 m -119.05 104.34 10.38 Favored 'General case' 0 N--CA 1.47 0.538 0 C-N-CA 124.734 1.213 . . . . 0.46000000000000002 111.272 179.078 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 114.713 -1.13 . . . . 0.56999999999999995 113.612 175.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.71 3.5 Favored 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 124.817 1.247 . . . . 0.56999999999999995 110.1 -179.013 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.634 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.77 -171.57 2.5 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 113.83 -1.532 . . . . 0.62 111.316 178.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' A' ' 54' ' ' ILE . 85.8 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 125.759 1.624 . . . . 0.60999999999999999 110.185 179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.16 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 123.568 1.651 . . . . 0.76000000000000001 112.075 177.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.543 1.835 0 CA-C-N 113.228 -1.805 . . . . 0.68999999999999995 110.849 174.431 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.94 -172.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.738 1 C-N-CA 136.205 5.802 . . . . 0.68999999999999995 106.409 8.19 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.3 31.97 Favored Pre-proline 0 CA--C 1.544 0.727 0 O-C-N 121.948 -0.47 . . . . 0.72999999999999998 110.114 174.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.4 Cg_exo -51.15 -21.94 10.14 Favored 'Trans proline' 0 N--CA 1.477 0.506 0 C-N-CA 124.809 3.673 . . . . 0.64000000000000001 112.842 174.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.584 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.94 16.26 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.675 1.19 . . . . 0.73999999999999999 112.604 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.1 mmt -87.98 -19.13 27.64 Favored 'General case' 0 N--CA 1.475 0.818 0 N-CA-C 113.528 0.936 . . . . 1.0800000000000001 113.528 175.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.1 mm -93.65 147.02 5.81 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.456 0 O-C-N 122.11 -0.369 . . . . 0.57999999999999996 111.317 -179.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 21.7 m -139.72 -28.81 0.75 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.464 -0.335 . . . . 0.68999999999999995 111.401 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.7 t30 -125.86 138.05 53.78 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.795 0.331 . . . . 0.78000000000000003 111.095 -179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.476 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 29.1 tp -121.06 145.92 47.27 Favored 'General case' 0 C--N 1.333 -0.135 0 CA-C-N 116.059 -0.519 . . . . 0.73999999999999999 110.822 179.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -139.87 98.39 3.46 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.128 -0.487 . . . . 1.1599999999999999 110.25 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 39.1 t -91.26 109.22 20.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.28 -0.418 . . . . 0.62 111.249 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.8 m-85 -103.32 126.86 50.7 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.317 -0.401 . . . . 0.72999999999999998 110.851 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.515 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.14 -143.24 0.16 Allowed 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 116.357 -0.383 . . . . 0.66000000000000003 111.618 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 37.6 mt -70.73 129.85 34.77 Favored 'Isoleucine or valine' 0 C--O 1.232 0.144 0 CA-C-N 116.222 -0.445 . . . . 1.1399999999999999 111.349 -179.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.06 -179.49 16.47 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.889 -0.672 . . . . 0.66000000000000003 112.461 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.0 -8.08 17.59 Favored 'Trans proline' 0 C--N 1.348 0.512 0 C-N-CA 123.099 2.533 . . . . 0.81000000000000005 112.516 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.57 -21.16 12.27 Favored 'General case' 0 N--CA 1.471 0.586 0 N-CA-C 113.097 0.777 . . . . 0.72999999999999998 113.097 -179.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -142.92 131.16 22.02 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.978 -0.555 . . . . 0.70999999999999996 110.891 -177.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -87.47 -22.31 25.01 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.467 -0.333 . . . . 1.0700000000000001 111.04 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 67.4 tttt -99.74 152.88 19.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 1.29 110.433 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.515 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.6 m -81.85 137.51 21.07 Favored 'Isoleucine or valine' 0 C--O 1.233 0.212 0 CA-C-O 121.194 0.521 . . . . 0.82999999999999996 111.118 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 28.0 mt-10 -132.44 138.09 47.5 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.678 -0.692 . . . . 0.79000000000000004 110.158 -179.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' HG3' ' A' ' 58' ' ' PRO . 4.4 m -107.23 112.89 41.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.42 0.628 . . . . 0.66000000000000003 112.119 -179.146 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -102.69 150.41 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.975 0 CA-C-O 122.552 1.168 . . . . 0.68999999999999995 110.841 178.378 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.24 153.46 46.55 Favored 'General case' 0 N--CA 1.477 0.924 0 CA-C-N 115.098 -0.956 . . . . 0.57999999999999996 111.144 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.78 132.59 53.82 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 115.027 -0.988 . . . . 0.65000000000000002 110.398 176.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -81.46 169.53 17.05 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.329 -0.85 . . . . 0.79000000000000004 110.546 179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.5 tptp -78.18 -11.49 59.93 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-O 120.998 0.428 . . . . 1.23 110.626 179.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -85.24 -11.62 54.44 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 115.918 -0.583 . . . . 1.05 110.975 179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.83 40.62 3.54 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 120.836 -0.697 . . . . 0.69999999999999996 112.342 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 47' ' ' SER . 63.3 mtpt -125.97 158.43 35.26 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.699 0.285 . . . . 1.1899999999999999 110.917 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -140.49 129.47 23.36 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-O 121.389 0.614 . . . . 0.68999999999999995 109.956 179.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.67 179.68 3.51 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.058 0 CA-C-N 114.688 -1.142 . . . . 0.53000000000000003 109.84 178.058 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.42 -1.264 . . . . 0.48999999999999999 109.24 177.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -113.98 152.38 30.97 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 114.064 -1.426 . . . . 0.51000000000000001 108.599 -178.547 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.634 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -100.51 108.66 54.23 Favored Pre-proline 0 C--N 1.326 -0.416 0 CA-C-N 116.02 -0.536 . . . . 0.67000000000000004 109.793 178.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.509 ' HG3' HG22 ' A' ' 44' ' ' VAL . 13.6 Cg_exo -68.12 -5.8 15.66 Favored 'Trans proline' 0 C--N 1.35 0.639 0 C-N-CA 122.641 2.228 . . . . 0.85999999999999999 112.471 -179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.6 tt0 -80.43 -9.0 59.76 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.088 -0.506 . . . . 1.3500000000000001 111.016 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.644 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.89 135.08 20.09 Favored Pre-proline 0 CA--C 1.542 0.663 0 C-N-CA 120.751 -0.379 . . . . 0.94999999999999996 110.683 178.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.91 14.8 Favored 'Trans proline' 0 N--CA 1.478 0.594 0 C-N-CA 123.514 2.81 . . . . 1.24 113.367 -178.849 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.644 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.77 -26.24 67.11 Favored 'General case' 0 N--CA 1.48 1.061 0 CA-C-O 121.257 0.551 . . . . 1.1899999999999999 111.761 176.988 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -80.75 -24.62 38.55 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.181 -0.463 . . . . 0.89000000000000001 110.368 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 25.6 ttpt -77.74 -17.48 57.51 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.468 0.651 . . . . 1.71 110.446 179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.84 -55.71 5.1 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.407 -0.815 . . . . 1.29 113.098 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 34.3 m -59.07 -26.91 34.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.415 0 CA-C-N 115.533 -0.758 . . . . 0.91000000000000003 111.565 178.616 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.575 ' O ' HG12 ' A' ' 70' ' ' ILE . 45.6 pt -83.17 -19.57 9.84 Favored 'Isoleucine or valine' 0 C--N 1.343 0.287 0 C-N-CA 120.849 -0.34 . . . . 1.05 110.215 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.12 -42.13 66.42 Favored 'General case' 0 N--CA 1.471 0.625 0 C-N-CA 120.87 -0.332 . . . . 1.52 110.562 176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -58.87 -26.97 64.74 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 113.177 0.806 . . . . 1.5800000000000001 113.177 -179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.575 HG12 ' O ' ' A' ' 67' ' ' ILE . 24.5 pt -79.48 -17.04 13.09 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.313 0 C-N-CA 120.642 -0.423 . . . . 1.3700000000000001 111.19 179.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.6 mt -94.33 -44.34 7.98 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.051 -0.522 . . . . 1.6699999999999999 110.048 179.464 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -73.53 -45.3 54.47 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-N 115.844 -0.617 . . . . 2.21 110.264 179.296 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.3 -27.51 67.89 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.984 -0.627 . . . . 1.77 112.38 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -76.69 -23.34 70.15 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 121.135 -0.555 . . . . 2.0899999999999999 112.57 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -85.2 -30.7 23.68 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-O 120.87 0.366 . . . . 2.29 110.643 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -83.22 -16.1 47.8 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.138 -0.483 . . . . 2.4399999999999999 111.116 -179.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 3.7 mm-40 -63.15 117.63 6.79 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.24 -0.436 . . . . 2.7000000000000002 110.874 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.0 m120 . . . . . 0 C--O 1.252 1.21 0 CA-C-O 118.35 -0.833 . . . . 2.5600000000000001 111.661 -179.465 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.736 1.255 . . . . 0.80000000000000004 110.145 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.74 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.422 -1.717 . . . . 0.84999999999999998 111.319 -179.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.62 115.14 4.5 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 123.903 0.881 . . . . 0.77000000000000002 110.465 -173.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.16 52.76 Favored 'General case' 0 N--CA 1.473 0.709 0 CA-C-N 113.776 -1.556 . . . . 0.65000000000000002 110.131 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.38 30.33 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.972 -1.467 . . . . 0.68000000000000005 108.441 -176.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.9 151.04 9.18 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 116.089 -0.505 . . . . 0.5 109.908 173.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.03 46.76 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.311 0 CA-C-O 121.736 0.779 . . . . 0.46999999999999997 111.522 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.513 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.9 m -119.05 104.12 10.18 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 124.78 1.232 . . . . 0.46999999999999997 111.443 178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.19 -33.28 29.49 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 114.61 -1.177 . . . . 0.57999999999999996 113.835 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.78 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.898 0 C-N-CA 124.9 1.28 . . . . 0.57999999999999996 110.067 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.85 -171.63 2.52 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.821 -1.536 . . . . 0.59999999999999998 111.336 178.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' B' ' 54' ' ' ILE . 86.2 m -157.83 152.22 24.72 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 125.841 1.656 . . . . 0.57999999999999996 110.152 -179.954 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 123.715 1.721 . . . . 0.72999999999999998 112.144 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.06 -177.14 51.39 Favored Glycine 0 CA--C 1.542 1.78 0 CA-C-N 113.183 -1.826 . . . . 0.64000000000000001 110.915 174.428 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.06 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.785 1 C-N-CA 136.189 5.795 . . . . 0.64000000000000001 106.397 8.02 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.39 32.13 Favored Pre-proline 0 CA--C 1.542 0.65 0 O-C-N 122.028 -0.42 . . . . 0.68000000000000005 110.012 174.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.439 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.2 Cg_exo -51.19 -21.91 10.23 Favored 'Trans proline' 0 N--CA 1.478 0.599 0 C-N-CA 124.772 3.648 . . . . 0.58999999999999997 112.878 174.078 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.81 15.98 Favored 'General case' 0 N--CA 1.47 0.569 0 C-N-CA 124.612 1.165 . . . . 0.68999999999999995 112.611 179.625 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.9 mmt -88.13 -19.65 26.7 Favored 'General case' 0 N--CA 1.475 0.802 0 N-CA-C 113.502 0.927 . . . . 0.94999999999999996 113.502 175.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 27.1 mm -89.73 139.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 120.76 0.315 . . . . 0.57999999999999996 111.646 -178.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.2 m -136.94 2.18 2.57 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.338 -0.392 . . . . 0.69999999999999996 111.216 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.527 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 10.1 t30 -152.65 132.42 13.21 Favored 'General case' 0 N--CA 1.463 0.205 0 CA-C-N 116.523 -0.308 . . . . 0.82999999999999996 110.527 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 48.1 tp -124.93 125.37 43.83 Favored 'General case' 0 C--N 1.334 -0.095 0 CA-C-O 120.982 0.42 . . . . 0.75 111.486 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 49.4 mt-30 -117.86 128.99 55.37 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.171 -0.468 . . . . 1.0800000000000001 111.169 -179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 39.2 t -111.13 108.49 25.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.196 0 CA-C-N 116.194 -0.457 . . . . 0.60999999999999999 110.585 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.7 m-85 -101.47 124.58 47.38 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.879 -0.601 . . . . 0.85999999999999999 111.007 -179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.52 -164.8 1.15 Allowed 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.891 0.377 . . . . 0.60999999999999999 111.164 179.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.447 HG23 ' HA ' ' B' ' 40' ' ' SER . 97.6 mt -74.15 124.84 32.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 1.1000000000000001 110.965 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.39 -169.41 13.44 Favored Glycine 0 C--N 1.332 0.346 0 C-N-CA 120.985 -0.626 . . . . 0.63 112.827 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -77.15 -9.37 17.79 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.254 2.636 . . . . 0.79000000000000004 112.799 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.9 -21.98 12.08 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 113.079 0.77 . . . . 0.70999999999999996 113.079 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.2 t -139.46 125.48 19.84 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.984 -0.553 . . . . 0.67000000000000004 111.415 -177.671 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.447 ' HA ' HG23 ' B' ' 35' ' ' ILE . 18.5 t -92.96 5.82 50.08 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.892 -0.595 . . . . 1.01 110.095 179.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 88.0 tttt -121.3 144.48 48.61 Favored 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.135 -0.484 . . . . 1.1599999999999999 110.897 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 16.1 m -81.67 132.24 31.95 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 CA-C-O 120.903 0.382 . . . . 0.78000000000000003 110.706 179.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.491 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 30.4 mt-10 -135.86 130.09 33.35 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.361 -0.381 . . . . 0.80000000000000004 110.16 -178.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.442 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.7 m -100.48 106.22 18.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.679 0.752 . . . . 0.59999999999999998 112.316 -178.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.513 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.9 OUTLIER -93.64 156.49 3.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-O 122.508 1.147 . . . . 0.62 110.793 178.4 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -147.77 154.56 40.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.425 -0.807 . . . . 0.55000000000000004 112.262 -178.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 47.4 m -123.69 131.62 53.65 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.87 -0.605 . . . . 0.63 110.632 179.648 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -83.78 163.84 19.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.072 -0.513 . . . . 0.75 110.487 179.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -76.26 -15.93 59.91 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.16 0.505 . . . . 1.27 110.389 179.473 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.6 m-20 -77.39 -25.46 50.9 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 115.719 -0.673 . . . . 0.98999999999999999 110.736 179.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.2 43.3 0.93 Allowed Glycine 0 C--N 1.333 0.379 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.709 179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 48.4 mtpt -132.55 162.48 31.14 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.778 0.323 . . . . 1.05 111.338 179.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -143.98 129.57 19.12 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.472 0.653 . . . . 0.70999999999999996 109.967 179.323 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.87 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 CA-C-N 114.723 -1.126 . . . . 0.52000000000000002 109.834 178.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.43 138.0 52.86 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 114.444 -1.253 . . . . 0.47999999999999998 109.291 177.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.724 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.91 151.83 31.67 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.091 -1.413 . . . . 0.48999999999999999 108.771 -178.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.28 105.68 47.63 Favored Pre-proline 0 N--CA 1.47 0.571 0 O-C-N 120.26 -1.525 . . . . 0.63 110.728 177.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.442 ' HG3' HG22 ' B' ' 44' ' ' VAL . 48.7 Cg_exo -53.65 -17.62 10.25 Favored 'Trans proline' 0 C--N 1.361 1.194 0 C-N-CA 123.248 2.632 . . . . 0.82999999999999996 112.782 179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 7.5 tt0 -64.19 -16.45 61.98 Favored 'General case' 0 CA--C 1.545 0.788 0 CA-C-N 115.049 -0.978 . . . . 1.3999999999999999 113.59 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.63 135.17 20.19 Favored Pre-proline 0 CA--C 1.54 0.588 0 O-C-N 122.283 -0.26 . . . . 0.91000000000000003 110.754 -179.056 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.76 14.9 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.633 2.888 . . . . 1.1899999999999999 113.386 -178.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.81 -25.79 66.84 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.303 0.573 . . . . 1.1499999999999999 111.727 176.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.724 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.98 -33.02 39.75 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 115.433 -0.803 . . . . 0.90000000000000002 109.959 178.11 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.449 ' HA ' HG12 ' B' ' 67' ' ' ILE . 37.1 ttpt -71.36 -15.04 62.37 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-O 121.413 0.625 . . . . 1.71 111.086 179.714 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -81.4 -55.41 4.72 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.087 0.773 . . . . 1.3600000000000001 113.087 179.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -63.03 -27.67 43.63 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.144 -0.48 . . . . 0.96999999999999997 111.202 178.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.511 HG23 ' O ' ' B' ' 63' ' ' LEU . 39.7 pt -74.78 -22.78 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 C-N-CA 120.855 -0.338 . . . . 1.0800000000000001 110.211 178.639 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.84 -43.41 45.97 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 120.874 -0.331 . . . . 1.52 110.522 176.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -61.38 -32.42 72.35 Favored 'General case' 0 N--CA 1.467 0.388 0 N-CA-C 112.783 0.66 . . . . 1.6100000000000001 112.783 -179.435 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.439 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 13.4 pt -81.32 -13.89 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.323 0 N-CA-C 112.059 0.392 . . . . 1.4299999999999999 112.059 -179.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.411 ' HG ' ' O ' ' B' ' 67' ' ' ILE . 62.9 mt -77.12 -36.45 55.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.709 0.29 . . . . 1.79 110.811 179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.7 t70 -85.67 -34.08 21.4 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.135 -0.484 . . . . 2.25 110.651 179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.0 -24.67 73.32 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.056 -0.592 . . . . 1.76 112.603 179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.15 15.02 63.02 Favored Glycine 0 C--N 1.331 0.303 0 C-N-CA 121.018 -0.61 . . . . 2.04 112.57 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -130.47 -33.48 1.66 Allowed 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.873 0.368 . . . . 2.3199999999999998 110.559 179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 15.5 tptp -79.76 -21.52 44.34 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 116.036 -0.529 . . . . 2.46 111.137 -179.757 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -66.96 116.82 8.23 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.468 -0.333 . . . . 2.7799999999999998 110.456 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.285 -0.864 . . . . 2.48 110.921 -179.683 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 122.785 1.278 . . . . 0.81000000000000005 110.062 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.496 -1.684 . . . . 0.83999999999999997 111.367 -179.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.458 -173.54 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.18 52.78 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.863 -1.517 . . . . 0.65000000000000002 110.242 178.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.41 30.32 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 114.096 -1.411 . . . . 0.66000000000000003 108.391 -176.022 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.99 151.04 9.38 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.057 -0.519 . . . . 0.48999999999999999 109.884 173.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.03 -31.01 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 CA-C-O 121.62 0.724 . . . . 0.45000000000000001 111.539 177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.514 ' SG ' HG12 ' A' ' 45' ' ' VAL . 63.1 m -118.95 104.31 10.4 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 124.783 1.233 . . . . 0.46000000000000002 111.345 178.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.33 28.48 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.652 -1.158 . . . . 0.56999999999999995 113.735 175.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.74 3.51 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.752 1.221 . . . . 0.56999999999999995 110.05 -179.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.581 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.77 -171.69 2.53 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 113.793 -1.549 . . . . 0.62 111.319 178.726 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 86.3 m -157.8 152.37 24.98 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 125.843 1.657 . . . . 0.60999999999999999 110.222 179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.18 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.695 1.712 . . . . 0.76000000000000001 112.11 177.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.32 51.45 Favored Glycine 0 CA--C 1.543 1.822 0 CA-C-N 113.145 -1.843 . . . . 0.68999999999999995 110.892 174.396 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.91 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.761 1 C-N-CA 136.25 5.82 . . . . 0.68999999999999995 106.355 8.236 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.3 t-80 -117.63 143.39 32.22 Favored Pre-proline 0 CA--C 1.544 0.713 0 O-C-N 121.975 -0.453 . . . . 0.72999999999999998 110.039 174.954 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.1 Cg_exo -51.14 -21.95 10.13 Favored 'Trans proline' 0 N--CA 1.477 0.55 0 C-N-CA 124.772 3.648 . . . . 0.64000000000000001 112.895 174.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.572 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -30.03 21.82 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.659 1.183 . . . . 0.73999999999999999 112.623 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -97.49 -17.74 19.44 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 116.537 -0.301 . . . . 1.0800000000000001 111.562 179.635 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 23.3 mm -89.05 141.52 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 116.48 -0.327 . . . . 0.57999999999999996 111.451 -179.38 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.3 m -150.75 27.9 0.71 Allowed 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.619 -0.264 . . . . 0.68999999999999995 111.261 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.402 ' HB3' ' H ' ' A' ' 47' ' ' SER . 55.0 t30 -162.43 150.97 14.72 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 116.65 -0.25 . . . . 0.78000000000000003 110.568 -179.674 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 20.6 tp -154.14 144.66 22.31 Favored 'General case' 0 N--CA 1.464 0.229 0 CA-C-N 116.533 -0.303 . . . . 0.73999999999999999 110.476 179.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.545 ' HB2' HG22 ' A' ' 45' ' ' VAL . 52.4 mt-30 -141.87 120.04 12.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.67 0.272 . . . . 1.1599999999999999 110.799 179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 4.7 t -105.82 95.19 3.6 Favored 'Isoleucine or valine' 0 C--O 1.233 0.221 0 CA-C-O 120.963 0.411 . . . . 0.62 111.06 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 -91.86 128.23 37.62 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.007 -0.542 . . . . 0.72999999999999998 110.717 179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.708 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -82.17 -164.76 0.87 Allowed 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.856 0.36 . . . . 0.66000000000000003 111.395 179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.453 HG23 ' HA ' ' A' ' 40' ' ' SER . 94.5 mt -72.25 124.47 29.01 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 CA-C-N 116.08 -0.509 . . . . 1.1399999999999999 111.305 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.77 -164.97 11.54 Favored Glycine 0 N--CA 1.451 -0.334 0 CA-C-N 115.957 -0.565 . . . . 0.66000000000000003 112.331 179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -77.87 -9.32 16.9 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 123.199 2.6 . . . . 0.81000000000000005 112.743 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.24 -22.04 12.27 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 112.978 0.733 . . . . 0.72999999999999998 112.978 -179.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.3 t -141.77 133.39 26.95 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.941 -0.572 . . . . 0.70999999999999996 111.191 -177.538 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.4 t -97.52 16.7 19.55 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.065 -0.516 . . . . 1.0700000000000001 110.653 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.482 ' HG2' ' N ' ' A' ' 42' ' ' VAL . 42.7 tttt -145.86 153.49 40.93 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.431 -0.35 . . . . 1.29 111.159 -179.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.708 HG12 ' HA ' ' A' ' 34' ' ' ALA . 28.9 m -82.29 136.39 23.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 CA-C-N 116.21 -0.45 . . . . 0.82999999999999996 110.481 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -135.08 130.24 35.23 Favored 'General case' 0 C--O 1.234 0.266 0 CA-C-N 116.424 -0.353 . . . . 0.79000000000000004 110.213 -179.367 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.536 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.4 m -100.62 106.26 19.04 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-O 121.798 0.809 . . . . 0.66000000000000003 112.338 -179.043 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.545 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.7 150.44 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 CA-C-O 122.608 1.194 . . . . 0.68999999999999995 110.741 178.405 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.48 46.62 Favored 'General case' 0 N--CA 1.479 1.006 0 CA-C-N 115.101 -0.954 . . . . 0.57999999999999996 111.103 179.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 53' ' ' GLU . 21.4 m -123.8 133.72 53.76 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.019 -0.991 . . . . 0.65000000000000002 110.445 176.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.1 mp -73.22 163.08 28.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.354 -0.839 . . . . 0.79000000000000004 110.496 179.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.3 tttp -70.64 -18.48 62.86 Favored 'General case' 0 CA--C 1.532 0.261 0 CA-C-O 121.139 0.495 . . . . 1.23 110.602 179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -79.1 -26.49 42.95 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 116.004 -0.544 . . . . 1.05 110.986 179.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.82 44.73 0.68 Allowed Glycine 0 C--N 1.332 0.336 0 C-N-CA 120.943 -0.646 . . . . 0.69999999999999996 112.63 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -131.37 107.22 8.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.713 0.292 . . . . 1.1899999999999999 111.552 -179.604 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' SER . 6.5 pt-20 -85.58 124.0 31.63 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.22 -0.445 . . . . 0.68999999999999995 110.8 179.636 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -124.99 179.6 2.96 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.982 0 CA-C-O 121.452 0.644 . . . . 0.53000000000000003 109.786 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.8 m -127.37 138.06 52.92 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.386 -1.279 . . . . 0.48999999999999999 109.287 177.392 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.65 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 151.72 31.98 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 114.016 -1.447 . . . . 0.51000000000000001 108.685 -178.614 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.581 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 4.6 t0 -101.34 108.65 56.1 Favored Pre-proline 0 N--CA 1.47 0.551 0 O-C-N 120.148 -1.595 . . . . 0.67000000000000004 110.636 178.106 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.536 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.3 Cg_exo -53.7 -17.56 10.3 Favored 'Trans proline' 0 C--N 1.361 1.204 0 C-N-CA 123.274 2.649 . . . . 0.85999999999999999 112.878 179.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.3 tt0 -64.07 -16.61 62.12 Favored 'General case' 0 CA--C 1.544 0.737 0 N-CA-C 113.635 0.976 . . . . 1.3500000000000001 113.635 179.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.01 20.32 Favored Pre-proline 0 CA--C 1.543 0.679 0 O-C-N 122.186 -0.321 . . . . 0.94999999999999996 110.744 -178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.22 -41.91 15.0 Favored 'Trans proline' 0 CA--C 1.536 0.578 0 C-N-CA 123.659 2.906 . . . . 1.24 113.36 -178.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.75 -27.22 67.79 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-O 121.287 0.565 . . . . 1.1899999999999999 111.794 176.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.65 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -69.21 -37.61 78.16 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.327 -0.851 . . . . 0.89000000000000001 110.396 178.631 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 38.1 ttpt -69.6 -22.45 63.51 Favored 'General case' 0 CA--C 1.533 0.315 0 CA-C-N 115.802 -0.635 . . . . 1.71 111.033 179.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.33 -55.57 5.57 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.062 0.764 . . . . 1.29 113.062 179.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 15.8 m -62.4 -29.37 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.175 -0.466 . . . . 0.91000000000000003 111.216 178.159 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.417 HG12 ' HA ' ' A' ' 64' ' ' LYS . 28.9 pt -85.41 -20.61 8.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.402 0 C-N-CA 120.862 -0.335 . . . . 1.05 110.218 178.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -75.95 -41.88 50.26 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.773 -0.371 . . . . 1.52 110.475 176.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 79.9 mttt -62.54 -31.1 71.83 Favored 'General case' 0 CA--C 1.535 0.374 0 N-CA-C 112.949 0.722 . . . . 1.5800000000000001 112.949 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 38.6 pt -73.81 -17.58 17.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 C-N-CA 120.774 -0.371 . . . . 1.3700000000000001 111.213 -179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 59.8 mt -95.32 -26.74 15.79 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 1.6699999999999999 110.299 179.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.4 t70 -81.55 -41.85 21.01 Favored 'General case' 0 C--N 1.334 -0.105 0 CA-C-N 116.096 -0.502 . . . . 2.21 110.123 179.8 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -85.84 -19.26 58.24 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.92 -0.657 . . . . 1.77 112.266 179.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.47 -39.6 41.77 Favored Glycine 0 C--N 1.332 0.315 0 C-N-CA 121.052 -0.594 . . . . 2.0899999999999999 112.35 179.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -73.87 -20.14 60.51 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.989 0.423 . . . . 2.29 110.891 179.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.5 tptp -76.12 -24.53 54.93 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 115.942 -0.572 . . . . 2.4399999999999999 110.372 179.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . 0.466 ' OE1' ' HA ' ' B' ' 41' ' ' LYS . 3.6 tm-20 -76.73 106.52 8.44 Favored 'General case' 0 C--O 1.233 0.192 0 CA-C-N 116.004 -0.544 . . . . 2.7000000000000002 109.837 179.58 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.249 1.046 0 CA-C-O 118.332 -0.842 . . . . 2.5600000000000001 111.071 -179.259 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.756 1.265 . . . . 0.80000000000000004 110.203 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.475 0.776 0 CA-C-N 113.425 -1.716 . . . . 0.84999999999999998 111.413 -179.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.58 114.97 4.48 Favored 'General case' 0 N--CA 1.467 0.39 0 C-N-CA 123.942 0.897 . . . . 0.77000000000000002 110.447 -173.591 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.23 52.76 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.836 -1.529 . . . . 0.65000000000000002 110.127 178.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.41 30.36 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.017 -1.447 . . . . 0.68000000000000005 108.404 -176.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.13 9.05 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.095 -0.502 . . . . 0.5 109.831 173.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.04 -31.15 47.16 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.272 0 CA-C-O 121.772 0.796 . . . . 0.46999999999999997 111.495 177.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.96 104.25 10.33 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.808 1.243 . . . . 0.46999999999999997 111.436 178.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.29 -33.48 29.06 Favored 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 114.678 -1.146 . . . . 0.57999999999999996 113.661 175.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.836 0 C-N-CA 124.905 1.282 . . . . 0.57999999999999996 110.069 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.582 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.799 -1.546 . . . . 0.59999999999999998 111.338 178.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 86.0 m -157.7 152.3 25.08 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 125.809 1.644 . . . . 0.57999999999999996 110.207 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.28 1.41 Allowed 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 123.624 1.678 . . . . 0.72999999999999998 112.066 177.172 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.34 51.43 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.237 -1.802 . . . . 0.64000000000000001 110.906 174.428 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.731 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.94 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.714 1 C-N-CA 136.198 5.799 . . . . 0.64000000000000001 106.342 8.154 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.731 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.57 143.41 32.19 Favored Pre-proline 0 CA--C 1.543 0.689 0 O-C-N 121.889 -0.507 . . . . 0.68000000000000005 110.092 174.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.17 -22.06 10.43 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.762 3.642 . . . . 0.58999999999999997 112.851 174.11 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.91 16.09 Favored 'General case' 0 N--CA 1.47 0.531 0 C-N-CA 124.626 1.17 . . . . 0.68999999999999995 112.606 179.693 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.3 mmt -87.89 -18.82 28.36 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 113.559 0.948 . . . . 0.94999999999999996 113.559 175.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 36.4 mm -85.76 132.85 30.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 O-C-N 122.072 -0.393 . . . . 0.57999999999999996 111.377 -179.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.1 m -140.39 12.63 2.36 Favored 'General case' 0 CA--C 1.529 0.158 0 CA-C-N 116.306 -0.407 . . . . 0.69999999999999996 111.055 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.431 ' HB3' ' HB2' ' B' ' 47' ' ' SER . 51.1 t30 -166.97 135.64 2.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.244 -0.435 . . . . 0.82999999999999996 110.387 -179.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 22.5 tp -126.07 143.73 51.0 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.441 -0.345 . . . . 0.75 110.808 -179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.455 ' HB2' ' CG2' ' B' ' 45' ' ' VAL . 45.6 mt-30 -138.14 103.98 5.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.358 -0.383 . . . . 1.0800000000000001 110.022 179.325 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.5 t -95.01 132.42 39.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.057 -0.519 . . . . 0.60999999999999999 111.355 -179.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.3 m-85 -124.78 125.67 44.41 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.121 -0.49 . . . . 0.85999999999999999 110.292 179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.65 -154.17 0.28 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-O 120.839 0.352 . . . . 0.60999999999999999 111.641 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 53.1 mt -67.7 122.33 18.64 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 116.016 -0.538 . . . . 1.1000000000000001 111.393 -179.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.07 -173.45 13.46 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.047 -0.597 . . . . 0.63 112.622 179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -77.1 -9.43 17.86 Favored 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.25 2.633 . . . . 0.79000000000000004 112.626 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.46 -21.3 12.55 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 113.116 0.784 . . . . 0.70999999999999996 113.116 -179.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -142.66 126.24 16.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.186 -0.461 . . . . 0.67000000000000004 110.972 -177.85 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 30.4 t -80.39 -34.19 36.52 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.246 -0.434 . . . . 1.01 110.797 179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.466 ' HA ' ' OE1' ' A' ' 77' ' ' GLU . 80.4 tttt -92.27 150.2 21.01 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.121 -0.49 . . . . 1.1599999999999999 110.552 -179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 23.0 m -79.34 142.06 14.52 Favored 'Isoleucine or valine' 0 C--O 1.232 0.166 0 CA-C-O 121.099 0.476 . . . . 0.78000000000000003 110.992 179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -131.29 137.62 48.9 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.082 -0.508 . . . . 0.80000000000000004 110.669 -179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.552 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.4 m -106.87 107.02 21.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 121.477 0.656 . . . . 0.59999999999999998 112.165 -179.265 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.455 ' CG2' ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -96.58 150.45 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 CA-C-O 122.498 1.142 . . . . 0.62 110.774 178.781 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.38 46.49 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 115.206 -0.907 . . . . 0.55000000000000004 111.137 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HB2' ' HB3' ' B' ' 29' ' ' ASN . 21.3 m -123.79 133.73 53.77 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 115.103 -0.953 . . . . 0.63 110.378 176.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.0 mp -80.5 172.86 13.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.086 -0.961 . . . . 0.75 110.947 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -78.6 -10.41 59.73 Favored 'General case' 0 CA--C 1.531 0.22 0 CA-C-O 121.155 0.502 . . . . 1.27 110.843 179.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -84.05 -1.3 54.56 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 115.938 -0.574 . . . . 0.98999999999999999 111.139 179.812 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.43 38.21 8.44 Favored Glycine 0 C--N 1.333 0.401 0 C-N-CA 121.026 -0.607 . . . . 0.67000000000000004 112.551 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.407 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.4 mtpt -125.44 161.42 27.12 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-O 120.677 0.275 . . . . 1.05 111.118 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -134.14 129.55 36.04 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 0.70999999999999996 109.96 179.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.92 179.67 3.58 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.908 0 CA-C-N 114.671 -1.149 . . . . 0.52000000000000002 109.742 178.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.51 138.1 52.83 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 114.361 -1.29 . . . . 0.47999999999999998 109.231 177.545 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.871 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.96 154.06 28.24 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 113.96 -1.473 . . . . 0.48999999999999999 108.63 -178.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.582 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.2 t0 -103.63 111.32 65.06 Favored Pre-proline 0 C--N 1.324 -0.53 0 O-C-N 121.85 -0.531 . . . . 0.63 110.24 177.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.552 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.6 Cg_exo -61.71 -15.67 43.71 Favored 'Trans proline' 0 C--N 1.358 1.045 0 C-N-CA 122.983 2.455 . . . . 0.82999999999999996 111.84 179.36 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -66.15 -16.57 64.08 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 114.699 -1.137 . . . . 1.3999999999999999 113.553 178.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.636 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.09 20.29 Favored Pre-proline 0 CA--C 1.54 0.596 0 O-C-N 122.293 -0.254 . . . . 0.91000000000000003 110.743 -179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.4 -41.77 14.79 Favored 'Trans proline' 0 CA--C 1.535 0.563 0 C-N-CA 123.665 2.91 . . . . 1.1899999999999999 113.316 -178.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.636 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.86 -26.23 67.23 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 121.357 0.599 . . . . 1.1499999999999999 111.74 176.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.871 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -79.88 -32.07 40.36 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.544 -0.753 . . . . 0.90000000000000002 110.158 178.3 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.488 ' HA ' HG12 ' B' ' 67' ' ' ILE . 24.4 ttpt -69.12 -19.34 64.04 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.394 0.616 . . . . 1.71 110.924 179.604 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.48 -55.65 5.05 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 115.478 -0.783 . . . . 1.3600000000000001 113.031 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 31.0 m -62.04 -33.23 57.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 CA-C-N 116.298 -0.41 . . . . 0.96999999999999997 111.218 178.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.488 HG12 ' HA ' ' B' ' 64' ' ' LYS . 35.9 pt -71.3 -24.92 24.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.407 0 C-N-CA 120.827 -0.349 . . . . 1.0800000000000001 110.194 178.798 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -75.73 -42.98 49.12 Favored 'General case' 0 N--CA 1.472 0.668 0 C-N-CA 120.8 -0.36 . . . . 1.52 110.469 176.449 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 86.6 mttt -61.53 -31.71 71.74 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 112.812 0.671 . . . . 1.6100000000000001 112.812 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 28.1 pt -78.33 -18.88 13.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.346 0 C-N-CA 120.822 -0.351 . . . . 1.4299999999999999 111.364 -179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 96.7 mt -91.78 -33.04 15.15 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.254 -0.43 . . . . 1.79 110.224 179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -80.2 -41.42 25.25 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.008 -0.542 . . . . 2.25 110.251 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.33 -31.13 73.86 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 121.085 -0.578 . . . . 1.76 112.617 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -79.1 -17.44 76.75 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 121.027 -0.606 . . . . 2.04 112.404 179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -90.99 -25.42 19.73 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.947 0.403 . . . . 2.3199999999999998 110.532 179.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.0 tptp -93.58 1.88 56.55 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.083 -0.508 . . . . 2.46 111.053 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -69.14 108.58 3.65 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.883 0.373 . . . . 2.7799999999999998 110.471 179.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 C--O 1.252 1.231 0 CA-C-O 118.549 -0.739 . . . . 2.48 111.496 -178.847 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.482 1.139 0 CA-C-O 122.796 1.284 . . . . 0.81000000000000005 110.036 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.64 -64.68 0.78 Allowed 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 113.329 -1.76 . . . . 0.83999999999999997 111.445 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.54 114.94 4.48 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 123.968 0.907 . . . . 0.76000000000000001 110.45 -173.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.01 140.29 52.72 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.85 -1.523 . . . . 0.65000000000000002 110.29 178.833 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.28 146.37 30.45 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.034 -1.439 . . . . 0.66000000000000003 108.339 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.88 150.99 9.2 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 116.023 -0.535 . . . . 0.48999999999999999 109.856 172.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.98 -31.08 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 CA-C-O 121.604 0.716 . . . . 0.45000000000000001 111.488 177.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -119.08 104.31 10.35 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 124.77 1.228 . . . . 0.46000000000000002 111.288 179.004 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.42 -33.34 28.66 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 114.584 -1.189 . . . . 0.56999999999999995 113.735 175.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.72 3.5 Favored 'General case' 0 C--N 1.315 -0.935 0 C-N-CA 124.819 1.248 . . . . 0.56999999999999995 110.062 -179.133 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.588 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.7 -171.59 2.51 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 113.747 -1.57 . . . . 0.62 111.35 178.717 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.61 HG21 HD12 ' A' ' 54' ' ' ILE . 86.5 m -157.85 152.29 24.78 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.826 1.65 . . . . 0.60999999999999999 110.263 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.12 72.23 1.41 Allowed 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 123.553 1.644 . . . . 0.76000000000000001 112.076 177.152 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.92 -177.29 51.49 Favored Glycine 0 CA--C 1.543 1.8 0 CA-C-N 113.245 -1.798 . . . . 0.68999999999999995 110.901 174.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.95 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.297 5.839 . . . . 0.68999999999999995 106.371 8.093 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.37 32.07 Favored Pre-proline 0 CA--C 1.543 0.691 0 O-C-N 121.914 -0.491 . . . . 0.72999999999999998 110.056 175.011 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.4 Cg_exo -51.29 -21.88 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.598 0 C-N-CA 124.819 3.68 . . . . 0.64000000000000001 112.802 174.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.574 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.95 16.12 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.628 1.171 . . . . 0.73999999999999999 112.589 179.627 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 32.8 mmt -87.93 -19.33 27.43 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 113.514 0.931 . . . . 1.0800000000000001 113.514 175.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 11.1 mm -95.55 150.11 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 O-C-N 122.112 -0.368 . . . . 0.57999999999999996 111.392 -178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.0 m -142.13 -21.45 0.7 Allowed 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.354 -0.385 . . . . 0.68999999999999995 111.356 179.708 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -137.02 135.86 37.94 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.673 0.273 . . . . 0.78000000000000003 111.006 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 8.2 tp -129.73 131.49 46.31 Favored 'General case' 0 N--CA 1.462 0.142 0 CA-C-N 116.24 -0.436 . . . . 0.73999999999999999 111.103 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.443 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.7 mt-30 -119.62 126.62 51.6 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.336 -0.393 . . . . 1.1599999999999999 110.447 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.458 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 11.8 t -109.06 112.15 39.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.269 -0.423 . . . . 0.62 111.123 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 57.3 m-85 -100.71 134.63 43.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.942 -0.572 . . . . 0.72999999999999998 110.709 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.413 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -92.88 -160.42 0.75 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 120.989 0.423 . . . . 0.66000000000000003 111.944 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.693 HG23 ' HA ' ' A' ' 40' ' ' SER . 85.7 mt -72.38 127.24 34.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 CA-C-N 115.817 -0.629 . . . . 1.1399999999999999 111.425 -179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -134.26 -166.77 11.33 Favored Glycine 0 CA--C 1.52 0.355 0 CA-C-N 116.037 -0.529 . . . . 0.66000000000000003 112.318 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.29 -8.63 17.49 Favored 'Trans proline' 0 C--N 1.347 0.491 0 C-N-CA 123.298 2.665 . . . . 0.81000000000000005 112.889 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.61 -21.03 12.63 Favored 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.983 0.735 . . . . 0.72999999999999998 112.983 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.7 t -148.76 130.35 14.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.70999999999999996 110.907 -177.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.693 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -98.99 25.73 6.44 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.062 0.458 . . . . 1.0700000000000001 110.511 179.73 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 16.2 tttt -141.46 156.47 45.76 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.003 -0.544 . . . . 1.29 110.776 -179.624 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.413 HG12 ' HA ' ' A' ' 34' ' ' ALA . 27.5 m -86.49 131.98 33.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.251 0 CA-C-N 116.32 -0.4 . . . . 0.82999999999999996 110.767 179.286 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.0 mt-10 -131.77 130.12 41.46 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-N 116.475 -0.33 . . . . 0.79000000000000004 110.179 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.6 m -100.54 106.01 18.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-O 121.659 0.743 . . . . 0.66000000000000003 112.29 -178.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.443 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.8 OUTLIER -93.52 150.36 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.965 0 CA-C-O 122.484 1.135 . . . . 0.68999999999999995 110.857 178.364 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.12 153.41 46.68 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 115.224 -0.898 . . . . 0.57999999999999996 111.189 179.92 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.476 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.78 132.31 53.77 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 115.102 -0.954 . . . . 0.65000000000000002 110.471 176.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -78.28 166.45 22.68 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.206 -0.906 . . . . 0.79000000000000004 110.442 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.2 tptp -77.53 -6.67 54.43 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-O 120.999 0.428 . . . . 1.23 110.767 179.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -89.93 -7.65 53.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.028 -0.533 . . . . 1.05 110.914 179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.21 47.16 2.66 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.013 -0.613 . . . . 0.69999999999999996 112.738 179.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.476 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.8 mtpt -133.38 162.1 32.75 Favored 'General case' 0 C--O 1.221 -0.431 0 CA-C-O 120.712 0.292 . . . . 1.1899999999999999 110.871 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -139.74 129.53 24.64 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-O 121.441 0.638 . . . . 0.68999999999999995 109.955 179.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.61 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.78 179.69 3.53 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.006 0 CA-C-N 114.665 -1.152 . . . . 0.53000000000000003 109.755 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.43 138.06 52.87 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-N 114.361 -1.29 . . . . 0.48999999999999999 109.22 177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.71 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -113.99 151.73 31.94 Favored 'General case' 0 C--N 1.314 -0.975 0 CA-C-N 114.074 -1.421 . . . . 0.51000000000000001 108.7 -178.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.588 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 9.9 t0 -104.23 101.56 27.36 Favored Pre-proline 0 N--CA 1.468 0.472 0 O-C-N 120.135 -1.603 . . . . 0.67000000000000004 110.712 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' A' ' 44' ' ' VAL . 49.7 Cg_exo -53.62 -17.57 10.06 Favored 'Trans proline' 0 C--N 1.361 1.235 0 C-N-CA 123.3 2.666 . . . . 0.85999999999999999 112.81 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.11 -16.63 62.22 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-N 115.003 -0.999 . . . . 1.3500000000000001 113.627 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.641 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.35 135.09 20.34 Favored Pre-proline 0 CA--C 1.542 0.641 0 O-C-N 122.196 -0.315 . . . . 0.94999999999999996 110.716 -179.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.479 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 72.0 Cg_endo -65.35 -41.87 14.69 Favored 'Trans proline' 0 N--CA 1.479 0.633 0 C-N-CA 123.505 2.804 . . . . 1.24 113.318 -178.816 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.641 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -25.98 66.94 Favored 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 121.298 0.57 . . . . 1.1899999999999999 111.809 176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.71 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.7 OUTLIER -83.25 -27.5 29.84 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.752 -0.658 . . . . 0.89000000000000001 110.118 178.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 33.4 ttpt -79.44 -13.88 59.29 Favored 'General case' 0 CA--C 1.539 0.542 0 CA-C-O 121.529 0.68 . . . . 1.71 110.768 179.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.479 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.6 mtpp -78.56 -57.23 3.88 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 115.447 -0.797 . . . . 1.29 113.07 179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 11.2 m -60.7 -28.34 42.69 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 CA-C-N 115.568 -0.742 . . . . 0.91000000000000003 111.793 178.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.63 ' O ' HG12 ' A' ' 70' ' ' ILE . 43.0 pt -77.21 -19.35 14.32 Favored 'Isoleucine or valine' 0 C--N 1.344 0.356 0 C-N-CA 120.757 -0.377 . . . . 1.05 110.439 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.35 -42.9 78.55 Favored 'General case' 0 N--CA 1.472 0.675 0 C-N-CA 120.543 -0.463 . . . . 1.52 110.478 175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -67.33 -23.89 65.68 Favored 'General case' 0 CA--C 1.535 0.389 0 N-CA-C 113.507 0.929 . . . . 1.5800000000000001 113.507 -178.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.63 HG12 ' O ' ' A' ' 67' ' ' ILE . 16.8 pt -75.46 -13.59 15.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 118.097 0.408 . . . . 1.3700000000000001 111.718 -179.326 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 36.1 mt -91.4 -5.26 54.69 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.911 0.386 . . . . 1.6699999999999999 110.473 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -101.53 -59.95 1.61 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.848 -0.614 . . . . 2.21 110.212 -179.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -81.74 -13.78 79.12 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 120.89 -0.671 . . . . 1.77 113.14 -179.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -82.85 -9.47 84.42 Favored Glycine 0 C--N 1.333 0.413 0 C-N-CA 120.982 -0.627 . . . . 2.0899999999999999 113.038 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -114.34 -8.38 12.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 121.035 0.445 . . . . 2.29 110.525 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -80.76 -32.06 35.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.98 -0.554 . . . . 2.4399999999999999 111.414 -179.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.3 mm-40 -71.34 110.19 5.81 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 121.026 0.441 . . . . 2.7000000000000002 110.928 -179.623 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 14.8 m120 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.44 -0.79 . . . . 2.5600000000000001 110.975 -179.524 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 122.665 1.221 . . . . 0.80000000000000004 110.175 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.39 -1.732 . . . . 0.84999999999999998 111.359 -179.725 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.04 4.49 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 123.812 0.845 . . . . 0.77000000000000002 110.362 -173.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.18 52.77 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.856 -1.52 . . . . 0.65000000000000002 110.213 178.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.42 30.3 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 113.918 -1.492 . . . . 0.68000000000000005 108.424 -176.131 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.79 151.09 8.87 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 116.086 -0.506 . . . . 0.5 109.87 172.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.13 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 CA-C-O 121.827 0.822 . . . . 0.46999999999999997 111.52 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.99 104.28 10.35 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.389 178.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.28 -33.38 29.14 Favored 'General case' 0 N--CA 1.476 0.841 0 CA-C-N 114.617 -1.174 . . . . 0.57999999999999996 113.765 175.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.79 3.52 Favored 'General case' 0 C--N 1.316 -0.853 0 C-N-CA 124.867 1.267 . . . . 0.57999999999999996 109.997 -178.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.574 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.63 -171.61 2.51 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 113.8 -1.546 . . . . 0.59999999999999998 111.386 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 86.9 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 125.863 1.665 . . . . 0.57999999999999996 110.171 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.14 72.15 1.41 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 123.645 1.688 . . . . 0.72999999999999998 112.217 177.146 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.04 -177.27 51.42 Favored Glycine 0 CA--C 1.544 1.856 0 CA-C-N 113.22 -1.809 . . . . 0.64000000000000001 110.927 174.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.734 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.93 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 1 C-N-CA 136.17 5.788 . . . . 0.64000000000000001 106.349 8.217 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.734 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.68 143.37 32.24 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.899 -0.501 . . . . 0.68000000000000005 110.003 174.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.432 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.9 Cg_exo -51.3 -21.9 10.63 Favored 'Trans proline' 0 N--CA 1.479 0.651 0 C-N-CA 124.721 3.614 . . . . 0.58999999999999997 112.804 174.144 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.71 16.37 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.575 1.15 . . . . 0.68999999999999995 112.618 179.671 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . 0.42 ' O ' ' HA ' ' B' ' 48' ' ' LEU . 38.7 mmt -88.13 -18.45 28.78 Favored 'General case' 0 N--CA 1.476 0.837 0 N-CA-C 113.517 0.932 . . . . 0.94999999999999996 113.517 175.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 28.4 mm -98.93 138.55 23.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 O-C-N 121.953 -0.467 . . . . 0.57999999999999996 111.743 -179.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 72.2 m -137.91 10.05 2.83 Favored 'General case' 0 CA--C 1.532 0.288 0 CA-C-N 116.47 -0.332 . . . . 0.69999999999999996 111.269 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.458 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 13.2 t30 -148.82 123.25 9.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.486 -0.324 . . . . 0.82999999999999996 110.659 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 37.2 tp -106.66 137.63 44.33 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.247 -0.433 . . . . 0.75 110.806 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 49.4 mt-30 -134.02 110.47 9.68 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.994 0.426 . . . . 1.0800000000000001 110.984 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 12.1 t -99.11 100.33 10.26 Favored 'Isoleucine or valine' 0 C--O 1.232 0.157 0 CA-C-N 116.049 -0.523 . . . . 0.60999999999999999 110.923 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.0 m-85 -98.47 128.24 44.75 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.865 -0.607 . . . . 0.85999999999999999 110.851 -179.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.508 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -94.47 -163.76 1.09 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.793 0.33 . . . . 0.60999999999999999 111.262 179.367 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.545 HG23 ' HA ' ' B' ' 40' ' ' SER . 89.0 mt -72.25 125.09 30.3 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 CA-C-N 116.157 -0.474 . . . . 1.1000000000000001 110.982 179.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.69 -169.16 14.1 Favored Glycine 0 C--N 1.334 0.424 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.748 -179.711 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.5 -9.37 17.36 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 123.323 2.682 . . . . 0.79000000000000004 112.806 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.3 -21.1 12.39 Favored 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 113.089 0.774 . . . . 0.70999999999999996 113.089 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.8 t -139.86 132.33 28.58 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.981 -0.554 . . . . 0.67000000000000004 110.973 -177.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.545 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.3 t -101.25 45.42 0.97 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.86 0.362 . . . . 1.01 110.806 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -163.38 149.7 11.98 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.1599999999999999 110.695 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.508 HG12 ' HA ' ' B' ' 34' ' ' ALA . 30.6 m -81.74 136.65 22.63 Favored 'Isoleucine or valine' 0 C--O 1.233 0.232 0 CA-C-O 120.795 0.331 . . . . 0.78000000000000003 110.29 179.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -135.35 130.13 34.51 Favored 'General case' 0 C--O 1.232 0.141 0 N-CA-C 110.221 -0.288 . . . . 0.80000000000000004 110.221 -179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.1 m -100.39 106.13 18.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 121.647 0.736 . . . . 0.59999999999999998 112.313 -178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.68 150.5 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 122.459 1.124 . . . . 0.62 110.882 178.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.33 153.35 46.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 115.3 -0.863 . . . . 0.55000000000000004 111.043 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.4 m -123.77 133.34 53.85 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 114.988 -1.006 . . . . 0.63 110.593 176.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . 0.42 ' HA ' ' O ' ' B' ' 26' ' ' MET . 6.9 mp -81.13 173.99 12.01 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.972 -1.013 . . . . 0.75 110.908 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -78.3 -12.95 60.04 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.04 -0.527 . . . . 1.27 110.674 179.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -84.64 -5.44 59.31 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.123 -0.49 . . . . 0.98999999999999999 111.049 179.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.38 41.93 5.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 120.962 -0.637 . . . . 0.67000000000000004 112.382 -179.868 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.468 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.6 mtpt -122.6 160.1 26.43 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.661 0.267 . . . . 1.05 111.082 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.81 129.58 36.73 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.407 0.622 . . . . 0.70999999999999996 109.91 179.55 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.3 pt -127.88 179.68 3.56 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.973 0 CA-C-N 114.622 -1.172 . . . . 0.52000000000000002 109.762 178.084 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 97.0 m -127.42 138.13 52.9 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.426 -1.261 . . . . 0.47999999999999998 109.23 177.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.587 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.6 mt -114.02 153.11 29.95 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 113.986 -1.461 . . . . 0.48999999999999999 108.744 -178.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.574 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.7 t0 -101.03 112.06 64.37 Favored Pre-proline 0 C--N 1.327 -0.379 0 O-C-N 121.211 -0.93 . . . . 0.63 110.665 178.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.26 -16.28 17.09 Favored 'Trans proline' 0 C--N 1.36 1.174 0 C-N-CA 123.184 2.589 . . . . 0.82999999999999996 112.546 -179.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.52 -16.59 63.83 Favored 'General case' 0 CA--C 1.546 0.801 0 CA-C-N 114.664 -1.153 . . . . 1.3999999999999999 113.606 178.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.09 20.26 Favored Pre-proline 0 CA--C 1.541 0.608 0 O-C-N 122.318 -0.239 . . . . 0.91000000000000003 110.788 -179.065 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . 0.447 ' O ' ' HG3' ' B' ' 65' ' ' LYS . 71.7 Cg_endo -65.21 -41.89 15.12 Favored 'Trans proline' 0 CA--C 1.535 0.564 0 C-N-CA 123.695 2.93 . . . . 1.1899999999999999 113.357 -178.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -26.08 67.06 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-O 121.263 0.554 . . . . 1.1499999999999999 111.774 176.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.587 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -68.91 -36.04 77.54 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.244 -0.889 . . . . 0.90000000000000002 110.623 178.497 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.526 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.0 ttpt -81.88 -13.84 57.03 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 115.717 -0.674 . . . . 1.71 110.798 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . 0.46 ' HD3' ' HA ' ' B' ' 62' ' ' PHE . 30.6 mtpp -78.8 -54.74 5.76 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 123.579 0.751 . . . . 1.3600000000000001 113.01 179.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.6 m -62.2 -28.75 45.12 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 114.81 -1.086 . . . . 0.96999999999999997 111.239 178.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 46.1 pt -87.64 -21.36 7.17 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.72 0.295 . . . . 1.0800000000000001 110.356 178.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.526 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.42 -43.35 50.37 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.479 -0.328 . . . . 1.52 110.532 177.118 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.5 mttt -60.85 -31.04 70.49 Favored 'General case' 0 N--CA 1.467 0.421 0 N-CA-C 113.283 0.846 . . . . 1.6100000000000001 113.283 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.7 pt -74.87 -7.81 10.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.4 0 N-CA-C 112.202 0.445 . . . . 1.4299999999999999 112.202 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 10.1 mt -88.2 -35.08 17.56 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.634 -0.257 . . . . 1.79 110.813 179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -83.63 -40.89 18.43 Favored 'General case' 0 C--N 1.332 -0.155 0 CA-C-N 116.404 -0.362 . . . . 2.25 110.253 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.6 -20.99 70.21 Favored Glycine 0 C--N 1.33 0.232 0 C-N-CA 120.971 -0.633 . . . . 1.76 112.246 179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.43 -27.97 58.53 Favored Glycine 0 C--N 1.334 0.464 0 C-N-CA 121.112 -0.566 . . . . 2.04 112.465 179.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 6.6 t30 -82.17 -19.14 40.5 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.949 0.404 . . . . 2.3199999999999998 110.599 179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.3 tptp -75.89 -21.55 57.03 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 115.953 -0.567 . . . . 2.46 110.716 179.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -71.4 105.28 3.48 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.204 -0.453 . . . . 2.7799999999999998 110.034 179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.5 m120 . . . . . 0 C--O 1.25 1.1 0 CA-C-O 118.317 -0.849 . . . . 2.48 111.065 -179.361 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.481 1.084 0 CA-C-O 122.731 1.253 . . . . 0.81000000000000005 110.102 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.62 -64.72 0.78 Allowed 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 113.396 -1.729 . . . . 0.83999999999999997 111.486 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.61 115.02 4.47 Favored 'General case' 0 N--CA 1.467 0.402 0 C-N-CA 123.927 0.891 . . . . 0.76000000000000001 110.383 -173.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.11 52.84 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-N 113.76 -1.563 . . . . 0.65000000000000002 110.189 178.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.09 146.46 30.13 Favored 'General case' 0 N--CA 1.476 0.855 0 CA-C-N 113.993 -1.458 . . . . 0.66000000000000003 108.355 -176.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.95 151.1 9.21 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 116.014 -0.539 . . . . 0.48999999999999999 109.865 172.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.453 ' HB ' ' NE2' ' A' ' 38' ' ' GLN . 12.9 p -59.96 -31.18 47.07 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.317 0 CA-C-O 121.617 0.722 . . . . 0.45000000000000001 111.463 177.728 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.99 104.39 10.45 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-N 114.564 -1.198 . . . . 0.46000000000000002 111.241 179.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.2 mt -82.48 -33.31 28.44 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.609 -1.178 . . . . 0.56999999999999995 113.702 175.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.68 -178.76 3.52 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 124.855 1.262 . . . . 0.56999999999999995 110.086 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.592 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.7 -171.59 2.51 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.748 -1.569 . . . . 0.62 111.466 178.591 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.621 HG21 HD12 ' A' ' 54' ' ' ILE . 85.7 m -157.85 152.32 24.8 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 125.761 1.624 . . . . 0.60999999999999999 110.183 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.26 1.42 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 123.661 1.696 . . . . 0.76000000000000001 112.075 177.178 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.01 -177.27 51.44 Favored Glycine 0 CA--C 1.544 1.902 0 CA-C-N 113.203 -1.817 . . . . 0.68999999999999995 110.865 174.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.719 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.93 -172.53 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.696 1 C-N-CA 136.236 5.815 . . . . 0.68999999999999995 106.422 8.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.719 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.41 32.16 Favored Pre-proline 0 CA--C 1.544 0.721 0 O-C-N 121.924 -0.485 . . . . 0.72999999999999998 110.067 174.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.429 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.3 Cg_exo -51.23 -21.94 10.45 Favored 'Trans proline' 0 N--CA 1.479 0.647 0 C-N-CA 124.767 3.644 . . . . 0.64000000000000001 112.855 174.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.86 15.83 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.581 1.153 . . . . 0.73999999999999999 112.658 179.608 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . 0.507 ' O ' ' HA ' ' A' ' 48' ' ' LEU . 1.7 mmt -88.01 -19.15 27.56 Favored 'General case' 0 N--CA 1.474 0.757 0 N-CA-C 113.526 0.935 . . . . 1.0800000000000001 113.526 175.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 13.5 mm -95.31 147.04 6.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-O 120.841 0.353 . . . . 0.57999999999999996 111.833 -178.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.9 m -144.47 6.72 1.28 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.307 -0.406 . . . . 0.68999999999999995 111.075 179.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 54.0 t30 -158.63 133.93 8.58 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-N 116.471 -0.331 . . . . 0.78000000000000003 110.849 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 26.5 tp -126.81 142.16 51.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.238 -0.437 . . . . 0.73999999999999999 110.653 179.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.497 ' HB2' HG23 ' A' ' 45' ' ' VAL . 52.7 mt-30 -137.01 116.47 12.79 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.003 0.43 . . . . 1.1599999999999999 110.958 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.8 t -103.62 105.34 18.19 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.821 -0.627 . . . . 0.62 111.067 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 74.7 m-85 -94.94 138.83 32.17 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.986 -0.552 . . . . 0.72999999999999998 110.84 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.42 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -100.24 -141.9 0.33 Allowed 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.719 0.295 . . . . 0.66000000000000003 111.34 179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 85.0 mt -76.34 128.29 37.58 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 CA-C-O 121.07 0.462 . . . . 1.1399999999999999 111.706 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.88 -177.44 15.03 Favored Glycine 0 CA--C 1.521 0.462 0 CA-C-N 115.666 -0.697 . . . . 0.66000000000000003 111.851 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.9 Cg_exo -76.48 -7.71 17.96 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 123.173 2.582 . . . . 0.81000000000000005 112.715 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.453 ' NE2' ' HB ' ' A' ' 14' ' ' VAL . 19.9 pt20 -111.07 -21.7 11.83 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.964 0.727 . . . . 0.72999999999999998 112.964 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -153.1 129.94 10.94 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.953 -0.567 . . . . 0.70999999999999996 110.99 -177.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -102.28 39.21 1.53 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.977 0.418 . . . . 1.0700000000000001 110.424 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -148.13 155.29 41.26 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.069 -0.514 . . . . 1.29 110.784 -179.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.42 HG12 ' HA ' ' A' ' 34' ' ' ALA . 4.2 m -83.47 128.57 38.66 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-N 116.25 -0.432 . . . . 0.82999999999999996 111.253 179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.0 mt-10 -129.77 130.18 45.05 Favored 'General case' 0 C--O 1.231 0.12 0 CA-C-N 116.487 -0.324 . . . . 0.79000000000000004 110.25 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -100.72 106.11 18.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.686 0.755 . . . . 0.66000000000000003 112.281 -178.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.497 HG23 ' HB2' ' A' ' 31' ' ' GLN . 13.0 m -93.58 150.55 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-O 122.586 1.184 . . . . 0.68999999999999995 110.805 178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.31 153.45 46.46 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.114 -0.948 . . . . 0.57999999999999996 111.114 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.415 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.1 m -123.74 133.24 53.89 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.084 -0.962 . . . . 0.65000000000000002 110.41 176.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.507 ' HA ' ' O ' ' A' ' 26' ' ' MET . 6.7 mp -83.31 170.32 14.73 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 114.834 -1.075 . . . . 0.79000000000000004 110.867 179.874 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -75.69 -16.43 60.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.151 -0.477 . . . . 1.23 110.602 179.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.3 m-20 -78.48 -12.76 60.03 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.984 -0.553 . . . . 1.05 111.078 179.749 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.75 43.56 3.33 Favored Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.929 -0.653 . . . . 0.69999999999999996 112.51 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 47' ' ' SER . 49.3 mtpt -126.91 163.36 23.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.906 0.384 . . . . 1.1899999999999999 111.39 -179.89 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -133.68 129.49 36.88 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.719 -0.673 . . . . 0.68999999999999995 109.918 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.621 HD12 HG21 ' A' ' 19' ' ' THR . 49.4 pt -127.74 179.56 3.62 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.026 0 CA-C-N 114.718 -1.128 . . . . 0.53000000000000003 109.841 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.32 138.12 52.97 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 114.387 -1.278 . . . . 0.48999999999999999 109.241 177.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.69 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.7 mt -114.04 153.45 29.38 Favored 'General case' 0 C--N 1.313 -0.992 0 CA-C-N 114.025 -1.443 . . . . 0.51000000000000001 108.69 -178.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.592 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -102.44 112.33 65.44 Favored Pre-proline 0 C--N 1.325 -0.489 0 O-C-N 121.562 -0.711 . . . . 0.67000000000000004 110.595 178.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_exo -57.94 -16.54 26.7 Favored 'Trans proline' 0 C--N 1.358 1.061 0 C-N-CA 123.189 2.592 . . . . 0.85999999999999999 112.294 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -65.7 -16.45 63.77 Favored 'General case' 0 CA--C 1.544 0.717 0 CA-C-N 114.689 -1.141 . . . . 1.3500000000000001 113.592 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.642 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.09 20.3 Favored Pre-proline 0 CA--C 1.542 0.67 0 O-C-N 122.17 -0.331 . . . . 0.94999999999999996 110.71 -179.029 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.38 -41.85 14.66 Favored 'Trans proline' 0 N--CA 1.478 0.582 0 C-N-CA 123.558 2.839 . . . . 1.24 113.329 -178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.642 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.76 -27.16 67.76 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-O 121.393 0.616 . . . . 1.1899999999999999 111.869 176.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.69 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.64 -35.03 70.27 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.173 -0.921 . . . . 0.89000000000000001 110.665 179.118 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 14.6 ttpt -73.73 -20.4 60.52 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.109 -0.496 . . . . 1.71 110.7 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.43 -55.54 5.3 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 115.29 -0.868 . . . . 1.29 113.064 179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 18.7 m -62.32 -29.67 47.22 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.19 -0.459 . . . . 0.91000000000000003 111.25 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.429 HG12 ' HA ' ' A' ' 64' ' ' LYS . 33.4 pt -85.07 -20.64 8.22 Favored 'Isoleucine or valine' 0 C--N 1.345 0.395 0 C-N-CA 120.811 -0.356 . . . . 1.05 110.316 178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.81 -43.23 47.14 Favored 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 120.888 -0.325 . . . . 1.52 110.489 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -59.02 -32.68 69.94 Favored 'General case' 0 CA--C 1.532 0.279 0 N-CA-C 112.975 0.731 . . . . 1.5800000000000001 112.975 -179.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 16.3 pt -79.36 -13.29 13.37 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 C-N-CA 120.981 -0.288 . . . . 1.3700000000000001 111.769 -179.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 92.8 mt -93.13 -34.5 13.62 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.936 0.398 . . . . 1.6699999999999999 109.996 178.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -79.96 -35.39 37.71 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 115.734 -0.666 . . . . 2.21 110.758 179.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.67 -23.29 77.1 Favored Glycine 0 C--N 1.333 0.4 0 CA-C-N 115.918 -0.583 . . . . 1.77 112.57 179.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.25 -26.03 69.34 Favored Glycine 0 C--N 1.332 0.319 0 C-N-CA 121.099 -0.572 . . . . 2.0899999999999999 112.333 179.468 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -76.36 -26.89 56.14 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.885 0.374 . . . . 2.29 110.767 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -92.81 -3.04 55.39 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.165 -0.47 . . . . 2.4399999999999999 110.814 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -72.35 119.86 17.15 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.169 -0.469 . . . . 2.7000000000000002 110.524 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.169 0 CA-C-O 118.285 -0.864 . . . . 2.5600000000000001 110.722 -179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.015 0 CA-C-O 122.787 1.28 . . . . 0.80000000000000004 110.168 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.407 -1.724 . . . . 0.84999999999999998 111.373 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.6 115.01 4.48 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.954 0.902 . . . . 0.77000000000000002 110.515 -173.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.19 140.22 52.73 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-N 113.906 -1.497 . . . . 0.65000000000000002 110.133 179.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.47 30.24 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.981 -1.463 . . . . 0.68000000000000005 108.395 -176.077 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.82 151.09 8.94 Favored 'General case' 0 N--CA 1.473 0.722 0 CA-C-N 116.119 -0.491 . . . . 0.5 109.877 172.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.05 -31.1 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.749 0.785 . . . . 0.46999999999999997 111.498 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.431 ' HB2' ' CD ' ' B' ' 43' ' ' GLU . 62.8 m -118.97 104.17 10.25 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 124.759 1.224 . . . . 0.46999999999999997 111.435 179.028 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.31 -33.4 29.03 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.671 -1.15 . . . . 0.57999999999999996 113.667 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.78 -178.82 3.53 Favored 'General case' 0 C--N 1.317 -0.843 0 C-N-CA 124.866 1.267 . . . . 0.57999999999999996 110.05 -178.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.568 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.6 -171.65 2.52 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 113.837 -1.528 . . . . 0.59999999999999998 111.376 178.653 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 86.1 m -157.76 152.3 24.97 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.786 1.635 . . . . 0.57999999999999996 110.15 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.24 72.17 1.41 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 123.65 1.691 . . . . 0.72999999999999998 112.183 177.1 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.2 51.39 Favored Glycine 0 CA--C 1.543 1.828 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.948 174.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.735 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.08 -172.39 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.756 1 C-N-CA 136.123 5.769 . . . . 0.64000000000000001 106.299 8.06 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.735 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.59 143.43 32.25 Favored Pre-proline 0 CA--C 1.541 0.621 0 O-C-N 121.976 -0.452 . . . . 0.68000000000000005 110.037 174.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HB3' HG22 ' B' ' 70' ' ' ILE . 84.9 Cg_exo -51.18 -21.93 10.27 Favored 'Trans proline' 0 N--CA 1.477 0.558 0 C-N-CA 124.834 3.69 . . . . 0.58999999999999997 112.921 173.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.589 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.82 16.42 Favored 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 124.623 1.169 . . . . 0.68999999999999995 112.576 179.645 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 12.0 mmt -88.02 -19.25 27.41 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 113.543 0.942 . . . . 0.94999999999999996 113.543 175.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.8 mm -84.16 137.97 19.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.751 0.31 . . . . 0.57999999999999996 111.453 -178.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 49.4 m -139.47 10.01 2.48 Favored 'General case' 0 CA--C 1.532 0.278 0 CA-C-N 116.348 -0.387 . . . . 0.69999999999999996 111.256 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -166.75 137.81 3.32 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.422 -0.354 . . . . 0.82999999999999996 110.37 -179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 20.2 tp -132.34 135.24 46.04 Favored 'General case' 0 C--O 1.225 -0.2 0 CA-C-N 116.526 -0.307 . . . . 0.75 111.141 -179.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.521 ' HB2' HG23 ' B' ' 45' ' ' VAL . 0.7 OUTLIER -130.81 117.88 19.99 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.858 0.361 . . . . 1.0800000000000001 110.533 179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -105.09 112.57 39.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.06 -0.518 . . . . 0.60999999999999999 111.214 -179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -102.92 134.0 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.791 -0.641 . . . . 0.85999999999999999 110.826 -179.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -93.28 -154.98 0.42 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.707 0.289 . . . . 0.60999999999999999 111.032 179.297 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 91.1 mt -68.98 119.23 14.51 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 CA-C-N 116.341 -0.391 . . . . 1.1000000000000001 110.952 179.813 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.16 -177.18 15.56 Favored Glycine 0 CA--C 1.52 0.359 0 C-N-CA 120.93 -0.653 . . . . 0.63 112.442 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.22 -9.6 19.1 Favored 'Trans proline' 0 C--N 1.349 0.557 0 C-N-CA 123.214 2.609 . . . . 0.79000000000000004 112.861 -179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.92 -21.0 12.25 Favored 'General case' 0 N--CA 1.471 0.609 0 N-CA-C 113.082 0.771 . . . . 0.70999999999999996 113.082 -179.533 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.3 t -151.72 126.32 9.51 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.115 -0.493 . . . . 0.67000000000000004 111.124 -177.609 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 6.7 t -98.05 34.79 1.85 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.118 0.485 . . . . 1.01 110.319 179.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -137.34 143.31 41.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.783 -0.644 . . . . 1.1599999999999999 110.938 -179.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 3.3 m -80.63 123.7 37.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.2 0 CA-C-O 120.934 0.397 . . . . 0.78000000000000003 110.473 178.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.431 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 15.9 mt-10 -127.99 129.96 47.59 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.80000000000000004 110.289 -179.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.452 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.6 OUTLIER -100.4 106.11 18.75 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.692 0.758 . . . . 0.59999999999999998 112.243 -178.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.521 HG23 ' HB2' ' B' ' 31' ' ' GLN . 12.9 m -93.57 150.52 3.93 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.978 0 CA-C-O 122.487 1.137 . . . . 0.62 110.768 178.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.32 153.42 46.43 Favored 'General case' 0 N--CA 1.476 0.839 0 CA-C-N 115.264 -0.88 . . . . 0.55000000000000004 111.183 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.573 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.8 132.58 53.82 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 115.104 -0.953 . . . . 0.63 110.411 176.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 10.1 mp -81.33 171.03 15.3 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.235 -0.893 . . . . 0.75 110.711 179.711 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -76.56 -16.42 59.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.013 0.435 . . . . 1.27 110.494 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 74.8 m-20 -82.71 -12.49 57.53 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.004 -0.544 . . . . 0.98999999999999999 110.933 179.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.03 49.26 1.93 Allowed Glycine 0 C--N 1.332 0.358 0 C-N-CA 120.97 -0.634 . . . . 0.67000000000000004 112.468 179.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.573 ' O ' ' HA ' ' B' ' 47' ' ' SER . 61.8 mtpt -129.63 154.55 47.0 Favored 'General case' 0 C--O 1.224 -0.276 0 CA-C-O 120.699 0.285 . . . . 1.05 111.127 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -133.59 129.58 37.18 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.482 0.658 . . . . 0.70999999999999996 109.929 179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.9 pt -127.93 179.65 3.6 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.986 0 CA-C-N 114.674 -1.148 . . . . 0.52000000000000002 109.713 178.159 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.45 138.01 52.85 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 114.44 -1.255 . . . . 0.47999999999999998 109.22 177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.739 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.97 151.88 31.7 Favored 'General case' 0 C--N 1.314 -0.944 0 CA-C-N 114.009 -1.451 . . . . 0.48999999999999999 108.744 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.568 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.2 t0 -102.32 104.27 36.26 Favored Pre-proline 0 N--CA 1.469 0.482 0 O-C-N 120.266 -1.521 . . . . 0.63 110.765 178.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.452 ' HG3' HG22 ' B' ' 44' ' ' VAL . 49.0 Cg_exo -53.58 -17.57 9.94 Favored 'Trans proline' 0 C--N 1.361 1.225 0 C-N-CA 123.173 2.582 . . . . 0.82999999999999996 112.832 179.794 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.6 tt0 -64.22 -16.43 61.98 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 114.99 -1.005 . . . . 1.3999999999999999 113.573 179.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.52 135.05 20.27 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 122.269 -0.269 . . . . 0.91000000000000003 110.744 -179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.29 -41.83 15.0 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.609 2.873 . . . . 1.1899999999999999 113.395 -178.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.79 -28.46 68.77 Favored 'General case' 0 N--CA 1.48 1.032 0 CA-C-O 121.301 0.572 . . . . 1.1499999999999999 111.785 176.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.739 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -74.12 -31.36 62.74 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 115.79 -0.641 . . . . 0.90000000000000002 110.438 179.111 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.483 ' HA ' HG12 ' B' ' 67' ' ' ILE . 39.8 ttpt -69.51 -24.99 63.83 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.091 -0.504 . . . . 1.71 110.792 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -72.87 -55.52 6.53 Favored 'General case' 0 N--CA 1.473 0.704 0 C-N-CA 123.631 0.772 . . . . 1.3600000000000001 113.074 179.391 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.33 -29.68 47.26 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-N 116.104 -0.498 . . . . 0.96999999999999997 111.211 178.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.483 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.7 pt -85.16 -20.66 8.18 Favored 'Isoleucine or valine' 0 C--N 1.346 0.42 0 C-N-CA 120.807 -0.357 . . . . 1.0800000000000001 110.218 178.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.471 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.76 -41.32 53.5 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 120.827 -0.349 . . . . 1.52 110.513 176.411 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -62.71 -30.31 71.31 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 113.275 0.843 . . . . 1.6100000000000001 113.275 -179.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.479 HG22 ' HB3' ' B' ' 24' ' ' PRO . 20.3 pt -72.9 -14.47 16.94 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.531 0 CA-C-N 118.22 0.464 . . . . 1.4299999999999999 111.606 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 57.3 mt -88.31 -15.13 36.53 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.394 . . . . 1.79 110.309 179.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -104.5 -55.12 2.4 Favored 'General case' 0 C--N 1.334 -0.093 0 CA-C-N 116.205 -0.452 . . . . 2.25 110.282 179.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.99 -27.39 68.79 Favored Glycine 0 C--N 1.331 0.269 0 C-N-CA 121.057 -0.592 . . . . 1.76 112.559 179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.92 -23.8 65.8 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.029 -0.605 . . . . 2.04 112.34 179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 62.7 t30 -91.58 -3.7 56.15 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 121.015 0.436 . . . . 2.3199999999999998 110.33 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 5.7 tptp -81.31 -14.46 57.32 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.977 -0.556 . . . . 2.46 110.677 179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -74.53 111.82 10.1 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 115.976 -0.556 . . . . 2.7799999999999998 110.07 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.9 m120 . . . . . 0 C--O 1.251 1.139 0 CA-C-O 118.235 -0.888 . . . . 2.48 111.019 -179.571 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.08 0 CA-C-O 122.68 1.228 . . . . 0.81000000000000005 110.107 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.73 0.78 Allowed 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 113.391 -1.731 . . . . 0.83999999999999997 111.446 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.06 4.5 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 123.949 0.9 . . . . 0.76000000000000001 110.385 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.17 52.8 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.776 -1.556 . . . . 0.65000000000000002 110.273 178.868 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.21 146.35 30.4 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 114.095 -1.411 . . . . 0.66000000000000003 108.421 -176.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.88 151.03 9.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 116.044 -0.526 . . . . 0.48999999999999999 109.866 173.012 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.1 46.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 121.616 0.722 . . . . 0.45000000000000001 111.489 177.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.01 104.35 10.41 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.763 1.225 . . . . 0.46000000000000002 111.292 178.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.43 -33.43 28.58 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.61 -1.177 . . . . 0.56999999999999995 113.71 175.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.65 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.89 0 C-N-CA 124.851 1.261 . . . . 0.56999999999999995 110.094 -179.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.563 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.71 -171.65 2.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 113.763 -1.562 . . . . 0.62 111.374 178.703 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.89 152.32 24.73 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 125.823 1.649 . . . . 0.60999999999999999 110.217 179.864 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.09 72.17 1.41 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 123.515 1.626 . . . . 0.76000000000000001 112.069 177.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.1 -177.35 51.41 Favored Glycine 0 CA--C 1.544 1.893 0 CA-C-N 113.279 -1.782 . . . . 0.68999999999999995 110.827 174.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.768 1 C-N-CA 136.241 5.816 . . . . 0.68999999999999995 106.373 8.353 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.61 143.28 31.97 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.826 -0.546 . . . . 0.72999999999999998 110.143 174.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.17 -21.96 10.25 Favored 'Trans proline' 0 N--CA 1.477 0.518 0 C-N-CA 124.745 3.63 . . . . 0.64000000000000001 112.864 174.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.573 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.88 15.95 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 124.707 1.203 . . . . 0.73999999999999999 112.547 179.669 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 37.7 mmt -87.98 -19.46 27.18 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 113.544 0.942 . . . . 1.0800000000000001 113.544 175.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 21.2 mm -85.49 145.38 7.97 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.455 0 O-C-N 122.098 -0.376 . . . . 0.57999999999999996 111.615 -178.769 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 71.7 m -148.48 6.49 0.74 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.402 -0.363 . . . . 0.68999999999999995 111.539 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -157.92 139.86 14.08 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.705 0.288 . . . . 0.78000000000000003 110.676 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 43.8 tp -128.05 131.52 49.12 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.178 -0.465 . . . . 0.73999999999999999 110.769 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.401 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.4 mt-30 -130.42 116.92 18.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.315 -0.402 . . . . 1.1599999999999999 110.188 179.169 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -113.8 128.64 70.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-O 120.96 0.41 . . . . 0.62 111.485 -179.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -120.7 129.01 53.48 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.663 -0.698 . . . . 0.72999999999999998 110.212 179.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.11 -152.22 0.21 Allowed 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.818 0.342 . . . . 0.66000000000000003 111.407 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 81.7 mt -67.17 117.92 9.5 Favored 'Isoleucine or valine' 0 C--O 1.232 0.18 0 CA-C-N 116.168 -0.469 . . . . 1.1399999999999999 111.206 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.83 -174.18 13.69 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.978 -0.629 . . . . 0.66000000000000003 112.392 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.87 -8.76 18.03 Favored 'Trans proline' 0 C--N 1.346 0.431 0 C-N-CA 123.198 2.599 . . . . 0.81000000000000005 112.758 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.91 -21.38 12.06 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.04 0.755 . . . . 0.72999999999999998 113.04 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.9 t -156.41 123.1 5.15 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.308 -0.405 . . . . 0.70999999999999996 111.251 -177.833 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.0 t -102.11 55.59 0.8 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.156 0.503 . . . . 1.0700000000000001 110.024 179.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 75.4 tttt -150.87 145.24 25.53 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.684 -0.689 . . . . 1.29 110.652 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 1.7 m -84.46 110.04 18.45 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.091 0.472 . . . . 0.82999999999999996 110.968 179.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -123.03 136.69 54.94 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.043 -0.526 . . . . 0.79000000000000004 110.734 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.826 HG22 ' HG3' ' A' ' 58' ' ' PRO . 3.4 m -105.7 106.57 20.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-O 121.568 0.699 . . . . 0.66000000000000003 111.633 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.401 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -96.28 150.52 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.93 0 CA-C-O 122.518 1.152 . . . . 0.68999999999999995 110.798 179.582 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.39 46.55 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-N 115.175 -0.92 . . . . 0.57999999999999996 111.098 -179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.7 m -123.82 133.98 53.7 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 115.059 -0.973 . . . . 0.65000000000000002 110.448 176.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 9.3 mp -76.69 169.09 18.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 114.807 -1.088 . . . . 0.79000000000000004 111.012 179.709 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -81.03 -8.44 59.77 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 121.139 0.495 . . . . 1.23 110.669 179.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -82.55 -2.14 52.75 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.07 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.28 37.95 7.44 Favored Glycine 0 C--N 1.333 0.39 0 C-N-CA 120.968 -0.634 . . . . 0.69999999999999996 112.264 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -128.27 156.49 42.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.954 0.407 . . . . 1.1899999999999999 111.397 -179.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -130.71 129.55 42.7 Favored 'General case' 0 N--CA 1.473 0.701 0 CA-C-N 115.689 -0.687 . . . . 0.68999999999999995 109.909 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.82 179.53 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.721 -1.127 . . . . 0.53000000000000003 109.917 177.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.3 m -127.37 138.17 52.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 114.505 -1.225 . . . . 0.48999999999999999 109.218 177.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.767 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.04 151.81 31.91 Favored 'General case' 0 C--N 1.314 -0.946 0 CA-C-N 113.98 -1.464 . . . . 0.51000000000000001 108.698 -178.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.0 t0 -100.81 102.26 18.87 Favored Pre-proline 0 N--CA 1.47 0.554 0 O-C-N 120.105 -1.622 . . . . 0.67000000000000004 110.732 178.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.826 ' HG3' HG22 ' A' ' 44' ' ' VAL . 48.5 Cg_exo -53.36 -17.77 9.6 Favored 'Trans proline' 0 C--N 1.361 1.218 0 C-N-CA 123.319 2.679 . . . . 0.85999999999999999 112.89 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.15 -16.53 62.09 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 114.956 -1.02 . . . . 1.3500000000000001 113.521 179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.38 135.08 20.33 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 122.281 -0.262 . . . . 0.94999999999999996 110.778 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.29 -41.95 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 123.534 2.823 . . . . 1.24 113.378 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.68 -28.63 68.75 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-O 121.29 0.567 . . . . 1.1899999999999999 111.777 176.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.767 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.4 OUTLIER -74.51 -30.78 61.93 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-N 115.693 -0.685 . . . . 0.89000000000000001 110.445 179.163 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 27.6 ttpt -66.69 -26.27 66.94 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.999 -0.546 . . . . 1.71 110.842 179.454 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -72.56 -55.55 6.74 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 113.012 0.745 . . . . 1.29 113.012 179.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 19.2 m -62.48 -29.49 46.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 CA-C-N 116.142 -0.481 . . . . 0.91000000000000003 111.235 178.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.454 HG12 ' HA ' ' A' ' 64' ' ' LYS . 26.3 pt -85.21 -20.48 8.24 Favored 'Isoleucine or valine' 0 C--N 1.346 0.441 0 CA-C-O 120.847 0.356 . . . . 1.05 110.251 178.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.468 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.3 tt0 -76.04 -39.86 54.63 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.867 -0.333 . . . . 1.52 110.507 176.513 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -65.09 -27.82 69.03 Favored 'General case' 0 CA--C 1.535 0.399 0 CA-C-N 115.579 -0.737 . . . . 1.5800000000000001 112.573 179.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 33.1 pt -76.32 -11.48 13.94 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 O-C-N 121.685 -0.635 . . . . 1.3700000000000001 111.169 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 85.2 mt -93.84 -31.44 14.35 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.161 -0.472 . . . . 1.6699999999999999 110.156 179.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -82.23 -41.05 20.76 Favored 'General case' 0 N--CA 1.458 -0.062 0 CA-C-N 116.195 -0.457 . . . . 2.21 110.191 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.57 -30.39 70.97 Favored Glycine 0 C--N 1.333 0.372 0 C-N-CA 120.948 -0.644 . . . . 1.77 112.322 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.95 -28.74 60.12 Favored Glycine 0 C--N 1.333 0.417 0 C-N-CA 121.226 -0.511 . . . . 2.0899999999999999 112.204 179.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -82.87 -25.58 32.42 Favored 'General case' 0 C--O 1.232 0.15 0 CA-C-O 121.008 0.432 . . . . 2.29 110.312 179.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -75.26 -27.18 59.33 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.819 -0.628 . . . . 2.4399999999999999 110.289 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.7 tm-20 -73.25 114.79 11.83 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-N 116.014 -0.539 . . . . 2.7000000000000002 109.957 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.7 m120 . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.293 -0.86 . . . . 2.5600000000000001 110.929 -179.437 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.044 0 CA-C-O 122.762 1.268 . . . . 0.80000000000000004 110.173 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.61 -64.85 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.357 -1.747 . . . . 0.84999999999999998 111.361 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 114.98 4.51 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 123.93 0.892 . . . . 0.77000000000000002 110.538 -173.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.07 140.18 52.8 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 113.891 -1.504 . . . . 0.65000000000000002 110.261 178.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.25 146.45 30.32 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.065 -1.425 . . . . 0.68000000000000005 108.315 -176.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.07 9.04 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.022 -0.535 . . . . 0.5 109.852 173.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -60.02 -31.16 47.14 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.683 0.754 . . . . 0.46999999999999997 111.455 177.771 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.7 m -118.94 104.25 10.34 Favored 'General case' 0 N--CA 1.469 0.493 0 C-N-CA 124.746 1.218 . . . . 0.46999999999999997 111.395 179.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.39 -33.3 28.76 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 114.729 -1.123 . . . . 0.57999999999999996 113.704 175.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.74 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.856 0 C-N-CA 124.871 1.269 . . . . 0.57999999999999996 110.092 -178.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.84 -171.64 2.52 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.927 -1.488 . . . . 0.59999999999999998 111.299 178.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.612 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.85 152.28 24.77 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.796 1.638 . . . . 0.57999999999999996 110.113 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.22 72.28 1.42 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 123.699 1.714 . . . . 0.72999999999999998 112.149 177.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.577 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.14 51.39 Favored Glycine 0 CA--C 1.543 1.829 0 CA-C-N 113.177 -1.829 . . . . 0.64000000000000001 110.936 174.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.73 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.12 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.83 1 C-N-CA 136.155 5.782 . . . . 0.64000000000000001 106.288 7.892 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.73 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.59 143.41 32.22 Favored Pre-proline 0 CA--C 1.542 0.651 0 O-C-N 122.051 -0.405 . . . . 0.68000000000000005 109.999 174.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 86.5 Cg_exo -51.23 -21.89 10.36 Favored 'Trans proline' 0 N--CA 1.478 0.583 0 C-N-CA 124.878 3.719 . . . . 0.58999999999999997 112.785 174.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.71 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.653 1.181 . . . . 0.68999999999999995 112.616 179.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -88.1 -19.11 27.48 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 113.524 0.935 . . . . 0.94999999999999996 113.524 175.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 10.6 mm -91.45 148.8 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.761 0.315 . . . . 0.57999999999999996 111.507 -178.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.9 m -147.11 7.12 0.9 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.354 -0.385 . . . . 0.69999999999999996 111.163 179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 3.7 t30 -158.05 133.71 9.02 Favored 'General case' 0 N--CA 1.467 0.422 0 CA-C-N 116.303 -0.408 . . . . 0.82999999999999996 110.67 -179.703 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 55.1 tp -129.2 122.36 29.59 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-O 120.952 0.406 . . . . 0.75 111.1 179.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 48.2 mt-30 -119.31 120.91 38.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.144 -0.48 . . . . 1.0800000000000001 110.896 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 6.6 t -111.89 107.51 23.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.203 0 CA-C-N 116.103 -0.499 . . . . 0.60999999999999999 111.183 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -98.95 141.82 31.23 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.952 -0.567 . . . . 0.85999999999999999 110.568 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.26 -153.25 0.4 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-O 120.58 0.229 . . . . 0.60999999999999999 110.933 179.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 84.4 mt -69.34 123.31 22.67 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-O 120.967 0.413 . . . . 1.1000000000000001 111.117 179.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -124.8 -172.94 13.62 Favored Glycine 0 N--CA 1.45 -0.37 0 CA-C-N 115.872 -0.603 . . . . 0.63 112.237 179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -77.37 -7.27 16.9 Favored 'Trans proline' 0 C--N 1.344 0.34 0 C-N-CA 123.227 2.618 . . . . 0.79000000000000004 112.83 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.91 -21.37 11.17 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 113.128 0.788 . . . . 0.70999999999999996 113.128 -179.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.2 t -146.98 132.16 18.37 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-N 116.004 -0.544 . . . . 0.67000000000000004 111.127 -177.706 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -102.27 33.29 3.16 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.068 0.461 . . . . 1.01 110.482 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 84.6 tttt -145.51 150.46 36.48 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 115.921 -0.581 . . . . 1.1599999999999999 110.804 -179.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 12.3 m -80.63 130.57 35.7 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 116.266 -0.424 . . . . 0.78000000000000003 110.935 179.435 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -132.53 130.17 40.05 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 116.365 -0.38 . . . . 0.80000000000000004 110.18 -179.745 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.7 m -100.44 106.22 18.93 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.203 0 CA-C-O 121.627 0.727 . . . . 0.59999999999999998 112.277 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -93.69 150.51 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.883 0 CA-C-O 122.483 1.135 . . . . 0.62 110.831 178.339 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.41 46.48 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.261 -0.881 . . . . 0.55000000000000004 111.219 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.8 132.83 53.86 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 115.085 -0.961 . . . . 0.63 110.413 176.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 8.4 mp -80.82 169.07 18.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.224 -0.898 . . . . 0.75 110.793 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 24.0 tptp -75.78 -14.43 60.31 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 1.27 110.819 179.805 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 79.4 m-20 -82.37 -25.87 33.4 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.158 -0.474 . . . . 0.98999999999999999 111.141 179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.91 36.99 1.44 Allowed Glycine 0 C--N 1.332 0.328 0 C-N-CA 120.863 -0.684 . . . . 0.67000000000000004 112.65 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -123.5 137.43 54.78 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.768 0.318 . . . . 1.05 111.572 -179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.3 pt-20 -113.19 126.92 55.96 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.175 0.512 . . . . 0.70999999999999996 110.866 179.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.612 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -124.48 179.68 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.921 0 CA-C-N 115.751 -0.659 . . . . 0.52000000000000002 109.775 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.43 137.99 52.85 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 114.401 -1.272 . . . . 0.47999999999999998 109.345 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.584 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.0 mt -113.9 151.9 31.54 Favored 'General case' 0 C--N 1.313 -0.987 0 CA-C-N 114.03 -1.441 . . . . 0.48999999999999999 108.76 -178.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.8 t0 -103.53 114.75 64.58 Favored Pre-proline 0 N--CA 1.471 0.586 0 O-C-N 120.248 -1.533 . . . . 0.63 110.6 178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -53.47 -17.67 9.75 Favored 'Trans proline' 0 C--N 1.362 1.278 0 C-N-CA 123.222 2.615 . . . . 0.82999999999999996 112.969 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.25 -16.45 62.09 Favored 'General case' 0 CA--C 1.546 0.818 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.58 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.5 135.13 20.26 Favored Pre-proline 0 CA--C 1.54 0.568 0 O-C-N 122.276 -0.265 . . . . 0.91000000000000003 110.823 -179.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.4 -41.82 14.64 Favored 'Trans proline' 0 CA--C 1.535 0.568 0 C-N-CA 123.578 2.852 . . . . 1.1899999999999999 113.318 -178.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.75 67.42 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-O 121.331 0.586 . . . . 1.1499999999999999 111.781 176.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.584 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -66.88 -43.56 83.16 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.406 -0.815 . . . . 0.90000000000000002 110.332 178.417 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 37.6 ttpt -68.0 -23.4 65.01 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 115.657 -0.701 . . . . 1.71 111.13 179.816 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -76.0 -55.63 5.43 Favored 'General case' 0 N--CA 1.473 0.701 0 N-CA-C 112.975 0.731 . . . . 1.3600000000000001 112.975 179.931 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 19.7 m -62.36 -29.6 47.1 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 CA-C-N 116.139 -0.482 . . . . 0.96999999999999997 111.269 178.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.435 HG12 ' HA ' ' B' ' 64' ' ' LYS . 29.2 pt -85.12 -20.6 8.22 Favored 'Isoleucine or valine' 0 C--N 1.346 0.448 0 CA-C-O 120.893 0.378 . . . . 1.0800000000000001 110.263 178.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.87 -43.22 46.61 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.921 -0.312 . . . . 1.52 110.538 176.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 85.4 mttt -61.34 -30.05 70.27 Favored 'General case' 0 N--CA 1.467 0.402 0 N-CA-C 112.936 0.717 . . . . 1.6100000000000001 112.936 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 16.7 pt -85.33 2.21 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.37 0 N-CA-C 112.187 0.439 . . . . 1.4299999999999999 112.187 -179.371 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 84.2 mt -115.65 -36.69 4.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.962 0.41 . . . . 1.79 110.46 179.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -84.47 -41.79 16.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.838 -0.619 . . . . 2.25 110.36 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.76 -23.37 75.65 Favored Glycine 0 C--N 1.333 0.409 0 CA-C-N 115.876 -0.602 . . . . 1.76 112.404 179.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -27.52 68.32 Favored Glycine 0 C--N 1.333 0.394 0 C-N-CA 121.189 -0.529 . . . . 2.04 112.124 179.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.1 t30 -76.97 -24.87 52.29 Favored 'General case' 0 C--N 1.333 -0.127 0 CA-C-O 121.018 0.437 . . . . 2.3199999999999998 110.274 179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 22.4 tptp -81.8 -18.67 43.26 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.002 -0.544 . . . . 2.46 110.748 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.4 tt0 -70.47 116.6 10.99 Favored 'General case' 0 CA--C 1.53 0.178 0 CA-C-N 115.988 -0.551 . . . . 2.7799999999999998 110.403 179.782 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.8 m120 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.414 -0.803 . . . . 2.48 111.668 -179.282 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 122.774 1.273 . . . . 0.81000000000000005 110.097 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.69 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 113.352 -1.749 . . . . 0.83999999999999997 111.43 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.15 4.53 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 123.875 0.87 . . . . 0.76000000000000001 110.305 -173.678 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.801 -1.545 . . . . 0.65000000000000002 110.286 178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.21 146.43 30.3 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 114.13 -1.396 . . . . 0.66000000000000003 108.325 -176.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.8 m -54.99 151.05 9.37 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.971 -0.558 . . . . 0.48999999999999999 109.863 173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.06 46.85 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.336 0 CA-C-O 121.611 0.72 . . . . 0.45000000000000001 111.518 177.779 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.441 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.2 m -119.09 104.37 10.4 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 114.562 -1.199 . . . . 0.46000000000000002 111.177 179.104 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.36 -33.46 28.81 Favored 'General case' 0 N--CA 1.477 0.897 0 CA-C-N 114.639 -1.164 . . . . 0.56999999999999995 113.72 175.059 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.7 -178.68 3.5 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.834 1.253 . . . . 0.56999999999999995 110.071 -179.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.517 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.78 -171.68 2.53 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 113.799 -1.546 . . . . 0.62 111.321 178.718 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.62 HG21 HD12 ' A' ' 54' ' ' ILE . 85.6 m -157.84 152.43 24.98 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.722 1.609 . . . . 0.60999999999999999 110.15 179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 123.617 1.675 . . . . 0.76000000000000001 112.038 177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.19 51.39 Favored Glycine 0 CA--C 1.545 1.907 0 CA-C-N 113.211 -1.813 . . . . 0.68999999999999995 110.917 174.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 138.06 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.694 1 C-N-CA 136.221 5.809 . . . . 0.68999999999999995 106.382 8.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.56 143.36 32.07 Favored Pre-proline 0 CA--C 1.543 0.705 0 O-C-N 121.96 -0.462 . . . . 0.72999999999999998 110.039 174.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.2 Cg_exo -51.22 -21.89 10.34 Favored 'Trans proline' 0 N--CA 1.477 0.551 0 C-N-CA 124.793 3.662 . . . . 0.64000000000000001 112.886 174.098 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.581 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.75 -28.88 16.59 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.641 1.177 . . . . 0.73999999999999999 112.577 179.641 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.9 mmt -87.93 -19.17 27.67 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 113.542 0.942 . . . . 1.0800000000000001 113.542 175.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 8.6 mm -92.18 145.8 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 O-C-N 121.991 -0.443 . . . . 0.57999999999999996 111.475 -178.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.9 m -145.99 6.3 1.02 Allowed 'General case' 0 CA--C 1.532 0.284 0 CA-C-N 116.581 -0.281 . . . . 0.68999999999999995 111.327 179.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 10.0 t30 -162.45 126.68 3.12 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.366 -0.379 . . . . 0.78000000000000003 110.507 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 39.3 tp -113.66 152.82 29.9 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.433 -0.349 . . . . 0.73999999999999999 110.591 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.551 ' HB2' HG22 ' A' ' 45' ' ' VAL . 39.2 mt-30 -144.24 137.79 27.56 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 1.1599999999999999 110.215 179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 15.8 t -127.6 131.24 70.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.8 0.334 . . . . 0.62 110.604 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -118.58 121.57 40.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.028 -0.533 . . . . 0.72999999999999998 110.393 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -85.18 -161.9 0.64 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.811 0.338 . . . . 0.66000000000000003 111.376 179.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 90.3 mt -68.98 118.77 13.74 Favored 'Isoleucine or valine' 0 C--O 1.233 0.185 0 CA-C-N 116.184 -0.462 . . . . 1.1399999999999999 111.317 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.53 -164.28 11.51 Favored Glycine 0 N--CA 1.451 -0.366 0 CA-C-N 115.919 -0.582 . . . . 0.66000000000000003 112.233 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.58 -7.42 14.73 Favored 'Trans proline' 0 C--N 1.346 0.418 0 C-N-CA 123.051 2.501 . . . . 0.81000000000000005 112.643 179.795 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.6 -21.37 11.31 Favored 'General case' 0 N--CA 1.47 0.566 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.375 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -144.39 158.55 43.69 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.185 -0.461 . . . . 0.70999999999999996 111.154 -177.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.4 t -127.82 30.51 5.28 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.099 0.476 . . . . 1.0700000000000001 110.303 179.688 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -143.04 149.72 38.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.821 -0.627 . . . . 1.29 110.931 -179.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -81.88 92.92 2.38 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 121.156 0.503 . . . . 0.82999999999999996 110.61 179.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -91.52 140.65 29.54 Favored 'General case' 0 CA--C 1.506 -0.747 0 N-CA-C 109.216 -0.661 . . . . 0.79000000000000004 109.216 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.594 HG22 ' HG3' ' A' ' 58' ' ' PRO . 11.2 m -113.75 101.79 12.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 121.653 0.739 . . . . 0.66000000000000003 112.383 -179.495 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.551 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.7 OUTLIER -93.56 150.44 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-O 122.542 1.163 . . . . 0.68999999999999995 110.809 178.523 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.19 153.34 46.57 Favored 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 115.235 -0.893 . . . . 0.57999999999999996 111.149 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.9 m -123.73 132.94 53.92 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.011 -0.995 . . . . 0.65000000000000002 110.465 176.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.2 mp -80.2 167.03 20.83 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.086 -0.961 . . . . 0.79000000000000004 110.596 179.637 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.02 -11.07 59.88 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-O 121.021 0.438 . . . . 1.23 110.596 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -81.29 -18.54 45.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.937 -0.574 . . . . 1.05 111.007 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.99 41.51 1.81 Allowed Glycine 0 C--N 1.333 0.376 0 C-N-CA 120.848 -0.691 . . . . 0.69999999999999996 112.622 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 57.4 mtpt -131.07 160.26 35.17 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 120.802 0.334 . . . . 1.1899999999999999 111.057 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -136.45 129.58 31.33 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-O 121.422 0.629 . . . . 0.68999999999999995 109.916 179.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.62 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.85 179.57 3.64 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 CA-C-N 114.686 -1.143 . . . . 0.53000000000000003 109.809 178.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.3 138.02 52.96 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 114.402 -1.272 . . . . 0.48999999999999999 109.247 177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.796 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -114.0 153.09 29.95 Favored 'General case' 0 C--N 1.313 -1.012 0 CA-C-N 114.074 -1.421 . . . . 0.51000000000000001 108.72 -178.677 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.517 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.1 t0 -97.98 110.0 53.89 Favored Pre-proline 0 C--N 1.325 -0.493 0 O-C-N 121.623 -0.673 . . . . 0.67000000000000004 110.256 177.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.594 ' HG3' HG22 ' A' ' 44' ' ' VAL . 30.3 Cg_exo -59.76 -16.94 40.28 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 123.039 2.493 . . . . 0.85999999999999999 111.978 179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.56 -16.54 62.81 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 114.669 -1.15 . . . . 1.3500000000000001 113.659 178.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.649 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.39 135.14 20.31 Favored Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 122.256 -0.277 . . . . 0.94999999999999996 110.681 -179.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.36 -41.83 14.76 Favored 'Trans proline' 0 CA--C 1.535 0.575 0 C-N-CA 123.532 2.821 . . . . 1.24 113.386 -178.834 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.649 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.8 -25.76 66.8 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-O 121.366 0.603 . . . . 1.1899999999999999 111.803 176.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.796 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -78.91 -33.28 45.64 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-N 115.165 -0.925 . . . . 0.89000000000000001 110.728 178.541 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.0 ttpt -73.46 -19.11 61.03 Favored 'General case' 0 CA--C 1.534 0.34 0 CA-C-O 121.373 0.606 . . . . 1.71 110.699 179.618 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.67 -57.08 3.85 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 115.39 -0.823 . . . . 1.29 112.977 179.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.8 m -58.1 -29.4 36.68 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.465 0 CA-C-N 115.709 -0.678 . . . . 0.91000000000000003 111.408 178.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 46.7 pt -80.7 -27.59 11.34 Favored 'Isoleucine or valine' 0 C--N 1.347 0.458 0 N-CA-C 110.146 -0.316 . . . . 1.05 110.146 178.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -70.24 -42.62 71.98 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 120.81 -0.356 . . . . 1.52 110.485 176.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 67.8 mttt -61.17 -34.49 75.13 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 112.791 0.663 . . . . 1.5800000000000001 112.791 -179.835 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.4 pt -80.27 -9.96 12.28 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.401 0 C-N-CA 120.956 -0.298 . . . . 1.3700000000000001 111.715 -179.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 80.1 mt -93.98 -32.29 13.91 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.932 0.396 . . . . 1.6699999999999999 110.192 179.093 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.49 -41.31 21.93 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.621 -0.718 . . . . 2.21 110.16 179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -61.67 -28.66 70.26 Favored Glycine 0 C--N 1.335 0.505 0 CA-C-N 115.968 -0.56 . . . . 1.77 113.078 -179.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.59 -33.32 58.4 Favored Glycine 0 C--N 1.332 0.349 0 C-N-CA 121.024 -0.607 . . . . 2.0899999999999999 112.355 179.477 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.2 t30 -84.6 -7.87 59.09 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.827 0.346 . . . . 2.29 111.017 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 22.8 tptp -93.81 -14.06 26.6 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 116.388 -0.369 . . . . 2.4399999999999999 110.931 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -69.31 110.61 4.74 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.331 -0.395 . . . . 2.7000000000000002 110.341 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 17.3 m120 . . . . . 0 C--O 1.253 1.252 0 CA-C-O 118.422 -0.799 . . . . 2.5600000000000001 111.727 -178.994 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.049 0 CA-C-O 122.805 1.288 . . . . 0.80000000000000004 110.144 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.572 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.78 0.78 Allowed 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 113.382 -1.736 . . . . 0.84999999999999998 111.408 -179.828 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.572 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.52 115.03 4.51 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.917 0.887 . . . . 0.77000000000000002 110.517 -173.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.26 52.71 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 113.83 -1.532 . . . . 0.65000000000000002 110.175 178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.14 146.49 30.14 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-N 113.943 -1.48 . . . . 0.68000000000000005 108.45 -176.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.07 9.11 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.068 -0.514 . . . . 0.5 109.874 172.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.27 0 CA-C-O 121.752 0.787 . . . . 0.46999999999999997 111.504 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.3 m -119.07 104.29 10.33 Favored 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 114.524 -1.216 . . . . 0.46999999999999997 111.309 179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.32 -33.29 29.04 Favored 'General case' 0 N--CA 1.477 0.885 0 CA-C-N 114.575 -1.193 . . . . 0.57999999999999996 113.769 175.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.907 0 C-N-CA 124.825 1.25 . . . . 0.57999999999999996 109.969 -178.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.555 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.78 -171.71 2.54 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 113.796 -1.547 . . . . 0.59999999999999998 111.365 178.638 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.611 HG21 HD12 ' B' ' 54' ' ' ILE . 85.7 m -157.75 152.34 25.04 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.766 1.626 . . . . 0.57999999999999996 110.164 179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.25 72.31 1.42 Allowed 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 123.663 1.697 . . . . 0.72999999999999998 112.065 177.175 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.18 -177.21 51.34 Favored Glycine 0 CA--C 1.544 1.867 0 CA-C-N 113.253 -1.794 . . . . 0.64000000000000001 110.856 174.525 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.99 -172.38 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 1 C-N-CA 136.18 5.792 . . . . 0.64000000000000001 106.277 8.124 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.65 143.41 32.29 Favored Pre-proline 0 CA--C 1.543 0.693 0 O-C-N 122.002 -0.436 . . . . 0.68000000000000005 109.983 175.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.3 Cg_exo -51.34 -21.94 10.9 Favored 'Trans proline' 0 N--CA 1.479 0.641 0 C-N-CA 124.741 3.627 . . . . 0.58999999999999997 112.794 174.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -29.35 17.92 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 124.529 1.132 . . . . 0.68999999999999995 112.678 179.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.2 mmt -89.09 -20.84 23.81 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 116.649 -0.251 . . . . 0.94999999999999996 111.589 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 30.9 mm -76.15 144.4 11.9 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 C-N-CA 122.606 0.362 . . . . 0.57999999999999996 111.459 -179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.6 m -146.81 10.7 1.06 Allowed 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.298 -0.41 . . . . 0.69999999999999996 110.78 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 10.9 t30 -166.77 139.95 3.76 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.233 -0.439 . . . . 0.82999999999999996 110.314 -179.816 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.8 tp -130.83 145.66 52.05 Favored 'General case' 0 C--O 1.223 -0.326 0 CA-C-N 116.403 -0.362 . . . . 0.75 110.59 179.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.507 ' HB2' HG22 ' B' ' 45' ' ' VAL . 52.9 mt-30 -141.07 124.77 16.9 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.849 0.356 . . . . 1.0800000000000001 110.465 179.418 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 16.5 t -108.04 124.02 63.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 0.60999999999999999 110.821 179.965 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -114.45 145.15 42.23 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.011 -0.541 . . . . 0.85999999999999999 110.473 -179.68 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.719 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -112.0 -161.04 0.74 Allowed 'General case' 0 C--O 1.234 0.279 0 CA-C-O 120.733 0.302 . . . . 0.60999999999999999 111.031 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 73.8 mt -71.67 118.63 16.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.198 -0.455 . . . . 1.1000000000000001 111.061 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -125.28 -168.4 12.73 Favored Glycine 0 CA--C 1.519 0.34 0 C-N-CA 120.925 -0.655 . . . . 0.63 112.636 -179.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.37 -9.18 17.53 Favored 'Trans proline' 0 C--N 1.348 0.529 0 C-N-CA 123.277 2.652 . . . . 0.79000000000000004 112.916 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.56 -21.13 12.29 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 113.031 0.752 . . . . 0.70999999999999996 113.031 -179.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.4 t -143.09 136.69 28.56 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.291 -0.413 . . . . 0.67000000000000004 111.225 -177.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.6 t -101.06 11.93 38.62 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 121.14 0.495 . . . . 1.01 110.633 179.737 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -132.02 146.7 52.23 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.869 -0.605 . . . . 1.1599999999999999 110.763 -179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.719 HG12 ' HA ' ' B' ' 34' ' ' ALA . 26.8 m -79.84 133.18 30.27 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 CA-C-O 121.026 0.441 . . . . 0.78000000000000003 110.712 179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -133.27 133.85 43.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.80000000000000004 110.591 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.481 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.5 m -105.02 111.83 36.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.563 0.696 . . . . 0.59999999999999998 111.906 -179.562 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.507 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.6 OUTLIER -99.87 150.43 5.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-O 122.525 1.155 . . . . 0.62 110.791 178.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.41 46.6 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.207 -0.906 . . . . 0.55000000000000004 111.231 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.73 133.62 53.83 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 115.161 -0.927 . . . . 0.63 110.506 176.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -80.51 176.26 9.94 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.244 -0.889 . . . . 0.75 110.726 179.58 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -78.82 -15.34 58.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.26 -0.427 . . . . 1.27 110.681 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -79.5 -23.9 42.63 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.095 -0.502 . . . . 0.98999999999999999 111.231 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.02 30.3 3.48 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.901 -0.666 . . . . 0.67000000000000004 112.443 179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -117.58 144.82 44.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.752 0.31 . . . . 1.05 111.261 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -124.03 129.08 50.31 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.124 -0.489 . . . . 0.70999999999999996 110.889 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.611 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -124.39 179.75 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.919 0 CA-C-O 121.37 0.605 . . . . 0.52000000000000002 109.821 179.707 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.53 138.06 52.8 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 114.519 -1.218 . . . . 0.47999999999999998 109.228 177.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.703 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.8 mt -114.04 153.33 29.59 Favored 'General case' 0 C--N 1.314 -0.971 0 CA-C-N 113.984 -1.462 . . . . 0.48999999999999999 108.581 -178.472 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.555 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.1 t0 -101.53 107.09 49.74 Favored Pre-proline 0 C--N 1.323 -0.565 0 O-C-N 121.631 -0.668 . . . . 0.63 110.144 177.392 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.481 ' HG3' HG22 ' B' ' 44' ' ' VAL . 23.3 Cg_exo -62.12 -15.26 42.79 Favored 'Trans proline' 0 C--N 1.358 1.06 0 C-N-CA 123.0 2.467 . . . . 0.82999999999999996 111.879 179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -66.28 -16.63 64.19 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.461 -1.245 . . . . 1.3999999999999999 113.504 178.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.08 20.31 Favored Pre-proline 0 CA--C 1.541 0.602 0 O-C-N 122.267 -0.27 . . . . 0.91000000000000003 110.704 -178.927 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.23 -41.92 14.97 Favored 'Trans proline' 0 N--CA 1.478 0.586 0 C-N-CA 123.696 2.931 . . . . 1.1899999999999999 113.394 -178.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.87 -27.66 68.28 Favored 'General case' 0 N--CA 1.479 0.987 0 CA-C-O 121.309 0.576 . . . . 1.1499999999999999 111.763 177.014 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.703 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.6 OUTLIER -77.54 -29.8 52.44 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.831 -0.622 . . . . 0.90000000000000002 110.337 178.791 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.486 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 35.1 ttpt -66.97 -23.51 65.95 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 115.896 -0.593 . . . . 1.71 110.914 179.515 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -73.87 -55.64 5.94 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 113.085 0.772 . . . . 1.3600000000000001 113.085 179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 20.1 m -62.32 -29.6 47.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 CA-C-N 116.021 -0.536 . . . . 0.96999999999999997 111.264 178.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.475 HG12 ' HA ' ' B' ' 64' ' ' LYS . 27.8 pt -85.14 -20.69 8.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 C-N-CA 120.77 -0.372 . . . . 1.0800000000000001 110.216 178.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.486 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.77 -42.06 51.35 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 120.822 -0.351 . . . . 1.52 110.57 176.398 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -61.72 -32.17 72.38 Favored 'General case' 0 N--CA 1.467 0.396 0 N-CA-C 112.857 0.688 . . . . 1.6100000000000001 112.857 -179.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.408 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.1 pt -76.82 -13.0 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 C-N-CA 120.958 -0.297 . . . . 1.4299999999999999 111.614 -179.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.9 mt -93.86 -28.06 16.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.42 -0.355 . . . . 1.79 110.627 179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.6 t70 -85.81 -50.62 7.0 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.216 -0.447 . . . . 2.25 110.295 179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.62 -25.13 70.78 Favored Glycine 0 C--N 1.332 0.317 0 CA-C-N 115.928 -0.578 . . . . 1.76 112.29 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.07 -19.18 77.69 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.016 179.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 14.2 t30 -87.0 -29.41 22.0 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.0 0.429 . . . . 2.3199999999999998 110.444 179.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.5 tptp -86.36 -2.04 58.07 Favored 'General case' 0 CA--C 1.532 0.26 0 CA-C-N 115.914 -0.585 . . . . 2.46 110.703 179.698 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 1.6 tm-20 -72.54 107.68 5.2 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.061 -0.518 . . . . 2.7799999999999998 110.101 179.676 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.2 m120 . . . . . 0 C--O 1.25 1.101 0 CA-C-O 118.286 -0.864 . . . . 2.48 111.071 -179.436 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.077 0 CA-C-O 122.723 1.249 . . . . 0.81000000000000005 110.117 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.57 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.427 -1.715 . . . . 0.83999999999999997 111.417 -179.813 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.57 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.59 115.0 4.48 Favored 'General case' 0 N--CA 1.468 0.433 0 C-N-CA 123.915 0.886 . . . . 0.76000000000000001 110.383 -173.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.03 140.14 52.85 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-N 113.752 -1.567 . . . . 0.65000000000000002 110.285 178.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.16 146.3 30.41 Favored 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 114.088 -1.414 . . . . 0.66000000000000003 108.456 -176.092 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.8 151.04 8.96 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 116.009 -0.541 . . . . 0.48999999999999999 109.922 172.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.04 46.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 CA-C-O 121.611 0.719 . . . . 0.45000000000000001 111.528 177.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.527 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.5 m -119.03 104.37 10.41 Favored 'General case' 0 N--CA 1.472 0.632 0 C-N-CA 124.744 1.218 . . . . 0.46000000000000002 111.246 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.3 mt -82.41 -33.5 28.62 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.652 -1.158 . . . . 0.56999999999999995 113.667 175.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.66 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.917 0 C-N-CA 124.882 1.273 . . . . 0.56999999999999995 110.127 -179.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.547 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.7 t -128.64 -171.63 2.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 113.783 -1.553 . . . . 0.62 111.396 178.649 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.8 152.31 24.9 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 125.825 1.65 . . . . 0.60999999999999999 110.218 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.15 72.13 1.41 Allowed 'General case' 0 C--N 1.324 -0.527 0 CA-C-O 123.542 1.639 . . . . 0.76000000000000001 112.055 177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.32 51.48 Favored Glycine 0 CA--C 1.542 1.759 0 CA-C-N 113.209 -1.814 . . . . 0.68999999999999995 110.935 174.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.88 -172.55 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 1 C-N-CA 136.206 5.803 . . . . 0.68999999999999995 106.4 8.239 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.43 143.45 32.1 Favored Pre-proline 0 CA--C 1.543 0.7 0 O-C-N 121.991 -0.443 . . . . 0.72999999999999998 110.091 174.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.22 -21.97 10.48 Favored 'Trans proline' 0 N--CA 1.479 0.621 0 C-N-CA 124.828 3.686 . . . . 0.64000000000000001 112.829 174.061 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -30.48 23.14 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 124.619 1.168 . . . . 0.73999999999999999 112.614 179.657 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.36 -20.43 25.34 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 120.724 0.297 . . . . 1.0800000000000001 111.346 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 24.4 mm -82.6 145.63 8.28 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.263 0 CA-C-N 116.225 -0.443 . . . . 0.57999999999999996 111.398 -179.486 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -143.47 -11.45 0.71 Allowed 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.222 -0.445 . . . . 0.68999999999999995 110.665 179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -145.61 138.91 26.28 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-N 116.166 -0.47 . . . . 0.78000000000000003 110.795 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.494 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 25.2 tp -125.73 147.59 49.33 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.304 -0.407 . . . . 0.73999999999999999 110.74 179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.514 ' HB2' HG22 ' A' ' 45' ' ' VAL . 32.4 mt-30 -137.98 110.11 7.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.33 -0.396 . . . . 1.1599999999999999 110.503 179.664 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.3 t -98.85 109.96 25.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.366 -0.379 . . . . 0.62 110.955 -179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -102.43 125.39 49.13 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.096 -0.502 . . . . 0.72999999999999998 110.832 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -91.31 -157.24 0.49 Allowed 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 116.305 -0.407 . . . . 0.66000000000000003 111.446 179.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 92.0 mt -72.11 126.72 33.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.217 0 CA-C-N 116.154 -0.475 . . . . 1.1399999999999999 111.28 -179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.83 -166.3 11.43 Favored Glycine 0 CA--C 1.52 0.362 0 CA-C-N 115.872 -0.604 . . . . 0.66000000000000003 112.183 179.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_exo -80.29 -7.68 13.96 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.09 2.527 . . . . 0.81000000000000005 112.589 179.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.31 -21.26 11.95 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.164 0.801 . . . . 0.72999999999999998 113.164 -179.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -146.17 147.13 31.18 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.70999999999999996 111.076 -177.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -119.44 11.36 12.13 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.147 -0.478 . . . . 1.0700000000000001 110.407 179.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -117.36 135.94 53.5 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.753 -0.658 . . . . 1.29 110.94 -179.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.441 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.0 m -74.83 122.93 29.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 CA-C-N 116.326 -0.397 . . . . 0.82999999999999996 110.404 178.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.527 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 19.3 mt-10 -133.88 130.01 37.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.215 -0.448 . . . . 0.79000000000000004 110.313 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.434 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.3 m -100.51 106.2 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-O 121.775 0.798 . . . . 0.66000000000000003 112.278 -178.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.514 HG22 ' HB2' ' A' ' 31' ' ' GLN . 0.6 OUTLIER -93.73 150.41 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 CA-C-O 122.568 1.175 . . . . 0.68999999999999995 110.75 178.44 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.29 153.35 46.45 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 115.049 -0.978 . . . . 0.57999999999999996 111.118 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.422 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.69 133.58 53.86 Favored 'General case' 0 N--CA 1.474 0.763 0 CA-C-N 115.047 -0.979 . . . . 0.65000000000000002 110.413 176.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.6 mp -76.59 173.99 10.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.194 -0.912 . . . . 0.79000000000000004 111.005 179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.1 tptp -79.06 -14.83 58.92 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.185 -0.461 . . . . 1.23 110.786 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -79.4 -10.51 59.82 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.123 -0.49 . . . . 1.05 111.209 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.34 34.56 5.54 Favored Glycine 0 C--N 1.332 0.306 0 C-N-CA 120.999 -0.619 . . . . 0.69999999999999996 112.425 -179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 47' ' ' SER . 60.0 mtpt -118.52 153.99 33.28 Favored 'General case' 0 C--O 1.221 -0.411 0 CA-C-O 120.608 0.242 . . . . 1.1899999999999999 110.942 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.33 129.64 41.68 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.375 0.607 . . . . 0.68999999999999995 109.947 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.82 179.63 3.59 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.07 0 CA-C-N 114.688 -1.142 . . . . 0.53000000000000003 109.839 178.085 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.36 138.12 52.94 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-N 114.446 -1.252 . . . . 0.48999999999999999 109.225 177.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.782 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.09 152.44 31.06 Favored 'General case' 0 C--N 1.314 -0.969 0 CA-C-N 113.989 -1.46 . . . . 0.51000000000000001 108.674 -178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.3 t0 -99.13 110.91 59.67 Favored Pre-proline 0 C--N 1.326 -0.456 0 O-C-N 121.523 -0.736 . . . . 0.67000000000000004 110.294 177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.441 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 28.1 Cg_exo -60.12 -16.31 39.06 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 123.098 2.532 . . . . 0.85999999999999999 112.019 -179.948 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -64.95 -16.59 63.51 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 114.6 -1.182 . . . . 1.3500000000000001 113.64 178.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.32 135.09 20.35 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 122.187 -0.32 . . . . 0.94999999999999996 110.764 -179.04 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.35 -41.74 15.04 Favored 'Trans proline' 0 CA--C 1.535 0.551 0 C-N-CA 123.558 2.838 . . . . 1.24 113.422 -178.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.9 -25.12 66.51 Favored 'General case' 0 N--CA 1.478 0.956 0 CA-C-O 121.371 0.605 . . . . 1.1899999999999999 111.831 176.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.53 -33.39 58.58 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-N 115.217 -0.901 . . . . 0.89000000000000001 110.498 178.201 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 34.2 ttpt -73.03 -15.84 61.51 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.334 0.587 . . . . 1.71 110.752 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.88 -56.18 4.3 Favored 'General case' 0 N--CA 1.475 0.788 0 N-CA-C 113.046 0.758 . . . . 1.29 113.046 179.108 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 35.8 m -60.29 -28.06 41.0 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-N 115.49 -0.777 . . . . 0.91000000000000003 111.486 178.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 49.5 pt -77.05 -27.73 16.42 Favored 'Isoleucine or valine' 0 C--N 1.345 0.394 0 N-CA-C 109.999 -0.371 . . . . 1.05 109.999 178.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 63.2 tt0 -71.28 -43.49 67.06 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 120.588 -0.445 . . . . 1.52 110.602 176.261 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -61.59 -33.63 74.21 Favored 'General case' 0 CA--C 1.533 0.316 0 N-CA-C 113.139 0.792 . . . . 1.5800000000000001 113.139 -179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 18.4 pt -76.28 -15.69 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 120.86 -0.336 . . . . 1.3700000000000001 111.577 -179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 90.3 mt -96.99 -27.05 14.79 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.317 -0.402 . . . . 1.6699999999999999 110.306 179.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 36.9 t70 -81.13 -37.05 29.48 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.887 -0.597 . . . . 2.21 110.157 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.13 -24.37 71.64 Favored Glycine 0 C--N 1.331 0.291 0 C-N-CA 121.146 -0.549 . . . . 1.77 112.151 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -74.8 -32.29 57.25 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 121.097 -0.573 . . . . 2.0899999999999999 111.875 179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 1.9 t30 -80.9 -5.01 56.84 Favored 'General case' 0 C--N 1.332 -0.164 0 CA-C-O 121.12 0.486 . . . . 2.29 110.705 179.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -90.97 -35.37 14.73 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.991 -0.55 . . . . 2.4399999999999999 110.745 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -75.7 117.18 17.18 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.946 0.403 . . . . 2.7000000000000002 110.763 179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.251 1.151 0 CA-C-O 118.292 -0.861 . . . . 2.5600000000000001 111.02 -179.498 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.756 1.265 . . . . 0.80000000000000004 110.141 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.557 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.58 -64.76 0.78 Allowed 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 113.398 -1.728 . . . . 0.84999999999999998 111.439 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.557 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.61 114.91 4.45 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 123.895 0.878 . . . . 0.77000000000000002 110.547 -173.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.06 140.24 52.75 Favored 'General case' 0 C--N 1.32 -0.708 0 CA-C-N 113.875 -1.511 . . . . 0.65000000000000002 110.214 178.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.24 146.5 30.25 Favored 'General case' 0 N--CA 1.475 0.789 0 CA-C-N 114.0 -1.455 . . . . 0.68000000000000005 108.381 -176.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.9 151.02 9.2 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.889 172.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.01 -31.07 46.91 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 CA-C-O 121.698 0.761 . . . . 0.46999999999999997 111.501 177.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.507 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.3 m -119.04 104.23 10.28 Favored 'General case' 0 N--CA 1.471 0.577 0 C-N-CA 124.714 1.206 . . . . 0.46999999999999997 111.316 178.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.43 29.49 Favored 'General case' 0 N--CA 1.476 0.845 0 CA-C-N 114.656 -1.156 . . . . 0.57999999999999996 113.754 175.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.79 3.53 Favored 'General case' 0 C--N 1.315 -0.913 0 C-N-CA 124.944 1.298 . . . . 0.57999999999999996 110.097 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.594 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.75 -171.68 2.53 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 113.909 -1.496 . . . . 0.59999999999999998 111.307 178.701 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.599 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.8 152.26 24.83 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 125.787 1.635 . . . . 0.57999999999999996 110.183 179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.23 1.41 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 123.719 1.724 . . . . 0.72999999999999998 112.126 177.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.584 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.08 -177.28 51.41 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-N 113.282 -1.781 . . . . 0.64000000000000001 110.838 174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.03 -172.45 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.804 1 C-N-CA 136.079 5.752 . . . . 0.64000000000000001 106.254 8.161 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.66 143.46 32.39 Favored Pre-proline 0 CA--C 1.543 0.694 0 O-C-N 121.939 -0.475 . . . . 0.68000000000000005 110.068 174.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 89.0 Cg_exo -51.34 -21.93 10.87 Favored 'Trans proline' 0 N--CA 1.477 0.544 0 C-N-CA 124.717 3.612 . . . . 0.58999999999999997 112.771 174.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.595 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.79 -28.69 16.26 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.657 1.183 . . . . 0.68999999999999995 112.601 179.718 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 35.3 mmt -88.11 -19.22 27.32 Favored 'General case' 0 N--CA 1.476 0.84 0 N-CA-C 113.49 0.922 . . . . 0.94999999999999996 113.49 175.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 16.8 mm -92.13 141.18 14.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 O-C-N 122.2 -0.312 . . . . 0.57999999999999996 111.374 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 66.7 m -137.88 -6.13 1.68 Allowed 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.343 -0.389 . . . . 0.69999999999999996 110.97 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 55.1 t30 -148.61 136.82 21.07 Favored 'General case' 0 CA--C 1.529 0.172 0 CA-C-O 120.84 0.353 . . . . 0.82999999999999996 110.709 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.498 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 26.7 tp -126.74 145.61 50.54 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-N 116.133 -0.485 . . . . 0.75 111.016 179.811 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 39.6 mt-30 -136.21 109.78 8.0 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.19 -0.459 . . . . 1.0800000000000001 110.224 179.284 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 t -96.5 138.88 20.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.154 -0.476 . . . . 0.60999999999999999 111.235 -179.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 7.7 m-85 -126.35 127.52 45.64 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.076 -0.511 . . . . 0.85999999999999999 110.829 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.22 -91.85 0.1 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.717 0.294 . . . . 0.60999999999999999 111.283 179.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 78.1 mt -124.63 125.37 69.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 116.444 -0.344 . . . . 1.1000000000000001 110.691 -179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -119.33 170.39 13.96 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.847 -0.692 . . . . 0.63 112.604 179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.9 -7.43 15.45 Favored 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 123.015 2.477 . . . . 0.79000000000000004 112.602 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.29 11.55 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.126 0.787 . . . . 0.70999999999999996 113.126 -179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 5.3 t -135.46 150.37 49.81 Favored 'General case' 0 C--N 1.333 -0.133 0 CA-C-N 116.061 -0.518 . . . . 0.67000000000000004 110.957 -177.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 33.5 t -103.03 -54.11 2.69 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 1.01 111.181 -179.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.5 tttt -71.76 144.7 49.14 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.233 -0.44 . . . . 1.1599999999999999 111.062 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 11.9 m -73.5 139.86 18.72 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 CA-C-O 121.096 0.474 . . . . 0.78000000000000003 110.972 179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.477 ' CD ' ' HB2' ' B' ' 15' ' ' CYS . 22.8 mt-10 -134.61 130.05 35.86 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.977 -0.556 . . . . 0.80000000000000004 110.251 179.842 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.472 HG23 ' HB2' ' B' ' 56' ' ' LEU . 1.4 m -100.43 106.31 19.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.713 0.768 . . . . 0.59999999999999998 112.239 -178.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.507 HG12 ' SG ' ' B' ' 15' ' ' CYS . 1.0 OUTLIER -93.79 150.43 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.944 0 CA-C-O 122.534 1.159 . . . . 0.62 110.747 178.341 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.23 153.49 46.57 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-N 115.144 -0.935 . . . . 0.55000000000000004 111.165 179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.81 132.82 53.85 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.067 -0.97 . . . . 0.63 110.478 176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -82.65 171.49 13.97 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.743 -0.662 . . . . 0.75 110.854 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -78.81 -19.47 52.06 Favored 'General case' 0 CA--C 1.531 0.25 0 CA-C-N 116.156 -0.475 . . . . 1.27 111.052 -179.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 -81.15 -25.32 36.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.184 -0.462 . . . . 0.98999999999999999 111.055 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.29 36.4 1.11 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.696 -0.764 . . . . 0.67000000000000004 112.285 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 59.1 mtpt -117.48 156.56 27.79 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.675 0.274 . . . . 1.05 110.786 179.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -140.98 129.56 22.69 Favored 'General case' 0 N--CA 1.473 0.716 0 CA-C-O 121.387 0.613 . . . . 0.70999999999999996 109.902 179.376 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.599 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.84 179.71 3.53 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 114.713 -1.13 . . . . 0.52000000000000002 109.825 178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.47 138.04 52.84 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 114.417 -1.265 . . . . 0.47999999999999998 109.322 177.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.793 ' HB3' HD21 ' B' ' 63' ' ' LEU . 40.1 mt -113.99 153.99 28.4 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.014 -1.448 . . . . 0.48999999999999999 108.71 -178.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.594 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 4.5 t0 -103.27 110.46 63.75 Favored Pre-proline 0 C--N 1.325 -0.472 0 O-C-N 121.709 -0.619 . . . . 0.63 110.375 178.103 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.466 ' HG3' HG22 ' B' ' 44' ' ' VAL . 24.5 Cg_exo -60.99 -14.89 35.59 Favored 'Trans proline' 0 C--N 1.357 1.017 0 C-N-CA 123.041 2.494 . . . . 0.82999999999999996 111.91 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 9.7 tt0 -67.2 -16.57 64.38 Favored 'General case' 0 CA--C 1.545 0.765 0 CA-C-N 114.563 -1.198 . . . . 1.3999999999999999 113.644 178.95 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.45 135.2 20.26 Favored Pre-proline 0 CA--C 1.54 0.56 0 O-C-N 122.255 -0.278 . . . . 0.91000000000000003 110.757 -179.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.44 -41.8 14.57 Favored 'Trans proline' 0 N--CA 1.479 0.643 0 C-N-CA 123.607 2.871 . . . . 1.1899999999999999 113.314 -178.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.82 -25.57 66.7 Favored 'General case' 0 N--CA 1.48 1.028 0 CA-C-O 121.314 0.578 . . . . 1.1499999999999999 111.772 176.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.793 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -75.02 -27.53 60.13 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.747 -0.66 . . . . 0.90000000000000002 110.457 178.373 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.411 ' HA ' HG12 ' B' ' 67' ' ' ILE . 36.0 ttpt -79.6 -9.73 59.68 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 121.466 0.65 . . . . 1.71 110.588 179.435 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -78.89 -55.46 5.13 Favored 'General case' 0 N--CA 1.473 0.714 0 N-CA-C 113.095 0.776 . . . . 1.3600000000000001 113.095 179.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 27.2 m -61.06 -26.93 40.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 CA-C-N 115.189 -0.914 . . . . 0.96999999999999997 111.485 178.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.411 HG12 ' HA ' ' B' ' 64' ' ' LYS . 28.2 pt -79.07 -24.62 12.85 Favored 'Isoleucine or valine' 0 C--N 1.344 0.358 0 N-CA-C 110.111 -0.329 . . . . 1.0800000000000001 110.111 178.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -73.55 -43.03 60.89 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 120.969 -0.293 . . . . 1.52 110.502 176.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -59.14 -35.82 74.14 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.836 0.68 . . . . 1.6100000000000001 112.836 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 35.3 pt -74.37 -19.03 16.98 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 120.995 -0.282 . . . . 1.4299999999999999 111.641 -179.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 95.4 mt -84.18 -30.63 25.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.916 0.389 . . . . 1.79 110.338 179.136 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -76.75 -45.07 30.59 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.868 -0.606 . . . . 2.25 110.476 179.524 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -78.65 -16.22 79.57 Favored Glycine 0 C--N 1.331 0.302 0 C-N-CA 121.09 -0.576 . . . . 1.76 112.275 179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.11 11.24 72.35 Favored Glycine 0 C--N 1.332 0.358 0 C-N-CA 121.106 -0.569 . . . . 2.04 112.462 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.7 t30 -124.41 -32.0 3.21 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.952 0.406 . . . . 2.3199999999999998 110.388 179.687 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.4 tptp -85.72 -10.95 54.83 Favored 'General case' 0 CA--C 1.531 0.229 0 CA-C-N 115.97 -0.559 . . . . 2.46 110.749 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -68.66 111.08 4.59 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.202 -0.454 . . . . 2.7799999999999998 110.087 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 17.4 m120 . . . . . 0 C--O 1.25 1.093 0 CA-C-O 118.361 -0.828 . . . . 2.48 111.028 -179.386 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 122.819 1.295 . . . . 0.81000000000000005 110.062 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.4 -1.727 . . . . 0.83999999999999997 111.481 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.08 4.5 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 123.91 0.884 . . . . 0.76000000000000001 110.363 -173.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.14 52.82 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-N 113.744 -1.571 . . . . 0.65000000000000002 110.311 178.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.11 146.4 30.24 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 114.062 -1.426 . . . . 0.66000000000000003 108.392 -176.051 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.92 151.02 9.25 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.037 -0.529 . . . . 0.48999999999999999 109.886 172.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.99 -31.0 46.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.25 0 CA-C-O 121.691 0.758 . . . . 0.45000000000000001 111.609 177.771 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.464 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.5 m -119.07 104.26 10.3 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 114.521 -1.218 . . . . 0.46000000000000002 111.326 178.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.35 -33.46 28.85 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 114.563 -1.198 . . . . 0.56999999999999995 113.697 175.171 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.59 -178.71 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.9 1.28 . . . . 0.56999999999999995 110.112 -179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.482 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.82 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 113.807 -1.542 . . . . 0.62 111.337 178.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' A' ' 54' ' ' ILE . 85.9 m -157.84 152.33 24.85 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 125.689 1.596 . . . . 0.60999999999999999 110.173 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.14 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.539 1.637 . . . . 0.76000000000000001 112.013 177.219 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.91 -177.34 51.5 Favored Glycine 0 CA--C 1.543 1.791 0 CA-C-N 113.307 -1.77 . . . . 0.68999999999999995 110.933 174.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.721 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.85 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.656 1 C-N-CA 136.25 5.82 . . . . 0.68999999999999995 106.38 8.215 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.721 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.52 143.28 31.88 Favored Pre-proline 0 CA--C 1.544 0.719 0 O-C-N 121.913 -0.492 . . . . 0.72999999999999998 110.06 175.017 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.433 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.2 Cg_exo -51.15 -21.92 10.12 Favored 'Trans proline' 0 N--CA 1.479 0.639 0 C-N-CA 124.717 3.611 . . . . 0.64000000000000001 112.826 174.081 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.78 -28.84 16.74 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 124.632 1.173 . . . . 0.73999999999999999 112.603 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.8 mmt -87.99 -19.81 26.7 Favored 'General case' 0 N--CA 1.476 0.841 0 N-CA-C 113.598 0.962 . . . . 1.0800000000000001 113.598 175.769 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -96.19 140.42 17.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.811 0.338 . . . . 0.57999999999999996 111.766 -178.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.0 m -137.96 1.69 2.29 Favored 'General case' 0 CA--C 1.529 0.147 0 CA-C-N 116.297 -0.411 . . . . 0.68999999999999995 110.968 179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 53.1 t30 -148.44 131.26 16.08 Favored 'General case' 0 C--O 1.232 0.174 0 CA-C-N 116.472 -0.331 . . . . 0.78000000000000003 111.05 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.436 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 36.2 tp -118.19 146.22 44.38 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.115 -0.493 . . . . 0.73999999999999999 110.424 179.476 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 39.0 mt-30 -139.13 118.64 12.94 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.46 -0.336 . . . . 1.1599999999999999 110.775 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.9 t -108.78 103.51 15.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.2 -0.454 . . . . 0.62 110.984 -179.877 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 46.2 m-85 -99.48 127.42 45.53 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.965 -0.562 . . . . 0.72999999999999998 111.082 -179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.429 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -85.9 -156.24 0.28 Allowed 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.956 0.408 . . . . 0.66000000000000003 111.471 179.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 44.0 mt -73.94 130.13 36.06 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.067 -0.515 . . . . 1.1399999999999999 111.146 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -129.96 -171.94 13.04 Favored Glycine 0 CA--C 1.521 0.433 0 C-N-CA 120.917 -0.659 . . . . 0.66000000000000003 112.753 -179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.68 -9.3 17.14 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 123.238 2.625 . . . . 0.81000000000000005 112.776 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.75 -22.17 12.04 Favored 'General case' 0 N--CA 1.471 0.622 0 N-CA-C 113.023 0.749 . . . . 0.72999999999999998 113.023 -179.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -139.0 136.83 35.77 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.887 -0.597 . . . . 0.70999999999999996 111.298 -177.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 32.1 t -93.65 -19.47 21.1 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.471 -0.332 . . . . 1.0700000000000001 111.209 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 77.0 tttt -106.26 153.37 22.26 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.788 0.328 . . . . 1.29 111.111 -179.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.429 HG12 ' HA ' ' A' ' 34' ' ' ALA . 34.4 m -80.6 136.45 23.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.228 -0.442 . . . . 0.82999999999999996 110.792 179.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -133.07 130.22 39.06 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 116.214 -0.448 . . . . 0.79000000000000004 110.198 -179.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.556 HG22 ' HG3' ' A' ' 58' ' ' PRO . 2.2 m -100.78 106.09 18.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 121.784 0.802 . . . . 0.66000000000000003 112.363 -179.076 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.464 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.58 150.48 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.934 0 CA-C-O 122.659 1.218 . . . . 0.68999999999999995 110.874 178.367 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.25 153.46 46.54 Favored 'General case' 0 N--CA 1.478 0.947 0 CA-C-N 115.176 -0.92 . . . . 0.57999999999999996 111.058 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.77 132.87 53.89 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.086 -0.961 . . . . 0.65000000000000002 110.417 176.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -80.04 173.59 12.44 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.242 -0.89 . . . . 0.79000000000000004 110.726 179.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -80.29 -14.98 57.95 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.228 -0.442 . . . . 1.23 110.788 179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -82.31 -15.41 52.99 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-N 116.082 -0.508 . . . . 1.05 111.088 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.62 35.98 3.65 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.857 -0.687 . . . . 0.69999999999999996 112.494 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 59.3 mtpt -119.59 158.84 25.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.594 0.235 . . . . 1.1899999999999999 110.695 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -138.33 129.53 27.28 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.408 0.623 . . . . 0.68999999999999995 109.957 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.79 179.52 3.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.034 0 CA-C-N 114.617 -1.174 . . . . 0.53000000000000003 109.827 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.3 138.07 52.97 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 114.466 -1.243 . . . . 0.48999999999999999 109.311 177.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.806 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.7 mt -114.01 151.69 32.04 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 114.046 -1.434 . . . . 0.51000000000000001 108.724 -178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.482 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.4 t0 -95.51 108.35 39.01 Favored Pre-proline 0 N--CA 1.47 0.531 0 O-C-N 120.237 -1.54 . . . . 0.67000000000000004 110.58 178.125 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.556 ' HG3' HG22 ' A' ' 44' ' ' VAL . 50.7 Cg_exo -53.77 -17.57 10.56 Favored 'Trans proline' 0 C--N 1.361 1.2 0 C-N-CA 123.232 2.622 . . . . 0.85999999999999999 112.833 179.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 6.3 tt0 -64.11 -16.51 61.96 Favored 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 115.084 -0.962 . . . . 1.3500000000000001 113.576 179.428 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.36 135.1 20.33 Favored Pre-proline 0 CA--C 1.542 0.657 0 O-C-N 122.192 -0.317 . . . . 0.94999999999999996 110.642 -178.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.34 -41.93 14.56 Favored 'Trans proline' 0 N--CA 1.478 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.361 -178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.78 -24.62 65.92 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 121.222 0.534 . . . . 1.1899999999999999 111.761 176.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.806 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -71.15 -30.97 67.13 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.256 -0.883 . . . . 0.89000000000000001 110.552 177.939 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 30.5 ttpt -88.55 -8.17 55.23 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.322 0.582 . . . . 1.71 110.474 179.56 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -83.98 -54.7 4.67 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-N 115.523 -0.762 . . . . 1.29 113.039 178.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.4 m -55.52 -26.03 18.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 CA-C-N 115.056 -0.975 . . . . 0.91000000000000003 111.344 178.132 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 30.0 pt -80.27 -21.12 11.7 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 O-C-N 122.398 -0.189 . . . . 1.05 110.6 178.914 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 61.4 tt0 -71.56 -43.27 66.65 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 120.73 -0.388 . . . . 1.52 110.533 177.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -57.56 -37.5 73.24 Favored 'General case' 0 N--CA 1.466 0.359 0 N-CA-C 112.965 0.728 . . . . 1.5800000000000001 112.965 -179.531 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.404 HG23 ' HB3' ' A' ' 24' ' ' PRO . 38.8 pt -74.25 -23.16 18.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-O 120.664 0.268 . . . . 1.3700000000000001 111.623 -179.696 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 95.7 mt -84.27 -23.18 30.48 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.47 -0.332 . . . . 1.6699999999999999 110.58 179.459 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -74.78 -38.12 62.24 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.1 -0.5 . . . . 2.21 110.634 179.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -72.22 -18.49 78.07 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.392 179.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.447 ' CA ' HG21 ' B' ' 42' ' ' VAL . . . -86.26 -9.83 75.57 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 121.054 -0.593 . . . . 2.0899999999999999 112.581 179.634 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -95.68 -29.37 14.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.927 0.394 . . . . 2.29 110.451 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.7 tptp -83.24 -26.91 30.31 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.004 -0.544 . . . . 2.4399999999999999 110.966 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 1.3 mm-40 -71.54 114.75 9.95 Favored 'General case' 0 N--CA 1.461 0.099 0 CA-C-O 120.901 0.381 . . . . 2.7000000000000002 110.688 179.763 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.1 m120 . . . . . 0 C--O 1.25 1.107 0 CA-C-O 118.403 -0.808 . . . . 2.5600000000000001 110.889 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.844 1.307 . . . . 0.80000000000000004 110.214 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.564 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.78 0.78 Allowed 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 113.401 -1.727 . . . . 0.84999999999999998 111.372 -179.76 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.564 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.889 0.876 . . . . 0.77000000000000002 110.461 -173.601 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.21 52.75 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.801 -1.545 . . . . 0.65000000000000002 110.183 178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.19 146.37 30.35 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.054 -1.43 . . . . 0.68000000000000005 108.381 -176.086 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.7 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-N 116.112 -0.495 . . . . 0.5 109.892 172.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.94 -31.2 47.08 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.303 0 CA-C-O 121.69 0.757 . . . . 0.46999999999999997 111.52 177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.8 m -118.94 104.23 10.32 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 124.817 1.247 . . . . 0.46999999999999997 111.365 179.039 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.35 -33.42 28.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 114.673 -1.148 . . . . 0.57999999999999996 113.715 175.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.73 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.945 1.298 . . . . 0.57999999999999996 110.03 -178.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.625 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.8 -171.62 2.52 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.776 -1.556 . . . . 0.59999999999999998 111.363 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.9 m -157.82 152.31 24.87 Favored 'General case' 0 N--CA 1.471 0.578 0 C-N-CA 125.868 1.667 . . . . 0.57999999999999996 110.206 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.13 72.19 1.41 Allowed 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 123.606 1.669 . . . . 0.72999999999999998 112.091 177.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.28 51.38 Favored Glycine 0 CA--C 1.546 1.969 0 CA-C-N 113.303 -1.771 . . . . 0.64000000000000001 110.849 174.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.76 1 C-N-CA 136.124 5.769 . . . . 0.64000000000000001 106.31 8.232 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.55 143.43 32.21 Favored Pre-proline 0 CA--C 1.542 0.665 0 O-C-N 121.945 -0.472 . . . . 0.68000000000000005 110.048 174.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.474 ' HB3' HG22 ' B' ' 70' ' ' ILE . 88.3 Cg_exo -51.26 -21.95 10.57 Favored 'Trans proline' 0 N--CA 1.478 0.566 0 C-N-CA 124.928 3.752 . . . . 0.58999999999999997 112.779 174.083 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.591 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.82 -28.76 16.75 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 124.589 1.156 . . . . 0.68999999999999995 112.594 179.723 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 38.3 mmt -88.13 -19.25 27.24 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 113.515 0.931 . . . . 0.94999999999999996 113.515 175.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 32.2 mm -85.39 136.51 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 O-C-N 122.134 -0.354 . . . . 0.57999999999999996 111.163 -179.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 58.3 m -136.77 -4.54 1.99 Allowed 'General case' 0 CA--C 1.531 0.217 0 CA-C-N 116.562 -0.29 . . . . 0.69999999999999996 111.5 -179.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 57.6 t30 -151.06 143.99 24.56 Favored 'General case' 0 N--CA 1.462 0.164 0 CA-C-N 116.606 -0.27 . . . . 0.82999999999999996 110.532 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.441 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 33.8 tp -132.64 144.86 50.63 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 116.398 -0.365 . . . . 0.75 111.043 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.476 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 32.8 mt-30 -139.25 108.35 6.05 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.02 -0.536 . . . . 1.0800000000000001 110.207 179.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 21.6 t -97.17 107.26 19.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 121.0 0.429 . . . . 0.60999999999999999 111.116 -179.778 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -101.01 123.51 45.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.893 -0.594 . . . . 0.85999999999999999 110.674 179.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.0 -159.25 0.37 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.958 0.408 . . . . 0.60999999999999999 111.625 -179.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 74.6 mt -69.91 120.99 18.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 CA-C-N 115.935 -0.575 . . . . 1.1000000000000001 111.035 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -121.48 -169.4 13.66 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.78 -0.724 . . . . 0.63 112.729 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -77.7 -8.08 16.84 Favored 'Trans proline' 0 C--N 1.348 0.511 0 C-N-CA 123.278 2.652 . . . . 0.79000000000000004 112.878 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.81 -20.75 12.37 Favored 'General case' 0 N--CA 1.471 0.578 0 N-CA-C 113.204 0.816 . . . . 0.70999999999999996 113.204 -179.598 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.2 t -139.81 134.34 31.63 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.179 -0.464 . . . . 0.67000000000000004 110.967 -177.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 20.1 t -89.59 -18.81 25.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.011 0.434 . . . . 1.01 110.717 179.689 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -105.63 146.13 30.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.8 -0.636 . . . . 1.1599999999999999 110.502 -179.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.447 HG21 ' CA ' ' A' ' 74' ' ' GLY . 23.0 m -76.97 139.11 19.3 Favored 'Isoleucine or valine' 0 C--O 1.234 0.238 0 CA-C-O 120.915 0.388 . . . . 0.78000000000000003 110.544 179.338 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -131.62 135.28 46.83 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.287 -0.415 . . . . 0.80000000000000004 110.804 -179.41 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.535 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.6 m -105.11 113.63 42.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.549 0.69 . . . . 0.59999999999999998 111.912 -179.17 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -102.55 150.5 6.41 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 CA-C-O 122.465 1.126 . . . . 0.62 110.726 178.84 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.18 153.36 46.6 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.124 -0.944 . . . . 0.55000000000000004 111.143 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.9 m -123.79 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 115.141 -0.936 . . . . 0.63 110.526 176.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -80.31 176.43 9.77 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 114.952 -1.022 . . . . 0.75 110.799 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -78.9 -14.5 59.19 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-O 121.06 0.457 . . . . 1.27 110.548 179.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.3 m-20 -84.25 -4.58 58.93 Favored 'General case' 0 CA--C 1.53 0.181 0 CA-C-N 115.923 -0.581 . . . . 0.98999999999999999 111.012 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.73 40.85 6.59 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 120.919 -0.658 . . . . 0.67000000000000004 112.361 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.519 ' O ' ' HA ' ' B' ' 47' ' ' SER . 62.2 mtpt -123.23 152.79 40.94 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-O 120.648 0.261 . . . . 1.05 110.965 -179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -130.46 129.51 43.06 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.359 0.6 . . . . 0.70999999999999996 110.022 179.82 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.88 179.58 3.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.968 0 CA-C-N 114.755 -1.111 . . . . 0.52000000000000002 109.759 178.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.35 138.1 52.95 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 114.436 -1.256 . . . . 0.47999999999999998 109.277 177.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.736 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.6 mt -113.97 153.42 29.35 Favored 'General case' 0 C--N 1.312 -1.022 0 CA-C-N 114.055 -1.43 . . . . 0.48999999999999999 108.743 -178.576 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.625 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 5.5 t0 -103.1 106.77 52.67 Favored Pre-proline 0 C--N 1.326 -0.447 0 N-CA-C 109.706 -0.479 . . . . 0.63 109.706 177.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.535 ' HG3' HG22 ' B' ' 44' ' ' VAL . 8.2 Cg_exo -69.33 -4.84 14.54 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.741 2.294 . . . . 0.82999999999999996 112.093 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 13.1 tt0 -79.17 -9.64 59.61 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.723 -0.671 . . . . 1.3999999999999999 110.645 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.91 134.99 19.8 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 120.853 -0.339 . . . . 0.91000000000000003 110.689 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.28 -41.87 14.92 Favored 'Trans proline' 0 CA--C 1.536 0.621 0 C-N-CA 123.573 2.849 . . . . 1.1899999999999999 113.376 -178.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.75 -26.7 67.41 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-O 121.328 0.585 . . . . 1.1499999999999999 111.762 176.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.736 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.9 OUTLIER -83.24 -29.38 28.51 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.278 -0.419 . . . . 0.90000000000000002 110.215 178.398 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.5 ttpt -72.91 -17.8 61.47 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.434 0.635 . . . . 1.71 110.651 179.217 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.07 -57.51 3.7 Favored 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 115.393 -0.821 . . . . 1.3600000000000001 113.065 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 28.7 m -60.5 -29.09 43.84 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.279 0 CA-C-N 115.238 -0.892 . . . . 0.96999999999999997 111.742 179.278 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.681 ' O ' HG12 ' B' ' 70' ' ' ILE . 45.7 pt -74.27 -20.01 17.28 Favored 'Isoleucine or valine' 0 C--N 1.343 0.295 0 C-N-CA 120.665 -0.414 . . . . 1.0800000000000001 110.227 178.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 60.8 tt0 -66.6 -41.86 87.78 Favored 'General case' 0 N--CA 1.473 0.723 0 C-N-CA 120.483 -0.487 . . . . 1.52 110.471 176.064 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -72.14 -22.24 61.34 Favored 'General case' 0 CA--C 1.536 0.427 0 N-CA-C 113.338 0.866 . . . . 1.6100000000000001 113.338 -179.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.681 HG12 ' O ' ' B' ' 67' ' ' ILE . 13.1 pt -70.56 -24.84 25.74 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.577 0 CA-C-N 118.345 0.52 . . . . 1.4299999999999999 111.036 -179.759 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 92.3 mt -99.53 -0.56 40.32 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.187 -0.461 . . . . 1.79 110.514 179.431 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -99.6 -34.95 10.01 Favored 'General case' 0 N--CA 1.456 -0.144 0 CA-C-N 116.123 -0.49 . . . . 2.25 110.281 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -79.21 -19.73 71.41 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.779 -0.724 . . . . 1.76 112.676 179.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.7 -13.56 56.61 Favored Glycine 0 CA--C 1.52 0.373 0 C-N-CA 120.918 -0.658 . . . . 2.04 112.825 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.0 t30 -95.28 -30.71 13.82 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.854 0.359 . . . . 2.3199999999999998 110.779 -179.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.1 tptp -80.28 -18.02 50.49 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.277 -0.419 . . . . 2.46 111.291 -179.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 5.3 mm-40 -69.75 115.55 9.11 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-O 121.017 0.437 . . . . 2.7799999999999998 110.703 179.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.2 m120 . . . . . 0 C--O 1.249 1.067 0 CA-C-O 118.333 -0.842 . . . . 2.48 110.76 -179.777 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 122.754 1.264 . . . . 0.81000000000000005 110.075 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.79 -64.65 0.78 Allowed 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 113.34 -1.754 . . . . 0.83999999999999997 111.395 -179.85 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.59 115.02 4.48 Favored 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 123.995 0.918 . . . . 0.76000000000000001 110.428 -173.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.16 52.8 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.822 -1.535 . . . . 0.65000000000000002 110.226 178.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.37 30.34 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 114.075 -1.42 . . . . 0.66000000000000003 108.377 -176.094 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.87 150.97 9.19 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.015 -0.538 . . . . 0.48999999999999999 109.889 172.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.355 0 CA-C-O 121.625 0.726 . . . . 0.45000000000000001 111.502 177.729 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.492 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.8 m -118.97 104.37 10.44 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.782 1.233 . . . . 0.46000000000000002 111.278 179.042 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.5 -33.32 28.36 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 114.589 -1.187 . . . . 0.56999999999999995 113.683 175.088 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 124.784 1.234 . . . . 0.56999999999999995 110.085 -179.084 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.583 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.79 -171.73 2.54 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.787 -1.551 . . . . 0.62 111.315 178.759 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.615 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.74 152.42 25.15 Favored 'General case' 0 N--CA 1.471 0.582 0 C-N-CA 125.819 1.648 . . . . 0.60999999999999999 110.173 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.28 72.16 1.42 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 123.571 1.653 . . . . 0.76000000000000001 112.048 177.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.31 51.43 Favored Glycine 0 CA--C 1.542 1.778 0 CA-C-N 113.262 -1.79 . . . . 0.68999999999999995 110.888 174.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.89 -172.42 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.68 1 C-N-CA 136.259 5.824 . . . . 0.68999999999999995 106.458 8.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.714 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.6 143.45 32.3 Favored Pre-proline 0 CA--C 1.544 0.715 0 O-C-N 121.894 -0.504 . . . . 0.72999999999999998 110.053 174.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.9 Cg_exo -51.31 -21.92 10.73 Favored 'Trans proline' 0 N--CA 1.479 0.631 0 C-N-CA 124.717 3.611 . . . . 0.64000000000000001 112.845 174.199 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.582 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.58 -28.99 15.68 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 124.729 1.211 . . . . 0.73999999999999999 112.598 179.599 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.0 mmt -87.96 -19.47 27.19 Favored 'General case' 0 N--CA 1.474 0.771 0 N-CA-C 113.562 0.949 . . . . 1.0800000000000001 113.562 175.887 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mm -93.76 146.63 6.31 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 CA-C-N 116.439 -0.346 . . . . 0.57999999999999996 111.4 -178.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 68.7 m -141.14 -16.82 0.84 Allowed 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 116.416 -0.356 . . . . 0.68999999999999995 111.047 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.417 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 7.9 t30 -137.68 137.29 38.23 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 110.92 -179.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.415 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 37.2 tp -124.54 148.07 48.01 Favored 'General case' 0 CA--C 1.53 0.174 0 CA-C-N 116.134 -0.484 . . . . 0.73999999999999999 110.613 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' B' ' 31' ' ' GLN . 44.6 mt-30 -140.35 109.37 6.07 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.391 -0.368 . . . . 1.1599999999999999 110.512 179.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.535 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.4 t -95.47 96.32 5.67 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.798 0.332 . . . . 0.62 111.226 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -89.63 126.02 35.47 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.133 -0.485 . . . . 0.72999999999999998 110.87 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.536 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -90.15 -160.36 0.69 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.355 -0.384 . . . . 0.66000000000000003 111.683 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 75.0 mt -70.0 129.98 34.37 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 CA-C-N 116.034 -0.53 . . . . 1.1399999999999999 111.234 -179.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -132.85 -166.26 11.42 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 121.148 -0.548 . . . . 0.66000000000000003 112.394 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -78.15 -7.59 16.23 Favored 'Trans proline' 0 C--N 1.345 0.382 0 C-N-CA 123.154 2.569 . . . . 0.81000000000000005 112.745 179.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -110.97 -21.31 12.07 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.03 0.752 . . . . 0.72999999999999998 113.03 -179.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.0 t -137.52 143.94 41.9 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.132 -0.485 . . . . 0.70999999999999996 111.262 -177.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 9.1 t -106.67 7.87 30.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.189 -0.46 . . . . 1.0700000000000001 110.545 179.685 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -132.83 150.63 52.14 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.959 -0.564 . . . . 1.29 110.92 -179.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.536 HG12 ' HA ' ' A' ' 34' ' ' ALA . 29.1 m -78.94 135.39 25.91 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 CA-C-O 120.859 0.361 . . . . 0.82999999999999996 110.655 179.4 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -133.71 130.03 37.58 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.514 -0.312 . . . . 0.79000000000000004 110.222 -179.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.518 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.9 m -101.08 105.64 18.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 CA-C-O 121.633 0.73 . . . . 0.66000000000000003 112.076 -178.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.492 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.25 150.48 3.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 CA-C-O 122.547 1.165 . . . . 0.68999999999999995 110.777 178.404 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.22 153.34 46.53 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-N 115.14 -0.936 . . . . 0.57999999999999996 111.181 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 21.1 m -123.73 133.6 53.84 Favored 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 115.083 -0.962 . . . . 0.65000000000000002 110.418 176.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.1 mp -78.74 169.0 18.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.078 -0.965 . . . . 0.79000000000000004 110.828 179.645 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.38 -18.16 57.57 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-N 116.201 -0.454 . . . . 1.23 110.842 179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -76.14 -29.85 57.96 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.071 -0.513 . . . . 1.05 111.076 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 116.82 47.69 0.48 Allowed Glycine 0 N--CA 1.45 -0.409 0 C-N-CA 120.829 -0.7 . . . . 0.69999999999999996 112.302 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -134.71 155.36 50.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.777 0.322 . . . . 1.1899999999999999 110.849 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -130.87 129.55 42.43 Favored 'General case' 0 N--CA 1.472 0.66 0 CA-C-O 121.41 0.624 . . . . 0.68999999999999995 109.972 179.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.615 HD12 HG21 ' A' ' 19' ' ' THR . 49.8 pt -127.81 179.55 3.64 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 114.723 -1.126 . . . . 0.53000000000000003 109.851 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.34 138.05 52.94 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.47 -1.241 . . . . 0.48999999999999999 109.236 177.499 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.535 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.96 151.52 32.2 Favored 'General case' 0 C--N 1.314 -0.968 0 CA-C-N 114.015 -1.448 . . . . 0.51000000000000001 108.757 -178.672 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.583 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 2.7 t0 -100.73 109.08 56.61 Favored Pre-proline 0 N--CA 1.471 0.583 0 O-C-N 120.449 -1.407 . . . . 0.67000000000000004 110.7 178.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.518 ' HG3' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_exo -53.35 -17.93 9.87 Favored 'Trans proline' 0 C--N 1.361 1.226 0 C-N-CA 123.304 2.67 . . . . 0.85999999999999999 112.88 179.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.9 -16.5 61.58 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-N 115.011 -0.995 . . . . 1.3500000000000001 113.58 179.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.639 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.43 135.18 20.28 Favored Pre-proline 0 CA--C 1.543 0.683 0 O-C-N 122.203 -0.311 . . . . 0.94999999999999996 110.739 -179.039 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -65.37 -41.94 14.44 Favored 'Trans proline' 0 N--CA 1.478 0.612 0 C-N-CA 123.526 2.817 . . . . 1.24 113.322 -178.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.639 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.65 -24.1 65.3 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-O 121.346 0.593 . . . . 1.1899999999999999 111.782 176.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.535 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -69.22 -40.74 77.8 Favored 'General case' 0 N--CA 1.437 -1.104 0 CA-C-N 114.874 -1.057 . . . . 0.89000000000000001 109.984 177.445 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.549 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 33.0 ttpt -66.16 -14.85 62.52 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 115.742 -0.663 . . . . 1.71 111.418 179.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -82.85 -55.39 4.44 Favored 'General case' 0 N--CA 1.474 0.749 0 N-CA-C 113.004 0.742 . . . . 1.29 113.004 179.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.1 m -62.44 -29.83 47.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-N 116.051 -0.522 . . . . 0.91000000000000003 111.289 178.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 28.5 pt -84.55 -21.76 8.08 Favored 'Isoleucine or valine' 0 C--N 1.345 0.391 0 C-N-CA 120.83 -0.348 . . . . 1.05 110.17 178.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.549 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -74.95 -43.3 54.86 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 120.755 -0.378 . . . . 1.52 110.502 176.813 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 89.4 mttt -63.72 -26.59 68.72 Favored 'General case' 0 N--CA 1.466 0.34 0 N-CA-C 113.136 0.791 . . . . 1.5800000000000001 113.136 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 17.1 pt -87.52 -3.05 9.02 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 N-CA-C 111.868 0.321 . . . . 1.3700000000000001 111.868 -179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 89.7 mt -102.73 -37.8 7.73 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.965 0.412 . . . . 1.6699999999999999 110.339 179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -89.05 -35.96 16.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.798 -0.637 . . . . 2.21 110.136 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -69.15 -35.63 78.16 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 121.104 -0.569 . . . . 1.77 112.487 -179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.09 -40.56 50.44 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.9 -0.667 . . . . 2.0899999999999999 111.837 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -68.59 -24.67 64.62 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.813 0.339 . . . . 2.29 110.803 179.732 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 20.7 tptp -73.62 -41.31 62.98 Favored 'General case' 0 C--O 1.233 0.235 0 CA-C-N 115.973 -0.558 . . . . 2.4399999999999999 110.814 179.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -75.87 123.7 26.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 120.981 0.42 . . . . 2.7000000000000002 110.661 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.1 m120 . . . . . 0 C--O 1.249 1.038 0 CA-C-O 118.428 -0.796 . . . . 2.5600000000000001 110.923 -179.467 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 122.895 1.331 . . . . 0.80000000000000004 110.107 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.67 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.318 -1.764 . . . . 0.84999999999999998 111.351 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.46 115.02 4.52 Favored 'General case' 0 N--CA 1.468 0.436 0 C-N-CA 123.915 0.886 . . . . 0.77000000000000002 110.508 -173.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.16 52.79 Favored 'General case' 0 C--N 1.321 -0.674 0 CA-C-N 113.96 -1.473 . . . . 0.65000000000000002 110.231 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.18 146.39 30.32 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.994 -1.457 . . . . 0.68000000000000005 108.387 -176.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.83 151.06 9.0 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-N 116.048 -0.524 . . . . 0.5 109.915 172.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.03 -31.11 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.262 0 CA-C-O 121.672 0.749 . . . . 0.46999999999999997 111.476 177.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -118.99 104.16 10.24 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 114.501 -1.227 . . . . 0.46999999999999997 111.402 178.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.26 -33.39 29.22 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.701 -1.136 . . . . 0.57999999999999996 113.733 175.122 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.69 -178.73 3.51 Favored 'General case' 0 C--N 1.316 -0.884 0 C-N-CA 124.881 1.272 . . . . 0.57999999999999996 109.97 -178.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.556 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.8 -171.7 2.54 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 113.728 -1.578 . . . . 0.59999999999999998 111.325 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.76 152.38 25.06 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 125.791 1.637 . . . . 0.57999999999999996 110.161 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.32 72.16 1.42 Allowed 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 123.67 1.7 . . . . 0.72999999999999998 112.063 177.202 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.585 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.01 -177.14 51.41 Favored Glycine 0 CA--C 1.543 1.827 0 CA-C-N 113.207 -1.815 . . . . 0.64000000000000001 110.968 174.386 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.727 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.791 1 C-N-CA 136.196 5.799 . . . . 0.64000000000000001 106.315 8.026 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.727 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.64 143.43 32.3 Favored Pre-proline 0 CA--C 1.544 0.725 0 O-C-N 121.943 -0.473 . . . . 0.68000000000000005 109.986 174.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.4 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.479 0.665 0 C-N-CA 124.753 3.635 . . . . 0.58999999999999997 112.827 174.077 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.98 16.41 Favored 'General case' 0 N--CA 1.471 0.591 0 C-N-CA 124.602 1.161 . . . . 0.68999999999999995 112.558 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.8 mmt -87.88 -19.3 27.55 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.594 0.961 . . . . 0.94999999999999996 113.594 175.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.8 mm -94.32 144.57 9.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 O-C-N 122.063 -0.398 . . . . 0.57999999999999996 111.464 -178.706 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -141.9 4.97 1.71 Allowed 'General case' 0 CA--C 1.53 0.177 0 CA-C-N 116.405 -0.361 . . . . 0.69999999999999996 111.073 179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.535 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 58.6 t30 -151.0 127.95 11.04 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-N 116.576 -0.284 . . . . 0.82999999999999996 111.032 -179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -114.3 109.83 18.97 Favored 'General case' 0 C--N 1.334 -0.092 0 CA-C-O 121.009 0.433 . . . . 0.75 111.094 179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.475 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 12.4 mt-30 -103.78 126.11 50.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.08 -0.509 . . . . 1.0800000000000001 110.471 179.638 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.417 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 16.8 t -114.5 128.2 71.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.193 -0.458 . . . . 0.60999999999999999 111.184 -179.375 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 48.0 m-85 -119.95 124.04 45.0 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.074 -0.512 . . . . 0.85999999999999999 110.586 179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -90.76 -140.03 0.16 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.522 -0.308 . . . . 0.60999999999999999 111.213 179.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 56.0 mt -75.41 127.52 36.94 Favored 'Isoleucine or valine' 0 C--O 1.232 0.163 0 CA-C-O 120.958 0.408 . . . . 1.1000000000000001 111.294 -179.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -131.86 174.04 20.35 Favored Glycine 0 CA--C 1.519 0.336 0 C-N-CA 121.002 -0.618 . . . . 0.63 112.45 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -76.09 -9.02 19.16 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.254 2.636 . . . . 0.79000000000000004 112.485 179.744 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.73 -21.24 12.5 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 113.078 0.77 . . . . 0.70999999999999996 113.078 -179.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -145.32 131.24 19.18 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.19 -0.459 . . . . 0.67000000000000004 111.032 -177.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.7 t -85.76 -39.58 17.0 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.205 -0.452 . . . . 1.01 110.919 179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 86.2 tttt -82.16 145.4 30.13 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.137 -0.483 . . . . 1.1599999999999999 110.584 179.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 19.6 m -77.43 140.43 17.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.167 0.508 . . . . 0.78000000000000003 110.965 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 31.9 mt-10 -133.26 131.58 40.43 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.687 -0.688 . . . . 0.80000000000000004 110.321 -179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' B' ' 58' ' ' PRO . 3.8 m -102.16 109.3 25.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 121.686 0.755 . . . . 0.59999999999999998 112.172 -179.249 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -97.77 150.52 4.66 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 CA-C-O 122.517 1.151 . . . . 0.62 110.788 178.692 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.28 153.37 46.47 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-N 115.171 -0.922 . . . . 0.55000000000000004 111.231 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 73.7 m -123.81 133.22 53.85 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.998 -1.001 . . . . 0.63 110.439 176.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -78.14 167.51 21.29 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.189 -0.914 . . . . 0.75 110.581 179.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 25.6 tptp -74.71 -16.04 60.76 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 116.249 -0.432 . . . . 1.27 110.746 179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -78.18 -29.28 48.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.06 -0.518 . . . . 0.98999999999999999 110.972 179.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.36 37.9 0.89 Allowed Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.843 -0.694 . . . . 0.67000000000000004 112.672 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' B' ' 47' ' ' SER . 36.8 mtpt -124.1 160.28 28.09 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.734 0.302 . . . . 1.05 111.0 179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.21 129.67 29.86 Favored 'General case' 0 N--CA 1.473 0.691 0 CA-C-O 121.478 0.656 . . . . 0.70999999999999996 109.905 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.98 179.57 3.67 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.925 0 CA-C-N 114.637 -1.165 . . . . 0.52000000000000002 109.789 178.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.5 m -127.32 137.98 52.93 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 114.498 -1.228 . . . . 0.47999999999999998 109.35 177.514 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.731 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 154.17 28.02 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 114.081 -1.418 . . . . 0.48999999999999999 108.725 -178.667 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.556 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.7 t0 -102.58 108.49 57.94 Favored Pre-proline 0 C--N 1.323 -0.563 0 O-C-N 121.879 -0.513 . . . . 0.63 110.121 177.554 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.563 ' HG3' HG22 ' B' ' 44' ' ' VAL . 22.3 Cg_exo -62.72 -14.83 42.75 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 122.975 2.45 . . . . 0.82999999999999996 111.757 179.542 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.13 -16.53 64.38 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-N 114.58 -1.191 . . . . 1.3999999999999999 113.592 178.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.632 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.46 135.14 20.28 Favored Pre-proline 0 CA--C 1.541 0.617 0 O-C-N 122.324 -0.235 . . . . 0.91000000000000003 110.788 -179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.31 -41.84 14.89 Favored 'Trans proline' 0 N--CA 1.477 0.525 0 C-N-CA 123.609 2.873 . . . . 1.1899999999999999 113.406 -178.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.632 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.74 -25.94 66.84 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 121.35 0.595 . . . . 1.1499999999999999 111.774 176.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.731 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.4 OUTLIER -80.21 -25.69 39.52 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.949 -0.568 . . . . 0.90000000000000002 110.321 178.123 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.479 ' HG2' ' O ' ' B' ' 64' ' ' LYS . 24.7 ttpt -80.21 -12.09 59.67 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-N 115.654 -0.703 . . . . 1.71 110.739 179.56 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -78.62 -56.23 4.58 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 115.403 -0.817 . . . . 1.3600000000000001 112.97 179.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 24.2 m -60.6 -27.44 40.47 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 CA-C-N 115.707 -0.678 . . . . 0.96999999999999997 111.575 178.611 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.425 HG12 ' HA ' ' B' ' 64' ' ' LYS . 33.4 pt -79.85 -22.53 11.94 Favored 'Isoleucine or valine' 0 C--N 1.342 0.254 0 C-N-CA 120.876 -0.33 . . . . 1.0800000000000001 110.226 178.691 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -72.16 -42.37 66.02 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 120.847 -0.341 . . . . 1.52 110.504 176.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.7 mttt -61.78 -28.33 69.38 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 113.202 0.816 . . . . 1.6100000000000001 113.202 -179.306 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 34.3 pt -81.57 -6.27 9.61 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 120.903 -0.319 . . . . 1.4299999999999999 111.839 -179.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 89.2 mt -94.17 -32.58 13.66 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.753 0.311 . . . . 1.79 110.638 179.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 33.7 t70 -91.14 -40.02 11.81 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.007 -0.542 . . . . 2.25 110.122 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.76 -24.32 72.61 Favored Glycine 0 N--CA 1.451 -0.326 0 CA-C-N 115.975 -0.557 . . . . 1.76 112.02 179.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -80.44 -14.5 80.03 Favored Glycine 0 N--CA 1.45 -0.425 0 C-N-CA 121.071 -0.585 . . . . 2.04 112.054 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 66.1 t30 -81.89 -20.25 39.22 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-O 120.748 0.309 . . . . 2.3199999999999998 111.05 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -77.36 -20.42 54.82 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 116.073 -0.512 . . . . 2.46 110.705 179.65 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -71.07 107.98 4.39 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.092 -0.504 . . . . 2.7799999999999998 110.235 179.23 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--O 1.249 1.039 0 CA-C-O 118.314 -0.851 . . . . 2.48 110.922 -179.413 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.006 0 CA-C-O 122.841 1.305 . . . . 0.81000000000000005 110.065 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.574 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.69 0.78 Allowed 'General case' 0 N--CA 1.475 0.813 0 CA-C-N 113.308 -1.769 . . . . 0.83999999999999997 111.414 -179.876 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.574 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.58 115.01 4.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 124.01 0.924 . . . . 0.76000000000000001 110.435 -173.659 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.09 140.19 52.78 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 113.779 -1.555 . . . . 0.65000000000000002 110.254 178.885 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.28 146.44 30.37 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 114.06 -1.427 . . . . 0.66000000000000003 108.327 -176.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.94 151.1 9.17 Favored 'General case' 0 N--CA 1.473 0.72 0 CA-C-N 115.978 -0.555 . . . . 0.48999999999999999 109.917 173.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.04 -31.01 46.84 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.288 0 CA-C-O 121.709 0.766 . . . . 0.45000000000000001 111.504 177.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.624 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.1 m -119.17 104.4 10.39 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-N 114.522 -1.217 . . . . 0.46000000000000002 111.158 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.46 -33.32 28.51 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 114.581 -1.19 . . . . 0.56999999999999995 113.777 175.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.71 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.89 1.276 . . . . 0.56999999999999995 110.003 -179.1 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.444 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.69 2.53 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.741 -1.572 . . . . 0.62 111.305 178.741 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.618 HG21 HD12 ' A' ' 54' ' ' ILE . 85.0 m -157.83 152.34 24.87 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 125.714 1.606 . . . . 0.60999999999999999 110.097 -179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.2 1.41 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 123.635 1.683 . . . . 0.76000000000000001 112.041 177.196 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.9 -177.29 51.5 Favored Glycine 0 CA--C 1.543 1.807 0 CA-C-N 113.234 -1.803 . . . . 0.68999999999999995 110.928 174.329 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.728 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.97 -172.56 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.704 1 C-N-CA 136.158 5.783 . . . . 0.68999999999999995 106.407 8.121 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.728 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.5 143.4 32.08 Favored Pre-proline 0 CA--C 1.545 0.769 0 O-C-N 121.97 -0.456 . . . . 0.72999999999999998 110.079 174.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.23 -21.93 10.44 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 124.749 3.633 . . . . 0.64000000000000001 112.868 174.123 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.586 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.65 -28.98 16.13 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 124.713 1.205 . . . . 0.73999999999999999 112.629 179.58 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 36.1 mmt -88.02 -19.74 26.75 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.601 0.963 . . . . 1.0800000000000001 113.601 175.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.1 mm -84.82 142.65 13.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.202 -0.454 . . . . 0.57999999999999996 111.348 -179.12 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 66.6 m -139.41 -13.37 1.15 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.432 -0.349 . . . . 0.68999999999999995 111.398 -179.895 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 44.8 t30 -146.51 141.67 27.28 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.576 -0.283 . . . . 0.78000000000000003 110.653 -179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.417 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 19.7 tp -128.4 145.12 51.18 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-N 116.305 -0.407 . . . . 0.73999999999999999 110.732 179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 54.5 mt-30 -138.53 105.36 5.39 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.255 -0.43 . . . . 1.1599999999999999 110.337 179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.45 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 37.0 t -96.01 115.04 34.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.225 -0.443 . . . . 0.62 110.929 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 34.9 m-85 -112.34 129.54 56.26 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.997 -0.547 . . . . 0.72999999999999998 110.765 -179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.85 -157.51 0.44 Allowed 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.934 0.397 . . . . 0.66000000000000003 111.526 179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 76.1 mt -71.11 126.97 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.202 0 CA-C-N 116.073 -0.512 . . . . 1.1399999999999999 111.015 179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -128.3 -165.05 11.72 Favored Glycine 0 C--N 1.333 0.391 0 C-N-CA 120.815 -0.707 . . . . 0.66000000000000003 112.84 -179.525 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -81.44 -5.91 12.66 Favored 'Trans proline' 0 C--N 1.348 0.502 0 C-N-CA 123.274 2.649 . . . . 0.81000000000000005 112.972 -179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -114.18 -22.01 10.2 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 112.971 0.73 . . . . 0.72999999999999998 112.971 -179.524 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.4 t -136.87 158.16 45.08 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.933 -0.576 . . . . 0.70999999999999996 111.315 -177.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 22.6 t -119.91 -24.92 5.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.933 -0.576 . . . . 1.0700000000000001 110.171 179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -93.14 146.06 23.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.099 -0.501 . . . . 1.29 110.815 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.438 ' O ' ' HG2' ' A' ' 58' ' ' PRO . 3.4 m -76.31 127.1 37.55 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-O 120.972 0.415 . . . . 0.82999999999999996 110.605 179.223 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -130.49 128.36 41.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.902 -0.59 . . . . 0.79000000000000004 110.601 -179.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG22 ' HG3' ' A' ' 58' ' ' PRO . 15.8 m -105.14 108.75 25.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 121.653 0.74 . . . . 0.66000000000000003 112.378 179.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.624 HG12 ' SG ' ' A' ' 15' ' ' CYS . 0.9 OUTLIER -93.69 150.47 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.942 0 CA-C-O 122.546 1.165 . . . . 0.68999999999999995 110.789 178.424 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.42 46.59 Favored 'General case' 0 N--CA 1.477 0.888 0 CA-C-N 115.087 -0.96 . . . . 0.57999999999999996 111.17 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.441 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.4 m -123.81 132.87 53.86 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 115.013 -0.994 . . . . 0.65000000000000002 110.401 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.4 mp -81.39 177.57 8.89 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.41 -0.814 . . . . 0.79000000000000004 110.771 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -76.39 -22.62 54.55 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.241 -0.436 . . . . 1.23 110.978 179.915 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.8 m-20 -78.81 -16.59 56.94 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 116.155 -0.475 . . . . 1.05 111.297 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.11 25.47 7.1 Favored Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.811 -0.709 . . . . 0.69999999999999996 112.513 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 47' ' ' SER . 58.9 mtpt -102.15 153.24 20.12 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.542 0.211 . . . . 1.1899999999999999 110.483 179.798 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -135.81 129.55 32.63 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.431 0.634 . . . . 0.68999999999999995 109.883 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.618 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.8 179.64 3.57 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.028 0 CA-C-N 114.68 -1.145 . . . . 0.53000000000000003 109.838 178.043 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.36 138.05 52.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 114.455 -1.248 . . . . 0.48999999999999999 109.236 177.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.799 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -114.02 153.35 29.53 Favored 'General case' 0 C--N 1.314 -0.954 0 CA-C-N 114.023 -1.444 . . . . 0.51000000000000001 108.681 -178.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.444 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.4 t0 -95.42 107.45 32.97 Favored Pre-proline 0 C--N 1.323 -0.546 0 O-C-N 121.805 -0.56 . . . . 0.67000000000000004 110.004 177.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.459 ' HD3' ' O ' ' A' ' 56' ' ' LEU . 24.9 Cg_exo -61.12 -16.56 46.76 Favored 'Trans proline' 0 C--N 1.358 1.051 0 C-N-CA 123.119 2.546 . . . . 0.85999999999999999 111.724 -179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 -64.46 -16.46 62.5 Favored 'General case' 0 CA--C 1.545 0.761 0 CA-C-N 114.675 -1.148 . . . . 1.3500000000000001 113.537 178.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.44 135.12 20.29 Favored Pre-proline 0 CA--C 1.542 0.664 0 O-C-N 122.296 -0.252 . . . . 0.94999999999999996 110.7 -179.019 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.89 14.55 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 123.602 2.868 . . . . 1.24 113.303 -178.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.79 -26.12 67.04 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-O 121.398 0.618 . . . . 1.1899999999999999 111.866 176.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.799 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -76.4 -24.79 54.06 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.659 -0.701 . . . . 0.89000000000000001 110.958 178.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -79.57 -13.95 59.18 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.45 0.643 . . . . 1.71 110.074 179.208 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.7 -56.71 4.37 Favored 'General case' 0 N--CA 1.474 0.738 0 CA-C-N 115.372 -0.831 . . . . 1.29 113.066 178.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 32.8 m -58.72 -26.98 33.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 115.71 -0.677 . . . . 0.91000000000000003 112.67 179.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 38.8 pt -84.62 -14.12 11.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 121.13 0.491 . . . . 1.05 111.139 179.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 56.9 tt0 -94.14 -20.23 20.07 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.783 -0.644 . . . . 1.52 110.152 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -80.01 -27.45 39.57 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.986 -0.552 . . . . 1.5800000000000001 111.311 179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 20.5 pt -80.22 -22.63 11.58 Favored 'Isoleucine or valine' 0 C--O 1.232 0.149 0 CA-C-O 120.924 0.392 . . . . 1.3700000000000001 110.653 179.672 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 21.0 mt -102.78 22.64 13.39 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.92 -0.582 . . . . 1.6699999999999999 110.079 178.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -133.16 -66.79 0.65 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.65 -0.704 . . . . 2.21 110.198 -179.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -65.23 -34.77 90.46 Favored Glycine 0 C--N 1.333 0.375 0 C-N-CA 120.99 -0.624 . . . . 1.77 112.583 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -91.28 -14.76 56.89 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.931 -0.652 . . . . 2.0899999999999999 112.417 179.548 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -79.13 -5.47 54.22 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-O 120.909 0.385 . . . . 2.29 110.994 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -72.95 -18.97 61.33 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.088 -0.506 . . . . 2.4399999999999999 111.176 179.651 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 9.1 mm-40 -65.91 113.47 4.41 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-O 120.848 0.356 . . . . 2.7000000000000002 111.115 179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 8.2 m120 . . . . . 0 C--O 1.25 1.085 0 CA-C-O 118.326 -0.845 . . . . 2.5600000000000001 110.758 179.952 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 1.023 0 CA-C-O 122.701 1.239 . . . . 0.80000000000000004 110.157 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.65 -64.67 0.78 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-N 113.418 -1.719 . . . . 0.84999999999999998 111.418 -179.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.67 114.93 4.44 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.888 0.875 . . . . 0.77000000000000002 110.461 -173.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.11 140.19 52.78 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 113.836 -1.529 . . . . 0.65000000000000002 110.242 178.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.23 146.48 30.25 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.9 -1.5 . . . . 0.68000000000000005 108.443 -176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.84 151.02 9.06 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 116.091 -0.504 . . . . 0.5 109.916 173.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.9 -31.16 46.9 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.361 0 CA-C-O 121.705 0.764 . . . . 0.46999999999999997 111.518 177.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 63.0 m -119.02 104.16 10.23 Favored 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 124.768 1.227 . . . . 0.46999999999999997 111.416 179.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.18 -33.41 29.48 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 114.643 -1.162 . . . . 0.57999999999999996 113.808 175.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.76 3.52 Favored 'General case' 0 C--N 1.316 -0.881 0 C-N-CA 124.844 1.258 . . . . 0.57999999999999996 110.071 -178.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.607 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.5 t -128.77 -171.56 2.5 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 113.81 -1.541 . . . . 0.59999999999999998 111.271 178.632 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.606 HG21 HD12 ' B' ' 54' ' ' ILE . 85.5 m -157.88 152.29 24.72 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 125.769 1.627 . . . . 0.57999999999999996 110.172 179.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.5 pm0 -128.17 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 123.726 1.727 . . . . 0.72999999999999998 112.142 177.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.03 -177.23 51.42 Favored Glycine 0 CA--C 1.542 1.744 0 CA-C-N 113.16 -1.836 . . . . 0.64000000000000001 110.98 174.421 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.736 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.08 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.725 1 C-N-CA 136.126 5.77 . . . . 0.64000000000000001 106.371 7.968 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.736 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.56 143.36 32.09 Favored Pre-proline 0 CA--C 1.543 0.685 0 O-C-N 121.933 -0.479 . . . . 0.68000000000000005 109.994 175.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.433 ' HB3' ' CG2' ' B' ' 70' ' ' ILE . 85.8 Cg_exo -51.26 -21.9 10.49 Favored 'Trans proline' 0 N--CA 1.478 0.572 0 C-N-CA 124.84 3.693 . . . . 0.58999999999999997 112.808 174.08 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.76 -28.87 16.61 Favored 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.653 1.181 . . . . 0.68999999999999995 112.547 179.698 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.6 mmt -88.03 -19.28 27.35 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 113.566 0.95 . . . . 0.94999999999999996 113.566 175.856 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 22.7 mm -88.78 142.73 12.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 120.813 0.34 . . . . 0.57999999999999996 111.287 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 70.7 m -140.23 -9.32 1.13 Allowed 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.381 -0.372 . . . . 0.69999999999999996 111.143 179.743 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.45 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 8.8 t30 -145.71 137.81 25.43 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 116.619 -0.264 . . . . 0.82999999999999996 111.075 179.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 33.0 tp -129.59 126.31 38.2 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 116.333 -0.394 . . . . 0.75 111.091 179.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.417 ' HA ' ' O ' ' A' ' 30' ' ' LEU . 50.3 mt-30 -117.55 117.09 28.46 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.296 -0.411 . . . . 1.0800000000000001 110.585 179.4 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 19.9 t -102.43 121.03 53.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-N 116.113 -0.494 . . . . 0.60999999999999999 111.102 -179.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.8 126.15 54.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.224 -0.444 . . . . 0.85999999999999999 110.693 -179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -82.67 -161.79 0.51 Allowed 'General case' 0 CA--C 1.531 0.221 0 CA-C-O 120.937 0.398 . . . . 0.60999999999999999 111.562 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 57.6 mt -68.8 123.93 23.37 Favored 'Isoleucine or valine' 0 C--O 1.232 0.175 0 CA-C-N 115.978 -0.555 . . . . 1.1000000000000001 111.062 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.48 -176.75 15.09 Favored Glycine 0 C--N 1.332 0.353 0 C-N-CA 120.823 -0.703 . . . . 0.63 112.968 -179.624 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -76.51 -9.86 18.72 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 123.486 2.791 . . . . 0.79000000000000004 112.579 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.05 -20.54 12.98 Favored 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.114 0.783 . . . . 0.70999999999999996 113.114 -179.53 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.0 t -143.79 127.55 17.2 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.116 -0.493 . . . . 0.67000000000000004 111.04 -177.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 27.4 t -80.83 -42.75 21.11 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.42 -0.354 . . . . 1.01 110.723 179.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.3 tttt -80.96 142.45 33.45 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.027 -0.533 . . . . 1.1599999999999999 110.496 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 20.9 m -77.83 138.48 20.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.151 0.501 . . . . 0.78000000000000003 110.388 179.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -127.21 136.61 52.27 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.014 -0.539 . . . . 0.80000000000000004 110.699 -179.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.418 HG22 ' HG3' ' B' ' 58' ' ' PRO . 0.9 OUTLIER -108.03 109.07 26.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 121.426 0.631 . . . . 0.59999999999999998 111.98 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -97.58 150.52 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.949 0 CA-C-O 122.494 1.14 . . . . 0.62 110.744 178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.21 153.37 46.55 Favored 'General case' 0 N--CA 1.476 0.863 0 CA-C-N 115.213 -0.903 . . . . 0.55000000000000004 111.275 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.431 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 21.0 m -123.78 133.39 53.84 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 115.176 -0.92 . . . . 0.63 110.444 176.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.3 mp -76.67 173.57 11.46 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 114.621 -1.172 . . . . 0.75 110.936 179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.4 tptp -79.16 -18.63 52.76 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.107 -0.497 . . . . 1.27 110.357 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.5 m-20 -75.59 -25.22 56.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.893 -0.594 . . . . 0.98999999999999999 111.079 179.866 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 110.56 42.48 1.14 Allowed Glycine 0 C--N 1.33 0.245 0 C-N-CA 120.799 -0.715 . . . . 0.67000000000000004 112.575 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.431 ' O ' ' HA ' ' B' ' 47' ' ' SER . 56.2 mtpt -129.59 154.94 46.58 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.785 0.326 . . . . 1.05 110.994 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.21 129.53 45.15 Favored 'General case' 0 N--CA 1.473 0.697 0 CA-C-O 121.352 0.596 . . . . 0.70999999999999996 109.959 179.786 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.606 HD12 HG21 ' B' ' 19' ' ' THR . 49.6 pt -127.85 179.68 3.55 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 114.665 -1.152 . . . . 0.52000000000000002 109.847 178.133 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.52 138.03 52.8 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.526 -1.215 . . . . 0.47999999999999998 109.247 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.833 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.98 151.76 31.89 Favored 'General case' 0 C--N 1.313 -1.021 0 CA-C-N 114.014 -1.448 . . . . 0.48999999999999999 108.785 -178.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.607 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 2.6 t0 -98.51 112.04 61.46 Favored Pre-proline 0 C--N 1.328 -0.35 0 O-C-N 122.041 -0.412 . . . . 0.63 109.975 178.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.418 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.0 Cg_exo -67.21 -1.75 6.87 Favored 'Trans proline' 0 C--N 1.348 0.548 0 C-N-CA 122.861 2.374 . . . . 0.82999999999999996 112.743 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 14.9 tt0 -84.05 -8.65 59.07 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.467 . . . . 1.3999999999999999 110.754 179.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -101.3 135.14 19.94 Favored Pre-proline 0 CA--C 1.54 0.59 0 C-N-CA 120.768 -0.373 . . . . 0.91000000000000003 110.738 178.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.39 -41.82 14.71 Favored 'Trans proline' 0 CA--C 1.535 0.542 0 C-N-CA 123.67 2.913 . . . . 1.1899999999999999 113.343 -178.703 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.83 -25.35 66.54 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.246 0.546 . . . . 1.1499999999999999 111.715 176.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.833 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.52 -28.88 56.55 Favored 'General case' 0 N--CA 1.448 -0.546 0 CA-C-N 115.581 -0.736 . . . . 0.90000000000000002 110.629 178.318 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt -75.86 -15.05 60.28 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.507 0.67 . . . . 1.71 110.49 179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -80.69 -56.06 4.41 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 115.489 -0.778 . . . . 1.3600000000000001 113.07 179.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.5 m -59.05 -27.25 35.46 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.446 0 CA-C-N 115.381 -0.827 . . . . 0.96999999999999997 111.405 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . . . . . . . . . 47.2 pt -79.98 -26.9 12.12 Favored 'Isoleucine or valine' 0 C--N 1.343 0.307 0 C-N-CA 120.898 -0.321 . . . . 1.0800000000000001 110.371 178.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.7 tt0 -70.4 -43.45 70.01 Favored 'General case' 0 N--CA 1.474 0.761 0 C-N-CA 120.407 -0.517 . . . . 1.52 110.429 176.492 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.1 mttt -64.05 -29.9 71.01 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 113.658 0.985 . . . . 1.6100000000000001 113.658 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.433 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 15.6 pt -78.4 -10.9 13.11 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.58 0 CA-C-N 118.143 0.429 . . . . 1.4299999999999999 111.947 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 86.8 mt -107.13 -11.43 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 1.79 110.716 179.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -103.58 -38.0 7.31 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.819 -0.628 . . . . 2.25 110.298 -179.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.41 -31.66 58.77 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 121.017 -0.611 . . . . 1.76 112.218 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.59 -26.49 60.93 Favored Glycine 0 CA--C 1.519 0.308 0 C-N-CA 121.143 -0.551 . . . . 2.04 112.49 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -85.3 -27.17 26.14 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.959 0.409 . . . . 2.3199999999999998 110.572 179.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.4 tptp -77.54 -30.12 52.62 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.947 -0.57 . . . . 2.46 110.391 179.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -69.88 113.62 7.29 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.977 -0.556 . . . . 2.7799999999999998 110.174 179.452 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.4 m120 . . . . . 0 C--O 1.252 1.226 0 CA-C-O 118.417 -0.801 . . . . 2.48 111.564 -179.016 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.479 0.999 0 CA-C-O 122.762 1.268 . . . . 0.81000000000000005 110.122 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.64 -64.77 0.78 Allowed 'General case' 0 N--CA 1.475 0.798 0 CA-C-N 113.369 -1.741 . . . . 0.83999999999999997 111.456 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.55 115.12 4.52 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 123.981 0.912 . . . . 0.76000000000000001 110.398 -173.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.21 140.21 52.72 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 113.743 -1.571 . . . . 0.65000000000000002 110.142 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.27 146.39 30.41 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.015 -1.448 . . . . 0.66000000000000003 108.383 -176.092 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.2 m -54.86 151.04 9.09 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-N 115.969 -0.56 . . . . 0.48999999999999999 109.9 173.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.99 -31.05 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 CA-C-O 121.598 0.714 . . . . 0.45000000000000001 111.478 177.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.678 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.4 m -119.05 104.23 10.29 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 124.802 1.241 . . . . 0.46000000000000002 111.244 179.121 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.36 -33.4 28.83 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 114.602 -1.181 . . . . 0.56999999999999995 113.71 175.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.76 -178.82 3.53 Favored 'General case' 0 C--N 1.314 -0.939 0 C-N-CA 124.863 1.265 . . . . 0.56999999999999995 110.048 -179.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.649 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.68 -171.59 2.5 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.781 -1.554 . . . . 0.62 111.302 178.692 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.0 m -157.83 152.37 24.91 Favored 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 125.814 1.646 . . . . 0.60999999999999999 110.181 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.512 ' HA ' ' CE1' ' A' ' 62' ' ' PHE . 6.4 pm0 -128.25 72.22 1.42 Allowed 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 123.611 1.672 . . . . 0.76000000000000001 112.101 177.146 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.581 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.0 -177.32 51.45 Favored Glycine 0 CA--C 1.544 1.88 0 CA-C-N 113.23 -1.804 . . . . 0.68999999999999995 110.884 174.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.72 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.2 p 137.96 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.725 1 C-N-CA 136.267 5.827 . . . . 0.68999999999999995 106.404 8.174 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.72 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.1 t-80 -117.55 143.3 31.94 Favored Pre-proline 0 CA--C 1.545 0.773 0 O-C-N 121.95 -0.469 . . . . 0.72999999999999998 110.067 174.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.436 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 85.7 Cg_exo -51.13 -21.97 10.14 Favored 'Trans proline' 0 N--CA 1.478 0.58 0 C-N-CA 124.708 3.605 . . . . 0.64000000000000001 112.852 174.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.579 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.63 -29.14 16.58 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.669 1.188 . . . . 0.73999999999999999 112.721 179.636 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.0 mmt -90.29 -19.39 24.14 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.446 -0.343 . . . . 1.0800000000000001 111.446 179.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 17.9 mm -84.74 150.07 4.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.309 -0.405 . . . . 0.57999999999999996 111.525 -179.376 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 35.1 m -149.17 6.89 0.69 Allowed 'General case' 0 CA--C 1.532 0.25 0 CA-C-N 116.286 -0.415 . . . . 0.68999999999999995 111.062 179.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.473 ' HB3' ' HB2' ' A' ' 47' ' ' SER . 47.2 t30 -164.2 133.1 3.7 Favored 'General case' 0 N--CA 1.465 0.292 0 CA-C-N 116.319 -0.4 . . . . 0.78000000000000003 110.497 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 15.4 tp -121.07 149.19 43.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.949 -0.568 . . . . 0.73999999999999999 110.221 179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.487 ' HB2' HG23 ' A' ' 45' ' ' VAL . 46.9 mt-30 -144.09 116.63 8.62 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.062 0.458 . . . . 1.1599999999999999 110.631 179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 20.4 t -105.18 110.75 31.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.99 -0.55 . . . . 0.62 111.43 -179.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 63.7 m-85 -102.96 129.57 49.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.705 -0.68 . . . . 0.72999999999999998 110.817 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.411 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -95.7 -158.7 0.67 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.618 -0.265 . . . . 0.66000000000000003 111.158 179.302 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 93.2 mt -69.1 121.11 17.81 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.181 0 CA-C-N 116.232 -0.44 . . . . 1.1399999999999999 111.026 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.68 -166.52 12.1 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.053 -0.594 . . . . 0.66000000000000003 112.427 179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -77.85 -8.26 16.73 Favored 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 123.323 2.682 . . . . 0.81000000000000005 112.803 179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.03 -21.01 11.75 Favored 'General case' 0 N--CA 1.47 0.563 0 N-CA-C 112.985 0.735 . . . . 0.72999999999999998 112.985 -179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.7 t -141.09 136.59 32.11 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.997 -0.547 . . . . 0.70999999999999996 111.093 -177.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -103.38 16.74 25.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.079 0.466 . . . . 1.0700000000000001 110.501 179.665 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -136.58 154.21 50.75 Favored 'General case' 0 C--O 1.232 0.16 0 CA-C-N 115.884 -0.598 . . . . 1.29 110.878 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.495 HG21 ' O ' ' B' ' 74' ' ' GLY . 16.5 m -82.7 131.39 33.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.248 -0.433 . . . . 0.82999999999999996 110.936 179.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -133.37 130.12 38.35 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.298 -0.41 . . . . 0.79000000000000004 110.219 -179.824 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -100.7 106.04 18.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-O 121.723 0.773 . . . . 0.66000000000000003 112.263 -178.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.678 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.4 m -93.48 150.54 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-O 122.454 1.121 . . . . 0.68999999999999995 110.864 178.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.45 46.52 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 115.194 -0.912 . . . . 0.57999999999999996 111.145 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.473 ' HB2' ' HB3' ' A' ' 29' ' ' ASN . 21.5 m -123.88 133.89 53.67 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 115.056 -0.975 . . . . 0.65000000000000002 110.385 176.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 8.7 mp -81.88 169.26 17.05 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.11 -0.95 . . . . 0.79000000000000004 111.141 179.745 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.2 tptp -77.59 -21.48 52.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.972 -0.558 . . . . 1.23 110.719 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -77.97 -20.35 52.84 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.365 -179.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.88 40.82 1.51 Allowed Glycine 0 C--N 1.332 0.334 0 C-N-CA 120.833 -0.698 . . . . 0.69999999999999996 112.287 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -123.21 137.38 54.9 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.673 0.273 . . . . 1.1899999999999999 111.246 -179.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -116.2 120.74 39.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.982 0.42 . . . . 0.68999999999999995 110.846 179.548 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -124.51 179.63 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.928 0 CA-C-O 121.409 0.623 . . . . 0.53000000000000003 109.833 179.898 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 95.9 m -127.33 138.07 52.95 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 114.48 -1.236 . . . . 0.48999999999999999 109.317 177.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.863 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.5 mt -114.03 153.59 29.14 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 114.127 -1.397 . . . . 0.51000000000000001 108.748 -178.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.649 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -108.18 117.96 53.61 Favored Pre-proline 0 C--N 1.326 -0.442 0 O-C-N 121.47 -0.769 . . . . 0.67000000000000004 110.407 178.134 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_exo -58.7 -16.97 33.32 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.962 2.441 . . . . 0.85999999999999999 111.981 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.6 -16.54 62.86 Favored 'General case' 0 CA--C 1.545 0.753 0 CA-C-N 114.854 -1.066 . . . . 1.3500000000000001 113.623 178.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.65 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.41 135.1 20.31 Favored Pre-proline 0 CA--C 1.543 0.676 0 O-C-N 122.272 -0.267 . . . . 0.94999999999999996 110.698 -179.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.446 ' O ' ' HG3' ' A' ' 65' ' ' LYS . 71.8 Cg_endo -65.32 -41.94 14.6 Favored 'Trans proline' 0 CA--C 1.536 0.579 0 C-N-CA 123.588 2.859 . . . . 1.24 113.345 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.65 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.7 -26.61 67.27 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-O 121.328 0.585 . . . . 1.1899999999999999 111.835 176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.863 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.2 OUTLIER -72.17 -40.68 67.78 Favored 'General case' 0 C--N 1.319 -0.743 0 CA-C-N 115.467 -0.788 . . . . 0.89000000000000001 110.318 178.436 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 36.8 ttpt -72.14 -21.35 61.47 Favored 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 115.949 -0.569 . . . . 1.71 110.921 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.446 ' HG3' ' O ' ' A' ' 61' ' ' PRO . 30.5 mtpp -77.38 -55.58 5.28 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 112.997 0.74 . . . . 1.29 112.997 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.5 m -62.34 -29.55 46.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 CA-C-N 116.157 -0.474 . . . . 0.91000000000000003 111.267 178.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.429 ' O ' HG12 ' A' ' 70' ' ' ILE . 29.7 pt -85.14 -20.77 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 C-N-CA 120.857 -0.337 . . . . 1.05 110.188 178.659 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -75.77 -41.98 51.54 Favored 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 120.875 -0.33 . . . . 1.52 110.487 176.5 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 99.1 mttt -62.81 -30.86 71.8 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 113.127 0.788 . . . . 1.5800000000000001 113.127 -179.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.429 HG12 ' O ' ' A' ' 67' ' ' ILE . 38.7 pt -71.02 -19.25 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.514 0 C-N-CA 120.973 -0.291 . . . . 1.3700000000000001 111.62 -179.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 58.7 mt -83.11 -13.5 55.52 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.945 0.402 . . . . 1.6699999999999999 110.153 179.271 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -98.87 -43.77 6.61 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-N 115.864 -0.607 . . . . 2.21 110.176 179.775 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -74.52 -29.5 61.62 Favored Glycine 0 C--N 1.332 0.323 0 C-N-CA 121.049 -0.596 . . . . 1.77 112.307 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.13 -23.14 75.07 Favored Glycine 0 C--N 1.332 0.348 0 C-N-CA 121.202 -0.523 . . . . 2.0899999999999999 112.177 179.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -81.45 -23.47 37.44 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.012 0.434 . . . . 2.29 110.39 179.515 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -78.48 -24.56 45.88 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.915 -0.584 . . . . 2.4399999999999999 110.597 179.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -76.28 106.12 7.72 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.16 -0.473 . . . . 2.7000000000000002 110.033 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.0 m120 . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.283 -0.865 . . . . 2.5600000000000001 111.105 -179.295 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.036 0 CA-C-O 122.702 1.239 . . . . 0.80000000000000004 110.173 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.57 -64.84 0.78 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.462 -1.699 . . . . 0.84999999999999998 111.419 -179.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.08 4.53 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 123.952 0.901 . . . . 0.77000000000000002 110.535 -173.639 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.2 140.13 52.79 Favored 'General case' 0 N--CA 1.474 0.749 0 CA-C-N 113.838 -1.528 . . . . 0.65000000000000002 110.115 179.084 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.52 30.18 Favored 'General case' 0 N--CA 1.476 0.834 0 CA-C-N 113.933 -1.485 . . . . 0.68000000000000005 108.347 -176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.0 m -54.9 151.06 9.14 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 116.124 -0.489 . . . . 0.5 109.833 172.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -59.93 -31.28 47.25 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.286 0 CA-C-O 121.746 0.784 . . . . 0.46999999999999997 111.458 177.712 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -118.87 104.26 10.38 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 124.771 1.228 . . . . 0.46999999999999997 111.37 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.33 -33.4 28.96 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.731 -1.122 . . . . 0.57999999999999996 113.733 175.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.71 -178.75 3.52 Favored 'General case' 0 C--N 1.317 -0.841 0 C-N-CA 124.84 1.256 . . . . 0.57999999999999996 110.1 -178.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.584 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.73 -171.55 2.5 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.88 -1.509 . . . . 0.59999999999999998 111.327 178.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.616 HG21 HD12 ' B' ' 54' ' ' ILE . 85.8 m -157.86 152.28 24.76 Favored 'General case' 0 N--CA 1.472 0.649 0 C-N-CA 125.731 1.612 . . . . 0.57999999999999996 110.117 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.21 72.28 1.42 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 123.754 1.74 . . . . 0.72999999999999998 112.165 177.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.07 -177.26 51.4 Favored Glycine 0 CA--C 1.544 1.884 0 CA-C-N 113.221 -1.808 . . . . 0.64000000000000001 110.94 174.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.725 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 138.05 -172.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.792 1 C-N-CA 136.132 5.773 . . . . 0.64000000000000001 106.293 8.079 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.725 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.57 143.41 32.18 Favored Pre-proline 0 CA--C 1.543 0.69 0 O-C-N 121.97 -0.456 . . . . 0.68000000000000005 110.022 174.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.431 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 85.9 Cg_exo -51.18 -22.09 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.554 0 C-N-CA 124.871 3.714 . . . . 0.58999999999999997 112.817 174.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.59 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.64 -28.79 15.49 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 124.707 1.203 . . . . 0.68999999999999995 112.619 179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 37.0 mmt -88.08 -18.81 28.08 Favored 'General case' 0 N--CA 1.476 0.847 0 N-CA-C 113.509 0.929 . . . . 0.94999999999999996 113.509 175.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 17.5 mm -88.14 147.81 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 O-C-N 122.014 -0.429 . . . . 0.57999999999999996 111.641 -178.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 69.6 m -144.76 -1.62 0.87 Allowed 'General case' 0 CA--C 1.533 0.325 0 CA-C-N 116.145 -0.48 . . . . 0.69999999999999996 111.218 179.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -159.08 132.36 7.19 Favored 'General case' 0 N--CA 1.467 0.396 0 CA-C-N 116.347 -0.388 . . . . 0.82999999999999996 110.203 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 12.8 tp -127.23 115.86 19.71 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.457 -0.338 . . . . 0.75 111.328 -179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.48 ' HB2' HG22 ' B' ' 45' ' ' VAL . 29.0 mt-30 -108.56 114.51 28.38 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.338 -0.392 . . . . 1.0800000000000001 110.411 179.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 13.1 t -97.9 113.12 31.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 115.992 -0.549 . . . . 0.60999999999999999 111.426 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 31.9 m-85 -96.59 128.62 43.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.229 -0.441 . . . . 0.85999999999999999 110.314 179.708 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.41 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -97.21 -156.15 0.52 Allowed 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.717 0.294 . . . . 0.60999999999999999 111.148 179.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 4.9 mp -71.47 118.85 16.87 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.238 0 CA-C-N 116.305 -0.407 . . . . 1.1000000000000001 110.973 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -127.84 -167.67 12.31 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 121.016 -0.611 . . . . 0.63 112.348 179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -79.32 -7.49 15.01 Favored 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.287 2.658 . . . . 0.79000000000000004 112.818 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -21.38 11.5 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 113.108 0.781 . . . . 0.70999999999999996 113.108 -179.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -147.52 127.58 13.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.026 -0.533 . . . . 0.67000000000000004 110.937 -177.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 8.7 t -99.55 38.08 1.49 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.097 0.475 . . . . 1.01 110.557 179.845 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 75.0 tttt -148.14 154.25 39.91 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.061 -0.518 . . . . 1.1599999999999999 110.84 -179.545 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.41 HG12 ' HA ' ' B' ' 34' ' ' ALA . 6.0 m -87.7 127.74 40.7 Favored 'Isoleucine or valine' 0 C--O 1.233 0.22 0 CA-C-N 116.256 -0.429 . . . . 0.78000000000000003 111.014 179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 58.8 mt-10 -133.4 130.15 38.33 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.32 -0.4 . . . . 0.80000000000000004 110.193 -179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 2.4 m -100.52 106.14 18.82 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.165 0 CA-C-O 121.721 0.772 . . . . 0.59999999999999998 112.354 -178.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.48 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.8 OUTLIER -93.65 150.49 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.958 0 CA-C-O 122.492 1.139 . . . . 0.62 110.699 178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.36 46.49 Favored 'General case' 0 N--CA 1.478 0.925 0 CA-C-N 115.154 -0.93 . . . . 0.55000000000000004 111.191 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 21.0 m -123.75 133.52 53.83 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 115.03 -0.986 . . . . 0.63 110.476 176.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -79.92 165.99 22.09 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.232 -0.894 . . . . 0.75 110.554 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.0 tptp -72.86 -16.5 61.59 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.058 0.456 . . . . 1.27 110.536 179.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -79.84 -22.38 43.04 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.717 -0.674 . . . . 0.98999999999999999 110.787 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.36 42.45 1.74 Allowed Glycine 0 C--N 1.332 0.306 0 C-N-CA 121.064 -0.589 . . . . 0.67000000000000004 112.53 179.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mtpt -128.64 117.93 22.04 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.77 0.319 . . . . 1.05 110.967 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -94.72 131.11 40.88 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-O 121.486 0.66 . . . . 0.70999999999999996 110.001 179.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.616 HD12 HG21 ' B' ' 19' ' ' THR . 50.0 pt -127.95 179.56 3.67 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.011 0 CA-C-N 114.749 -1.114 . . . . 0.52000000000000002 109.811 178.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.39 137.96 52.88 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 114.443 -1.253 . . . . 0.47999999999999998 109.333 177.587 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.611 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.92 151.88 31.61 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.046 -1.434 . . . . 0.48999999999999999 108.719 -178.554 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.584 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.9 t0 -102.22 112.93 65.97 Favored Pre-proline 0 N--CA 1.469 0.506 0 O-C-N 120.278 -1.514 . . . . 0.63 110.733 178.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_exo -53.69 -17.47 10.07 Favored 'Trans proline' 0 C--N 1.362 1.243 0 C-N-CA 123.2 2.6 . . . . 0.82999999999999996 112.925 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.28 -16.39 62.02 Favored 'General case' 0 CA--C 1.546 0.791 0 CA-C-N 114.939 -1.028 . . . . 1.3999999999999999 113.598 179.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.643 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.49 135.07 20.27 Favored Pre-proline 0 CA--C 1.541 0.609 0 O-C-N 122.242 -0.286 . . . . 0.91000000000000003 110.736 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.41 -41.75 14.83 Favored 'Trans proline' 0 CA--C 1.536 0.581 0 C-N-CA 123.612 2.875 . . . . 1.1899999999999999 113.37 -178.78 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.643 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.86 -27.01 67.8 Favored 'General case' 0 N--CA 1.479 1.01 0 CA-C-O 121.24 0.543 . . . . 1.1499999999999999 111.729 176.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.611 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -67.6 -41.8 83.45 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 110.326 178.686 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.505 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 40.0 ttpt -67.03 -23.97 65.96 Favored 'General case' 0 CA--C 1.533 0.319 0 CA-C-N 115.752 -0.658 . . . . 1.71 111.071 179.888 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.6 mtpp -75.82 -55.57 5.51 Favored 'General case' 0 N--CA 1.473 0.684 0 C-N-CA 123.64 0.776 . . . . 1.3600000000000001 113.022 179.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 16.4 m -62.3 -29.66 47.17 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.518 0 CA-C-N 116.187 -0.461 . . . . 0.96999999999999997 111.218 178.095 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 22.6 pt -85.07 -20.79 8.15 Favored 'Isoleucine or valine' 0 C--N 1.345 0.382 0 C-N-CA 120.878 -0.329 . . . . 1.0800000000000001 110.226 178.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.73 -43.75 45.39 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 120.837 -0.345 . . . . 1.52 110.475 176.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -59.98 -32.14 70.56 Favored 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 112.733 0.642 . . . . 1.6100000000000001 112.733 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 12.0 pt -83.69 -23.37 8.08 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.266 0 C-N-CA 121.035 -0.266 . . . . 1.4299999999999999 111.624 -179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 46.9 mt -81.8 -33.93 30.55 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.886 0.374 . . . . 1.79 110.333 179.311 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -83.02 -32.38 26.94 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.988 -0.551 . . . . 2.25 110.212 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.23 -28.52 66.02 Favored Glycine 0 C--N 1.334 0.439 0 CA-C-N 115.901 -0.591 . . . . 1.76 112.268 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . 0.495 ' O ' HG21 ' A' ' 42' ' ' VAL . . . -74.39 -24.82 72.09 Favored Glycine 0 C--N 1.334 0.438 0 C-N-CA 121.159 -0.544 . . . . 2.04 111.983 179.223 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 64.6 t30 -88.02 -14.31 39.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.181 0.515 . . . . 2.3199999999999998 110.405 179.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 25.1 tptp -92.94 -12.26 31.27 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.819 -0.628 . . . . 2.46 111.054 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -70.09 113.98 7.8 Favored 'General case' 0 C--O 1.232 0.158 0 CA-C-O 120.819 0.342 . . . . 2.7799999999999998 110.399 179.828 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.051 0 CA-C-O 118.33 -0.843 . . . . 2.48 111.034 -179.503 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.061 0 CA-C-O 122.8 1.286 . . . . 0.81000000000000005 110.045 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.8 0.78 Allowed 'General case' 0 N--CA 1.475 0.823 0 CA-C-N 113.311 -1.768 . . . . 0.83999999999999997 111.364 -179.855 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.47 115.11 4.54 Favored 'General case' 0 N--CA 1.466 0.374 0 C-N-CA 124.042 0.937 . . . . 0.76000000000000001 110.443 -173.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.19 52.74 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.797 -1.547 . . . . 0.65000000000000002 110.218 178.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.2 146.44 30.28 Favored 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 114.014 -1.448 . . . . 0.66000000000000003 108.386 -176.057 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.1 m -54.89 151.1 9.07 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 116.07 -0.513 . . . . 0.48999999999999999 109.832 173.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.0 -31.12 47.02 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 CA-C-O 121.719 0.771 . . . . 0.45000000000000001 111.564 177.652 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.635 ' SG ' HG12 ' A' ' 45' ' ' VAL . 62.7 m -118.99 104.31 10.37 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 124.837 1.255 . . . . 0.46000000000000002 111.326 178.937 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.49 -33.28 28.44 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.599 -1.182 . . . . 0.56999999999999995 113.702 175.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.75 -178.7 3.5 Favored 'General case' 0 C--N 1.315 -0.92 0 C-N-CA 124.836 1.255 . . . . 0.56999999999999995 109.981 -179.042 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.589 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.64 2.52 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 113.757 -1.565 . . . . 0.62 111.347 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 85.5 m -157.9 152.32 24.72 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 125.791 1.636 . . . . 0.60999999999999999 110.177 179.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.1 72.17 1.41 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 123.483 1.611 . . . . 0.76000000000000001 112.093 177.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.583 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.95 -177.37 51.49 Favored Glycine 0 CA--C 1.543 1.787 0 CA-C-N 113.305 -1.77 . . . . 0.68999999999999995 110.904 174.401 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 8.9 p 137.95 -172.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.753 1 C-N-CA 136.196 5.799 . . . . 0.68999999999999995 106.42 8.08 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.52 143.44 32.19 Favored Pre-proline 0 CA--C 1.543 0.703 0 O-C-N 121.793 -0.567 . . . . 0.72999999999999998 110.108 174.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 86.4 Cg_exo -51.25 -21.93 10.53 Favored 'Trans proline' 0 N--CA 1.477 0.537 0 C-N-CA 124.773 3.649 . . . . 0.64000000000000001 112.828 174.145 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.583 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.66 -28.85 15.82 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 124.565 1.146 . . . . 0.73999999999999999 112.653 179.615 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 34.3 mmt -87.98 -18.13 29.73 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 113.535 0.939 . . . . 1.0800000000000001 113.535 175.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.5 mm -91.43 136.67 23.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 O-C-N 122.046 -0.409 . . . . 0.57999999999999996 111.185 -179.361 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 69.7 m -140.14 10.79 2.37 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.408 -0.36 . . . . 0.68999999999999995 110.902 179.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -161.51 127.5 3.74 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.025 -0.534 . . . . 0.78000000000000003 110.15 -179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 53.4 tp -116.19 146.99 41.87 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.372 -0.376 . . . . 0.73999999999999999 110.802 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.655 ' HB2' HG23 ' A' ' 45' ' ' VAL . 54.0 mt-30 -142.41 115.29 8.71 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.892 0.377 . . . . 1.1599999999999999 110.196 179.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 19.2 t -102.69 123.19 55.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-O 121.071 0.462 . . . . 0.62 111.431 -179.549 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -112.09 125.77 54.46 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.98 -0.554 . . . . 0.72999999999999998 110.321 179.551 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -96.56 -153.91 0.43 Allowed 'General case' 0 CA--C 1.531 0.231 0 CA-C-O 120.718 0.294 . . . . 0.66000000000000003 111.131 179.844 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 3.5 mt -67.3 124.48 22.72 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.189 0 CA-C-N 116.055 -0.52 . . . . 1.1399999999999999 111.183 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -130.78 -175.87 14.19 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 120.887 -0.673 . . . . 0.66000000000000003 112.526 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -79.25 -7.72 15.12 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 123.167 2.578 . . . . 0.81000000000000005 112.721 179.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.39 -20.75 12.13 Favored 'General case' 0 N--CA 1.471 0.595 0 N-CA-C 113.124 0.787 . . . . 0.72999999999999998 113.124 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.1 t -142.76 137.59 29.87 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.035 -0.529 . . . . 0.70999999999999996 110.881 -177.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 27.2 t -85.69 -50.92 6.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 116.415 -0.357 . . . . 1.0700000000000001 110.816 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -80.11 148.81 30.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.115 -0.493 . . . . 1.29 110.574 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 3.0 m -76.07 148.66 7.05 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.16 0.505 . . . . 0.82999999999999996 110.65 179.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 20.2 mt-10 -136.35 130.25 32.55 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.792 -0.64 . . . . 0.79000000000000004 110.128 -179.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.602 HG22 ' HG3' ' A' ' 58' ' ' PRO . 1.5 m -100.61 106.19 18.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 121.626 0.727 . . . . 0.66000000000000003 112.378 -178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 31' ' ' GLN . 4.8 m -93.65 150.49 3.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 CA-C-O 122.576 1.179 . . . . 0.68999999999999995 110.794 178.473 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.32 46.48 Favored 'General case' 0 N--CA 1.478 0.929 0 CA-C-N 115.195 -0.911 . . . . 0.57999999999999996 111.189 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.64 132.92 53.97 Favored 'General case' 0 N--CA 1.474 0.766 0 CA-C-N 115.11 -0.95 . . . . 0.65000000000000002 110.466 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.0 172.4 13.79 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.286 -0.87 . . . . 0.79000000000000004 110.739 179.609 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -80.88 -12.94 59.33 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.21 -0.45 . . . . 1.23 110.696 179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 77.8 m-20 -84.26 -10.32 57.76 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 116.061 -0.518 . . . . 1.05 111.185 179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.73 44.7 2.84 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.952 -0.642 . . . . 0.69999999999999996 112.517 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -129.73 159.78 35.44 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 120.75 0.31 . . . . 1.1899999999999999 110.834 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -137.24 129.51 29.57 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-O 121.417 0.627 . . . . 0.68999999999999995 109.924 179.192 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.7 pt -127.83 179.52 3.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.027 0 CA-C-N 114.633 -1.167 . . . . 0.53000000000000003 109.778 178.001 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.25 138.0 52.99 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 114.307 -1.315 . . . . 0.48999999999999999 109.281 177.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.869 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.4 mt -113.9 153.23 29.58 Favored 'General case' 0 C--N 1.314 -0.974 0 CA-C-N 114.113 -1.403 . . . . 0.51000000000000001 108.731 -178.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.589 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 3.3 t0 -100.88 110.9 62.25 Favored Pre-proline 0 C--N 1.328 -0.354 0 O-C-N 121.637 -0.665 . . . . 0.67000000000000004 110.109 178.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.602 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.2 Cg_exo -65.44 -9.16 21.26 Favored 'Trans proline' 0 C--N 1.352 0.749 0 C-N-CA 122.992 2.461 . . . . 0.85999999999999999 112.678 -179.592 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 -75.57 -13.22 60.34 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.968 -0.56 . . . . 1.3500000000000001 110.93 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.64 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -98.92 135.09 21.01 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 120.235 -0.586 . . . . 0.94999999999999996 110.723 -179.762 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.34 -41.88 14.69 Favored 'Trans proline' 0 N--CA 1.478 0.584 0 C-N-CA 123.616 2.877 . . . . 1.24 113.34 -178.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.64 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.86 68.2 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-O 121.324 0.583 . . . . 1.1899999999999999 111.775 176.942 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.869 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -77.62 -30.6 52.36 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.72 -0.673 . . . . 0.89000000000000001 110.516 178.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.498 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.2 ttpt -69.49 -22.39 63.62 Favored 'General case' 0 CA--C 1.534 0.335 0 CA-C-N 116.0 -0.545 . . . . 1.71 110.879 179.306 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.25 -57.1 4.1 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.662 0.785 . . . . 1.29 113.04 179.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 33.4 m -60.73 -29.07 44.32 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-N 115.702 -0.681 . . . . 0.91000000000000003 111.399 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.444 HG12 ' O ' ' A' ' 63' ' ' LEU . 42.5 pt -85.24 -26.05 6.68 Favored 'Isoleucine or valine' 0 C--N 1.344 0.366 0 N-CA-C 110.169 -0.308 . . . . 1.05 110.169 178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.498 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.4 -42.92 71.02 Favored 'General case' 0 N--CA 1.473 0.693 0 CA-C-N 116.637 -0.256 . . . . 1.52 110.472 177.204 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -61.19 -32.96 72.71 Favored 'General case' 0 N--CA 1.465 0.315 0 N-CA-C 112.824 0.676 . . . . 1.5800000000000001 112.824 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 24.5 pt -82.66 -7.03 10.59 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 N-CA-C 111.858 0.318 . . . . 1.3700000000000001 111.858 -179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 75.4 mt -95.6 -38.92 10.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.799 0.333 . . . . 1.6699999999999999 110.429 179.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -81.91 -41.21 21.22 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.979 -0.555 . . . . 2.21 110.209 179.528 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.82 73.93 Favored Glycine 0 C--N 1.333 0.397 0 CA-C-N 115.844 -0.617 . . . . 1.77 112.784 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.4 -26.33 70.46 Favored Glycine 0 C--N 1.333 0.362 0 C-N-CA 121.09 -0.576 . . . . 2.0899999999999999 112.223 179.408 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.2 t30 -85.53 -27.95 25.25 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.039 0.447 . . . . 2.29 110.4 179.442 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -82.49 -18.21 42.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.932 -0.577 . . . . 2.4399999999999999 110.792 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -69.36 122.21 18.47 Favored 'General case' 0 C--N 1.332 -0.16 0 CA-C-N 116.179 -0.464 . . . . 2.7000000000000002 110.547 179.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 1.001 0 CA-C-O 118.225 -0.893 . . . . 2.5600000000000001 111.066 -179.725 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.748 1.261 . . . . 0.80000000000000004 110.223 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.563 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.71 0.78 Allowed 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 113.367 -1.742 . . . . 0.84999999999999998 111.338 -179.775 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.563 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.03 4.5 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 123.885 0.874 . . . . 0.77000000000000002 110.523 -173.663 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.15 140.28 52.69 Favored 'General case' 0 N--CA 1.472 0.665 0 CA-C-N 113.893 -1.503 . . . . 0.65000000000000002 110.15 179.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.3 146.39 30.44 Favored 'General case' 0 N--CA 1.475 0.81 0 CA-C-N 113.988 -1.46 . . . . 0.68000000000000005 108.398 -176.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -54.88 151.02 9.15 Favored 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 116.081 -0.509 . . . . 0.5 109.805 173.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.99 -31.07 46.88 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.334 0 CA-C-O 121.753 0.787 . . . . 0.46999999999999997 111.453 177.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.47 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.6 m -119.01 104.17 10.24 Favored 'General case' 0 N--CA 1.469 0.515 0 C-N-CA 124.793 1.237 . . . . 0.46999999999999997 111.352 179.037 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.7 mt -82.16 -33.46 29.53 Favored 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 114.679 -1.146 . . . . 0.57999999999999996 113.788 175.081 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.84 3.54 Favored 'General case' 0 C--N 1.316 -0.867 0 C-N-CA 124.987 1.315 . . . . 0.57999999999999996 110.108 -178.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.646 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.73 -171.72 2.54 Favored 'General case' 0 N--CA 1.474 0.725 0 CA-C-N 113.853 -1.521 . . . . 0.59999999999999998 111.315 178.671 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.613 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.7 152.34 25.13 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 125.862 1.665 . . . . 0.57999999999999996 110.238 179.909 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . 0.526 ' HA ' ' CE1' ' B' ' 62' ' ' PHE . 6.4 pm0 -128.24 72.34 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.713 1.721 . . . . 0.72999999999999998 112.144 177.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.14 -177.16 51.35 Favored Glycine 0 CA--C 1.545 1.925 0 CA-C-N 113.209 -1.814 . . . . 0.64000000000000001 110.829 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.729 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.1 -172.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.229 5.812 . . . . 0.64000000000000001 106.356 7.943 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.729 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.1 t-80 -117.67 143.4 32.28 Favored Pre-proline 0 CA--C 1.542 0.672 0 O-C-N 121.977 -0.452 . . . . 0.68000000000000005 110.05 174.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.428 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 87.6 Cg_exo -51.29 -21.99 10.78 Favored 'Trans proline' 0 N--CA 1.477 0.521 0 C-N-CA 124.864 3.71 . . . . 0.58999999999999997 112.783 174.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.594 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.7 -28.67 15.6 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.536 1.134 . . . . 0.68999999999999995 112.777 179.569 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.9 mmt -88.08 -19.43 27.09 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 113.527 0.936 . . . . 0.94999999999999996 113.527 175.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 13.3 mm -92.44 146.83 5.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.809 0.338 . . . . 0.57999999999999996 111.659 -178.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 54.7 m -144.35 6.28 1.29 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.318 -0.401 . . . . 0.69999999999999996 110.942 179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 5.6 t30 -165.82 134.47 3.13 Favored 'General case' 0 N--CA 1.466 0.342 0 CA-C-O 120.897 0.38 . . . . 0.82999999999999996 110.856 -179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 19.8 tp -121.98 148.98 44.12 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.07 -0.514 . . . . 0.75 110.453 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.603 ' HB2' HG22 ' B' ' 45' ' ' VAL . 36.0 mt-30 -138.98 125.19 20.17 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.782 0.325 . . . . 1.0800000000000001 110.592 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 3.4 t -110.3 143.62 19.95 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-N 116.199 -0.455 . . . . 0.60999999999999999 110.736 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -130.89 135.72 47.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.85999999999999999 110.475 -179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -99.25 -158.22 0.66 Allowed 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.66 0.267 . . . . 0.60999999999999999 110.978 179.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 67.6 mt -73.16 126.08 33.21 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 116.322 -0.399 . . . . 1.1000000000000001 111.106 -179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -136.84 -168.25 11.36 Favored Glycine 0 CA--C 1.519 0.335 0 C-N-CA 121.024 -0.608 . . . . 0.63 112.427 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -78.43 -8.28 16.09 Favored 'Trans proline' 0 C--N 1.346 0.421 0 C-N-CA 123.261 2.641 . . . . 0.79000000000000004 112.781 179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.64 -21.27 11.8 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 113.038 0.755 . . . . 0.70999999999999996 113.038 -179.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 2.5 t -145.3 152.52 40.05 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.191 -0.459 . . . . 0.67000000000000004 111.332 -177.518 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 7.9 t -127.65 27.0 5.84 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.1 0.476 . . . . 1.01 110.21 179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 79.2 tttt -141.38 144.45 34.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.844 -0.617 . . . . 1.1599999999999999 110.924 -179.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 4.1 m -78.73 124.81 37.64 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-O 121.011 0.434 . . . . 0.78000000000000003 110.553 179.088 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . 0.421 ' OE1' ' HB2' ' B' ' 15' ' ' CYS . 24.3 mt-10 -132.53 130.2 40.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.145 -0.48 . . . . 0.80000000000000004 110.128 -178.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -100.5 106.31 19.1 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-O 121.758 0.79 . . . . 0.59999999999999998 112.35 -179.109 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.603 HG22 ' HB2' ' B' ' 31' ' ' GLN . 0.7 OUTLIER -93.69 150.35 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.966 0 CA-C-O 122.503 1.144 . . . . 0.62 110.748 178.443 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.2 153.44 46.6 Favored 'General case' 0 N--CA 1.477 0.91 0 CA-C-N 115.228 -0.896 . . . . 0.55000000000000004 111.195 179.867 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 61.7 m -123.78 133.25 53.86 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.089 -0.96 . . . . 0.63 110.467 176.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -80.79 172.89 13.18 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.268 -0.878 . . . . 0.75 111.119 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.8 tptp -79.76 -16.04 56.33 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 115.941 -0.572 . . . . 1.27 111.035 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 87.1 m-20 -82.76 -6.76 59.57 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.313 -0.403 . . . . 0.98999999999999999 111.462 -179.828 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.87 37.96 4.79 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.742 -0.742 . . . . 0.67000000000000004 112.21 -179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.49 162.21 18.34 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.58 0.229 . . . . 1.05 110.788 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -142.57 124.39 15.13 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.129 0.49 . . . . 0.70999999999999996 110.863 179.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.613 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -125.96 179.67 3.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-O 121.317 0.58 . . . . 0.52000000000000002 109.851 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.5 m -127.46 137.97 52.83 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.423 -1.262 . . . . 0.47999999999999998 109.213 177.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.647 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.7 mt -113.89 152.8 30.25 Favored 'General case' 0 C--N 1.313 -1.011 0 CA-C-N 114.054 -1.43 . . . . 0.48999999999999999 108.676 -178.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.646 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.5 t0 -108.83 116.24 56.11 Favored Pre-proline 0 C--N 1.325 -0.458 0 O-C-N 121.055 -1.028 . . . . 0.63 110.493 178.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_exo -55.98 -17.32 18.85 Favored 'Trans proline' 0 C--N 1.358 1.079 0 C-N-CA 123.148 2.565 . . . . 0.82999999999999996 112.52 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -63.96 -16.53 61.74 Favored 'General case' 0 CA--C 1.546 0.809 0 CA-C-N 114.957 -1.019 . . . . 1.3999999999999999 113.54 178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.51 135.14 20.25 Favored Pre-proline 0 CA--C 1.539 0.526 0 O-C-N 122.236 -0.29 . . . . 0.91000000000000003 110.763 -179.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.41 -41.74 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.508 2.806 . . . . 1.1899999999999999 113.363 -178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.2 p90 -60.85 -26.76 67.59 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-O 121.236 0.541 . . . . 1.1499999999999999 111.716 176.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.647 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.2 OUTLIER -70.34 -44.17 68.74 Favored 'General case' 0 N--CA 1.443 -0.802 0 CA-C-N 115.17 -0.923 . . . . 0.90000000000000002 110.062 178.311 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.513 ' O ' ' HB2' ' B' ' 68' ' ' GLN . 39.3 ttpt -58.69 -28.33 65.67 Favored 'General case' 0 N--CA 1.466 0.366 0 CA-C-N 115.932 -0.576 . . . . 1.71 111.387 179.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.92 -55.52 5.39 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.082 0.771 . . . . 1.3600000000000001 113.082 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 18.8 m -62.51 -29.33 46.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.199 -0.455 . . . . 0.96999999999999997 111.235 178.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.474 HG23 ' O ' ' B' ' 63' ' ' LEU . 18.4 pt -85.28 -20.72 8.11 Favored 'Isoleucine or valine' 0 C--N 1.346 0.421 0 C-N-CA 120.91 -0.316 . . . . 1.0800000000000001 110.18 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' B' ' 64' ' ' LYS . 53.2 tt0 -75.95 -43.17 46.11 Favored 'General case' 0 N--CA 1.473 0.679 0 C-N-CA 120.794 -0.362 . . . . 1.52 110.393 176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 94.8 mttt -62.69 -26.56 68.72 Favored 'General case' 0 N--CA 1.466 0.327 0 N-CA-C 112.814 0.672 . . . . 1.6100000000000001 112.814 -179.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . . . . . . . . . 13.5 pt -94.27 8.9 5.35 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 N-CA-C 111.994 0.368 . . . . 1.4299999999999999 111.994 -179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 45.3 mt -108.26 -52.34 2.78 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.776 0.322 . . . . 1.79 110.632 179.259 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -86.26 -23.01 26.54 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.093 -0.503 . . . . 2.25 110.948 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -68.07 -29.3 73.36 Favored Glycine 0 C--N 1.333 0.381 0 C-N-CA 120.947 -0.644 . . . . 1.76 112.573 179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -81.76 -28.08 43.98 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.938 -0.648 . . . . 2.04 112.391 179.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 48.0 t30 -63.72 -19.46 64.96 Favored 'General case' 0 N--CA 1.466 0.328 0 CA-C-O 120.836 0.35 . . . . 2.3199999999999998 111.208 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 21.4 tptp -78.17 -32.22 50.03 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.099 -0.501 . . . . 2.46 110.666 179.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -69.14 118.19 11.72 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.266 -0.425 . . . . 2.7799999999999998 111.387 -179.711 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 8.7 m120 . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.251 -0.88 . . . . 2.48 110.852 -179.842 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.046 0 CA-C-O 122.669 1.223 . . . . 0.81000000000000005 110.095 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.568 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.63 -64.84 0.78 Allowed 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 113.315 -1.766 . . . . 0.83999999999999997 111.409 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.568 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.48 115.04 4.52 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 123.967 0.907 . . . . 0.76000000000000001 110.419 -173.609 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.15 52.8 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 113.853 -1.521 . . . . 0.65000000000000002 110.244 178.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.46 30.22 Favored 'General case' 0 N--CA 1.475 0.814 0 CA-C-N 114.038 -1.437 . . . . 0.66000000000000003 108.414 -176.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.3 m -54.94 151.08 9.21 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 116.064 -0.516 . . . . 0.48999999999999999 109.868 173.034 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -60.06 -30.96 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.299 0 CA-C-O 121.7 0.762 . . . . 0.45000000000000001 111.588 177.728 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.524 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.9 m -119.07 104.4 10.43 Favored 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 124.815 1.246 . . . . 0.46000000000000002 111.274 178.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.47 -33.46 28.42 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 114.575 -1.193 . . . . 0.56999999999999995 113.596 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.7 -178.7 3.5 Favored 'General case' 0 C--N 1.314 -0.949 0 C-N-CA 124.847 1.259 . . . . 0.56999999999999995 110.036 -178.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.564 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.75 -171.69 2.53 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.772 -1.558 . . . . 0.62 111.398 178.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.614 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.71 152.39 25.16 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 125.861 1.664 . . . . 0.60999999999999999 110.245 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.18 72.22 1.41 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-O 123.51 1.624 . . . . 0.76000000000000001 112.048 177.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.58 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.05 -177.32 51.43 Favored Glycine 0 CA--C 1.544 1.883 0 CA-C-N 113.292 -1.776 . . . . 0.68999999999999995 110.914 174.378 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.1 p 137.9 -172.52 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.732 1 C-N-CA 136.206 5.802 . . . . 0.68999999999999995 106.399 8.287 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.36 32.03 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.914 -0.492 . . . . 0.72999999999999998 110.121 174.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.434 ' HD2' ' CG ' ' A' ' 23' ' ' HIS . 87.8 Cg_exo -51.21 -21.94 10.39 Favored 'Trans proline' 0 N--CA 1.477 0.539 0 C-N-CA 124.813 3.675 . . . . 0.64000000000000001 112.814 174.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.67 -28.98 16.32 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 124.628 1.171 . . . . 0.73999999999999999 112.553 179.671 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 15.2 mmt -87.93 -19.24 27.56 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 113.558 0.947 . . . . 1.0800000000000001 113.558 175.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.412 HG23 ' HB1' ' A' ' 46' ' ' ALA . 43.5 mm -89.97 143.38 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.419 -0.355 . . . . 0.57999999999999996 111.427 -179.082 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m -138.99 -23.11 0.93 Allowed 'General case' 0 CA--C 1.532 0.261 0 CA-C-N 116.348 -0.387 . . . . 0.68999999999999995 111.391 179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . . . . . . . . . 49.9 t30 -129.81 142.87 50.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.722 0.296 . . . . 0.78000000000000003 110.912 -179.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 42.4 tp -129.64 139.55 51.39 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.156 -0.474 . . . . 0.73999999999999999 110.641 179.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . . . . . . . . . 51.4 mt-30 -133.38 108.43 8.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.295 -0.412 . . . . 1.1599999999999999 110.188 179.394 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.43 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 16.2 t -96.26 102.93 14.09 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.977 0.417 . . . . 0.62 111.462 -179.416 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -98.08 124.49 42.62 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.874 -0.603 . . . . 0.72999999999999998 110.684 179.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.27 -158.27 0.43 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-O 120.957 0.408 . . . . 0.66000000000000003 111.737 -179.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG23 ' HA ' ' A' ' 40' ' ' SER . 79.7 mt -72.01 124.47 28.68 Favored 'Isoleucine or valine' 0 C--O 1.233 0.202 0 CA-C-N 116.035 -0.53 . . . . 1.1399999999999999 111.372 -179.762 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.63 -167.69 12.44 Favored Glycine 0 N--CA 1.451 -0.349 0 CA-C-N 115.81 -0.632 . . . . 0.66000000000000003 112.228 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 4.2 Cg_exo -78.65 -6.09 15.13 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 123.242 2.628 . . . . 0.81000000000000005 113.031 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.74 -21.63 11.12 Favored 'General case' 0 N--CA 1.471 0.59 0 N-CA-C 113.092 0.775 . . . . 0.72999999999999998 113.092 -179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 2.7 t -148.13 129.62 14.9 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.105 -0.498 . . . . 0.70999999999999996 110.674 -177.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.598 ' HA ' HG23 ' A' ' 35' ' ' ILE . 8.3 t -100.19 26.03 6.92 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.951 0.405 . . . . 1.0700000000000001 110.87 -179.917 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 25.7 mtpp -129.79 156.39 44.41 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.323 -0.399 . . . . 1.29 111.187 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 4.5 m -94.63 125.22 47.29 Favored 'Isoleucine or valine' 0 C--O 1.233 0.189 0 CA-C-N 116.091 -0.504 . . . . 0.82999999999999996 110.449 179.174 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.524 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 0.3 OUTLIER -134.49 130.3 36.47 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-N 116.472 -0.331 . . . . 0.79000000000000004 110.149 -178.532 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -100.69 106.5 19.45 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.19 0 CA-C-O 121.834 0.826 . . . . 0.66000000000000003 112.333 -179.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -93.9 150.45 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.976 0 CA-C-O 122.522 1.153 . . . . 0.68999999999999995 110.801 178.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . 0.412 ' HB1' HG23 ' A' ' 27' ' ' ILE . . . -140.22 153.42 46.57 Favored 'General case' 0 N--CA 1.477 0.896 0 CA-C-N 115.134 -0.939 . . . . 0.57999999999999996 111.104 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.408 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.7 m -123.8 133.83 53.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.059 -0.973 . . . . 0.65000000000000002 110.456 176.82 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 7.9 mp -74.63 173.86 9.86 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 114.321 -1.309 . . . . 0.79000000000000004 110.828 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 25.2 tptp -79.88 -17.68 52.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.082 -0.508 . . . . 1.23 110.28 179.185 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 75.5 m-20 -74.92 -30.49 61.28 Favored 'General case' 0 C--O 1.232 0.182 0 CA-C-N 115.822 -0.626 . . . . 1.05 110.938 179.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.02 43.73 0.71 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.899 -0.667 . . . . 0.69999999999999996 112.574 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.408 ' O ' ' HA ' ' A' ' 47' ' ' SER . 43.6 mtpt -128.61 151.85 49.01 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.836 0.351 . . . . 1.1899999999999999 111.132 179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.23 129.56 48.0 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.391 0.615 . . . . 0.68999999999999995 109.938 -179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.614 HD12 HG21 ' A' ' 19' ' ' THR . 49.9 pt -127.85 179.47 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.063 0 CA-C-N 114.617 -1.174 . . . . 0.53000000000000003 109.795 178.077 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.6 m -127.32 138.03 52.95 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 114.434 -1.257 . . . . 0.48999999999999999 109.271 177.512 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.794 ' HB3' HD11 ' A' ' 63' ' ' LEU . 39.5 mt -113.95 151.91 31.63 Favored 'General case' 0 C--N 1.314 -0.948 0 CA-C-N 114.002 -1.453 . . . . 0.51000000000000001 108.671 -178.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.564 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.6 t0 -101.02 109.06 57.23 Favored Pre-proline 0 N--CA 1.471 0.62 0 O-C-N 120.188 -1.57 . . . . 0.67000000000000004 110.657 178.021 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -53.8 -17.38 10.25 Favored 'Trans proline' 0 C--N 1.36 1.176 0 C-N-CA 123.06 2.507 . . . . 0.85999999999999999 112.899 179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -64.22 -16.55 62.23 Favored 'General case' 0 CA--C 1.545 0.771 0 CA-C-N 115.085 -0.961 . . . . 1.3500000000000001 113.586 179.484 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.645 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.48 135.15 20.26 Favored Pre-proline 0 CA--C 1.542 0.666 0 O-C-N 122.329 -0.232 . . . . 0.94999999999999996 110.704 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -65.29 -41.88 14.86 Favored 'Trans proline' 0 CA--C 1.535 0.567 0 C-N-CA 123.575 2.85 . . . . 1.24 113.415 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.2 p90 -60.89 -26.6 67.54 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-O 121.267 0.556 . . . . 1.1899999999999999 111.725 177.028 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.794 HD11 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -72.8 -37.5 67.51 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.266 -0.879 . . . . 0.89000000000000001 110.426 178.722 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.51 ' HA ' HG12 ' A' ' 67' ' ' ILE . 38.0 ttpt -69.3 -19.57 63.9 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 115.959 -0.564 . . . . 1.71 111.011 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -76.75 -55.36 5.56 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 115.427 -0.806 . . . . 1.29 113.073 179.48 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.4 m -63.86 -27.64 43.28 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 116.254 -0.43 . . . . 0.91000000000000003 111.214 178.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.51 HG12 ' HA ' ' A' ' 64' ' ' LYS . 37.1 pt -83.41 -18.6 10.19 Favored 'Isoleucine or valine' 0 C--N 1.346 0.424 0 C-N-CA 120.851 -0.34 . . . . 1.05 110.206 178.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -76.0 -45.21 35.76 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.803 -0.359 . . . . 1.52 110.519 176.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -60.9 -36.38 79.1 Favored 'General case' 0 N--CA 1.465 0.32 0 N-CA-C 112.546 0.573 . . . . 1.5800000000000001 112.546 -179.194 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . . . . . . . . . 27.4 pt -76.87 -16.95 14.71 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.315 0 N-CA-C 111.907 0.336 . . . . 1.3700000000000001 111.907 -179.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 29.4 mt -92.38 -8.57 44.54 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.516 -0.311 . . . . 1.6699999999999999 111.17 179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -95.79 -35.82 11.38 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-N 116.481 -0.327 . . . . 2.21 110.81 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -71.86 -25.8 74.1 Favored Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.978 -0.629 . . . . 1.77 112.608 179.865 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -93.05 27.14 11.87 Favored Glycine 0 CA--C 1.52 0.355 0 C-N-CA 121.098 -0.572 . . . . 2.0899999999999999 112.467 179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 48.9 t30 -144.5 -40.35 0.26 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.865 0.364 . . . . 2.29 110.533 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -69.32 -38.16 78.1 Favored 'General case' 0 CA--C 1.531 0.248 0 CA-C-N 115.902 -0.59 . . . . 2.4399999999999999 111.136 -179.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -74.19 115.53 13.8 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.467 -0.333 . . . . 2.7000000000000002 110.352 179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.5 m120 . . . . . 0 C--O 1.248 0.991 0 CA-C-O 118.318 -0.849 . . . . 2.5600000000000001 110.877 -179.809 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.058 0 CA-C-O 122.789 1.281 . . . . 0.80000000000000004 110.133 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.562 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.8 ptt-85 -131.63 -64.76 0.78 Allowed 'General case' 0 N--CA 1.474 0.771 0 CA-C-N 113.393 -1.73 . . . . 0.84999999999999998 111.392 -179.796 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.562 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.57 115.03 4.49 Favored 'General case' 0 N--CA 1.466 0.362 0 C-N-CA 123.786 0.834 . . . . 0.77000000000000002 110.448 -173.636 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.13 140.2 52.76 Favored 'General case' 0 N--CA 1.473 0.695 0 CA-C-N 113.831 -1.532 . . . . 0.65000000000000002 110.18 179.006 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.39 146.47 30.44 Favored 'General case' 0 N--CA 1.476 0.848 0 CA-C-N 113.944 -1.48 . . . . 0.68000000000000005 108.396 -176.081 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.11 8.96 Favored 'General case' 0 N--CA 1.474 0.74 0 CA-C-N 116.013 -0.539 . . . . 0.5 109.795 173.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.21 47.1 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.266 0 CA-C-O 121.787 0.803 . . . . 0.46999999999999997 111.551 177.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.04 104.25 10.31 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 114.42 -1.263 . . . . 0.46999999999999997 111.404 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.5 mt -82.27 -33.36 29.16 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 114.597 -1.183 . . . . 0.57999999999999996 113.714 175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.77 -178.86 3.54 Favored 'General case' 0 C--N 1.316 -0.874 0 C-N-CA 124.909 1.284 . . . . 0.57999999999999996 110.025 -178.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.587 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.8 t -128.68 -171.65 2.52 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-N 113.796 -1.547 . . . . 0.59999999999999998 111.271 178.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.608 HG21 HD12 ' B' ' 54' ' ' ILE . 86.3 m -157.81 152.29 24.85 Favored 'General case' 0 N--CA 1.471 0.622 0 C-N-CA 125.816 1.646 . . . . 0.57999999999999996 110.242 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.3 pm0 -128.21 72.21 1.41 Allowed 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 123.705 1.717 . . . . 0.72999999999999998 112.129 177.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.579 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.15 -177.27 51.37 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 113.195 -1.821 . . . . 0.64000000000000001 110.872 174.502 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.2 p 137.95 -172.41 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.67 1 C-N-CA 136.253 5.821 . . . . 0.64000000000000001 106.339 8.253 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.3 t-80 -117.59 143.36 32.11 Favored Pre-proline 0 CA--C 1.543 0.702 0 O-C-N 121.819 -0.551 . . . . 0.68000000000000005 110.072 174.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.479 ' HG3' ' O ' ' B' ' 66' ' ' VAL . 88.4 Cg_exo -51.29 -21.88 10.6 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 124.764 3.642 . . . . 0.58999999999999997 112.822 174.192 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.593 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.72 -28.83 16.23 Favored 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 124.71 1.204 . . . . 0.68999999999999995 112.568 179.641 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 31.1 mmt -88.16 -18.98 27.57 Favored 'General case' 0 N--CA 1.476 0.83 0 N-CA-C 113.529 0.937 . . . . 0.94999999999999996 113.529 175.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 33.6 mm -93.14 137.01 23.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 O-C-N 122.155 -0.34 . . . . 0.57999999999999996 111.685 -178.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -135.69 4.48 3.08 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 116.292 -0.413 . . . . 0.69999999999999996 110.979 179.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.43 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 42.1 t30 -154.45 125.38 7.18 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.194 -0.457 . . . . 0.82999999999999996 110.429 -179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . . . . . . . . . 42.0 tp -121.75 110.88 16.47 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.852 0.358 . . . . 0.75 110.85 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . . . . . . . . . 50.4 mt-30 -107.04 121.78 45.14 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.177 -0.465 . . . . 1.0800000000000001 110.673 179.856 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . . . . . . . . . 22.4 t -110.14 115.14 48.95 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.157 0 CA-C-N 116.197 -0.456 . . . . 0.60999999999999999 111.208 -179.717 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 87.6 m-85 -105.87 130.24 53.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.831 -0.622 . . . . 0.85999999999999999 110.367 179.556 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -84.18 -163.16 0.75 Allowed 'General case' 0 C--O 1.233 0.199 0 CA-C-O 120.76 0.314 . . . . 0.60999999999999999 111.291 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.52 HG23 ' HA ' ' B' ' 40' ' ' SER . 85.4 mt -71.63 122.45 23.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 1.1000000000000001 111.051 179.778 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -116.78 -168.68 14.93 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.971 -0.633 . . . . 0.63 112.726 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -77.87 -7.41 16.46 Favored 'Trans proline' 0 C--N 1.347 0.462 0 C-N-CA 123.229 2.619 . . . . 0.79000000000000004 112.866 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -111.92 -21.01 11.8 Favored 'General case' 0 N--CA 1.471 0.58 0 N-CA-C 113.061 0.763 . . . . 0.70999999999999996 113.061 -179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 3.8 t -140.12 128.45 22.59 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.67000000000000004 110.952 -177.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.52 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.5 t -97.36 18.85 14.27 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.184 -0.462 . . . . 1.01 110.777 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -132.91 145.08 50.6 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.038 -0.528 . . . . 1.1599999999999999 110.828 -179.697 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 15.3 m -79.58 126.53 39.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.201 0 CA-C-O 120.978 0.418 . . . . 0.78000000000000003 110.623 179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -125.5 136.91 53.85 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.117 -0.492 . . . . 0.80000000000000004 110.635 -179.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.447 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.9 m -106.85 116.89 51.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 121.489 0.661 . . . . 0.59999999999999998 112.015 -179.267 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . . . . . . . . . 1.3 m -104.45 150.46 7.44 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-O 122.425 1.107 . . . . 0.62 110.763 179.386 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.26 153.41 46.51 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 115.185 -0.916 . . . . 0.55000000000000004 111.136 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . 0.46 ' HA ' ' O ' ' B' ' 52' ' ' LYS . 20.8 m -123.74 132.61 53.85 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 115.059 -0.973 . . . . 0.63 110.528 176.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.6 mp -82.09 170.6 15.32 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 114.987 -1.006 . . . . 0.75 110.898 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.4 tptp -77.04 -15.87 59.46 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.139 -0.482 . . . . 1.27 110.473 179.614 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 75.9 m-20 -80.15 -18.57 49.41 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 115.999 -0.546 . . . . 0.98999999999999999 110.857 179.781 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 102.28 47.47 1.43 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.992 -0.623 . . . . 0.67000000000000004 112.611 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . 0.46 ' O ' ' HA ' ' B' ' 47' ' ' SER . 58.1 mtpt -131.3 158.22 41.24 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.824 0.345 . . . . 1.05 111.089 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.83 129.49 40.53 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.419 0.628 . . . . 0.70999999999999996 110.042 179.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.608 HD12 HG21 ' B' ' 19' ' ' THR . 49.7 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 114.743 -1.117 . . . . 0.52000000000000002 109.812 178.115 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.0 m -127.42 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 114.469 -1.241 . . . . 0.47999999999999998 109.308 177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.784 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.5 mt -113.98 152.62 30.63 Favored 'General case' 0 C--N 1.313 -0.979 0 CA-C-N 114.041 -1.436 . . . . 0.48999999999999999 108.659 -178.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.587 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.6 t0 -100.74 113.41 65.65 Favored Pre-proline 0 C--N 1.327 -0.399 0 O-C-N 121.72 -0.613 . . . . 0.63 110.005 178.273 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.447 ' HG3' HG22 ' B' ' 44' ' ' VAL . 15.5 Cg_exo -66.46 -7.19 17.01 Favored 'Trans proline' 0 C--N 1.354 0.823 0 C-N-CA 122.933 2.422 . . . . 0.82999999999999996 112.983 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 39.7 tt0 -77.97 -13.74 59.77 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.938 -0.574 . . . . 1.3999999999999999 111.043 -179.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -97.62 135.05 21.81 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 120.284 -0.567 . . . . 0.91000000000000003 110.718 -179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -65.3 -41.78 15.09 Favored 'Trans proline' 0 N--CA 1.478 0.585 0 C-N-CA 123.603 2.869 . . . . 1.1899999999999999 113.441 -178.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.0 p90 -60.84 -25.97 67.02 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-O 121.347 0.594 . . . . 1.1499999999999999 111.832 176.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.784 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -76.82 -31.02 56.64 Favored 'General case' 0 N--CA 1.446 -0.662 0 CA-C-N 115.822 -0.626 . . . . 0.90000000000000002 110.371 178.551 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -74.24 -21.48 59.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.327 0.584 . . . . 1.71 110.497 179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.55 -56.96 4.09 Favored 'General case' 0 N--CA 1.474 0.75 0 CA-C-N 115.475 -0.784 . . . . 1.3600000000000001 113.113 179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . 0.479 ' O ' ' HG3' ' B' ' 24' ' ' PRO . 34.6 m -58.75 -29.61 40.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.403 0 CA-C-N 115.348 -0.842 . . . . 0.96999999999999997 111.456 179.033 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.404 ' O ' HG13 ' B' ' 70' ' ' ILE . 48.5 pt -79.84 -26.25 12.2 Favored 'Isoleucine or valine' 0 C--N 1.342 0.241 0 C-N-CA 120.532 -0.467 . . . . 1.0800000000000001 109.972 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -68.46 -42.03 79.36 Favored 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 120.779 -0.368 . . . . 1.52 110.383 177.054 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.69 -31.23 66.17 Favored 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.633 0.975 . . . . 1.6100000000000001 113.633 -179.224 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.404 HG13 ' O ' ' B' ' 67' ' ' ILE . 0.0 OUTLIER -77.5 -13.39 14.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.496 0 C-N-CA 120.625 -0.43 . . . . 1.4299999999999999 111.452 -179.853 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 27.7 mt -99.24 -25.41 14.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.387 -0.369 . . . . 1.79 110.568 179.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -91.73 -50.09 5.93 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.909 -0.587 . . . . 2.25 110.253 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.37 -25.27 73.3 Favored Glycine 0 C--N 1.33 0.231 0 C-N-CA 120.973 -0.632 . . . . 1.76 112.174 179.33 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -77.56 -19.32 76.32 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.084 -0.579 . . . . 2.04 112.001 179.19 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.2 t30 -83.56 -19.93 34.72 Favored 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.03 0.443 . . . . 2.3199999999999998 110.267 179.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.8 tptp -74.83 -25.44 59.01 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-N 115.832 -0.622 . . . . 2.46 110.694 179.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.54 117.42 9.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.447 -0.342 . . . . 2.7799999999999998 110.364 179.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.6 m120 . . . . . 0 C--O 1.25 1.099 0 CA-C-O 118.328 -0.844 . . . . 2.48 110.996 -179.565 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.481 1.096 0 CA-C-O 122.723 1.249 . . . . 0.81000000000000005 110.108 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.573 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.67 -64.7 0.78 Allowed 'General case' 0 N--CA 1.475 0.775 0 CA-C-N 113.395 -1.73 . . . . 0.83999999999999997 111.446 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.573 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.5 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.469 0.502 0 C-N-CA 123.997 0.919 . . . . 0.76000000000000001 110.403 -173.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.12 140.13 52.82 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 113.777 -1.556 . . . . 0.65000000000000002 110.303 178.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.4 30.3 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 114.075 -1.421 . . . . 0.66000000000000003 108.465 -176.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 52.9 m -54.85 151.1 8.99 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 116.09 -0.505 . . . . 0.48999999999999999 109.879 173.057 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.9 p -60.15 -30.95 46.93 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.349 0 CA-C-O 121.629 0.728 . . . . 0.45000000000000001 111.522 177.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . . . . . . . . . 62.5 m -119.1 104.36 10.39 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 114.556 -1.202 . . . . 0.46000000000000002 111.245 178.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.4 -33.46 28.67 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 114.579 -1.191 . . . . 0.56999999999999995 113.721 175.08 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.52 -178.7 3.51 Favored 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 124.905 1.282 . . . . 0.56999999999999995 110.083 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.549 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.5 t -128.86 -171.66 2.53 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 113.718 -1.583 . . . . 0.62 111.345 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.619 HG21 HD12 ' A' ' 54' ' ' ILE . 86.4 m -157.73 152.35 25.08 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 125.852 1.661 . . . . 0.60999999999999999 110.245 179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.17 72.13 1.41 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 123.464 1.602 . . . . 0.76000000000000001 112.051 177.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -83.93 -177.26 51.47 Favored Glycine 0 CA--C 1.543 1.805 0 CA-C-N 113.228 -1.806 . . . . 0.68999999999999995 110.905 174.352 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.715 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.96 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.716 1 C-N-CA 136.165 5.786 . . . . 0.68999999999999995 106.36 8.063 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.715 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.53 143.31 31.95 Favored Pre-proline 0 CA--C 1.543 0.692 0 O-C-N 121.885 -0.509 . . . . 0.72999999999999998 110.048 175.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.522 ' HB3' HG23 ' A' ' 70' ' ' ILE . 85.2 Cg_exo -51.11 -22.01 10.13 Favored 'Trans proline' 0 N--CA 1.478 0.608 0 C-N-CA 124.831 3.687 . . . . 0.64000000000000001 112.852 174.074 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.68 -28.87 16.04 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.637 1.175 . . . . 0.73999999999999999 112.639 179.662 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.96 -19.39 27.31 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.553 0.946 . . . . 1.0800000000000001 113.553 175.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 32.7 mm -91.28 137.59 21.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.756 0.312 . . . . 0.57999999999999996 111.524 -178.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.0 m -132.99 -12.52 2.87 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.318 -0.401 . . . . 0.68999999999999995 111.285 179.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 10.3 t30 -141.2 132.75 27.0 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.449 -0.341 . . . . 0.78000000000000003 110.812 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . . . . . . . . . 38.4 tp -124.17 130.43 52.53 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-O 120.919 0.39 . . . . 0.73999999999999999 111.351 179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.627 ' HB2' HG22 ' A' ' 45' ' ' VAL . 54.5 mt-30 -122.68 118.88 29.16 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.266 -0.424 . . . . 1.1599999999999999 110.917 179.637 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.0 t -102.14 108.62 24.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.353 -0.385 . . . . 0.62 111.039 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 55.0 m-85 -99.23 128.36 45.35 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.012 -0.54 . . . . 0.72999999999999998 111.122 -179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.55 ' HA ' HG12 ' A' ' 42' ' ' VAL . . . -91.6 -160.39 0.72 Allowed 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.458 -0.337 . . . . 0.66000000000000003 111.022 179.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.482 HG23 ' HA ' ' A' ' 40' ' ' SER . 93.3 mt -74.9 125.94 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 CA-C-N 116.192 -0.458 . . . . 1.1399999999999999 110.996 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -126.55 -164.76 11.82 Favored Glycine 0 C--N 1.332 0.343 0 C-N-CA 120.914 -0.66 . . . . 0.66000000000000003 112.683 -179.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -79.52 -7.05 14.76 Favored 'Trans proline' 0 C--N 1.348 0.549 0 C-N-CA 123.319 2.679 . . . . 0.81000000000000005 112.858 -179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.51 -20.9 11.58 Favored 'General case' 0 N--CA 1.471 0.602 0 N-CA-C 112.977 0.732 . . . . 0.72999999999999998 112.977 -179.524 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 3.1 t -141.92 140.75 32.89 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 0.70999999999999996 111.078 -177.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.482 ' HA ' HG23 ' A' ' 35' ' ' ILE . 7.9 t -108.43 26.61 10.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.122 0.487 . . . . 1.0700000000000001 110.49 179.742 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 85.1 tttt -142.49 150.29 40.3 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.926 -0.579 . . . . 1.29 110.871 -179.442 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.55 HG12 ' HA ' ' A' ' 34' ' ' ALA . 9.1 m -82.65 129.81 36.82 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.187 -0.46 . . . . 0.82999999999999996 110.549 179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . . . . . . . . . 25.7 mt-10 -131.76 130.16 41.51 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 110.173 -0.306 . . . . 0.79000000000000004 110.173 -179.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 3.2 m -100.6 106.16 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.686 0.755 . . . . 0.66000000000000003 112.297 -178.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.627 HG22 ' HB2' ' A' ' 31' ' ' GLN . 1.1 m -93.6 150.42 3.96 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.961 0 CA-C-O 122.533 1.158 . . . . 0.68999999999999995 110.851 178.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.13 153.37 46.66 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.171 -0.922 . . . . 0.57999999999999996 111.2 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.2 m -123.8 132.76 53.85 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 115.1 -0.954 . . . . 0.65000000000000002 110.466 176.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.9 mp -78.58 170.1 17.19 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.332 -0.849 . . . . 0.79000000000000004 110.811 179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -75.52 -17.62 60.04 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 120.967 0.413 . . . . 1.23 110.71 179.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 74.5 m-20 -79.44 -20.23 47.95 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.036 -0.529 . . . . 1.05 110.922 179.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 105.17 45.96 1.3 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.942 -0.646 . . . . 0.69999999999999996 112.46 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 47' ' ' SER . 62.5 mtpt -127.61 154.53 45.12 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.562 0.22 . . . . 1.1899999999999999 110.767 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -131.79 129.68 40.85 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.352 0.596 . . . . 0.68999999999999995 109.928 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.619 HD12 HG21 ' A' ' 19' ' ' THR . 49.5 pt -127.92 179.5 3.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.05 0 CA-C-N 114.761 -1.109 . . . . 0.53000000000000003 109.818 178.09 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.4 m -127.33 138.14 52.97 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 114.419 -1.264 . . . . 0.48999999999999999 109.281 177.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.832 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.6 mt -114.12 153.96 28.61 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-N 114.026 -1.443 . . . . 0.51000000000000001 108.654 -178.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.549 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.5 t0 -101.54 110.78 62.67 Favored Pre-proline 0 C--N 1.324 -0.518 0 O-C-N 121.8 -0.563 . . . . 0.67000000000000004 110.209 178.019 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_exo -61.72 -15.07 39.87 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 122.852 2.368 . . . . 0.85999999999999999 111.809 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 8.8 tt0 -66.72 -16.51 64.29 Favored 'General case' 0 CA--C 1.545 0.783 0 CA-C-N 114.592 -1.185 . . . . 1.3500000000000001 113.588 178.821 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.648 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.37 135.14 20.32 Favored Pre-proline 0 CA--C 1.542 0.655 0 O-C-N 122.3 -0.25 . . . . 0.94999999999999996 110.734 -179.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.39 -41.88 14.54 Favored 'Trans proline' 0 N--CA 1.477 0.555 0 C-N-CA 123.501 2.8 . . . . 1.24 113.344 -178.806 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.648 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.1 p90 -60.7 -27.87 68.2 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-O 121.264 0.554 . . . . 1.1899999999999999 111.76 176.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.832 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.3 OUTLIER -73.25 -29.57 62.84 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.762 -0.654 . . . . 0.89000000000000001 110.568 179.269 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . 0.487 ' O ' ' HB2' ' A' ' 68' ' ' GLN . 39.1 ttpt -70.74 -22.24 62.44 Favored 'General case' 0 CA--C 1.533 0.29 0 CA-C-N 116.106 -0.497 . . . . 1.71 110.571 179.425 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -74.29 -56.45 4.86 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.655 0.782 . . . . 1.29 113.052 179.159 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.0 m -61.44 -27.82 42.72 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 CA-C-N 115.276 -0.875 . . . . 0.91000000000000003 111.456 178.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.416 HG12 ' HA ' ' A' ' 64' ' ' LYS . 40.7 pt -86.96 -26.0 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 N-CA-C 109.929 -0.397 . . . . 1.05 109.929 178.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . 0.487 ' HB2' ' O ' ' A' ' 64' ' ' LYS . 53.2 tt0 -70.2 -44.05 69.46 Favored 'General case' 0 N--CA 1.472 0.652 0 C-N-CA 121.067 -0.253 . . . . 1.52 110.538 177.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -60.29 -31.71 70.52 Favored 'General case' 0 N--CA 1.468 0.445 0 N-CA-C 113.375 0.88 . . . . 1.5800000000000001 113.375 -178.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.522 HG23 ' HB3' ' A' ' 24' ' ' PRO . 19.8 pt -82.55 -1.51 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.466 0 N-CA-C 112.275 0.472 . . . . 1.3700000000000001 112.275 -179.447 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . 0.614 HD13 HD13 ' B' ' 71' ' ' LEU . 95.6 mt -97.23 -36.86 10.3 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.876 0.37 . . . . 1.6699999999999999 110.728 179.382 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -79.98 -42.98 22.84 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.779 -0.646 . . . . 2.21 110.295 179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -76.63 -23.47 70.01 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.965 -0.636 . . . . 1.77 112.022 179.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.493 ' O ' HG21 ' B' ' 42' ' ' VAL . . . -75.65 -30.56 57.87 Favored Glycine 0 C--N 1.332 0.345 0 C-N-CA 121.154 -0.546 . . . . 2.0899999999999999 112.287 179.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 65.6 t30 -85.93 -20.85 28.37 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.926 0.393 . . . . 2.29 110.597 179.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 24.6 tptp -81.84 -15.8 52.87 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 115.984 -0.553 . . . . 2.4399999999999999 110.771 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.21 105.77 3.07 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 116.079 -0.509 . . . . 2.7000000000000002 110.34 179.428 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 16.8 m120 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.433 -0.794 . . . . 2.5600000000000001 111.065 -179.319 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 122.717 1.246 . . . . 0.80000000000000004 110.132 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.74 -64.78 0.78 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 113.462 -1.699 . . . . 0.84999999999999998 111.372 -179.779 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.6 mt-10 -152.53 115.06 4.51 Favored 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 123.943 0.897 . . . . 0.77000000000000002 110.53 -173.735 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.17 140.21 52.74 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 113.747 -1.569 . . . . 0.65000000000000002 110.173 178.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.33 146.36 30.51 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.989 -1.46 . . . . 0.68000000000000005 108.43 -176.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 53.4 m -54.69 151.03 8.71 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 116.005 -0.543 . . . . 0.5 109.912 173.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.7 p -59.97 -31.16 47.06 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.352 0 CA-C-O 121.741 0.782 . . . . 0.46999999999999997 111.525 177.732 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.414 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.8 m -119.0 104.23 10.3 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 114.511 -1.222 . . . . 0.46999999999999997 111.352 178.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.22 -33.47 29.3 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 114.618 -1.173 . . . . 0.57999999999999996 113.822 175.027 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 pm0 -111.58 -178.66 3.5 Favored 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.851 1.26 . . . . 0.57999999999999996 110.113 -179.049 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.642 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.6 t -128.8 -171.57 2.5 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 113.817 -1.538 . . . . 0.59999999999999998 111.323 178.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.596 HG21 HD12 ' B' ' 54' ' ' ILE . 86.6 m -157.85 152.27 24.75 Favored 'General case' 0 N--CA 1.47 0.574 0 C-N-CA 125.853 1.661 . . . . 0.57999999999999996 110.187 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.26 72.32 1.42 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 123.642 1.687 . . . . 0.72999999999999998 112.025 177.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.13 -177.23 51.37 Favored Glycine 0 CA--C 1.543 1.84 0 CA-C-N 113.245 -1.798 . . . . 0.64000000000000001 110.883 174.437 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.732 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 137.97 -172.48 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.707 1 C-N-CA 136.131 5.772 . . . . 0.64000000000000001 106.395 8.137 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.732 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.38 32.06 Favored Pre-proline 0 CA--C 1.543 0.681 0 O-C-N 121.984 -0.447 . . . . 0.68000000000000005 110.059 174.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.426 ' HD2' ' CG ' ' B' ' 23' ' ' HIS . 88.9 Cg_exo -51.38 -21.83 10.85 Favored 'Trans proline' 0 N--CA 1.478 0.615 0 C-N-CA 124.783 3.655 . . . . 0.58999999999999997 112.739 174.194 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.596 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.83 -28.79 16.91 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.58 1.152 . . . . 0.68999999999999995 112.516 179.714 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 33.8 mmt -87.98 -19.76 26.77 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 113.579 0.955 . . . . 0.94999999999999996 113.579 175.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 20.3 mm -89.66 144.33 9.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.402 -0.363 . . . . 0.57999999999999996 111.194 -178.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 74.7 m -139.97 -11.4 1.13 Allowed 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 116.471 -0.331 . . . . 0.69999999999999996 111.6 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . . . . . . . . . 61.2 t30 -143.8 140.09 29.69 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-O 120.615 0.245 . . . . 0.82999999999999996 110.843 179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.442 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 40.2 tp -123.23 149.52 44.6 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-N 116.315 -0.402 . . . . 0.75 111.015 179.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.492 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 36.0 mt-30 -142.03 109.78 5.77 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.027 -0.533 . . . . 1.0800000000000001 110.605 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 13.1 t -102.46 106.61 20.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.22 0 CA-C-N 116.267 -0.424 . . . . 0.60999999999999999 110.791 -179.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 10.8 m-85 -103.31 132.94 49.17 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.124 -0.489 . . . . 0.85999999999999999 111.677 -179.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.632 ' HA ' HG12 ' B' ' 42' ' ' VAL . . . -91.87 -143.82 0.2 Allowed 'General case' 0 CA--C 1.534 0.354 0 CA-C-N 116.205 -0.452 . . . . 0.60999999999999999 111.824 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . . . . . . . . . 15.1 mt -77.84 141.15 15.92 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 CA-C-N 115.966 -0.561 . . . . 1.1000000000000001 111.61 -179.334 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -146.94 -171.92 16.67 Favored Glycine 0 C--N 1.334 0.435 0 C-N-CA 120.983 -0.627 . . . . 0.63 112.561 179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 5.3 Cg_exo -79.59 -9.09 14.81 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 123.307 2.671 . . . . 0.79000000000000004 112.549 179.634 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -109.86 -21.26 12.44 Favored 'General case' 0 N--CA 1.471 0.623 0 N-CA-C 112.99 0.737 . . . . 0.70999999999999996 112.99 -179.42 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 1.8 t -143.77 160.31 40.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.843 0.354 . . . . 0.67000000000000004 111.142 -177.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . . . . . . . . . 32.9 t -115.05 -44.0 3.05 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.197 -0.456 . . . . 1.01 111.057 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 81.2 tttt -83.88 151.14 25.28 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.759 0.314 . . . . 1.1599999999999999 110.514 179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.632 HG12 ' HA ' ' B' ' 34' ' ' ALA . 24.9 m -76.74 138.32 20.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.35 0.595 . . . . 0.78000000000000003 111.464 179.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 25.0 mt-10 -132.88 130.1 39.26 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.396 -0.82 . . . . 0.80000000000000004 110.24 179.64 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . 0.503 HG22 ' HG3' ' B' ' 58' ' ' PRO . 2.2 m -100.5 106.33 19.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.723 0.773 . . . . 0.59999999999999998 112.326 -178.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.414 HG12 ' SG ' ' B' ' 15' ' ' CYS . 0.8 OUTLIER -93.67 150.5 3.94 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.946 0 CA-C-O 122.56 1.171 . . . . 0.62 110.796 178.362 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.35 153.35 46.36 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 115.186 -0.915 . . . . 0.55000000000000004 111.168 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.8 m -123.67 132.93 53.95 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 115.029 -0.987 . . . . 0.63 110.523 176.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 7.0 mp -78.77 165.38 23.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.414 -0.812 . . . . 0.75 110.673 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 26.1 tptp -74.44 -18.5 60.63 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.199 -0.455 . . . . 1.27 110.876 179.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 -76.61 -32.24 57.93 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.001 -0.545 . . . . 0.98999999999999999 111.078 179.886 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 122.18 42.29 0.44 Allowed Glycine 0 C--N 1.332 0.344 0 C-N-CA 120.865 -0.683 . . . . 0.67000000000000004 112.614 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 57.2 mtpt -127.57 165.72 19.39 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.668 0.27 . . . . 1.05 111.085 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -144.62 129.49 18.35 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 121.453 0.644 . . . . 0.70999999999999996 109.969 179.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.596 HD12 HG21 ' B' ' 19' ' ' THR . 50.2 pt -127.81 179.66 3.56 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.996 0 CA-C-N 114.688 -1.142 . . . . 0.52000000000000002 109.726 178.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 95.7 m -127.44 137.95 52.84 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.349 -1.296 . . . . 0.47999999999999998 109.302 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.696 ' HB3' HD11 ' B' ' 63' ' ' LEU . 39.7 mt -113.93 151.6 32.04 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 114.058 -1.428 . . . . 0.48999999999999999 108.725 -178.57 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.642 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 3.3 t0 -100.26 111.0 61.64 Favored Pre-proline 0 C--N 1.329 -0.32 0 O-C-N 121.918 -0.489 . . . . 0.63 110.252 178.325 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . 0.503 ' HG3' HG22 ' B' ' 44' ' ' VAL . 13.2 Cg_exo -67.58 -6.38 16.48 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.772 2.315 . . . . 0.82999999999999996 112.831 -179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -79.26 -11.38 59.95 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.12 -0.491 . . . . 1.3999999999999999 110.946 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.635 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -99.44 135.11 20.75 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 120.088 -0.645 . . . . 0.91000000000000003 110.682 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -65.34 -41.82 14.85 Favored 'Trans proline' 0 N--CA 1.478 0.565 0 C-N-CA 123.616 2.877 . . . . 1.1899999999999999 113.398 -178.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.635 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.79 -27.07 67.73 Favored 'General case' 0 N--CA 1.479 1.013 0 CA-C-O 121.329 0.585 . . . . 1.1499999999999999 111.788 176.943 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.696 HD11 ' HB3' ' B' ' 56' ' ' LEU . 0.5 OUTLIER -79.2 -29.28 42.76 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 115.66 -0.7 . . . . 0.90000000000000002 110.396 178.925 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.435 ' HA ' HG12 ' B' ' 67' ' ' ILE . 33.6 ttpt -72.45 -20.26 61.43 Favored 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 121.336 0.588 . . . . 1.71 110.859 179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -75.66 -56.76 4.37 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 115.432 -0.804 . . . . 1.3600000000000001 113.033 179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 34.8 m -61.46 -28.1 43.31 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.449 0 CA-C-N 115.596 -0.729 . . . . 0.96999999999999997 111.637 178.827 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.464 ' O ' ' HG ' ' B' ' 71' ' ' LEU . 42.6 pt -82.68 -25.84 8.48 Favored 'Isoleucine or valine' 0 C--N 1.342 0.247 0 C-N-CA 120.647 -0.421 . . . . 1.0800000000000001 110.255 178.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 -69.08 -42.81 75.69 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 120.547 -0.461 . . . . 1.52 110.508 176.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -57.46 -29.09 63.94 Favored 'General case' 0 N--CA 1.47 0.529 0 N-CA-C 113.57 0.952 . . . . 1.6100000000000001 113.57 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.402 ' CG2' ' HB3' ' B' ' 24' ' ' PRO . 26.4 pt -86.9 -1.28 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 112.212 0.449 . . . . 1.4299999999999999 112.212 -179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . 0.614 HD13 HD13 ' A' ' 71' ' ' LEU . 60.3 mt -98.05 -54.46 3.07 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.753 0.311 . . . . 1.79 110.809 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 20.2 t70 -76.5 -29.01 56.65 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-N 116.08 -0.509 . . . . 2.25 110.313 179.529 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.85 -25.8 70.84 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 121.024 -0.608 . . . . 1.76 112.123 179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -75.75 -32.0 54.86 Favored Glycine 0 C--N 1.333 0.399 0 C-N-CA 121.098 -0.572 . . . . 2.04 112.375 179.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -81.15 -27.56 35.4 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.958 0.408 . . . . 2.3199999999999998 110.542 179.675 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 26.6 tptp -76.25 -31.45 58.33 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.864 -0.607 . . . . 2.46 110.611 179.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 12.7 mm-40 -78.01 126.93 31.55 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-N 116.239 -0.437 . . . . 2.7799999999999998 110.518 179.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 15.2 m120 . . . . . 0 C--O 1.25 1.11 0 CA-C-O 118.384 -0.817 . . . . 2.48 110.922 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 9.5 tt . . . . . 0 N--CA 1.48 1.048 0 CA-C-O 122.663 1.221 . . . . 0.81000000000000005 110.07 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ARG . . . . . 0.569 ' HG3' ' H ' ' A' ' 10' ' ' GLU . 26.6 ptt-85 -131.66 -64.77 0.78 Allowed 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 113.318 -1.765 . . . . 0.83999999999999997 111.384 -179.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLU . . . . . 0.569 ' H ' ' HG3' ' A' ' 9' ' ' ARG . 65.6 mt-10 -152.56 115.09 4.51 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.889 0.876 . . . . 0.76000000000000001 110.386 -173.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.23 140.14 52.78 Favored 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 113.845 -1.525 . . . . 0.65000000000000002 110.191 178.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ARG . . . . . . . . . . . . . 11.0 mmt85 -106.17 146.39 30.32 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-N 114.002 -1.454 . . . . 0.66000000000000003 108.427 -176.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' CYS . . . . . . . . . . . . . 53.5 m -54.81 151.0 9.03 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 116.065 -0.516 . . . . 0.48999999999999999 109.967 172.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.93 -31.14 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.323 0 CA-C-O 121.709 0.766 . . . . 0.45000000000000001 111.529 177.72 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' CYS . . . . . 0.554 ' HB2' ' OE1' ' A' ' 43' ' ' GLU . 62.4 m -118.99 104.36 10.43 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 124.715 1.206 . . . . 0.46000000000000002 111.228 179.077 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 94.4 mt -82.47 -33.38 28.45 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 114.658 -1.156 . . . . 0.56999999999999995 113.714 175.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.69 -178.74 3.51 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.905 1.282 . . . . 0.56999999999999995 110.019 -179.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.522 ' OG1' ' HB2' ' A' ' 57' ' ' ASP . 13.6 t -128.83 -171.68 2.53 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 113.729 -1.578 . . . . 0.62 111.359 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.609 HG21 HD12 ' A' ' 54' ' ' ILE . 86.1 m -157.78 152.33 24.96 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 125.842 1.657 . . . . 0.60999999999999999 110.157 -180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.19 72.24 1.41 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 123.546 1.641 . . . . 0.76000000000000001 112.078 177.142 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.576 ' CA ' ' HB ' ' A' ' 22' ' ' VAL . . . -84.07 -177.29 51.41 Favored Glycine 0 CA--C 1.544 1.865 0 CA-C-N 113.244 -1.798 . . . . 0.68999999999999995 110.953 174.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' VAL . . . . . 0.716 HG22 ' H ' ' A' ' 23' ' ' HIS . 9.0 p 137.99 -172.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.803 1 C-N-CA 136.161 5.784 . . . . 0.68999999999999995 106.271 8.157 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' HIS . . . . . 0.716 ' H ' HG22 ' A' ' 22' ' ' VAL . 66.2 t-80 -117.51 143.33 31.96 Favored Pre-proline 0 CA--C 1.544 0.723 0 O-C-N 121.913 -0.492 . . . . 0.72999999999999998 110.093 174.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.535 ' HB3' HG23 ' A' ' 70' ' ' ILE . 86.0 Cg_exo -51.14 -22.0 10.22 Favored 'Trans proline' 0 N--CA 1.478 0.617 0 C-N-CA 124.812 3.675 . . . . 0.64000000000000001 112.819 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.58 ' HB2' ' ND1' ' A' ' 23' ' ' HIS . 1.0 OUTLIER -51.74 -28.81 16.32 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.646 1.178 . . . . 0.73999999999999999 112.574 179.709 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' MET . . . . . . . . . . . . . 38.2 mmt -88.04 -19.88 26.52 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 113.493 0.923 . . . . 1.0800000000000001 113.493 175.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 33.1 mm -89.3 139.13 17.92 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 115.993 -0.548 . . . . 0.57999999999999996 111.581 -178.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 50.9 m -128.24 -19.07 3.96 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.153 -0.476 . . . . 0.68999999999999995 110.838 179.788 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASN . . . . . 0.544 ' HA ' ' O ' ' B' ' 32' ' ' VAL . 12.5 t30 -142.49 135.84 28.78 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-N 116.361 -0.381 . . . . 0.78000000000000003 111.337 -179.82 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' LEU . . . . . 0.408 ' O ' ' HA ' ' B' ' 31' ' ' GLN . 45.1 tp -122.06 139.31 53.86 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.079 -0.51 . . . . 0.73999999999999999 110.906 179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLN . . . . . 0.519 ' HA ' ' O ' ' B' ' 30' ' ' LEU . 41.1 mt-30 -122.3 136.95 54.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.058 0.456 . . . . 1.1599999999999999 110.995 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' B' ' 29' ' ' ASN . 24.8 t -114.99 127.44 72.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 115.823 -0.626 . . . . 0.62 110.957 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' PHE . . . . . . . . . . . . . 50.7 m-85 -120.12 116.86 26.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.131 -0.486 . . . . 0.72999999999999998 110.554 179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -88.5 -80.34 0.28 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.76 0.314 . . . . 0.66000000000000003 111.626 -179.677 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . . . . . . . . . 1.2 pp -120.48 161.09 20.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.25 -0.432 . . . . 1.1399999999999999 111.506 -179.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLY . . . . . . . . . . . . . . . -164.5 160.89 34.04 Favored Glycine 0 C--N 1.332 0.327 0 C-N-CA 120.837 -0.697 . . . . 0.66000000000000003 112.551 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -81.81 -5.82 12.34 Favored 'Trans proline' 0 C--N 1.348 0.535 0 C-N-CA 123.142 2.561 . . . . 0.81000000000000005 112.85 179.813 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.26 -20.93 11.68 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 113.064 0.764 . . . . 0.72999999999999998 113.064 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' CYS . . . . . . . . . . . . . 4.6 t -133.58 153.56 51.56 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-N 115.801 -0.636 . . . . 0.70999999999999996 111.143 -177.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 8.2 t -126.25 29.06 5.89 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.229 -0.441 . . . . 1.0700000000000001 110.476 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 82.0 tttt -143.94 139.84 29.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.098 -0.501 . . . . 1.29 111.218 -179.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 20.8 m -75.87 131.18 35.38 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 CA-C-N 116.225 -0.443 . . . . 0.82999999999999996 109.928 178.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLU . . . . . 0.554 ' OE1' ' HB2' ' A' ' 15' ' ' CYS . 25.2 mt-10 -139.11 130.46 26.94 Favored 'General case' 0 C--N 1.331 -0.223 0 N-CA-C 109.821 -0.437 . . . . 0.79000000000000004 109.821 -178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.46 HG23 ' HB2' ' A' ' 56' ' ' LEU . 2.1 m -100.65 106.61 19.62 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-O 121.744 0.783 . . . . 0.66000000000000003 112.27 -179.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' VAL . . . . . 0.479 HG12 ' SG ' ' A' ' 15' ' ' CYS . 1.0 OUTLIER -93.84 150.37 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.955 0 CA-C-O 122.534 1.159 . . . . 0.68999999999999995 110.877 178.374 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.14 153.36 46.64 Favored 'General case' 0 N--CA 1.478 0.954 0 CA-C-N 115.174 -0.921 . . . . 0.57999999999999996 111.128 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 21.0 m -123.73 132.78 53.89 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 115.057 -0.974 . . . . 0.65000000000000002 110.425 176.807 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.69 174.06 11.73 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.046 -0.979 . . . . 0.79000000000000004 110.826 -179.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 27.7 tptp -78.51 -19.25 53.37 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.815 179.847 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -78.43 -14.22 59.48 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.205 -0.452 . . . . 1.05 111.266 179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.87 38.33 3.66 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.912 -0.661 . . . . 0.69999999999999996 112.394 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 47' ' ' SER . 56.0 mtpt -118.74 155.0 31.86 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.701 0.286 . . . . 1.1899999999999999 110.901 179.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.18 129.55 33.95 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-O 121.397 0.617 . . . . 0.68999999999999995 109.903 179.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.609 HD12 HG21 ' A' ' 19' ' ' THR . 50.0 pt -127.82 179.65 3.57 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 CA-C-N 114.664 -1.153 . . . . 0.53000000000000003 109.814 178.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' CYS . . . . . . . . . . . . . 96.1 m -127.43 138.01 52.87 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.429 -1.259 . . . . 0.48999999999999999 109.249 177.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LEU . . . . . 0.868 ' HB3' HD21 ' A' ' 63' ' ' LEU . 39.9 mt -113.97 153.61 29.02 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 114.021 -1.445 . . . . 0.51000000000000001 108.688 -178.597 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.522 ' HB2' ' OG1' ' A' ' 18' ' ' THR . 1.1 t0 -100.16 111.22 61.89 Favored Pre-proline 0 C--N 1.323 -0.585 0 N-CA-C 109.779 -0.452 . . . . 0.67000000000000004 109.779 177.541 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PRO . . . . . 0.45 ' HG3' HG22 ' A' ' 44' ' ' VAL . 16.9 Cg_exo -64.73 -14.95 47.65 Favored 'Trans proline' 0 C--N 1.355 0.904 0 C-N-CA 122.923 2.416 . . . . 0.85999999999999999 111.495 179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.9 tt0 -66.26 -16.56 64.12 Favored 'General case' 0 CA--C 1.545 0.779 0 CA-C-N 114.464 -1.244 . . . . 1.3500000000000001 113.524 178.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.646 ' HB1' ' CE2' ' A' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.543 0.709 0 O-C-N 122.231 -0.293 . . . . 0.94999999999999996 110.68 -178.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -65.38 -41.84 14.67 Favored 'Trans proline' 0 N--CA 1.478 0.603 0 C-N-CA 123.477 2.785 . . . . 1.24 113.409 -178.834 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.646 ' CE2' ' HB1' ' A' ' 60' ' ' ALA . 53.0 p90 -60.74 -26.55 67.28 Favored 'General case' 0 N--CA 1.48 1.057 0 CA-C-O 121.351 0.596 . . . . 1.1899999999999999 111.821 176.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.868 HD21 ' HB3' ' A' ' 56' ' ' LEU . 0.5 OUTLIER -82.54 -29.49 30.35 Favored 'General case' 0 N--CA 1.445 -0.721 0 CA-C-N 115.569 -0.741 . . . . 0.89000000000000001 110.57 178.824 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LYS . . . . . . . . . . . . . 39.5 ttpt -70.79 -21.66 62.46 Favored 'General case' 0 N--CA 1.467 0.411 0 CA-C-O 121.289 0.566 . . . . 1.71 110.66 179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -77.76 -58.47 3.25 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 115.409 -0.814 . . . . 1.29 112.98 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 25.4 m -57.66 -30.71 37.76 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 115.701 -0.681 . . . . 0.91000000000000003 111.654 179.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.418 HG12 ' O ' ' A' ' 63' ' ' LEU . 47.0 pt -77.3 -32.52 18.98 Favored 'Isoleucine or valine' 0 C--N 1.343 0.317 0 C-N-CA 120.758 -0.377 . . . . 1.05 110.056 178.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLN . . . . . . . . . . . . . 59.7 tt0 -65.38 -42.9 92.19 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 120.312 -0.555 . . . . 1.52 110.523 176.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -57.68 -32.18 67.08 Favored 'General case' 0 N--CA 1.468 0.432 0 N-CA-C 112.724 0.638 . . . . 1.5800000000000001 112.724 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ILE . . . . . 0.535 HG23 ' HB3' ' A' ' 24' ' ' PRO . 7.7 pt -91.41 16.34 1.19 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 N-CA-C 112.19 0.441 . . . . 1.3700000000000001 112.19 -179.715 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.84 -46.99 2.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.329 -0.396 . . . . 1.6699999999999999 110.444 179.13 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -87.55 -31.47 19.88 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.24 -0.436 . . . . 2.21 110.354 179.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLY . . . . . . . . . . . . . . . -73.94 -22.79 77.6 Favored Glycine 0 C--N 1.333 0.374 0 CA-C-N 115.901 -0.59 . . . . 1.77 112.182 179.676 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.37 -27.96 70.6 Favored Glycine 0 C--N 1.334 0.44 0 C-N-CA 121.162 -0.542 . . . . 2.0899999999999999 112.265 179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 66.4 t30 -78.34 -28.14 47.18 Favored 'General case' 0 C--N 1.333 -0.152 0 CA-C-O 121.111 0.482 . . . . 2.29 110.22 179.388 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LYS . . . . . . . . . . . . . 25.0 tptp -78.54 -32.47 47.95 Favored 'General case' 0 CA--C 1.53 0.208 0 CA-C-N 115.673 -0.694 . . . . 2.4399999999999999 110.802 179.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -72.89 134.7 44.92 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.304 -0.407 . . . . 2.7000000000000002 110.87 179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASN . . . . . . . . . . . . . 15.8 m120 . . . . . 0 C--O 1.247 0.963 0 CA-C-O 118.377 -0.821 . . . . 2.5600000000000001 110.82 -179.897 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . . . . . . . . . 9.4 tt . . . . . 0 N--CA 1.48 1.064 0 CA-C-O 122.718 1.247 . . . . 0.80000000000000004 110.249 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' ARG . . . . . 0.565 ' HG3' ' H ' ' B' ' 10' ' ' GLU . 26.7 ptt-85 -131.6 -64.81 0.78 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 113.405 -1.725 . . . . 0.84999999999999998 111.362 -179.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' GLU . . . . . 0.565 ' H ' ' HG3' ' B' ' 9' ' ' ARG . 65.7 mt-10 -152.51 115.03 4.51 Favored 'General case' 0 N--CA 1.467 0.415 0 C-N-CA 123.883 0.873 . . . . 0.77000000000000002 110.51 -173.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' LEU . . . . . . . . . . . . . 1.2 mt -126.14 140.17 52.78 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 113.832 -1.531 . . . . 0.65000000000000002 110.209 179.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' ARG . . . . . . . . . . . . . 11.1 mmt85 -106.23 146.57 30.14 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 113.975 -1.466 . . . . 0.68000000000000005 108.344 -176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' CYS . . . . . . . . . . . . . 52.7 m -55.03 151.1 9.42 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 116.075 -0.511 . . . . 0.5 109.82 173.027 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' VAL . . . . . . . . . . . . . 12.8 p -59.96 -31.07 46.81 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-O 121.746 0.784 . . . . 0.46999999999999997 111.515 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' CYS . . . . . 0.515 ' SG ' HG12 ' B' ' 45' ' ' VAL . 62.7 m -119.07 104.2 10.25 Favored 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.767 1.227 . . . . 0.46999999999999997 111.429 179.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' LEU . . . . . . . . . . . . . 94.6 mt -82.34 -33.39 28.93 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 114.641 -1.163 . . . . 0.57999999999999996 113.706 175.214 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' GLN . . . . . . . . . . . . . 9.1 pm0 -111.73 -178.73 3.51 Favored 'General case' 0 C--N 1.315 -0.902 0 C-N-CA 124.85 1.26 . . . . 0.57999999999999996 110.092 -179.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' THR . . . . . 0.538 ' OG1' ' HB2' ' B' ' 57' ' ' ASP . 13.7 t -128.78 -171.66 2.53 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 113.808 -1.542 . . . . 0.59999999999999998 111.334 178.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' THR . . . . . 0.605 HG21 HD12 ' B' ' 54' ' ' ILE . 86.4 m -157.82 152.29 24.83 Favored 'General case' 0 CA--C 1.54 0.578 0 C-N-CA 125.761 1.624 . . . . 0.57999999999999996 110.19 -179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' GLN . . . . . . . . . . . . . 6.4 pm0 -128.2 72.23 1.41 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 123.657 1.694 . . . . 0.72999999999999998 112.067 177.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.582 ' CA ' ' HB ' ' B' ' 22' ' ' VAL . . . -84.2 -177.25 51.34 Favored Glycine 0 CA--C 1.544 1.849 0 CA-C-N 113.287 -1.779 . . . . 0.64000000000000001 110.815 174.53 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' VAL . . . . . 0.733 HG22 ' H ' ' B' ' 23' ' ' HIS . 9.1 p 138.02 -172.4 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.794 1 C-N-CA 136.157 5.783 . . . . 0.64000000000000001 106.292 8.158 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' HIS . . . . . 0.733 ' H ' HG22 ' B' ' 22' ' ' VAL . 66.2 t-80 -117.58 143.32 32.03 Favored Pre-proline 0 CA--C 1.543 0.687 0 O-C-N 121.874 -0.516 . . . . 0.68000000000000005 110.074 174.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' PRO . . . . . 0.541 ' HB3' HG23 ' B' ' 70' ' ' ILE . 88.5 Cg_exo -51.14 -22.04 10.3 Favored 'Trans proline' 0 N--CA 1.477 0.542 0 C-N-CA 124.88 3.72 . . . . 0.58999999999999997 112.754 174.12 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.592 ' HB2' ' ND1' ' B' ' 23' ' ' HIS . 1.0 OUTLIER -51.77 -30.84 24.42 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.661 1.184 . . . . 0.68999999999999995 112.574 179.741 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' MET . . . . . . . . . . . . . 36.4 mmt -88.45 -18.41 28.33 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-O 120.854 0.359 . . . . 0.94999999999999996 111.492 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' ILE . . . . . . . . . . . . . 24.3 mm -89.62 150.75 3.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.172 -0.467 . . . . 0.57999999999999996 111.234 -179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' SER . . . . . . . . . . . . . 63.3 m -138.82 -22.9 0.95 Allowed 'General case' 0 C--O 1.234 0.24 0 CA-C-N 116.422 -0.353 . . . . 0.69999999999999996 110.943 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' ASN . . . . . 0.532 ' HA ' ' O ' ' A' ' 32' ' ' VAL . 9.6 t30 -137.51 139.55 40.59 Favored 'General case' 0 N--CA 1.463 0.177 0 CA-C-N 116.296 -0.411 . . . . 0.82999999999999996 111.088 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 31' ' ' GLN . 15.2 tp -126.78 141.69 51.76 Favored 'General case' 0 C--O 1.226 -0.138 0 CA-C-N 116.301 -0.409 . . . . 0.75 111.024 179.516 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLN . . . . . 0.441 ' HG2' ' HG2' ' A' ' 31' ' ' GLN . 45.1 mt-30 -127.89 124.08 36.55 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.251 -0.431 . . . . 1.0800000000000001 110.496 179.255 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' VAL . . . . . 0.544 ' O ' ' HA ' ' A' ' 29' ' ' ASN . 15.7 t -104.24 105.16 17.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.282 -0.417 . . . . 0.60999999999999999 110.733 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' PHE . . . . . . . . . . . . . 39.6 m-85 -102.52 122.56 44.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.131 -0.486 . . . . 0.85999999999999999 111.001 -179.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -87.7 -146.36 0.14 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 111.546 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' ILE . . . . . 0.468 HG23 ' HA ' ' B' ' 40' ' ' SER . 90.3 mt -86.37 123.31 39.57 Favored 'Isoleucine or valine' 0 C--O 1.233 0.226 0 CA-C-N 116.352 -0.386 . . . . 1.1000000000000001 111.052 -179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' GLY . . . . . . . . . . . . . . . -122.6 -167.06 12.88 Favored Glycine 0 CA--C 1.52 0.389 0 C-N-CA 121.046 -0.597 . . . . 0.63 112.625 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -78.69 -7.36 15.65 Favored 'Trans proline' 0 C--N 1.349 0.564 0 C-N-CA 123.259 2.639 . . . . 0.79000000000000004 112.888 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -112.17 -20.69 11.8 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 113.173 0.805 . . . . 0.70999999999999996 113.173 -179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' CYS . . . . . . . . . . . . . 4.7 t -142.36 140.13 31.98 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.411 -0.359 . . . . 0.67000000000000004 111.16 -177.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' SER . . . . . 0.468 ' HA ' HG23 ' B' ' 35' ' ' ILE . 8.6 t -111.67 25.61 11.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.082 0.468 . . . . 1.01 110.61 179.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -135.73 142.02 44.95 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.949 -0.569 . . . . 1.1599999999999999 110.519 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 17.3 m -77.73 127.65 38.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.215 0 CA-C-O 121.031 0.443 . . . . 0.78000000000000003 110.61 179.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' GLU . . . . . . . . . . . . . 37.2 mt-10 -133.64 137.73 45.54 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.159 -0.473 . . . . 0.80000000000000004 110.753 -179.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' VAL . . . . . . . . . . . . . 1.7 m -108.1 110.42 31.87 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.212 0 CA-C-O 121.631 0.729 . . . . 0.59999999999999998 111.885 -179.556 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' VAL . . . . . 0.515 HG12 ' SG ' ' B' ' 15' ' ' CYS . 2.0 m -99.08 150.41 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.995 0 CA-C-O 122.493 1.14 . . . . 0.62 110.849 179.134 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' ALA . . . . . . . . . . . . . . . -140.17 153.46 46.63 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-N 115.215 -0.902 . . . . 0.55000000000000004 111.191 179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 47' ' ' SER . . . . . . . . . . . . . 20.7 m -123.82 132.69 53.82 Favored 'General case' 0 N--CA 1.476 0.83 0 CA-C-N 115.1 -0.955 . . . . 0.63 110.448 176.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 48' ' ' LEU . . . . . . . . . . . . . 6.8 mp -81.91 174.24 11.47 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.158 -0.928 . . . . 0.75 110.871 179.911 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -79.27 -17.03 55.48 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 1.27 110.808 179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 80.8 m-20 -81.61 -11.17 59.22 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.059 -0.519 . . . . 0.98999999999999999 111.236 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.67 37.01 4.87 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.884 -0.674 . . . . 0.67000000000000004 112.334 -179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 52' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -117.33 154.1 31.85 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.714 0.292 . . . . 1.05 110.684 -179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 53' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -135.7 129.59 32.93 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-O 121.416 0.627 . . . . 0.70999999999999996 109.945 179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 54' ' ' ILE . . . . . 0.605 HD12 HG21 ' B' ' 19' ' ' THR . 49.8 pt -127.85 179.64 3.59 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.018 0 CA-C-N 114.674 -1.148 . . . . 0.52000000000000002 109.869 178.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 55' ' ' CYS . . . . . . . . . . . . . 96.2 m -127.38 138.04 52.91 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.546 -1.206 . . . . 0.47999999999999998 109.339 177.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 56' ' ' LEU . . . . . 0.716 ' HB3' HD21 ' B' ' 63' ' ' LEU . 39.9 mt -113.91 153.61 28.95 Favored 'General case' 0 C--N 1.313 -1.003 0 CA-C-N 114.084 -1.416 . . . . 0.48999999999999999 108.737 -178.571 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 57' ' ' ASP . . . . . 0.538 ' HB2' ' OG1' ' B' ' 18' ' ' THR . 1.1 t0 -101.37 111.96 64.43 Favored Pre-proline 0 C--N 1.325 -0.464 0 O-C-N 121.442 -0.786 . . . . 0.63 110.246 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 58' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_exo -60.06 -15.69 35.09 Favored 'Trans proline' 0 C--N 1.359 1.083 0 C-N-CA 123.069 2.512 . . . . 0.82999999999999996 111.923 -179.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 59' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -65.87 -16.6 63.98 Favored 'General case' 0 CA--C 1.546 0.79 0 CA-C-N 114.722 -1.126 . . . . 1.3999999999999999 113.488 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 60' ' ' ALA . . . . . 0.652 ' HB1' ' CE2' ' B' ' 62' ' ' PHE . . . -100.42 135.11 20.3 Favored Pre-proline 0 CA--C 1.54 0.561 0 O-C-N 122.286 -0.259 . . . . 0.91000000000000003 110.731 -179.009 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 61' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -65.37 -41.78 14.85 Favored 'Trans proline' 0 CA--C 1.536 0.595 0 C-N-CA 123.565 2.843 . . . . 1.1899999999999999 113.412 -178.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 62' ' ' PHE . . . . . 0.652 ' CE2' ' HB1' ' B' ' 60' ' ' ALA . 53.1 p90 -60.73 -25.49 66.5 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.388 0.613 . . . . 1.1499999999999999 111.846 176.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 63' ' ' LEU . . . . . 0.716 HD21 ' HB3' ' B' ' 56' ' ' LEU . 0.3 OUTLIER -73.48 -31.9 64.01 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.397 -0.819 . . . . 0.90000000000000002 110.55 178.2 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 64' ' ' LYS . . . . . 0.4 ' HA ' HG12 ' B' ' 67' ' ' ILE . 26.3 ttpt -77.13 -14.7 59.76 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-O 121.365 0.602 . . . . 1.71 110.625 179.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 65' ' ' LYS . . . . . . . . . . . . . 30.5 mtpp -79.93 -55.32 5.05 Favored 'General case' 0 N--CA 1.472 0.631 0 N-CA-C 113.156 0.798 . . . . 1.3600000000000001 113.156 179.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 66' ' ' VAL . . . . . . . . . . . . . 33.8 m -60.67 -27.53 40.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.431 0 CA-C-N 115.06 -0.973 . . . . 0.96999999999999997 111.47 178.516 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 67' ' ' ILE . . . . . 0.4 HG12 ' HA ' ' B' ' 64' ' ' LYS . 48.4 pt -79.77 -25.68 12.19 Favored 'Isoleucine or valine' 0 C--N 1.344 0.332 0 C-N-CA 120.861 -0.335 . . . . 1.0800000000000001 110.158 178.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 68' ' ' GLN . . . . . . . . . . . . . 64.8 tt0 -72.86 -42.88 63.22 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 120.763 -0.375 . . . . 1.52 110.444 176.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 69' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -60.57 -32.51 71.59 Favored 'General case' 0 CA--C 1.535 0.387 0 N-CA-C 113.406 0.891 . . . . 1.6100000000000001 113.406 -179.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 70' ' ' ILE . . . . . 0.541 HG23 ' HB3' ' B' ' 24' ' ' PRO . 9.4 pt -74.96 -12.86 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.493 0 CA-C-N 118.068 0.395 . . . . 1.4299999999999999 111.603 -179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 71' ' ' LEU . . . . . . . . . . . . . 39.7 mt -94.3 -31.24 14.14 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.289 -0.414 . . . . 1.79 110.532 179.481 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 72' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -84.06 -41.3 17.33 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 116.065 -0.516 . . . . 2.25 110.318 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 73' ' ' GLY . . . . . . . . . . . . . . . -75.35 -28.53 61.64 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 121.054 -0.593 . . . . 1.76 112.03 179.466 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 74' ' ' GLY . . . . . . . . . . . . . . . -92.86 42.4 2.65 Favored Glycine 0 C--N 1.332 0.351 0 C-N-CA 121.089 -0.577 . . . . 2.04 111.982 179.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 75' ' ' ASN . . . . . . . . . . . . . 65.5 t30 -152.39 -28.56 0.16 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.953 0.406 . . . . 2.3199999999999998 110.129 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 76' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -84.34 -26.51 28.39 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 115.873 -0.603 . . . . 2.46 111.067 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 77' ' ' GLU . . . . . . . . . . . . . 20.4 mm-40 -62.82 135.54 57.39 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.313 -0.403 . . . . 2.7799999999999998 111.32 -179.764 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 78' ' ' ASN . . . . . . . . . . . . . 16.3 m120 . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.262 -0.875 . . . . 2.48 110.939 -179.88 . . . . . . . . 0 0 . 1 stop_ save_